Browse by UCL people
Group by: Type | Date
Number of items: 1521.
2025
Ahn, Jehyun;
Lee, Eun Hye;
Yoo, Heejin;
Shin, Daeun;
Kang, Heekyoung;
Yim, Sohyun;
Kim, Seongmi;
... K-ROAD study group; + view all
(2025)
Tailoring thresholds for interpreting plasma p-tau217 levels.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2025-335830.
|
|
Ao, Jiarui;
Picard, Cynthia;
Auld, Daniel;
Zetterberg, Henrik;
Brinkmalm, Ann;
Blennow, Kaj;
Villeneuve, Sylvia;
... PREVENT-AD research group; + view all
(2025)
Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease.
Molecular Psychiatry
, 30
pp. 2810-2820.
10.1038/s41380-024-02884-z.
|
|
Belder, Christopher RS;
Boche, Delphine;
Nicoll, James AR;
Jaunmuktane, Zane;
Zetterberg, Henrik;
Schott, Jonathan M;
Barkhof, Frederik;
(2025)
Amyloid-related iatrogenic atrophy of the brain: data transparency is an urgent safety priority – Authors' reply.
The Lancet Neurology
, 24
(3)
p. 190.
10.1016/S1474-4422(25)00030-4.
|
|
Cacciaglia, R;
Falcón, C;
Benavides, GS;
Brugulat-Serrat, A;
Alomà, MM;
Calvet, MS;
Molinuevo, JL;
... The ALFA study; + view all
(2025)
Soluble Aβ pathology predicts neurodegeneration and cognitive decline independently on p-tau in the earliest Alzheimer's continuum: Evidence across two independent cohorts.
Alzheimer's and Dementia
, Article e14415. 10.1002/alz.14415.
(In press).
|
|
Carrol, D;
Busse, WW;
Frye, CJ;
Klaus, DR;
Bach, JC;
Floerke, H;
Bendlin, BB;
... Rosenkranz, MA; + view all
(2025)
Regional brain structural alterations in reward and salience networks in asthma.
Brain, Behavior, and Immunity
, 126
pp. 80-97.
10.1016/j.bbi.2025.01.028.
|
|
De Strooper, Bart;
Haass, Christian;
Hardy, John;
Zetterberg, Henrik;
(2025)
The regulatory rollercoaster continues—EMA refuses donanemab.
The Lancet
, 405
(10492)
pp. 1810-1812.
10.1016/S0140-6736(25)00833-5.
|
|
Delvenne, Aurore;
Gobom, Johan;
Reus, Lianne M;
Dobricic, Valerija;
Ten Kate, Mara;
Schindler, Suzanne E;
Ramakers, Inez;
... Vos, Stephanie JB; + view all
(2025)
Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology.
Brain Communications
, 7
(4)
, Article fcaf253. 10.1093/braincomms/fcaf253.
|
|
Eratne, Dhamidhu;
Li, Qiao-Xin;
Lewis, Courtney;
Dang, Christa;
Kang, Matthew JY;
Grewal, Jasleen;
Loi, Samantha;
... MiND Study Group; + view all
(2025)
Strong diagnostic performance of plasma ptau217 for CSF biomarker-defined young-onset Alzheimer disease in a diagnostically heterogeneous clinical cohort.
Journal of Neurology
, 272
, Article 25. 10.1007/s00415-024-12732-3.
|
|
Gogniat, Marissa A;
Khan, Omair A;
Ratangee, Brina;
Bolton, Corey J;
Zhang, Panpan;
Liu, Dandan;
Pechman, Kimberly R;
... Jefferson, Angela L; + view all
(2025)
Cross-Sectional and Longitudinal Associations of Neighborhood Disadvantage With Fluid Biomarkers of Neuroinflammation and Neurodegeneration.
Neurology
, 105
(2)
, Article e213770. 10.1212/WNL.0000000000213770.
|
|
Heneka, Michael T;
Van der Flier, Wiesje M;
Jessen, Frank;
Hoozemanns, Jeroen;
Thal, Dietmar Rudolf;
Boche, Delphine;
Brosseron, Frederic;
... Riechers, Sean-Patrick; + view all
(2025)
Neuroinflammation in Alzheimer disease.
Nature Reviews Immunology
, 25
pp. 321-352.
10.1038/s41577-024-01104-7.
|
|
Knorr, Ulla;
Simonsen, Anja Hviid;
Nilsson, Johanna;
Brinkmalm, Ann;
Zetterberg, Henrik;
Blennow, Kaj;
Knudsen, Mark Bech;
... Kessing, Lars Vedel; + view all
(2025)
Associations between cerebrospinal fluid synaptic protein biomarkers and cognitive function in bipolar disorder.
Journal of Psychiatric Research
, 184
pp. 288-296.
10.1016/j.jpsychires.2025.03.005.
|
|
Kodosaki, E;
Zetterberg, H;
Heslegrave, A;
(2025)
Current Methods in Clinical Alzheimer’s Disease Research and Diagnosis.
Molecular Diagnosis and Therapy
10.1007/s40291-025-00789-3.
(In press).
|
|
Leuzy, Antoine;
Bollack, Ariane;
Pellegrino, Daniela;
Teunissen, Charlotte E;
La Joie, Renaud;
Rabinovici, Gil D;
Franzmeier, Nicolai;
... Farrar, Gill; + view all
(2025)
Considerations in the clinical use of amyloid PET and CSF biomarkers for Alzheimer's disease.
Alzheimer's & Dementia
, 21
(3)
, Article e14528. 10.1002/alz.14528.
|
 |
|
Liu, Ella;
Jones, Sherri Lee;
Light, Victoria;
Teunissen, Charlotte;
Bouzigues, Arabella;
Russell, Lucy L;
Foster, Phoebe H;
... Ducharme, Simon; + view all
(2025)
Accuracy of blood-based neurofilament light to different genetic frontotemporal dementia from primary psychiatric disorders.
Journal of Alzheimer’s Disease
, 106
(4)
pp. 1337-1354.
10.1177/13872877251352103.
|
 |
|
Ly, Monica T;
Altaras, Caroline;
Tripodis, Yorghos;
Adler, Charles H;
Balcer, Laura J;
Bernick, Charles;
Zetterberg, Henrik;
... Alosco, Michael L; + view all
(2025)
Single- versus two-test criteria for cognitive impairment: associations with CSF and imaging markers in former American football players.
The Clinical Neuropsychologist
10.1080/13854046.2025.2451828.
(In press).
|
|
Michaëlsson, Isak;
Hallén, Tobias;
Farahmand, Dan;
Mahamud, Ubah;
Blennow, Kaj;
Zetterberg, Henrik;
Jakola, Asgeir S;
(2025)
Assessing Brain Injury After Extra-Axial Brain Tumor Resection: Circulating Neurofilament Light Levels, Neurological Deficits, and Fatigue.
Neurosurgery
10.1227/neu.0000000000003612.
(In press).
|
|
Mossavar-Rahmani, Y;
Hyun, N;
Hakun, JG;
Katz, MJ;
Pavlovic, JM;
Zetterberg, H;
Wang, Z;
... Shaw, PA; + view all
(2025)
The effects of the Multicultural Healthy Diet on cognitive decline and Alzheimer's disease risk: a phase II randomized controlled trial in middle-aged adults.
The American Journal of Clinical Nutrition
, 122
(1)
pp. 48-59.
10.1016/j.ajcnut.2025.05.011.
|
|
Pilotto, Andrea;
Quaresima, Virginia;
Trasciatti, Chiara;
Tolassi, Chiara;
Bertoli, Diego;
Mordenti, Cristina;
Galli, Alice;
... Padovani, Alessandro; + view all
(2025)
Plasma p-tau217 in Alzheimer’s disease: Lumipulse and ALZpath SIMOA head-to-head comparison.
Brain
, 148
(2)
pp. 408-415.
10.1093/brain/awae368.
|
|
Pussinen, Christel;
Anttonen, Mikko;
Wihersaari, Lauri;
Tiainen, Marjaana;
Reinikainen, Matti;
Hästbacka, Johanna;
Zetterberg, Henrik;
... Skrifvars, Markus B; + view all
(2025)
Neurofilament light chain evaluated with a new automated commercially available method for outcome prediction in out-of-hospital cardiac arrest patients.
Resuscitation
, 215
, Article 110698. 10.1016/j.resuscitation.2025.110698.
|
|
Sanchez, Erlan;
Coughlan, Gillian T;
Wilkinson, Tim;
Ramirez, Joel;
Mirza, Saira Saeed;
Baril, Andrée-Ann;
Dilliott, Allison A;
... ONDRI Investigators; + view all
(2025)
Association of Plasma Biomarkers With Longitudinal Atrophy and Microvascular Burden on MRI Across Neurodegenerative and Cerebrovascular Diseases.
Neurology
, 104
(7)
, Article e213438. 10.1212/WNL.0000000000213438.
|
|
Sanfilippo, Cristina;
Castrogiovanni, Paola;
Imbesi, Rosa;
Vecchio, Michele;
Vinciguerra, Manlio;
Blennow, Kaj;
Zetterberg, Henrik;
(2025)
Sex-specific modulation of FOLR1 and its cycle enzyme genes in Alzheimer’s disease brain regions.
Metabolic Brain Disease
, 40
(4)
, Article 163. 10.1007/s11011-025-01578-x.
|
|
Scahill, Rachael I;
Farag, Mena;
Murphy, Michael J;
Hobbs, Nicola Z;
Leocadi, Michela;
Langley, Christelle;
Knights, Harry;
... Tabrizi, Sarah J; + view all
(2025)
Somatic CAG repeat expansion in blood associates with biomarkers of neurodegeneration in Huntington's disease decades before clinical motor diagnosis.
Nature Medicine
10.1038/s41591-024-03424-6.
(In press).
|
|
|
Selma-Gonzalez, Judit;
Rubio-Guerra, Sara;
García-Castro, Jesús;
Vera-Campuzano, Elena;
Sala, Isabel;
Sánchez-Saudinós, María Belén;
Zhu, Nuole;
... Illan-Gala, Ignacio; + view all
(2025)
Association of Plasma Phosphorylated Tau 217 With Clinical Deterioration Across Alzheimer Disease Stages.
Neurology
, 105
(1)
, Article e213769. 10.1212/WNL.0000000000213769.
|
|
Sogorb-Esteve, Aitana;
Weiner, Sophia;
Simrén, Joel;
Swift, Imogen J;
Bocchetta, Martina;
Todd, Emily G;
Cash, David M;
... GENFI; + view all
(2025)
Proteomic analysis reveals distinct cerebrospinal fluid signatures across genetic frontotemporal dementia subtypes.
Science Translational Medicine
, 17
(784)
, Article eadm9654. 10.1126/scitranslmed.adm9654.
|
|
|
Terracciano, Antonio;
Walker, Keenan A;
An, Yang;
Bilgel, Murat;
Sutin, Angelina R;
Luchetti, Martina;
Karakose, Selin;
... Resnick, Susan M; + view all
(2025)
Loneliness and biomarkers of Alzheimer's disease, axonal damage, and astrogliosis: A coordinated analysis of two longitudinal cohorts.
The Journals of Gerontology, Series B: Psychological Sciences and Social Sciences
, Article gbaf006. 10.1093/geronb/gbaf006.
(In press).
|
|
Therriault, J;
Brum, WS;
Trudel, L;
Macedo, AC;
Bitencourt, FV;
Martins-Pfeifer, CC;
Nakouzi, M;
... Rosa-Neto, P; + view all
(2025)
Blood phosphorylated tau for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
Lancet Neurology
, 24
(9)
pp. 740-752.
10.1016/S1474-4422(25)00227-3.
|
|
Wiels, WA;
Oomens, JE;
Engelborghs, S;
Baeken, C;
Von Arnim, CAF;
Boada, M;
Didic, M;
... Ramakers, IH; + view all
(2025)
Depressive Symptoms and Amyloid Pathology.
JAMA Psychiatry
, 82
(3)
pp. 296-310.
10.1001/jamapsychiatry.2024.4305.
|
|
Yun, Jihwan;
Shin, Daeun;
Lee, Eun Hye;
Kim, Jun Pyo;
Ham, Hongki;
Gu, Yuna;
Chun, Min Young;
... Jang, Hyemin; + view all
(2025)
Temporal Dynamics and Biological Variability of Alzheimer Biomarkers.
JAMA Neurology
, 82
(4)
pp. 384-396.
10.1001/jamaneurol.2024.5263.
|
|
Zhang, Jingwei;
Wang, Zicong;
Liu, Yuan;
Zetterberg, Henrik;
Li, Lingjun;
(2025)
Boosting Quantification of N-Glycans by an Enhanced Isobaric Multiplex Reagents for Carbonyl-Containing Compound (SUGAR) Tagging Strategy.
Journal of the American Society for Mass Spectrometry
, Article jasms.5c00153. 10.1021/jasms.5c00153.
|
2024
|
Alagaratnam, J;
Stöhr, W;
Hamlyn, E;
Porter, K;
Toombs, J;
Heslegrave, A;
Zetterberg, H;
... Fidler, S; + view all
(2024)
Impact of interrupting antiretroviral therapy started during primary HIV-1 infection on plasma neurofilament light chain protein, a marker of neuronal injury: The SPARTAC trial.
Journal of Virus Eradication
, 10
(2)
, Article 100381. 10.1016/j.jve.2024.100381.
|
|
Ashton, Nicholas J;
Brum, Wagner S;
Di Molfetta, Guglielmo;
Benedet, Andrea L;
Arslan, Burak;
Jonaitis, Erin;
Langhough, Rebecca E;
... Zetterberg, Henrik; + view all
(2024)
Diagnostic Accuracy of a Plasma Phosphorylated Tau 217 Immunoassay for Alzheimer Disease Pathology.
JAMA Neurology
10.1001/jamaneurol.2023.5319.
(In press).
|
|
|
Ashton, Nicholas J;
Di Molfetta, Guglielmo;
Tan, Kübra;
Blennow, Kaj;
Zetterberg, Henrik;
Messing, Albee;
(2024)
Plasma concentrations of glial fibrillary acidic protein, neurofilament light, and tau in Alexander disease.
Neurological Sciences
10.1007/s10072-024-07495-8.
(In press).
|
|
Bastgen, T;
Evers, J;
Oedekoven, C;
Weide, C;
Herzog, L;
Ashton, N;
Zetterberg, H;
... Ross, JA; + view all
(2024)
Repetitive head injuries in German American football players do not change blood-based biomarker candidates for CTE during a single season.
Neurological Research and Practice
, 6
(1)
, Article 13. 10.1186/s42466-024-00307-6.
|
|
Bavato, Francesco;
Barro, Christian;
Schnider, Laura K;
Simrén, Joel;
Zetterberg, Henrik;
Seifritz, Erich;
Quednow, Boris B;
(2024)
Introducing neurofilament light chain measure in psychiatry: current evidence, opportunities, and pitfalls.
Molecular Psychiatry
10.1038/s41380-024-02524-6.
(In press).
|
|
Belder, CRS;
Boche, D;
Nicoll, JAR;
Jaunmuktane, Z;
Zetterberg, H;
Schott, JM;
Barkhof, F;
(2024)
Brain volume change following anti-amyloid β immunotherapy for Alzheimer's disease: amyloid-removal-related pseudo-atrophy.
The Lancet Neurology
, 23
(10)
pp. 1025-1034.
10.1016/S1474-4422(24)00335-1.
|
|
Bieger, Andrei;
Brum, Wagner S;
Borelli, Wyllians V;
Therriault, Joseph;
De Bastiani, Marco A;
Moreira, Amanda G;
Benedet, Andrea L;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2024)
Influence of Different Diagnostic Criteria on Alzheimer Disease Clinical Research.
Neurology
, 103
(5)
, Article e209753. 10.1212/WNL.0000000000209753.
|
|
Bjursten, Sara;
Zhao, Zhiyuan;
Al Remawi, Hifaa;
Studahl, Marie;
Pandita, Ankur;
Simrén, Joel;
Zetterberg, Henrik;
... Levin, Max; + view all
(2024)
Concentrations of S100B and neurofilament light chain in blood as biomarkers for checkpoint inhibitor–induced CNS inflammation.
eBioMedicine
, 100
, Article 104955. 10.1016/j.ebiom.2023.104955.
|
|
|
Brum, Wagner S;
Cullen, Nicholas C;
Therriault, Joseph;
Janelidze, Shorena;
Rahmouni, Nesrine;
Stevenson, Jenna;
Servaes, Stijn;
... Hansson, Oskar; + view all
(2024)
A blood-based biomarker workflow for optimal tau-PET referral in memory clinic settings.
Nature Communications
, 15
(1)
, Article 2311. 10.1038/s41467-024-46603-2.
|
|
Chong, JR;
Chai, YL;
Yam, ATY;
Hilal, S;
Vrooman, H;
Venketasubramanian, N;
Blennow, K;
... Lai, MKP; + view all
(2024)
Association of plasma GFAP with elevated brain amyloid is dependent on severity of white matter lesions in an Asian cognitively impaired cohort.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 16
(2)
, Article e12576. 10.1002/dad2.12576.
|
|
Cook, N;
Driscoll, I;
Gaitán, JM;
Glittenberg, M;
Betthauser, TJ;
Carlsson, CM;
Johnson, SC;
... Okonkwo, OC; + view all
(2024)
Amyloid-β positivity is less prevalent in cognitively unimpaired KLOTHO KL-VS heterozygotes.
Journal of Alzheimer’s Disease
, 102
(2)
pp. 480-490.
10.1177/13872877241289785.
|
|
De Strooper, Bart;
Haass, Christian;
Hardy, John;
Zetterberg, Henrik;
(2024)
Divisions over the regulation of lecanemab.
The Lancet
, 404
(10468)
pp. 2160-2161.
10.1016/S0140-6736(24)02513-3.
|
|
Dittrich, Anna;
Westman, Eric;
Shams, Sara;
Skillbäck, Tobias;
Zetterberg, Henrik;
Blennow, Kaj;
Zettergren, Anna;
... Kern, Silke; + view all
(2024)
Proportion of Community-Dwelling Individuals Older Than 70 Years Eligible for Lecanemab Initiation: The Gothenburg H70 Birth Cohort Study.
Neurology
, 102
(9)
, Article e209402. 10.1212/WNL.0000000000209402.
|
|
Emeršič, Andreja;
Karikari, Thomas K;
Kac, Przemysław R;
Gonzalez-Ortiz, Fernando;
Dulewicz, Maciej;
Ashton, Nicholas J;
Brecl Jakob, Gregor;
... Blennow, Kaj; + view all
(2024)
Biomarkers of tau phosphorylation state are associated with the clinical course of multiple sclerosis.
Multiple Sclerosis and Related Disorders
, 90
, Article 105801. 10.1016/j.msard.2024.105801.
|
|
Ferrari-Souza, JP;
Brum, WS;
Hauschild, LA;
Da Ros, LU;
Ferreira, PCL;
Bellaver, B;
Leffa, DT;
... Zimmer, ER; + view all
(2024)
Vascular risk burden is a key player in the early progression of Alzheimer's disease.
Neurobiology of Aging
, 136
pp. 88-98.
10.1016/j.neurobiolaging.2023.12.008.
|
|
Frank, Brandon;
Walsh, Michael;
Hurley, Landon;
Groh, Jenna;
Blennow, Kaj;
Zetterberg, Henrik;
Tripodis, Yorghos;
... Alosco, Michael L; + view all
(2024)
Cognition Mediates the Association Between Cerebrospinal Fluid Biomarkers of Amyloid and P-Tau and Neuropsychiatric Symptoms.
Journal of Alzheimer's Disease
, 100
(3)
pp. 1055-1073.
10.3233/JAD-240125.
|
|
Franzmeier, Nicolai;
Dehsarvi, Amir;
Steward, Anna;
Biel, Davina;
Dewenter, Anna;
Roemer, Sebastian Niclas;
Wagner, Fabian;
... Schöll, Michael; + view all
(2024)
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer's disease.
Nature Communications
, 15
(1)
, Article 202. 10.1038/s41467-023-44374-w.
|
|
Friberg, Susanna;
Lindblad, Caroline;
Zeiler, Frederick A;
Zetterberg, Henrik;
Granberg, Tobias;
Svenningsson, Per;
Piehl, Fredrik;
(2024)
Fluid biomarkers of chronic traumatic brain injury.
Nature Reviews Neurology
, 20
pp. 671-684.
10.1038/s41582-024-01024-z.
|
|
Garcia-Cordero, Indira;
Vasilevskaya, Anna;
Taghdiri, Foad;
Khodadadi, Mozhgan;
Mikulis, David;
Tarazi, Apameh;
Mushtaque, Asma;
... Tartaglia, Maria C; + view all
(2024)
Functional connectivity changes in neurodegenerative biomarker-positive athletes with repeated concussions.
Journal of Neurology
, 271
pp. 4180-4190.
10.1007/s00415-024-12340-1.
|
|
Gobom, Johan;
Brinkmalm, Ann;
Brinkmalm, Gunnar;
Blennow, Kaj;
Zetterberg, Henrik;
(2024)
Alzheimer's disease biomarker analysis using targeted mass spectrometry.
Molecular & Cellular Proteomics
, 23
(2)
, Article 100721. 10.1016/j.mcpro.2024.100721.
|
|
Gómez-Pascual, A;
Naccache, T;
Xu, J;
Hooshmand, K;
Wretlind, A;
Gabrielli, M;
Lombardo, MT;
... Legido-Quigley, C; + view all
(2024)
Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.
Computers in Biology and Medicine
, 176
, Article 108588. 10.1016/j.compbiomed.2024.108588.
|
|
Gonzalez-Ortiz, Fernando;
Kirsebom, Bjørn-Eivind;
Contador, José;
Tanley, Jordan E;
Selnes, Per;
Gísladóttir, Berglind;
Pålhaugen, Lene;
... Blennow, Kaj; + view all
(2024)
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer’s disease.
Nature Communications
, 15
, Article 2908. 10.1038/s41467-024-47286-5.
|
|
Gustafsson, Johan;
Robinson, Jonathan L;
Zetterberg, Henrik;
Nielsen, Jens;
(2024)
Brain energy metabolism is optimized to minimize the cost of enzyme synthesis and transport.
Proceedings of the National Academy of Sciences (PNAS)
, 121
(7)
, Article e2305035121. 10.1073/pnas.2305035121.
|
|
|
Hale, MR;
Langhough, R;
Du, L;
Hermann, BP;
Van Hulle, CA;
Carboni, M;
Kollmorgen, G;
... Mueller, KD; + view all
(2024)
Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment.
Neurobiology of Aging
, 133
pp. 87-98.
10.1016/j.neurobiolaging.2023.09.018.
|
|
Jha, D;
Blennow, K;
Zetterberg, H;
Savas, JN;
Hanrieder, J;
(2024)
Spatial neurolipidomics—MALDI mass spectrometry imaging of lipids in brain pathologies.
Journal of Mass Spectrometry
, 59
(3)
, Article e5008. 10.1002/jms.5008.
|
|
Kac, Przemysław R;
González-Ortiz, Fernando;
Emeršič, Andreja;
Dulewicz, Maciej;
Koutarapu, Srinivas;
Turton, Michael;
An, Yang;
... Karikari, Thomas K; + view all
(2024)
Plasma p-tau212 antemortem diagnostic performance and prediction of autopsy verification of Alzheimer's disease neuropathology.
Nature Communications
, 15
(1)
, Article 2615. 10.1038/s41467-024-46876-7.
|
|
Kalaria, R;
Maestre, G;
Mahinrad, S;
Acosta, DM;
Akinyemi, RO;
Alladi, S;
Allegri, RF;
... Ismail, O; + view all
(2024)
The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact.
Alzheimer's and Dementia
10.1002/alz.13836.
(In press).
|
|
|
Khalil, Michael;
Teunissen, Charlotte E;
Lehmann, Sylvain;
Otto, Markus;
Piehl, Fredrik;
Ziemssen, Tjalf;
Bittner, Stefan;
... Kuhle, Jens; + view all
(2024)
Neurofilaments as biomarkers in neurological disorders - towards clinical application.
Nature Reviews Neurology
, 20
(5)
pp. 269-287.
10.1038/s41582-024-00955-x.
|
|
Leckey, Claire A;
Coulton, John B;
Giovannucci, Tatiana A;
He, Yingxin;
Aslanyan, Aram;
Laban, Rhiannon;
Heslegrave, Amanda;
... Paterson, Ross W; + view all
(2024)
Cerebrospinal fluid neurofilament light chain profiling and quantitation in neurological diseases.
Brain Communications
, 6
(3)
, Article fcae132. 10.1093/braincomms/fcae132.
|
|
|
Li, Ge;
Iliff, Jeffrey;
Shofer, Jane;
Mayer, Cynthia L;
Meabon, James;
Cook, David;
Pagulayan, Kathleen F;
... Peskind, Elaine R; + view all
(2024)
CSF β-Amyloid and Tau Biomarker Changes in Veterans With Mild Traumatic Brain Injury.
Neurology
, 102
(7)
, Article e209197. 10.1212/WNL.0000000000209197.
|
|
Linnemann, Christoph;
Wilke, Carlo;
Mengel, David;
Zetterberg, Henrik;
Heller, Carolin;
Kuhle, Jens;
Bouzigues, Arabella;
... Synofzik, Matthis; + view all
(2024)
NfL reliability across laboratories, stage-dependent diagnostic performance and matrix comparability in genetic FTD: a large GENFI study.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2023-332464.
(In press).
|
|
Lista, Simone;
Santos-Lozano, Alejandro;
Emanuele, Enzo;
Mercuri, Nicola B;
Gabelle, Audrey;
López-Ortiz, Susana;
Martín-Hernández, Juan;
... Nisticò, Robert; + view all
(2024)
Monitoring synaptic pathology in Alzheimer's disease through fluid and PET imaging biomarkers: a comprehensive review and future perspectives.
Molecular Psychiatry
, 29
pp. 847-857.
10.1038/s41380-023-02376-6.
|
|
Ly, Monica T;
Tuz-Zahra, Fatima;
Tripodis, Yorghos;
Adler, Charles H;
Balcer, Laura J;
Bernick, Charles;
Zetterberg, Henrik;
... Alosco, Michael L; + view all
(2024)
Association of Vascular Risk Factors and CSF and Imaging Biomarkers With White Matter Hyperintensities in Former American Football Players.
Neurology
, 102
(2)
, Article e208030. 10.1212/wnl.0000000000208030.
|
|
Ma, Y;
Farris, CM;
Weber, S;
Schade, S;
Nguyen, H;
Pérez-Soriano, A;
Giraldo, DM;
... Concha-Marambio, L; + view all
(2024)
Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study.
The Lancet Neurology
, 23
(12)
pp. 1225-1237.
10.1016/S1474-4422(24)00395-8.
|
|
Malzbender, K;
Barbarino, P;
Ferrell, P Barkman;
Bradshaw, A;
Brookes, AJ;
Diaz, C;
Van der Flier, WM;
... AD-RIDDLE Consortium; + view all
(2024)
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer’s Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project.
The Journal of Prevention of Alzheimer's Disease
, 11
pp. 329-338.
10.14283/jpad.2024.32.
|
|
Martínez-Dubarbie, F;
López-García, S;
Lage, C;
Di Molfetta, G;
Fernández-Matarrubia, M;
Pozueta-Cantudo, A;
García-Martínez, M;
... Sánchez-Juan, P; + view all
(2024)
Plasma Phosphorylated Tau 231 Increases at One-Year Intervals in Cognitively Unimpaired Subjects.
Journal of Alzheimer's Disease
, 98
(3)
pp. 1029-1042.
10.3233/JAD-231479.
|
|
Murray-Smith, H;
Barker, S;
Barkhof, F;
Barnes, J;
Brown, TM;
Captur, G;
R.E.Cartlidge, M;
... Schott, JM; + view all
(2024)
Updating the study protocol: Insight 46 – a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development – phases 2 and 3.
BMC Neurology
, 24
, Article 40. 10.1186/s12883-023-03465-3.
|
|
Peretti, Débora E;
Boccalini, Cecilia;
Ribaldi, Federica;
Scheffler, Max;
Marizzoni, Moira;
Ashton, Nicholas J;
Zetterberg, Henrik;
... Garibotto, Valentina; + view all
(2024)
Association of glial fibrillary acid protein, Alzheimer's disease pathology and cognitive decline.
Brain
, Article awae211. 10.1093/brain/awae211.
(In press).
|
|
Perino, JH;
Patterson, M;
Momen, M;
Borisova, M;
Heslegrave, A;
Zetterberg, H;
Gruel, J;
... Sample, SJ; + view all
(2024)
Neurofilament light chain concentration does not correlate with disease status in Labrador Retrievers affected with idiopathic laryngeal paralysis.
American journal of veterinary research
, 85
(4)
pp. 1-8.
10.2460/ajvr.23.12.0292.
|
|
Princen, Katrien;
Van Dooren, Tom;
van Gorsel, Marit;
Louros, Nikolaos;
Yang, Xiaojuan;
Dumbacher, Michael;
Bastiaens, Ilse;
... Griffioen, Gerard; + view all
(2024)
Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease.
Science
, 384
(6699)
, Article eadd6260. 10.1126/science.add6260.
|
|
Quesnel, Marc James;
Labonté, Anne;
Picard, Cynthia;
Zetterberg, Henrik;
Blennow, Kaj;
Brinkmalm, Ann;
Villeneuve, Sylvia;
... Alzheimer’s Disease Neuroimaging Initiative and the PREVENT-AD R; + view all
(2024)
Insulin-like growth factor binding protein-2 in at-risk adults and autopsy-confirmed Alzheimer brains.
Brain
, 147
(5)
pp. 1680-1695.
10.1093/brain/awad398.
|
|
Safransky, Michelle;
Groh, Jenna R;
Blennow, Kaj;
Zetterberg, Henrik;
Tripodis, Yorghos;
Martin, Brett;
Weller, Jason;
... Alosco, Michael L; + view all
(2024)
Lumipulse-Measured Cerebrospinal Fluid Biomarkers for the Early Detection of Alzheimer Disease.
Neurology
, 103
(11)
, Article e209866. 10.1212/WNL.0000000000209866.
|
|
Sanchez-Rodriguez, Lazaro M;
Bezgin, Gleb;
Carbonell, Felix;
Therriault, Joseph;
Fernandez-Arias, Jaime;
Servaes, Stijn;
Rahmouni, Nesrine;
... Iturria-Medina, Yasser; + view all
(2024)
Personalized whole-brain neural mass models reveal combined Aβ and tau hyperexcitable influences in Alzheimer’s disease.
Communications Biology
, 7
, Article 528. 10.1038/s42003-024-06217-2.
|
|
|
Shahim, Bahira;
Xu, Hong;
Haugaa, Kristina;
Zetterberg, Henrik;
Jurga, Juliane;
Religa, Dorota;
Eriksdotter, Maria;
(2024)
Cholinesterase inhibitors are associated with reduced mortality in patients with Alzheimer's disease and previous myocardial infarction.
European Heart Journal - Cardiovascular Pharmacotherapy
, 10
(2)
pp. 128-136.
10.1093/ehjcvp/pvad102.
|
|
Swift, Imogen J;
Rademakers, Rosa;
Finch, NiCole;
Baker, Matt;
Ghidoni, Roberta;
Benussi, Luisa;
Binetti, Giuliano;
... Rohrer, Jonathan D; + view all
(2024)
A systematic review of progranulin concentrations in biofluids in over 7,000 people-assessing the pathogenicity of GRN mutations and other influencing factors.
Alzheimer's Research & Therapy
, 16
(1)
, Article 66. 10.1186/s13195-024-01420-z.
|
|
Taquet, Maxime;
Skorniewska, Zuzanna;
Zetterberg, Henrik;
Geddes, John R;
Mummery, Catherine J;
Chalmers, James D;
Ho, Ling-Pei;
... PHOSP-COVID Study Collaborative Group; + view all
(2024)
Post-acute COVID-19 neuropsychiatric symptoms are not associated with ongoing nervous system injury.
Brain Communications
, 6
(1)
, Article fcad357. 10.1093/braincomms/fcad357.
|
|
Therriault, Joseph;
Schindler, Suzanne E;
Salvadó, Gemma;
Pascoal, Tharick A;
Benedet, Andréa Lessa;
Ashton, Nicholas J;
Karikari, Thomas K;
... Rosa-Neto, Pedro; + view all
(2024)
Biomarker-based staging of Alzheimer disease: rationale and clinical applications.
Nature Reviews Neurology
, 20
pp. 232-244.
10.1038/s41582-024-00942-2.
|
|
Toniolo, S;
Zhao, S;
Scholcz, A;
Amein, B;
Ganse-Dumrath, A;
Heslegrave, AJ;
Thompson, S;
... Husain, M; + view all
(2024)
Relationship of plasma biomarkers to digital cognitive tests in Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 16
(2)
, Article e12590. 10.1002/dad2.12590.
|
|
van den Berg, Emma;
Kersten, Iris;
Brinkmalm, Gunnar;
Johansson, Kjell;
de Kort, Anna M;
Klijn, Catharina JM;
Schreuder, Floris HBM;
... Verbeek, Marcel M; + view all
(2024)
Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy.
Journal of Neurochemistry
10.1111/jnc.16074.
(In press).
|
|
|
Van Hulle, Carol;
Ince, Selvi;
Okonkwo, Ozioma C;
Bendlin, Barbara B;
Johnson, Sterling C;
Carlsson, Cynthia M;
Asthana, Sanjay;
... Scott Miners, J; + view all
(2024)
Elevated CSF angiopoietin-2 correlates with blood-brain barrier leakiness and markers of neuronal injury in early Alzheimer's disease.
Translational Psychiatry
, 14
(1)
, Article 3. 10.1038/s41398-023-02706-w.
|
|
Wang, Yi-Ting;
Therriault, Joseph;
Servaes, Stijn;
Tissot, Cécile;
Rahmouni, Nesrine;
Macedo, Arthur Cassa;
Fernandez-Arias, Jaime;
... Rosa-Neto, Pedro; + view all
(2024)
Sex-specific modulation of amyloid-β on tau phosphorylation underlies faster tangle accumulation in females.
Brain
, 147
(4)
pp. 1497-1510.
10.1093/brain/awad397.
|
|
Watamura, Naoto;
Foiani, Martha S;
Bez, Sumi;
Bourdenx, Mathieu;
Santambrogio, Alessia;
Frodsham, Claire;
Camporesi, Elena;
... Saido, Takaomi C; + view all
(2024)
In vivo hyperphosphorylation of tau is associated with synaptic loss and behavioral abnormalities in the absence of tau seeds.
Nature Neuroscience
, 28
pp. 293-307.
10.1038/s41593-024-01829-7.
|
|
Wilson, David;
Chan, Dandan;
Chang, Lei;
Mathis, Robert;
Verberk, Inge;
Montalban, Xavier;
Comabella, Manuel;
... Kuhle, Jens; + view all
(2024)
Development and multi-center validation of a fully automated digital immunoassay for neurofilament light chain: toward a clinical blood test for neuronal injury.
Clinical Chemistry and Laboratory Medicine
, 62
(2)
10.1515/cclm-2023-0518.
|
2023
|
Abdelhak, Ahmed;
Barba, Lorenzo;
Romoli, Michele;
Benkert, Pascal;
Conversi, Francesco;
D'Anna, Lucio;
Masvekar, Ruturaj R;
... Abu-Rumeileh, Samir; + view all
(2023)
Prognostic performance of blood neurofilament light chain protein in hospitalized COVID-19 patients without major central nervous system manifestations: an individual participant data meta-analysis.
Journal of Neurology
, 270
(7)
pp. 3315-3328.
10.1007/s00415-023-11768-1.
|
|
Åberg, Daniel;
Gadd, Gustaf;
Jood, Katarina;
Redfors, Petra;
Stanne, Tara M;
Isgaard, Jörgen;
Blennow, Kaj;
... Svensson, Johan; + view all
(2023)
Serum IGFBP-1 Concentration as a Predictor of Outcome after Ischemic Stroke—A Prospective Observational Study.
International Journal of Molecular Sciences
, 24
(11)
, Article 9120. 10.3390/ijms24119120.
|
|
Aguillon, David;
Langella, Stephanie;
Chen, Yinghua;
Sanchez, Justin S;
Su, Yi;
Vila-Castelar, Clara;
Vasquez, Daniel;
... Quiroz, Yakeel T; + view all
(2023)
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
Alzheimer's and Dementia
, 19
(6)
pp. 2585-2594.
10.1002/alz.12906.
|
|
Akel, Sarah;
Asztely, Fredrik;
Banote, Rakesh Kumar;
Axelsson, Markus;
Zetterberg, Henrik;
Zelano, Johan;
(2023)
Neurofilament light, glial fibrillary acidic protein, and tau in a regional epilepsy cohort: High plasma levels are rare but related to seizures.
Epilepsia
10.1111/epi.17713.
(In press).
|
|
Aksnes, Mari;
Capogna, Elettra;
Vidal-Piñeiro, Didac;
Chaudhry, Farrukh Abbas;
Myrstad, Marius;
Idland, Ane-Victoria;
Halaas, Nathalie Bodd;
... Fjell, Anders Martin; + view all
(2023)
Matrix metalloproteinases are associated with brain atrophy in cognitively unimpaired individuals.
Neurobiology of Aging
, 131
pp. 11-23.
10.1016/j.neurobiolaging.2023.05.012.
|
|
Altomare, Daniele;
Stampacchia, Sara;
Ribaldi, Federica;
Tomczyk, Szymon;
Chevalier, Claire;
Poulain, Géraldine;
Asadi, Saina;
... Frisoni, Giovanni B; + view all
(2023)
Plasma biomarkers for Alzheimer’s disease: a field-test in a memory clinic.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2022-330619.
(In press).
|
|
Andersson, E;
Schultz, N;
Saito, T;
Saido, TC;
Blennow, K;
Gouras, GK;
Zetterberg, H;
(2023)
Cerebral Aβ deposition precedes reduced cerebrospinal fluid and serum Aβ42/Aβ40 ratios in the AppNL−F/NL−F knock-in mouse model of Alzheimer’s disease.
Alzheimer's Research & Therapy
, 15
, Article 64. 10.1186/s13195-023-01196-8.
|
|
Andreasson, Ulf;
Gobom, Johan;
Delatour, Vincent;
Auclair, Guy;
Noam, Yoav;
Lee, Stephen;
Wen, Jason;
... Blennow, Kaj; + view all
(2023)
Assessing the commutability of candidate reference materials for the harmonization of neurofilament light measurements in blood.
Clinical Chemistry and Laboratory Medicine (CCLM)
10.1515/cclm-2022-1181.
(In press).
|
|
Arslan, B;
Zetterberg, H;
(2023)
Neurofilament light chain as neuronal injury marker - What is needed to facilitate implementation in clinical laboratory practice?
Clinical Chemistry and Laboratory Medicine
10.1515/cclm-2023-0036.
(In press).
|
|
Arvidsson Rådestig, M;
Skoog, I;
Skillbäck, T;
Zetterberg, H;
Kern, J;
Zettergren, A;
Andreasson, U;
... Blennow, K; + view all
(2023)
Cerebrospinal fluid biomarkers of axonal and synaptic degeneration in a population-based sample.
Alzheimer's Research and Therapy
, 15
(1)
, Article 44. 10.1186/s13195-023-01193-x.
(In press).
|
|
Ashton, NJ;
Moseby-Knappe, M;
Benedet, AL;
Grötschel, L;
Lantero-Rodriguez, J;
Karikari, TK;
Hassager, C;
... Blennow, K; + view all
(2023)
Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest.
JAMA Neurology
, 80
(4)
pp. 388-396.
10.1001/jamaneurol.2023.0050.
|
|
Assogna, Martina;
Premi, Enrico;
Gazzina, Stefano;
Benussi, Alberto;
Ashton, Nicholas J;
Zetterberg, Henrik;
Blennow, Kaj;
... Santarnecchi, Emiliano; + view all
(2023)
Association of Choroid Plexus Volume With Serum Biomarkers, Clinical Features, and Disease Severity in Patients With Frontotemporal Lobar Degeneration Spectrum.
Neurology
, 101
(12)
e1218-e1230.
10.1212/WNL.0000000000207600.
|
|
Axelsson Andrén, E;
Kettunen, P;
Bjerke, M;
Rolstad, S;
Zetterberg, H;
Blennow, K;
Wallin, A;
... Zhu, YC; + view all
(2023)
Diagnostic Performance of Cerebrospinal Fluid Neurofilament Light Chain and Soluble Amyloid-β Protein Precursor β in the Subcortical Small Vessel Type of Dementia.
Journal of Alzheimer's Disease
, 96
(4)
pp. 1515-1528.
10.3233/JAD-230680.
|
|
Balogun, Wasiu G;
Zetterberg, Henrik;
Blennow, Kaj;
Karikari, Thomas K;
(2023)
Plasma biomarkers for neurodegenerative disorders: ready for prime time?
Current Opinion in Psychiatry
, 36
(2)
pp. 112-118.
10.1097/YCO.0000000000000851.
|
|
Balusu, Sriram;
Horré, Katrien;
Thrupp, Nicola;
Craessaerts, Katleen;
Snellinx, An;
Serneels, Lutgarde;
T'Syen, Dries;
... De Strooper, Bart; + view all
(2023)
MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease.
Science
, 381
(6663)
pp. 1176-1182.
10.1126/science.abp9556.
|
|
|
Bellaver, B;
Puig-Pijoan, A;
Ferrari-Souza, JP;
Leffa, DT;
Lussier, FZ;
Ferreira, PCL;
Tissot, C;
... Pascoal, TA; + view all
(2023)
Blood-brain barrier integrity impacts the use of plasma amyloid-β as a proxy of brain amyloid-β pathology.
Alzheimer's and Dementia
, 19
(9)
pp. 3815-3825.
10.1002/alz.13014.
|
|
Bellaver, Bruna;
Povala, Guilherme;
Ferreira, Pamela CL;
Ferrari-Souza, João Pedro;
Leffa, Douglas T;
Lussier, Firoza Z;
Benedet, Andréa L;
... Pascoal, Tharick A; + view all
(2023)
Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer's disease.
Nature Medicine
10.1038/s41591-023-02380-x.
(In press).
|
|
|
Bernhardt, Alexander M;
Tiedt, Steffen;
Teupser, Daniel;
Dichgans, Martin;
Meyer, Bernhard;
Gempt, Jens;
Kuhn, Peer-Hendrik;
... Levin, Johannes; + view all
(2023)
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases.
eBioMedicine
, 89
, Article 104456. 10.1016/j.ebiom.2023.104456.
|
|
Bhan, Alok;
Jacobsen, Cecilie;
Dalen, Ingvild;
Alves, Guido;
Bergsland, Niels;
Myhr, Kjell-Morten;
Zetterberg, Henrik;
... Farbu, Elisabeth; + view all
(2023)
Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study.
Acta Neurologica Scandinavica
, 2023
, Article 7136599. 10.1155/2023/7136599.
|
|
Bilgel, Murat;
An, Yang;
Walker, Keenan A;
Moghekar, Abhay R;
Ashton, Nicholas J;
Kac, Przemysław R;
Karikari, Thomas K;
... Resnick, Susan M; + view all
(2023)
Longitudinal changes in Alzheimer's-related plasma biomarkers and brain amyloid.
Alzheimer's and Dementia
, 19
(10)
pp. 4335-4345.
10.1002/alz.13157.
|
|
Bokström-Rees, Emma;
Zetterberg, Henrik;
Blennow, Kaj;
Hastie, Roxanne;
Schell, Sonja;
Cluver, Catherine;
Bergman, Lina;
(2023)
Correlation between cognitive assessment scores and circulating cerebral biomarkers in women with pre-eclampsia and eclampsia.
Pregnancy Hypertens
, 31
pp. 38-45.
10.1016/j.preghy.2022.12.001.
|
|
Bowman, Emily ML;
Brummel, Nathan E;
Caplan, Gideon A;
Cunningham, Colm;
Evered, Lis A;
Fiest, Kirsten M;
Girard, Timothy D;
... Cunningham, Emma L; + view all
(2023)
Advancing specificity in delirium: The delirium subtyping initiative.
Alzheimer's & Dementia
, 20
(1)
pp. 183-194.
10.1002/alz.13419.
|
|
Brown, J;
Camporesi, E;
Lantero-Rodriguez, J;
Olsson, M;
Wang, A;
Medem, B;
Zetterberg, H;
... Hill, E; + view all
(2023)
Tau in cerebrospinal fluid induces neuronal hyperexcitability and alters hippocampal theta oscillations.
Acta Neuropathologica Communications
, 11
, Article 67. 10.1186/s40478-023-01562-5.
|
|
|
Bruno, D;
Jauregi Zinkunegi, A;
Kollmorgen, G;
Carboni, M;
Wild, N;
Carlsson, C;
Bendlin, B;
... Mueller, KD; + view all
(2023)
A comparison of diagnostic performance of word-list and story recall tests for biomarker-determined Alzheimer’s disease.
Journal of Clinical and Experimental Neuropsychology
pp. 1-7.
10.1080/13803395.2023.2240060.
(In press).
|
|
Bruno, D;
Jauregi Zinkunegi, A;
Kollmorgen, G;
Suridjan, I;
Wild, N;
Carlsson, C;
Bendlin, B;
... Mueller, KD; + view all
(2023)
The recency ratio assessed by story recall is associated with cerebrospinal fluid levels of neurodegeneration biomarkers.
Cortex
, 159
pp. 167-174.
10.1016/j.cortex.2022.12.004.
|
|
Bucci, Marco;
Bluma, Marina;
Savitcheva, Irina;
Ashton, Nicholas J;
Chiotis, Konstantinos;
Matton, Anna;
Kivipelto, Miia;
... Nordberg, Agneta; + view all
(2023)
Profiling of plasma biomarkers in the context of memory assessment in a tertiary memory clinic.
Translational Psychiatry
, 13
(1)
, Article 268. 10.1038/s41398-023-02558-4.
|
|
Butler, Tracy;
Zhou, Liangdong;
Ozsahin, Ilker;
Wang, Xiuyuan Hugh;
Garetti, Jacob;
Zetterberg, Henrik;
Blennow, Kaj;
... Shah, Sudhin A; + view all
(2023)
Glymphatic clearance estimated using diffusion tensor imaging along perivascular spaces is reduced after traumatic brain injury and correlates with plasma neurofilament light, a biomarker of injury severity.
Brain Communications
, 5
(3)
, Article fcad134. 10.1093/braincomms/fcad134.
|
|
|
Capogna, Elettra;
Watne, Leiv Otto;
Sørensen, Øystein;
Guichelaar, Carlijn Jamila;
Idland, Ane Victoria;
Halaas, Nathalie Bodd;
Blennow, Kaj;
... Vidal-Piñeiro, Didac; + view all
(2023)
Associations of neuroinflammatory IL-6 and IL-8 with brain atrophy, memory decline, and core AD biomarkers - in cognitively unimpaired older adults.
Brain, Behavior, and Immunity
, 113
pp. 56-65.
10.1016/j.bbi.2023.06.027.
|
|
Chong, JR;
Hilal, S;
Ashton, NJ;
Karikari, TK;
Reilhac, A;
Vrooman, H;
Schöll, M;
... Lai, MKP; + view all
(2023)
Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 15
(1)
, Article e12396. 10.1002/dad2.12396.
|
|
Cicognola, Claudia;
Mattsson-Carlgren, Niklas;
van Westen, Danielle;
Zetterberg, Henrik;
Blennow, Kaj;
Palmqvist, Sebastian;
Ahmadi, Khazar;
... Hansson, Oskar; + view all
(2023)
Associations of CSF PDGFRβ With Aging, Blood-Brain Barrier Damage, Neuroinflammation, and Alzheimer Disease Pathologic Changes.
Neurology
, 101
(1)
e30-e39.
10.1212/WNL.0000000000207358.
|
|
Coleman, Annabelle;
Touzé, Alexiane;
Farag, Mena;
Pengo, Marta;
Murphy, Michael J;
Hassan, Yara;
Thackeray, Olivia;
... Byrne, Lauren M; + view all
(2023)
Validation of remote collection and quantification of blood Neurofilament light in neurological diseases.
MedRxiv: Cold Spring Harbor, NY, USA.
|
|
Cumplido-Mayoral, Irene;
García-Prat, Marina;
Operto, Grégory;
Falcon, Carles;
Shekari, Mahnaz;
Cacciaglia, Raffaele;
Milà-Alomà, Marta;
... OASIS study; + view all
(2023)
Biological brain age prediction using machine learning on structural neuroimaging data: Multi-cohort validation against biomarkers of Alzheimer's disease and neurodegeneration stratified by sex.
eLife
, 12
, Article e81067. 10.7554/eLife.81067.
|
|
|
Dai, Linbin;
Gao, Feng;
Wang, Qiong;
Lv, Xinyi;
Cheng, Zhaozhao;
Wu, Yan;
Chai, Xianliang;
... CANDI Consortium; + view all
(2023)
Molecules of senescent glial cells differentiate Alzheimer's disease from ageing.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2022-330743.
(In press).
|
|
Dams-O'Connor, Kristen;
Awwad, Hibah O;
Hoffman, Stuart W;
Pugh, Mary Jo;
Johnson, Victoria;
Keene, C Dirk;
McGavern, Linda;
... Zetterberg, Henrik; + view all
(2023)
Alzheimer's Disease-Related Dementias Summit 2022: National Research Priorities for the Investigation of Post-Traumatic Brain Injury Alzheimer's Disease and Related Dementias.
Journal of Neurotrauma
, 40
(15-16)
pp. 1512-1523.
10.1089/neu.2022.0514.
|
|
Daniilidou, Makrina;
Eroli, Francesca;
Alanko, Vilma;
Goikolea, Julen;
Latorre-Leal, Maria;
Rodriguez-Rodriguez, Patricia;
Griffiths, William J;
... Matton, Anna; + view all
(2023)
Alzheimer's disease biomarker profiling in a memory clinic cohort without common comorbidities.
Brain Communications
, 5
(5)
, Article fcad228. 10.1093/braincomms/fcad228.
(In press).
|
|
Davenport, F;
Gallacher, J;
Kourtzi, Z;
Koychev, I;
Matthews, PM;
Oxtoby, NP;
Parkes, LM;
... Zetterberg, H; + view all
(2023)
Neurodegenerative disease of the brain: a survey of interdisciplinary approaches.
Journal of the Royal Society: Interface
, 20
(198)
, Article 20220406. 10.1098/rsif.2022.0406.
|
|
Davidy, Tal;
Yore, Iscka;
Cukierman-Yaffe, Tali;
Ravona-Springer, Ramit;
Livny, Abigail;
Lesman-Segev, Orit H;
Azuri, Yossi;
... Beeri, Michal Schnaider; + view all
(2023)
A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk – Study rationale and design.
Mechanisms of Ageing and Development
, 213
, Article 111825. 10.1016/j.mad.2023.111825.
|
|
De Bastiani, MA;
Bellaver, B;
Brum, WS;
Souza, DG;
Ferreira, PCL;
Rocha, AS;
Povala, G;
... Zimmer, ER; + view all
(2023)
Hippocampal GFAP-positive astrocyte responses to amyloid and tau pathologies.
Brain, Behavior, and Immunity
, 110
pp. 175-184.
10.1016/j.bbi.2023.03.001.
|
|
Deming, Y;
Vasiljevic, E;
Morrow, A;
Miao, J;
Van Hulle, C;
Jonaitis, E;
Ma, Y;
... Engelman, CD; + view all
(2023)
Neuropathology-based APOE genetic risk score better quantifies Alzheimer's risk.
Alzheimer's and Dementia
10.1002/alz.12990.
(In press).
|
|
Depypere, Herman;
Vergallo, Andrea;
Lemercier, Pablo;
Lista, Simone;
Benedet, Andrea;
Ashton, Nicholas;
Cavedo, Enrica;
... Neurodegeneration Precision Medicine Initiative (NPMI), (NPMI); + view all
(2023)
Menopause hormone therapy significantly alters pathophysiological biomarkers of Alzheimer's disease.
Alzheimer's & Dementia
, 19
(4)
pp. 1320-1330.
10.1002/alz.12759.
|
|
Dittrich, Anna;
Ashton, Nicholas J;
Zetterberg, Henrik;
Blennow, Kaj;
Zettergren, Anna;
Simrén, Joel;
Skillbäck, Tobias;
... Kern, Silke; + view all
(2023)
Association of Chronic Kidney Disease With Plasma NfL and Other Biomarkers of Neurodegeneration: The H70 Birth Cohort Study in Gothenburg.
Neurology
10.1212/WNL.0000000000207419.
10.1212/WNL.0000000000207419.
(In press).
|
|
|
Dong, R;
Denier-Fields, DN;
Van Hulle, CA;
Kollmorgen, G;
Suridjan, I;
Wild, N;
Lu, Q;
... Engelman, CD; + view all
(2023)
Identification of plasma metabolites associated with modifiable risk factors and endophenotypes reflecting Alzheimer's disease pathology.
European Journal of Epidemiology
, 38
pp. 559-571.
10.1007/s10654-023-00988-4.
|
|
Dong, R;
Lu, Q;
Kang, H;
Suridjan, I;
Kollmorgen, G;
Wild, N;
Deming, Y;
... Engelman, CD; + view all
(2023)
CSF metabolites associated with biomarkers of Alzheimer’s disease pathology.
Frontiers in Aging Neuroscience
, 15
, Article 1214932. 10.3389/fnagi.2023.1214932.
|
|
|
Eide, Per Kristian;
Lashkarivand, Aslan;
Pripp, Are;
Valnes, Lars Magnus;
Hovd, Markus Herberg;
Ringstad, Geir;
Blennow, Kaj;
(2023)
Plasma neurodegeneration biomarker concentrations associate with glymphatic and meningeal lymphatic measures in neurological disorders.
Nature Communications
, 14
(1)
, Article 2084. 10.1038/s41467-023-37685-5.
|
|
Eide, Per Kristian;
Lashkarivand, Aslan;
Pripp, Are Hugo;
Valnes, Lars Magnus;
Hovd, Markus;
Ringstad, Geir;
Blennow, Kaj;
(2023)
Mechanisms behind changes of neurodegeneration biomarkers in plasma induced by sleep deprivation.
Brain Communications
, 5
(6)
, Article fcad343. 10.1093/braincomms/fcad343.
|
|
Eratne, Dhamidhu;
Kang, Matthew;
Malpas, Charles;
Simpson-Yap, Steve;
Lewis, Courtney;
Dang, Christa;
Grewal, Jasleen;
... The MiND Study Group; + view all
(2023)
Plasma neurofilament light in behavioural variant frontotemporal dementia compared to mood and psychotic disorders.
Australian and New Zealand Journal of Psychiatry
10.1177/00048674231187312.
(In press).
|
|
Erickson, Pontus;
Simrén, Joel;
Brum, Wagner S;
Ennis, Gilda E;
Kollmorgen, Gwendlyn;
Suridjan, Ivonne;
Langhough, Rebecca;
... ADNI Cohort; + view all
(2023)
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease.
JAMA Neurology
10.1001/jamaneurol.2023.2338.
(In press).
|
|
Fernqvist, A;
Alexiou, E;
Zetterberg, H;
Howner, K;
Nilsson, T;
Andiné, P;
(2023)
Plasma neurofilament light chain protein is not increased in forensic psychiatric populations: a pilot study.
Frontiers in Psychiatry
, 14
, Article 1176266. 10.3389/fpsyt.2023.1176266.
|
|
|
Ferrari-Souza, João Pedro;
Bellaver, Bruna;
Ferreira, Pâmela CL;
Benedet, Andréa L;
Povala, Guilherme;
Lussier, Firoza Z;
Leffa, Douglas T;
... Pascoal, Tharick A; + view all
(2023)
APOEε4 potentiates amyloid β effects on longitudinal tau pathology.
Nature Aging
, 3
pp. 1210-1218.
10.1038/s43587-023-00490-2.
|
|
Ferrari-Souza, JP;
Lussier, FZ;
Leffa, DT;
Therriault, J;
Tissot, C;
Bellaver, B;
Ferreira, PCL;
... Pascoal, TA; + view all
(2023)
APOEε4 associates with microglial activation independently of Aβ plaques and tau tangles.
Science Advances
, 9
(14)
, Article eade1474. 10.1126/sciadv.ade1474.
|
|
Ferreira, Pamela CL;
Ferrari-Souza, João Pedro;
Tissot, Cécile;
Bellaver, Bruna;
Leffa, Douglas T;
Lussier, Firoza;
Povala, Guilherme;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2023)
Potential Utility of Plasma P-Tau and Neurofilament Light Chain as Surrogate Biomarkers for Preventive Clinical Trials.
Neurology
, 101
(1)
pp. 38-45.
10.1212/WNL.0000000000207115.
|
|
Ferreira, Pamela CL;
Therriault, Joseph;
Tissot, Cécile;
Ferrari-Souza, João Pedro;
Benedet, Andréa L;
Povala, Guilherme;
Bellaver, Bruna;
... Pascoal, Tharick A; + view all
(2023)
Plasma p-tau231 and p-tau217 inform on tau tangles aggregation in cognitively impaired individuals.
Alzheimer’s & Dementia
, 19
(10)
pp. 4463-4474.
10.1002/alz.13393.
|
|
Ferreira, PCL;
Zhang, Y;
Snitz, B;
Chang, CCH;
Bellaver, B;
Jacobsen, E;
Kamboh, MI;
... Karikari, TK; + view all
(2023)
Plasma biomarkers identify older adults at risk of Alzheimer's disease and related dementias in a real-world population-based cohort.
Alzheimer's and Dementia
10.1002/alz.12986.
(In press).
|
|
Fruhwürth, Stefanie;
Reinert, Line S;
Öberg, Carl;
Sakr, Marcelina;
Henricsson, Marcus;
Zetterberg, Henrik;
Paludan, Søren R;
(2023)
TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain.
Science Advances
, 9
(33)
, Article eadf5808. 10.1126/sciadv.adf5808.
|
|
Funkquist, A;
Wandt, B;
Blennow, K;
Zetterberg, H;
Svensson, J;
Bjellerup, P;
Freund-Levi, Y;
(2023)
Higher CSF/serum free-T4 ratio is associated with improvement of quality of life during treatment with L-thyroxine.
Journal of Neuroendocrinology
, Article e13272. 10.1111/jne.13272.
(In press).
|
|
|
Gallagher, RL;
Koscik, RL;
Moody, JF;
Vogt, NM;
Adluru, N;
Kecskemeti, SR;
Van Hulle, CA;
... Bendlin, BB; + view all
(2023)
Neuroimaging of tissue microstructure as a marker of neurodegeneration in the AT(N) framework: defining abnormal neurodegeneration and improving prediction of clinical status.
Alzheimer's Research and Therapy
, 15
(1)
, Article 180. 10.1186/s13195-023-01281-y.
|
|
Ge, J;
Koutarapu, S;
Jha, D;
Dulewicz, M;
Zetterberg, H;
Blennow, K;
Hanrieder, J;
(2023)
Tetramodal Chemical Imaging Delineates the Lipid–Amyloid Peptide Interplay at Single Plaques in Transgenic Alzheimer’s Disease Models.
Analytical Chemistry
, 95
(10)
pp. 4692-4702.
10.1021/acs.analchem.2c05302.
|
|
Georgiou, E;
Kagiava, A;
Sargiannidou, I;
Schiza, N;
Stavrou, M;
Richter, J;
Tryfonos, C;
... Kleopa, KA; + view all
(2023)
AAV9-mediated SH3TC2 gene replacement therapy targeted to Schwann cells for the treatment of CMT4C.
Molecular Therapy
10.1016/j.ymthe.2023.08.020.
(In press).
|
|
|
Ghahremani, Maryam;
Wang, Meng;
Chen, Hung-Yu;
Zetterberg, Henrik;
Smith, Eric;
Ismail, Zahinoor;
Alzheimer’s Disease Neuroimaging Initiative;
(2023)
Plasma Phosphorylated Tau at Threonine 181 and Neuropsychiatric Symptoms in Preclinical and Prodromal Alzheimer Disease.
Neurology
, 100
(7)
e683-e693.
10.1212/WNL.0000000000201517.
|
|
Gibson, Lucy L;
Pollak, Thomas A;
Hart, Melanie;
Heslegrave, Amanda;
Hye, Abdul;
Church, Andrew J;
Lakdawala, Neghat;
... Aarsland, Dag; + view all
(2023)
NMDA Receptor Antibodies and Neuropsychiatric Symptoms in Parkinson's Disease.
Journal of Neuropsychiatry and Clinical Neurosciences
10.1176/appi.neuropsych.20220107.
(In press).
|
|
Giudici, KV;
De Souto Barreto, P;
Guyonnet, S;
Cantet, C;
Zetterberg, H;
Boschat, C;
Hudry, J;
... NOLAN/DSA group; + view all
(2023)
Effect of a 1-Year Nutritional Blend Supplementation on Plasma p-tau181 and GFAP Levels among Community-Dwelling Older Adults: A Secondary Analysis of the Nolan Trial.
The Journal of Aging Research and Lifestyle (JARLife)
, 12
pp. 25-34.
10.14283/jarlife.2023.7.
|
|
Gonzalez-Ortiz, F;
Dias, A;
Turton, M;
Magalhães, R;
Kac, PR;
Correia, M;
Harrison, P;
... Karikari, TK; + view all
(2023)
Preanalytical stability of plasma/serum brain-derived tau.
Alzheimer's and Dementia
10.1002/alz.13156.
(In press).
|
|
|
Gonzalez-Ortiz, F;
Dulewicz, M;
Ashton, NJ;
Kac, PR;
Zetterberg, H;
Andersson, E;
Yakoub, Y;
... Blennow, K; + view all
(2023)
Association of Serum Brain-Derived Tau With Clinical Outcome and Longitudinal Change in Patients With Severe Traumatic Brain Injury.
JAMA Network Open
, 6
(7)
, Article e2321554. 10.1001/jamanetworkopen.2023.21554.
|
|
Gonzalez-Ortiz, F;
Kac, PR;
Brum, WS;
Zetterberg, H;
Blennow, K;
Karikari, TK;
(2023)
Plasma phospho-tau in Alzheimer’s disease: towards diagnostic and therapeutic trial applications.
Molecular Neurodegeneration
, 18
, Article 18. 10.1186/s13024-023-00605-8.
(In press).
|
|
Gonzalez-Robles, C;
Bartlett, M;
Burnell, M;
Clarke, CS;
Haar, S;
Hu, MT;
Huxford, B;
... Schrag, A; + view all
(2023)
Embedding Patient Input in Outcome Measures for Long-Term Disease-Modifying Parkinson Disease Trials.
Movement Disorders
10.1002/mds.29691.
(In press).
|
|
Götze, Karl;
Vrillon, Agathe;
Bouaziz-Amar, Elodie;
Mouton-Liger, François;
Hugon, Jacques;
Martinet, Matthieu;
Dumurgier, Julien;
... Lilamand, Matthieu; + view all
(2023)
Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study.
Neurobiology of Disease
, 176
, Article 105937. 10.1016/j.nbd.2022.105937.
|
|
Graham, Neil;
Zimmerman, Karl;
Heslegrave, Amanda J;
Keshavan, Ashvini;
Moro, Federico;
Abed-Maillard, Samia;
Bernini, Adriano;
... Sharp, David; + view all
(2023)
Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2023-331854.
(In press).
|
|
|
Graham, NSN;
Blissitt, G;
Zimmerman, K;
Friedland, D;
Dumas, ME;
Coady, E;
Heslegrave, A;
... Sharp, DJ; + view all
(2023)
ADVANCE-TBI study protocol: traumatic brain injury outcomes in UK military personnel serving in Afghanistan between 2003 and 2014 - a longitudinal cohort study.
BMJ open
, 13
(3)
, Article e069243. 10.1136/bmjopen-2022-069243.
|
|
Grossman, Murray;
Seeley, William W;
Boxer, Adam L;
Hillis, Argye E;
Knopman, David S;
Ljubenov, Peter A;
Miller, Bruce;
... van Swieten, John C; + view all
(2023)
Frontotemporal lobar degeneration.
Nature Reviews Disease Primers
, 9
, Article 40. 10.1038/s41572-023-00447-0.
|
|
Grut, Viktor;
Biström, Martin;
Salzer, Jonatan;
Stridh, Pernilla;
Jons, Daniel;
Gustafsson, Rasmus;
Fogdell-Hahn, Anna;
... Sundström, Peter; + view all
(2023)
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.
Brain
10.1093/brain/awad374.
(In press).
|
|
|
Hamilton, Calum Alexander;
O'Brien, John;
Heslegrave, Amanda;
Laban, Rhiannon;
Donaghy, Paul;
Durcan, Rory;
Lawley, Sarah;
... Thomas, Alan; + view all
(2023)
Plasma biomarkers of neurodegeneration in mild cognitive impairment with Lewy bodies.
Psychological Medicine
10.1017/S0033291723001952.
(In press).
|
|
Hansson, Oskar;
Blennow, Kaj;
Zetterberg, Henrik;
Dage, Jeffrey;
(2023)
Blood biomarkers for Alzheimer’s disease in clinical practice and trials.
Nature Aging
, 3
pp. 506-519.
10.1038/s43587-023-00403-3.
|
|
Heston, MB;
Hanslik, KL;
Zarbock, KR;
Harding, SJ;
Davenport-Sis, NJ;
Kerby, RL;
Chin, N;
... Ulland, TK; + view all
(2023)
Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study.
Scientific Reports
, 13
(1)
, Article 18924. 10.1038/s41598-023-45929-z.
|
|
Hossain, I;
Mohammadian, M;
Maanpää, HR;
Takala, RSK;
Tenovuo, O;
van Gils, M;
Hutchinson, P;
... Posti, JP; + view all
(2023)
Plasma neurofilament light admission levels and development of axonal pathology in mild traumatic brain injury.
BMC Neurology
, 23
, Article 304. 10.1186/s12883-023-03284-6.
|
|
Huber, H;
Asthon, NJ;
Schieren, A;
Montoliu-Gaya, L;
Molfetta, GD;
Brum, WS;
Lantero-Rodriguez, J;
... Simon, MC; + view all
(2023)
Levels of Alzheimer's disease blood biomarkers are altered after food intake—A pilot intervention study in healthy adults.
Alzheimer's and Dementia
10.1002/alz.13163.
(In press).
|
|
|
Iulita, M Florencia;
Bejanin, Alexandre;
Vilaplana, Eduard;
Carmona-Iragui, Maria;
Benejam, Bessy;
Videla, Laura;
Barroeta, Isabel;
... Fortea, Juan; + view all
(2023)
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome.
Brain Communications
, 5
(2)
, Article fcad074. 10.1093/braincomms/fcad074.
|
|
Jeppsson, A;
Sandelius, Å;
Zettergren, A;
Kern, S;
Skoog, I;
Blennow, K;
Zetterberg, H;
... Tullberg, M; + view all
(2023)
Plasma and cerebrospinal fluid concentrations of neurofilament light protein correlate in patients with idiopathic normal pressure hydrocephalus.
Fluids and Barriers of the CNS
, 20
(1)
, Article 54. 10.1186/s12987-023-00455-y.
|
|
Jiang, Xiaotong;
Shen, Changyu;
Teunissen, Charlotte E;
Wessels, Mark;
Zetterberg, Henrik;
Giovannoni, Gavin;
Singh, Carol M;
... Gafson, Arie R; + view all
(2023)
Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation.
Multiple Sclerosis Journal
, 29
(9)
pp. 1070-1079.
10.1177/13524585231176732.
|
|
Johansson, Charlotte;
Thordardottir, Steinunn;
Laffita-Mesa, Jose;
Rodriguez-Vieitez, Elena;
Zetterberg, Henrik;
Blennow, Kaj;
Graff, Caroline;
(2023)
Plasma biomarker profiles in autosomal dominant Alzheimer's disease.
Brain
, Article awac399. 10.1093/brain/awac399.
|
|
Johnson, SC;
Suárez-Calvet, M;
Suridjan, I;
Minguillón, C;
Gispert, JD;
Jonaitis, E;
Michna, A;
... Blennow, K; + view all
(2023)
Identifying clinically useful biomarkers in neurodegenerative disease through a collaborative approach: the NeuroToolKit.
Alzheimer's Research and Therapy
, 15
(1)
, Article 25. 10.1186/s13195-023-01168-y.
|
|
Kagiava, A;
Karaiskos, C;
Lapathitis, G;
Heslegrave, A;
Sargiannidou, I;
Zetterberg, H;
Bosch, A;
(2023)
Gene replacement therapy in two Golgi-retained CMT1X mutants before and after the onset of demyelinating neuropathy.
Molecular Therapy - Methods and Clinical Development
, 30
pp. 377-393.
10.1016/j.omtm.2023.07.011.
(In press).
|
|
Kang, MJY;
Eratne, D;
Dobson, H;
Malpas, CB;
Keem, M;
Lewis, C;
Grewal, J;
... Velakoulis, D; + view all
(2023)
Cerebrospinal fluid neurofilament light predicts longitudinal diagnostic change in patients with psychiatric and neurodegenerative disorders.
Acta Neuropsychiatrica
pp. 1-12.
10.1017/neu.2023.25.
(In press).
|
|
|
Keddie, Stephen;
Smyth, Duncan;
Keh, Ryan YS;
Chou, Michael KL;
Grant, Donna;
Surana, Sunaina;
Heslegrave, Amanda;
... Lunn, Michael P; + view all
(2023)
Peripherin is a biomarker of axonal damage in peripheral nervous system disease.
Brain
10.1093/brain/awad234.
(In press).
|
|
Kincer, Laura P;
Joseph, Sarah Beth;
Gilleece, Maria M;
Hauser, Blake M;
Sizemore, Sabrina;
Zhou, Shuntai;
Di Germanio, Clara;
... Swanstrom, Ronald; + view all
(2023)
Rebound HIV-1 in cerebrospinal fluid after antiviral therapy interruption is mainly clonally amplified R5 T cell-tropic virus.
Nature Microbiology
, 8
(2)
pp. 260-271.
10.1038/s41564-022-01306-6.
|
|
Kloske, CM;
Barnum, CJ;
Batista, AF;
Bradshaw, EM;
Brickman, AM;
Bu, G;
Dennison, J;
... Carrillo, MC; + view all
(2023)
APOE and immunity: Research highlights.
Alzheimer's and Dementia
10.1002/alz.13020.
(In press).
|
|
Knorr, Ulla;
Simonsen, Anja Hviid;
Engström, Eva Letty Susanne;
Zetterberg, Henrik;
Blennow, Kaj;
Willkan, Mira;
Forman, Julie;
... Kessing, Lars Vedel; + view all
(2023)
Associations between sleep quality and biomarkers for neurodegeneration - A longitudinal one-year case-control study of patients with bipolar disorder and healthy control individuals.
Neuroscience Applied
, 2
, Article 101011. 10.1016/j.nsa.2022.101011.
|
|
Korhonen, O;
Mononen, M;
Mohammadian, M;
Tenovuo, O;
Blennow, K;
Hossain, I;
Hutchinson, P;
... Posti, JP; + view all
(2023)
Outlier analysis for acute blood biomarkers of moderate and severe traumatic brain injury.
Journal of Neurotrauma
10.1089/neu.2023.0120.
(In press).
|
|
Kulczyńska-Przybik, Agnieszka;
Dulewicz, Maciej;
Doroszkiewicz, Julia;
Borawska, Renata;
Słowik, Agnieszka;
Zetterberg, Henrik;
Hanrieder, Jörg;
... Mroczko, Barbara; + view all
(2023)
The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer’s Disease.
International Journal of Molecular Sciences
, 24
(17)
, Article 13166. 10.3390/ijms241713166.
|
|
LaBarbera, KM;
Sheline, YI;
Izzo, NJ;
Yuede, CM;
Waybright, L;
Yurko, R;
Edwards, HM;
... Hamby, ME; + view all
(2023)
A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer’s disease using an indwelling CSF catheter.
Translational Neurodegeneration
, 12
(1)
, Article 24. 10.1186/s40035-023-00358-w.
|
|
|
Lancini, Elisa;
Haag, Lena;
Bartl, Franziska;
Rühling, Maren;
Ashton, Nicholas J;
Zetterberg, Henrik;
Düzel, Emrah;
... Betts, Matthew J; + view all
(2023)
Cerebrospinal fluid and positron-emission tomography biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis.
Brain Communications
, 5
, Article fcad085. 10.1093/braincomms/fcad085.
|
|
|
Lantero-Rodriguez, J;
Tissot, C;
Snellman, A;
Servaes, S;
Benedet, AL;
Rahmouni, N;
Montoliu-Gaya, L;
... Blennow, K; + view all
(2023)
Plasma and CSF concentrations of N-terminal tau fragments associate with in vivo neurofibrillary tangle burden.
Alzheimer's and Dementia
10.1002/alz.13119.
(In press).
|
|
|
Lantero-Rodriguez, J;
Vrillon, A;
Fernández-Lebrero, A;
Ortiz-Romero, P;
Snellman, A;
Montoliu-Gaya, L;
Brum, WS;
... Blennow, K; + view all
(2023)
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts.
Alzheimer's Research & Therapy
, 15
, Article 48. 10.1186/s13195-023-01201-0.
|
|
Le Guen, Y;
Luo, G;
Ambati, A;
Damotte, V;
Jansen, I;
Yu, E;
Nicolas, A;
... van Swieten, J; + view all
(2023)
Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes.
Proceedings of the National Academy of Sciences
, 120
(36)
, Article e2302720120. 10.1073/pnas.2302720120.
|
|
Lennol, MP;
Ashton, NJ;
Moreno-Pérez, O;
García-Ayllón, MS;
Ramos-Rincon, JM;
Andrés, M;
León-Ramírez, JM;
... Sáez-Valero, J; + view all
(2023)
Transient Changes in the Plasma of Astrocytic and Neuronal Injury Biomarkers in COVID-19 Patients without Neurological Syndromes.
International Journal of Molecular Sciences
, 24
(3)
, Article 2715. 10.3390/ijms24032715.
|
|
Leuzy, Antoine;
Mattsson-Carlgren, Niklas;
Cullen, Nicholas C;
Stomrud, Erik;
Palmqvist, Sebastian;
La Joie, Renaud;
Iaccarino, Leonardo;
... Hansson, Oskar; + view all
(2023)
Robustness of CSF Aβ42/40 and Aβ42/P-tau181 measured using fully automated immunoassays to detect AD-related outcomes.
Alzheimer's & Dementia
10.1002/alz.12897.
(In press).
|
|
Levin, H;
Lybeck, A;
Frigyesi, A;
Arctaedius, I;
Thorgeirsdóttir, B;
Annborn, M;
Moseby-Knappe, M;
... Mattsson-Carlgren, N; + view all
(2023)
Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest.
Critical Care
, 27
, Article 74. 10.1186/s13054-023-04355-3.
|
|
Li, LM;
Heslegrave, A;
Soreq, E;
Nattino, G;
Rosnati, M;
Garbero, E;
Zimmerman, KA;
... Sharp, DJ; + view all
(2023)
Investigating the characteristics and correlates of systemic inflammation after traumatic brain injury: the TBI-BraINFLAMM study.
BMJ open
, 13
(5)
, Article e069594. 10.1136/bmjopen-2022-069594.
|
|
|
Li, X;
Yucel, R;
Clervius, H;
Kamalakar, K;
Zetterberg, H;
Blennow, K;
Zhang, J;
... Gustafson, DR; + view all
(2023)
Plasma Biomarkers of Alzheimer Disease in Women With and Without HIV.
JAMA Network Open
, 6
(11)
, Article e2344194. 10.1001/jamanetworkopen.2023.44194.
|
|
Libby, Julia B;
Seto, Mabel;
Khan, Omair A;
Liu, Dandan;
Petyuk, Vlad;
Oliver, Nekesa C;
Choi, Min Ji;
... Hohman, Timothy J; + view all
(2023)
Whole blood transcript and protein abundance of the vascular endothelial growth factor family relate to cognitive performance.
Neurobiology of Aging
, 124
pp. 11-17.
10.1016/j.neurobiolaging.2023.01.002.
|
|
López-Martos, David;
Brugulat-Serrat, Anna;
Cañas-Martínez, Alba;
Canals-Gispert, Lidia;
Marne, Paula;
Gramunt, Nina;
Suárez-Calvet, Marc;
... ALFA study; + view all
(2023)
Reference Data for Attentional, Executive, Linguistic, and Visual Processing Tests Obtained from Cognitively Healthy Individuals with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
Journal of Alzheimer's Disease
10.3233/JAD-230290.
(In press).
|
|
Lu, Haiyan;
Wang, Bin;
Liu, Yuan;
Wang, Danqing;
Fields, Lauren;
Zhang, Hua;
Li, Miyang;
... Li, Lingjun; + view all
(2023)
DiLeu Isobaric Labeling Coupled with Limited Proteolysis Mass Spectrometry for High-Throughput Profiling of Protein Structural Changes in Alzheimer's Disease.
Analytical Chemistry
, 95
(26)
pp. 9746-9753.
10.1021/acs.analchem.2c05731.
|
|
Malek-Ahmadi, Michael;
Su, Yi;
Ghisays, Valentina;
Luo, Ji;
Devadas, Vivek;
Chen, Yinghua;
Lee, Wendy;
... Reiman, Eric M; + view all
(2023)
Plasma NfL is associated with the APOE ε4 allele, brain imaging measurements of neurodegeneration, and lower recall memory scores in cognitively unimpaired late-middle-aged and older adults.
Alzheimer's Research & Therapy
, 15
, Article 74. 10.1186/s13195-023-01221-w.
|
|
Marra, Christina M;
Sahi, Sharon K;
Tantalo, Lauren C;
Zetterberg, Henrik;
(2023)
Serum Neurofilament Light in Neurosyphilis: A Pilot Study.
Sexually Transmitted Diseases
, 50
(1)
pp. 42-44.
10.1097/OLQ.0000000000001717.
|
|
|
Maruszak, Aleksandra;
Silajdžić, Edina;
Lee, Hyunah;
Murphy, Tytus;
Liu, Benjamine;
Shi, Liu;
de Lucia, Chiara;
... Thuret, Sandrine; + view all
(2023)
Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum.
Brain
, Article awac472. 10.1093/brain/awac472.
(In press).
|
|
Mattsson-Carlgren, Niklas;
Salvadó, Gemma;
Ashton, Nicholas J;
Tideman, Pontus;
Stomrud, Erik;
Zetterberg, Henrik;
Ossenkoppele, Rik;
... Hansson, Oskar; + view all
(2023)
Prediction of Longitudinal Cognitive Decline in Preclinical Alzheimer Disease Using Plasma Biomarkers.
JAMA Neurology
10.1001/jamaneurol.2022.5272.
(In press).
|
|
Meda, Francisco;
Simrén, Joel;
Borroni, Barbara;
Cantoni, Valentina;
Archetti, Silvana;
Biasiotto, Giorgio;
Andreasson, Ulf;
... Zetterberg, Henrik; + view all
(2023)
Analytical and clinical validation of a blood progranulin ELISA in frontotemporal dementias.
Clinical Chemistry and Laboratory Medicine (CCLM)
10.1515/cclm-2023-0562.
(In press).
|
|
Meda, Francisco J;
Knowles, Kathryn;
Swift, Imogen J;
Sogorb-Esteve, Aitana;
Rohrer, Jonathan D;
Dittrich, Anna;
Skoog, Ingmar;
... Zetterberg, Henrik; + view all
(2023)
Neurofilament light oligomers in neurodegenerative diseases: quantification by homogeneous immunoassay in cerebrospinal fluid.
BMJ Neurology Open
, 5
(1)
, Article e000395. 10.1136/bmjno-2022-000395.
|
|
Meng, Ying;
Goubran, Maged;
Rabin, Jennifer S;
McSweeney, Melissa;
Ottoy, Julie;
Pople, Christopher B;
Huang, Yuexi;
... Lipsman, Nir; + view all
(2023)
Blood–brain barrier opening of the default mode network in Alzheimer's disease with magnetic resonance-guided focused ultrasound.
Brain
, 146
(3)
pp. 865-872.
10.1093/brain/awac459.
|
|
Mens, Helene;
Fjordside, Lasse;
Gynthersen, Rosa;
Ørbaek, Mathilde;
Andersen, Åse Bengaard;
Andreasson, Ulf;
Blennow, Kaj;
... Lebech, Anne-Mette; + view all
(2023)
Plasma neurofilament light significantly decreases following treatment in Lyme neuroborreliosis and not associated with persistent symptoms.
European Journal of Neurology
, 30
(5)
pp. 1371-1377.
10.1111/ene.15707.
|
|
Mgaieth, F;
Baksh, RA;
Startin, CM;
Hamburg, S;
Hithersay, R;
Pape, S;
Zetterberg, H;
... Strydom, A; + view all
(2023)
Exploring semantic verbal fluency patterns and their relationship to age and Alzheimer's disease in adults with Down syndrome.
Alzheimer's and Dementia
10.1002/alz.13097.
(In press).
|
|
|
Michaëlsson, I;
Skoglund, T;
Hallén, T;
Olsson, R;
Maltese, G;
Tarnow, P;
Bhatti-Søfteland, M;
... Kölby, L; + view all
(2023)
Circulating Brain-Injury Markers After Surgery for Craniosynostosis.
World Neurosurgery
10.1016/j.wneu.2023.02.102.
(In press).
|
|
Michaëlsson, Isak;
Hallén, Tobias;
Carstam, Louise;
Laesser, Mats;
Björkman-Burtscher, Isabella M;
Sörbo, Ann;
Blennow, Kaj;
... Skoglund, Thomas; + view all
(2023)
Circulating Brain Injury Biomarkers: A Novel Method for Quantification of the Impact on the Brain After Tumor Surgery.
Neurosurgery
, 93
(4)
pp. 847-856.
10.1227/neu.0000000000002510.
|
|
Mok, Tze How;
Nihat, Akin;
Majbour, Nour;
Sequeira, Danielle;
Holm-Mercer, Leah;
Coysh, Thomas;
Darwent, Lee;
... Mead, Simon; + view all
(2023)
Seed amplification and neurodegeneration marker trajectories in individuals at risk of prion disease.
Brain
, Article awad101. 10.1093/brain/awad101.
|
|
|
Montoliu-Gaya, L;
Alcolea, D;
Ashton, NJ;
Pegueroles, J;
Levin, J;
Bosch, B;
Lantero-Rodriguez, J;
... Fortea, J; + view all
(2023)
Plasma and cerebrospinal fluid glial fibrillary acidic protein levels in adults with Down syndrome: a longitudinal cohort study.
eBioMedicine
, 90
, Article 104547. 10.1016/j.ebiom.2023.104547.
|
|
Montoliu-Gaya, L;
Benedet, AL;
Tissot, C;
Vrillon, A;
Ashton, NJ;
Brum, WS;
Lantero-Rodriguez, J;
... Blennow, K; + view all
(2023)
Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies.
Nature Aging
10.1038/s43587-023-00405-1.
(In press).
|
|
|
Nair, Ajay Kumar;
Van Hulle, Carol A;
Bendlin, Barbara B;
Zetterberg, Henrik;
Blennow, Kaj;
Wild, Norbert;
Kollmorgen, Gwendlyn;
... Rosenkranz, Melissa A; + view all
(2023)
Impact of asthma on the brain: evidence from diffusion MRI, CSF biomarkers and cognitive decline.
Brain Communications
, 5
(3)
, Article fcad180. 10.1093/braincomms/fcad180.
|
|
Neumann, A;
Ohlei, O;
Küçükali, F;
Bos, IJ;
Timsina, J;
Vos, S;
Prokopenko, D;
... Bertram, L; + view all
(2023)
Multivariate GWAS of Alzheimer’s disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Genome medicine
, 15
, Article 79. 10.1186/s13073-023-01233-z.
|
|
|
O'Donnell, Luke F;
Pipis, Menelaos;
Thornton, John S;
Kanber, Baris;
Wastling, Stephen;
McDowell, Amy;
Zafeiropoulos, Nick;
... Reilly, Mary M; + view all
(2023)
Quantitative MRI outcome measures in CMT1A using automated lower limb muscle segmentation.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2023-332454.
|
|
Oeckl, Patrick;
Bluma, Marina;
Bucci, Marco;
Halbgebauer, Steffen;
Chiotis, Konstantinos;
Sandebring-Matton, Anna;
Ashton, Nicholas J;
... Otto, Markus; + view all
(2023)
Blood β-synuclein is related to amyloid PET positivity in memory clinic patients.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
10.1002/alz.13046.
(In press).
|
|
Öhrfelt, Annika;
Benedet, Andréa L;
Ashton, Nicholas J;
Kvartsberg, Hlin;
Vandijck, Manu;
Weiner, Michael W;
Trojanowski, John Q;
... Blennow, Kaj; + view all
(2023)
Association of CSF GAP-43 With the Rate of Cognitive Decline and Progression to Dementia in Amyloid-Positive Individuals.
Neurology
, 100
(3)
e275-e285.
10.1212/WNL.0000000000201417.
|
|
Panyard, Daniel J;
Deming, Yuetiva K;
Darst, Burcu F;
Van Hulle, Carol A;
Zetterberg, Henrik;
Blennow, Kaj;
Kollmorgen, Gwendlyn;
... Lu, Qiongshi; + view all
(2023)
Liver-Specific Polygenic Risk Score Is Associated with Alzheimer's Disease Diagnosis.
Journal of Alzheimer's Disease
, 92
(2)
pp. 395-409.
10.3233/JAD-220599.
|
|
Panyard, DJ;
McKetney, J;
Deming, YK;
Morrow, AR;
Ennis, GE;
Jonaitis, EM;
Van Hulle, CA;
... Engelman, CD; + view all
(2023)
Large-scale proteome and metabolome analysis of CSF implicates altered glucose and carbon metabolism and succinylcarnitine in Alzheimer's disease.
Alzheimer's and Dementia
10.1002/alz.13130.
(In press).
|
|
|
Payne, T;
Taylor, J;
Casey, C;
Kunkel, D;
Parker, M;
Blennow, K;
Zetterberg, H;
... Sanders, RD; + view all
(2023)
Prospective analysis of plasma amyloid beta and postoperative delirium in the Interventions for Postoperative Delirium: Biomarker-3 study.
British Journal of Anaesthesia
, 130
(5)
pp. 546-556.
10.1016/j.bja.2023.01.020.
|
|
Pelkmans, Wiesje;
Shekari, Mahnaz;
Brugulat-Serrat, Anna;
Sánchez-Benavides, Gonzalo;
Minguillón, Carolina;
Fauria, Karine;
Molinuevo, Jose Luis;
... ALFA study, .; + view all
(2023)
Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
Alzheimer's & Dementia
10.1002/alz.13450.
(In press).
|
|
Rådestig, MA;
Skoog, J;
Zetterberg, H;
Skillbäck, T;
Zettergren, A;
Sterner, TR;
Fässberg, MM;
... Kern, S; + view all
(2023)
Subtle Differences in Cognition in 70-Year-Olds with Elevated Cerebrospinal Fluid Neurofilament Light and Neurogranin: A H70 Cross-Sectional Study.
Journal of Alzheimer's disease : JAD
, 91
(1)
pp. 291-303.
10.3233/JAD-220452.
|
|
Ripamonti, Enrico;
Edén, Arvid;
Nilsson, Staffan;
Sönnerborg, Anders;
Zetterberg, Henrik;
Gisslén, Magnus;
(2023)
Longitudinal decline of plasma neurofilament light levels after antiretroviral initiation in people living with HIV.
Journal of Internal Medicine
, 293
(4)
pp. 445-456.
10.1111/joim.13594.
|
|
Roselli, Sandra;
Satir, Tugce Munise;
Camacho, Rafael;
Fruhwürth, Stefanie;
Bergström, Petra;
Zetterberg, Henrik;
Agholme, Lotta;
(2023)
APP‑BACE1 Interaction and Intracellular Localization Regulate Aβ Production in iPSC‑Derived Cortical Neurons.
Cellular and Molecular Neurobiology
10.1007/s10571-023-01374-0.
|
|
Rosenstein, Igal;
Axelsson, Markus;
Novakova, Lenka;
Malmeström, Clas;
Blennow, Kaj;
Zetterberg, Henrik;
Lycke, Jan;
(2023)
Intrathecal kappa free light chain synthesis is associated with worse prognosis in relapsing-remitting multiple sclerosis.
Journal of Neurology
10.1007/s00415-023-11817-9.
(In press).
|
|
Rosenstein, Igal;
Axelsson, Markus;
Novakova, Lenka;
Rasch, Sofia;
Blennow, Kaj;
Zetterberg, Henrik;
Lycke, Jan;
(2023)
High levels of kappa free light chain synthesis predict cognitive decline in relapsing-remitting multiple sclerosis.
Frontiers in Immunology
, 14
, Article 1106028. 10.3389/fimmu.2023.1106028.
|
|
Rostgaard, Nina;
Olsen, Markus Harboe;
Ottenheijm, Maud;
Drici, Lylia;
Simonsen, Anja Hviid;
Plomgaard, Peter;
Gredal, Hanne;
... Juhler, Marianne; + view all
(2023)
Differential proteomic profile of lumbar and ventricular cerebrospinal fluid.
Fluids and Barriers of the CNS
, 20
, Article 6. 10.1186/s12987-022-00405-0.
|
|
Rozalem Aranha, M;
Iulita, MF;
Montal, V;
Pegueroles, J;
Bejanin, A;
Vaqué-Alcázar, L;
Grothe, MJ;
... Fortea, J; + view all
(2023)
Basal forebrain atrophy along the Alzheimer's disease continuum in adults with Down syndrome.
Alzheimer's and Dementia
10.1002/alz.12999.
|
|
Rymo, Irma;
Fässberg, Madeleine Mellqvist;
Kern, Silke;
Zetterberg, Henrik;
Skoog, Ingmar;
Waern, Margda;
Sacuiu, Simona;
(2023)
Mild cognitive impairment is associated with passive suicidal ideation in older adults: A population-based study.
Acta Psychiatrica Scandinavica
, 148
(1)
pp. 91-101.
10.1111/acps.13549.
|
|
Salvadó, G;
Larsson, V;
Cody, KA;
Cullen, NC;
Jonaitis, EM;
Stomrud, E;
Kollmorgen, G;
... Hansson, O; + view all
(2023)
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi-cohort study.
Alzheimer's and Dementia
10.1002/alz.12907.
(In press).
|
|
Salvadó, G;
Ossenkoppele, R;
Ashton, NJ;
Beach, TG;
Serrano, GE;
Reiman, EM;
Zetterberg, H;
... Hansson, O; + view all
(2023)
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads.
EMBO Molecular Medicine
, Article e2463. 10.15252/emmm.202217123.
|
|
Sanchez, E;
Wilkinson, T;
Coughlan, G;
Mirza, S;
Baril, AA;
Ramirez, J;
Binns, MA;
... Masellis, M; + view all
(2023)
Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.
Alzheimer's and Dementia
10.1002/alz.13560.
(In press).
|
|
Sanfilippo, Cristina;
Castrogiovanni, Paola;
Vinciguerra, Manlio;
Imbesi, Rosa;
Ulivieri, Martina;
Fazio, Francesco;
Blennow, Kaj;
... Di Rosa, Michelino; + view all
(2023)
A sex-stratified analysis of neuroimmune gene expression signatures in Alzheimer's disease brains.
GeroScience
, 45
pp. 523-541.
10.1007/s11357-022-00664-7.
|
|
Sanfilippo, Cristina;
Giuliano, Loretta;
Castrogiovanni, Paola;
Imbesi, Rosa;
Ulivieri, Martina;
Fazio, Francesco;
Blennow, Kaj;
... Di Rosa, Michelino; + view all
(2023)
Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances.
Current Neuropharmacology
, 21
(3)
pp. 740-760.
10.2174/1570159X21666221207091209.
|
|
Saunders, T;
Gunn, C;
Blennow, K;
Kvartsberg, H;
Zetterberg, H;
Shenkin, SD;
Cox, SR;
... Spires-Jones, T; + view all
(2023)
Neurogranin in Alzheimer's disease and ageing: A human post-mortem study.
Neurobiology of Disease
, 177
, Article 105991. 10.1016/j.nbd.2023.105991.
|
|
Saunders, Tyler S;
Pozzolo, Francesca E;
Heslegrave, Amanda;
King, Declan;
McGeachan, Robert I;
Spires-Jones, Maxwell P;
Harris, Sarah E;
... Spires-Jones, Tara L; + view all
(2023)
Predictive blood biomarkers and brain changes associated with age-related cognitive decline.
Brain Communications
, 5
(3)
, Article fcad113. 10.1093/braincomms/fcad113.
|
|
|
Schilling, S;
Pradhan, A;
Heesch, A;
Helbig, A;
Blennow, K;
Koch, C;
Bertgen, L;
... Eggert, S; + view all
(2023)
Differential effects of familial Alzheimer’s disease-causing mutations on amyloid precursor protein (APP) trafficking, proteolytic conversion, and synaptogenic activity.
Acta Neuropathologica Communications
, 11
, Article 87. 10.1186/s40478-023-01577-y.
|
|
|
Selvakumar, J;
Havdal, LB;
Drevvatne, M;
Brodwall, EM;
Lund Berven, L;
Stiansen-Sonerud, T;
Einvik, G;
... Wyller, VBB; + view all
(2023)
Prevalence and Characteristics Associated With Post-COVID-19 Condition Among Nonhospitalized Adolescents and Young Adults.
JAMA Network Open
, 6
(3)
, Article e235763. 10.1001/jamanetworkopen.2023.5763.
|
|
Setlere, Signe;
Grosmane, Arta;
Kurjane, Natalja;
Gailite, Linda;
Rots, Dmitrijs;
Blennow, Kaj;
Zetterberg, Henrik;
(2023)
Plasma neurofilament light chain level is not a biomarker of Charcot–Marie–Tooth disease progression: Results of 3-year follow-up study.
European Journal of Neurology
, 30
(8)
pp. 2453-2460.
10.1111/ene.15858.
|
|
Shi, Liu;
Xu, Jin;
Green, Rebecca;
Wretlind, Asger;
Homann, Jan;
Buckley, Noel J;
Tijms, Betty M;
... Legido-Quigley, Cristina; + view all
(2023)
Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
10.1002/alz.12961.
(In press).
|
|
Snellman, A;
Ekblad, LL;
Tuisku, J;
Koivumäki, M;
Ashton, NJ;
Lantero-Rodriguez, J;
Karikari, TK;
... Rinne, JO; + view all
(2023)
APOE ε4 gene dose effect on imaging and blood biomarkers of neuroinflammation and beta-amyloid in cognitively unimpaired elderly.
Alzheimer's Research & Therapy
, 15
(1)
, Article 71. 10.1186/s13195-023-01209-6.
|
|
Snellman, Anniina;
Ekblad, Laura L;
Ashton, Nicholas J;
Karikari, Thomas K;
Lantero-Rodriguez, Juan;
Pietilä, Elina;
Koivumäki, Mikko;
... Rinne, Juha O; + view all
(2023)
Head-to-head comparison of plasma p-tau181, p-tau231 and glial fibrillary acidic protein in clinically unimpaired elderly with three levels of APOE4-related risk for Alzheimer's disease.
Neurobiology of Disease
, 183
, Article 106175. 10.1016/j.nbd.2023.106175.
|
|
Srikrishna, Meera;
Ashton, Nicholas J;
Moscoso, Alexis;
Pereira, Joana B;
Heckemann, Rolf A;
Van Westen, Danielle;
Volpe, Giovanni;
... Schöll, Michael; + view all
(2023)
CT-based volumetric measures obtained through deep learning: Association with biomarkers of neurodegeneration.
Alzheimer's & Dementia
10.1002/alz.13445.
(In press).
|
|
|
Stankeviciute, L;
Falcon, C;
Operto, G;
Garcia, M;
Shekari, M;
Iranzo, Á;
Niñerola-Baizán, A;
... Grau-Rivera, O; + view all
(2023)
Differential effects of sleep on brain structure and metabolism at the preclinical stages of AD.
Alzheimer's and Dementia
10.1002/alz.13102.
(In press).
|
|
|
Sunde, Anita L;
Alsnes, Ingvild V;
Aarsland, Dag;
Ashton, Nicholas J;
Tovar-Rios, Diego A;
De Santis, Giovanni;
Blennow, Kaj;
... Kjosavik, Svein R; + view all
(2023)
Preanalytical stability of plasma biomarkers for Alzheimer's disease pathology.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 15
(2)
, Article e12439. 10.1002/dad2.12439.
|
|
Swift, Imogen J;
Sjödin, Simon;
Gobom, Johan;
Brinkmalm, Ann;
Blennow, Kaj;
Zetterberg, Henrik;
Rohrer, Jonathan D;
(2023)
Differential patterns of lysosomal dysfunction are seen in the clinicopathological forms of primary progressive aphasia.
Journal of Neurology
10.1007/s00415-023-12063-9.
(In press).
|
|
|
Tabor, Jason B;
Brett, Benjamin L;
Nelson, Lindsay;
Meier, Timothy;
Penner, Linden C;
Mayer, Andrew R;
Echemendia, Ruben J;
... McCrea, Michael; + view all
(2023)
Role of biomarkers and emerging technologies in defining and assessing neurobiological recovery after sport-related concussion: a systematic review.
British Journal of Sports Medicine
, 57
(12)
pp. 789-797.
10.1136/bjsports-2022-106680.
|
|
Taylor, J;
Eisenmenger, L;
Lindroth, H;
Booth, J;
Mohanty, R;
Nair, V;
Parker, M;
... Sanders, RD; + view all
(2023)
Perioperative ischaemic brain injury and plasma neurofilament light: a secondary analysis of two prospective cohort studies.
British Journal of Anaesthesia
, 130
(2)
e361-e369.
10.1016/j.bja.2022.10.018.
|
|
Taylor, J;
Payne, T;
Casey, C;
Kunkel, D;
Parker, M;
Rivera, C;
Zetterberg, H;
... Sanders, RD; + view all
(2023)
Sevoflurane dose and postoperative delirium: a prospective cohort analysis.
British Journal of Anaesthesia
, 130
(2)
e289-e297.
10.1016/j.bja.2022.08.022.
|
|
Teunissen, Charlotte E;
Kimble, Leighann;
Bayoumy, Sherif;
Bolsewig, Katharina;
Burtscher, Felicia;
Coppens, Salomé;
Das, Shreyasee;
... MIRIADE consortium; + view all
(2023)
Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias.
Molecular & Cellular Proteomics
, Article 100629. 10.1016/j.mcpro.2023.100629.
(In press).
|
|
Thela, L;
Decloedt, E;
Zetterberg, H;
Gisslén, M;
Lesosky, M;
Gleich, M;
Koutsilieri, E;
... Joska, J; + view all
(2023)
Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial.
Journal of NeuroVirology
10.1007/s13365-023-01116-4.
(In press).
|
|
Therriault, J;
Servaes, S;
Tissot, C;
Rahmouni, N;
Ashton, NJ;
Benedet, AL;
Karikari, TK;
... Rosa-Neto, P; + view all
(2023)
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's disease.
Alzheimer's and Dementia
10.1002/alz.13026.
(In press).
|
|
|
Thorsson, Martin;
Hallén, Tobias;
Olsson, Daniel S;
Blennow, Kaj;
Zetterberg, Henrik;
Johannsson, Gudmundur;
Skoglund, Thomas;
(2023)
Hypotension during transsphenoidal pituitary surgery associated with increase in plasma levels of brain injury markers.
Acta Anaesthesiologica Scandinavica
10.1111/aas.14315.
(In press).
|
|
Toft, Anders;
Sjödin, Simon;
Simonsen, Anja Hviid;
Ejlerskov, Patrick;
Roos, Peter;
Musaeus, Christian Sandøe;
Henriksen, Emil Elbæk;
... Nielsen, Jørgen Erik; + view all
(2023)
Endo-lysosomal protein concentrations in CSF from patients with frontotemporal dementia caused by CHMP2B mutation.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 15
(1)
, Article e12402. 10.1002/dad2.12402.
|
|
Toorell, Hanna;
Carlsson, Ylva;
Hallberg, BouBou;
O'Riordian, Mairead N;
Walsh, Brian Henry;
O'Sullivan, Marc Paul;
Boylan, Geraldine B;
... Hagberg, Henrik; + view all
(2023)
Neuro-Specific and Immuno-Inflammatory Biomarkers in Umbilical Cord Blood in Neonatal Hypoxic-Ischemic Encephalopathy.
Neonatology
10.1159/000533473.
(In press).
|
|
|
Torell, Agnes;
Stockfelt, Marit;
Larsson, Gunilla;
Blennow, Kaj;
Zetterberg, Henrik;
Leonard, Dag;
Rönnblom, Lars;
... Lundell, Anna-Carin; + view all
(2023)
Low-density granulocytes are related to shorter pregnancy duration but not to interferon alpha protein blood levels in systemic lupus erythematosus.
Arthritis Research & Therapy
, 25
(1)
, Article 107. 10.1186/s13075-023-03092-w.
|
|
Tristão-Pereira, Catarina;
Fuster, Valentin;
Oliva, Belen;
Moreno-Arciniegas, Andrea;
Garcia-Lunar, Ines;
Perez-Herreras, Cristina;
Schöll, Michael;
... Cortes-Canteli, Marta; + view all
(2023)
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study.
The Lancet Healthy Longevity
, 4
(9)
e487-e498.
10.1016/S2666-7568(23)00134-4.
|
|
van den Berg, Emma;
Nilsson, Johanna;
Kersten, Iris;
Brinkmalm, Gunnar;
de Kort, Anna M;
Klijn, Catharina JM;
Schreuder, Floris HBM;
... Verbeek, Marcel M; + view all
(2023)
Cerebrospinal Fluid Panel of Synaptic Proteins in Cerebral Amyloid Angiopathy and Alzheimer's Disease.
Journal of Alzheimer's Disease
10.3233/JAD-220977.
(In press).
|
|
Van Egroo, M;
Riphagen, JM;
Ashton, NJ;
Janelidze, S;
Sperling, RA;
Johnson, KA;
Yang, HS;
... Jacobs, HIL; + view all
(2023)
Ultra-high field imaging, plasma markers and autopsy data uncover a specific rostral locus coeruleus vulnerability to hyperphosphorylated tau.
Molecular Psychiatry
pp. 1-11.
10.1038/s41380-023-02041-y.
(In press).
|
|
van Zalm, Patrick W;
Ahmed, Saima;
Fatou, Benoit;
Schreiber, Rudy;
Barnaby, Omar;
Boxer, Adam;
Zetterberg, Henrik;
... Steen, Hanno; + view all
(2023)
Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers.
Cell Reports Medicine
, 4
(4)
, Article 101005. 10.1016/j.xcrm.2023.101005.
|
|
Vanninen, Aleksi;
Lukkarinen, Heikki;
Kokkola, Tarja;
Koivisto, Anne M;
Kokki, Merja;
Musialowicz, Tadeusz;
Hiltunen, Mikko;
... Rauramaa, Tuomas; + view all
(2023)
Cerebrospinal Fluid Diagnostics of Alzheimer’s Disease in Patients with Idiopathic Normal Pressure Hydrocephalus.
Journal of Alzheimer's Disease
, 94
(2)
pp. 727-736.
10.3233/JAD-230144.
|
|
Veje, Malin;
Griška, Vytautas;
Pakalnienė, Jolita;
Mickienė, Auksė;
Bremell, Daniel;
Zetterberg, Henrik;
Blennow, Kaj;
... Studahl, Marie; + view all
(2023)
Serum and cerebrospinal fluid brain damage markers neurofilament light and glial fibrillary acidic protein correlate with tick-borne encephalitis disease severity—a multicentre study on Lithuanian and Swedish patients.
European Journal of Neurology
, Article 15978. 10.1111/ene.15978.
(In press).
|
|
Veréb, D;
Mijalkov, M;
Canal-Garcia, A;
Chang, YW;
Gomez-Ruiz, E;
Gerboles, BZ;
Kivipelto, M;
... Pereira, JB; + view all
(2023)
Age-related differences in the functional topography of the locus coeruleus and their implications for cognitive and affective functions.
eLife
, 12
, Article RP87188. 10.7554/eLife.87188.
|
|
Verma, N;
Velmurugan, GV;
Winford, E;
Coburn, H;
Kotiya, D;
Leibold, N;
Radulescu, L;
... Despa, F; + view all
(2023)
Aβ efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas.
Communications biology
, 6
(1)
, Article 2. 10.1038/s42003-022-04398-2.
|
|
Veteleanu, A;
Stevenson-Hoare, J;
Keat, S;
Daskoulidou, N;
Zetterberg, H;
Heslegrave, A;
Escott-Price, V;
... Morgan, BP; + view all
(2023)
Alzheimer’s disease-associated complement gene variants influence plasma complement protein levels.
Journal of Neuroinflammation
, 20
(1)
, Article 169. 10.1186/s12974-023-02850-6.
|
|
Vila-Castelar, Clara;
Chen, Yinghua;
Langella, Stephanie;
Lopera, Francisco;
Zetterberg, Henrik;
Hansson, Oskar;
Dage, Jeffrey L;
... Quiroz, Yakeel T; + view all
(2023)
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's disease.
Alzheimers & Dementia
, 19
(9)
pp. 4127-4138.
10.1002/alz.13314.
|
|
Wehrli, PM;
Ge, J;
Michno, W;
Koutarapu, S;
Dreos, A;
Jha, D;
Zetterberg, H;
... Hanrieder, J; + view all
(2023)
Correlative Chemical Imaging and Spatial Chemometrics Delineate Alzheimer Plaque Heterogeneity at High Spatial Resolution.
JACS Au
10.1021/jacsau.2c00492.
(In press).
|
|
Weiner, S;
Junkkari, A;
Sauer, M;
Luikku, A;
Rauramaa, T;
Kokkola, T;
Herukka, SK;
... Gobom, J; + view all
(2023)
Novel cerebrospinal fluid biomarkers correlating with shunt responsiveness in patients with idiopathic normal pressure hydrocephalus.
Fluids and barriers of the CNS
, 20
, Article 40. 10.1186/s12987-023-00440-5.
|
|
|
Weiner, S;
Sauer, M;
Brinkmalm, G;
Constantinescu, J;
Constantinescu, R;
Gomes, BF;
Becker, B;
... Gobom, J; + view all
(2023)
SCRN1: A cerebrospinal fluid biomarker correlating with tau in Alzheimer's disease.
Alzheimer's & Dementia
10.1002/alz.13042.
(In press).
|
|
Willumsen, Nanet;
Arber, Charles;
Lovejoy, Christopher;
Toombs, Jamie;
Alatza, Argyro;
Weston, Philip SJ;
Chávez-Gutiérrez, Lucia;
... Wray, Selina; + view all
(2023)
The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue.
Brain Communications
, 5
(1)
, Article fcac321. 10.1093/braincomms/fcac321.
|
|
Wilson, DM;
Cookson, MR;
Van Den Bosch, L;
Zetterberg, H;
Holtzman, DM;
Dewachter, I;
(2023)
Hallmarks of neurodegenerative diseases.
Cell
, 186
(4)
pp. 693-714.
10.1016/j.cell.2022.12.032.
|
|
Wolzak, K;
Vermunt, L;
Campo, MD;
Jorge-Oliva, M;
van Ziel, AM;
Li, KW;
Smit, AB;
... Scheper, W; + view all
(2023)
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology.
Alzheimer's and Dementia
10.1002/alz.12978.
(In press).
|
|
Woo, MS;
Nilsson, J;
Therriault, J;
Rahmouni, N;
Brinkmalm, A;
Benedet, AL;
Ashton, NJ;
... Rosa-Neto, P; + view all
(2023)
14-3-3 ζ/δ-reported early synaptic injury in Alzheimer’s disease is independently mediated by sTREM2.
Journal of Neuroinflammation
, 20
, Article 278. 10.1186/s12974-023-02962-z.
|
|
Woo, MS;
Tissot, C;
Lantero-Rodriguez, J;
Snellman, A;
Therriault, J;
Rahmouni, N;
Macedo, AC;
... Rosa-Neto, P; + view all
(2023)
Plasma pTau-217 and N-terminal tau (NTA) enhance sensitivity to identify tau PET positivity in amyloid-β positive individuals.
Alzheimer's and Dementia
10.1002/alz.13528.
(In press).
|
|
|
Xu, Yuexuan;
Vasiljevic, Eva;
Deming, Yuetiva K;
Jonaitis, Erin M;
Koscik, Rebecca L;
Van Hulle, Carol A;
Lu, Qiongshi;
... Engelman, Corinne D; + view all
(2023)
Effect of Pathway-Specific Polygenic Risk Scores for Alzheimer's Disease (AD) on Rate of Change in Cognitive Function and AD-Related Biomarkers Among Asymptomatic Individuals.
Journal of Alzheimer's Disease
, 94
(4)
pp. 1587-1605.
10.3233/JAD-230097.
|
|
Yuan, J;
Pedrini, S;
Thota, R;
Doecke, J;
Chatterjee, P;
Sohrabi, HR;
Teunissen, CE;
... Martins, RN; + view all
(2023)
Elevated plasma sclerostin is associated with high brain amyloid-β load in cognitively normal older adults.
npj Aging
, 9
, Article 17. 10.1038/s41514-023-00114-4.
|
|
Zapater-Fajarí, Mariola;
Diaz-Galvan, Patricia;
Cedres, Nira;
Rydberg Sterner, Therese;
Rydén, Lina;
Sacuiu, Simona;
Waern, Margda;
... Ferreira, Daniel; + view all
(2023)
Biomarkers of Alzheimer’s disease and cerebrovascular disease in relation to depressive symptomatology in individuals with subjective cognitive decline.
The Journals of Gerontology, Series A
, Article glad216. 10.1093/gerona/glad216.
(In press).
|
|
Zetterberg, Hedvig;
Owiredua, Christiana;
Åsenlöf, Pernilla;
Lennartsson, Rebecca;
Brodda Jansen, Gunilla;
Boersma, Katja;
Linton, Steven J;
... Flink, Ida; + view all
(2023)
Preventing Pain and Stress-Related Ill-Health in Employees: A 6-Months Follow-Up of a Psychosocial Program in a Cluster Randomized Controlled Trial.
Journal of Occupational Rehabilitation
, 33
(2)
pp. 316-328.
10.1007/s10926-022-10074-3.
|
|
Zetterberg, Henrik;
Teunissen, Charlotte;
van Swieten, John;
Kuhle, Jens;
Boxer, Adam;
Rohrer, Jonathan D;
Mitic, Laura;
... Tatton, Nadine; + view all
(2023)
The role of neurofilament light in genetic frontotemporal lobar degeneration.
Brain Communications
, 5
(1)
, Article fcac310. 10.1093/braincomms/fcac310.
|
|
Zettergren, A;
Jonson, M;
Mellqvist Fässberg, M;
Najar, J;
Rydberg Sterner, T;
Seidu, NM;
Kern, S;
... Waern, M; + view all
(2023)
Passive and active suicidal ideation in a population-based sample of older adults: Associations with polygenic risk scores of relevance for suicidal behavior.
Frontiers in Psychiatry
, 14
, Article 1101956. 10.3389/fpsyt.2023.1101956.
|
2022
|
Akinci, Muge;
Peña-Gómez, Cleofé;
Operto, Gregory;
Fuentes-Julian, Sherezade;
Deulofeu, Carme;
Sánchez-Benavides, Gonzalo;
Milà-Alomà, Marta;
... Arenaza-Urquijo, Eider M; + view all
(2022)
Pre-pandemic Alzheimer Disease Biomarkers and Anxious-Depressive Symptoms During the COVID-19 Confinement in Cognitively Unimpaired Adults.
Neurology
, 99
e1486-e1498.
10.1212/WNL.0000000000200948.
|
|
Alawode, Deborah OT;
Fox, Nick C;
Zetterberg, Henrik;
Heslegrave, Amanda J;
(2022)
Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint.
Frontiers in Neuroscience
, 16
, Article 837390. 10.3389/fnins.2022.837390.
|
|
Ashton, Nicholas J;
Benedet, Andréa L;
Pascoal, Tharick A;
Karikari, Thomas K;
Lantero-Rodriguez, Juan;
Brum, Wagner S;
Mathotaarachchi, Sulantha;
... Rosa-Neto, Pedro; + view all
(2022)
Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease.
EBioMedicine
, 76
, Article 103836. 10.1016/j.ebiom.2022.103836.
|
|
|
Ashton, Nicholas J;
Janelidze, Shorena;
Mattsson-Carlgren, Niklas;
Binette, Alexa Pichet;
Strandberg, Olof;
Brum, Wagner S;
Karikari, Thomas K;
... Hansson, Oskar; + view all
(2022)
Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring.
Nature Medicine
10.1038/s41591-022-02074-w.
(In press).
|
|
Ashton, Nicholas J;
Puig-Pijoan, Albert;
Mila-Aloma, Marta;
Fernandez-Lebrero, Aida;
Garcia-Escobar, Greta;
Gonzalez-Ortiz, Fernando;
Kac, Przemyslaw R;
... Suarez-Calvet, Marc; + view all
(2022)
Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
Alzheimer's & Dementia
10.1002/alz.12841.
(In press).
|
|
Aveneau, C;
Hourregue, C;
Cognat, E;
Dumurgier, J;
Vanderstichele, H;
Vanmechelen, E;
Zetterberg, H;
... Bouaziz-Amar, E; + view all
(2022)
Cerebrospinal fluid neurogranin in Alzheimer's disease studies: are immunoassay results interchangeable?
Clinical Chemistry and Laboratory Medicine (CCLM)
, 60
(1)
e13-e17.
10.1515/cclm-2021-0505.
|
|
Bäckström, David;
Granåsen, Gabriel;
Mo, Susanna Jakobson;
Riklund, Katrine;
Trupp, Miles;
Zetterberg, Henrik;
Blennow, Kaj;
... Domellöf, Magdalena Eriksson; + view all
(2022)
Prediction and early biomarkers of cognitive decline in Parkinson disease and atypical parkinsonism: a population-based study.
Brain Communications
, 4
(2)
, Article fcac040. 10.1093/braincomms/fcac040.
|
|
|
Banote, Rakesh Kumar;
Håkansson, Samuel;
Zetterberg, Henrik;
Zelano, Johan;
(2022)
Cerebrospinal fluid biomarkers in patients with epilepsy in Alzheimer's disease: a nation-wide study.
Brain Communications
10.1093/braincomms/fcac210.
(In press).
|
|
Barbu, Mikael;
Jónsson, Kristján;
Zetterberg, Henrik;
Blennow, Kaj;
Kolsrud, Oscar;
Ricksten, Sven-Erik;
Dellgren, Göran;
... Jeppsson, Anders; + view all
(2022)
Serum biomarkers of brain injury after uncomplicated cardiac surgery: Secondary analysis from a randomized trial.
Acta Anaesthesiologica Scandinavica
10.1111/aas.14033.
|
|
|
Batzu, Lucia;
Rota, Silvia;
Hye, Abdul;
Heslegrave, Amanda;
Trivedi, Dhaval;
Gibson, Lucy L;
Farrell, Chloe;
... Aarsland, Dag; + view all
(2022)
Plasma p-tau181, neurofilament light chain and association with cognition in Parkinson's disease.
npj Parkinson's Disease
, 8
, Article 154. 10.1038/s41531-022-00384-x.
|
|
Bendlin, Barbara B;
Zetterberg, Henrik;
(2022)
The iterative process of fluid biomarker development and validation in Alzheimer's disease.
Alzheimer's & Dementia
, 14
(1)
, Article e12341. 10.1002/dad2.12341.
|
|
|
Benedet, Andréa L;
Brum, Wagner S;
Hansson, Oskar;
Alzheimer’s Disease Neuroimaging Initiative;
Karikari, Thomas K;
Zimmer, Eduardo R;
Zetterberg, Henrik;
... Ashton, Nicholas J; + view all
(2022)
The accuracy and robustness of plasma biomarker models for amyloid PET positivity.
Alzheimer's Research & Therapy
, 14
(1)
, Article 26. 10.1186/s13195-021-00942-0.
|
|
|
Benkert, P;
Meier, S;
Schaedelin, S;
Manouchehrinia, A;
Yaldizli, Ö;
Maceski, A;
Oechtering, J;
... Zecca, C; + view all
(2022)
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
The Lancet Neurology
, 21
(3)
pp. 246-257.
10.1016/S1474-4422(22)00009-6.
|
|
Benussi, A;
Cantoni, V;
Rivolta, J;
Archetti, S;
Micheli, A;
Ashton, N;
Zetterberg, H;
... Borroni, B; + view all
(2022)
Classification accuracy of blood-based and neurophysiological markers in the differential diagnosis of Alzheimer’s disease and frontotemporal lobar degeneration.
Alzheimer's Research and Therapy
, 14
(1)
, Article 155. 10.1186/s13195-022-01094-5.
|
|
Benussi, Alberto;
Libri, Ilenia;
Premi, Enrico;
Alberici, Antonella;
Cantoni, Valentina;
Gadola, Yasmine;
Rivolta, Jasmine;
... Borroni, Barbara; + view all
(2022)
Differences and similarities between familial and sporadic frontotemporal dementia: An Italian single-center cohort study.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 8
(1)
, Article e12326. 10.1002/trc2.12326.
|
|
|
Bergman, Lina;
Hastie, Roxanne;
Bokström-Rees, Emma;
Zetterberg, Henrik;
Blennow, Kaj;
Schell, Sonja;
Imberg, Henrik;
... Cluver, Catherine; + view all
(2022)
Cerebral biomarkers in neurological complications of preeclampsia.
American Journal of Obstetrics and Gynecology
10.1016/j.ajog.2022.02.036.
(In press).
|
|
Bernini, Adriano;
Magnoni, Sandra;
Miroz, John-Paul;
Corredor-Jerez, Ricardo;
Bertolini, Guido;
Zetterberg, Henrik;
Graham, Neil;
... Dunet, Vincent; + view all
(2022)
Cerebral Metabolic Dysfunction at the Acute Phase of Traumatic Brain Injury Correlates with Long-Term Tissue Loss.
Journal of Neurotrauma
10.1089/neu.2022.0161.
(In press).
|
|
Betancor, M;
Pérez-Lázaro, S;
Otero, A;
Marín, B;
Martín-Burriel, I;
Blennow, K;
Badiola, JJ;
... Bolea, R; + view all
(2022)
Neurogranin and Neurofilament Light Chain as Preclinical Biomarkers in Scrapie.
International Journal of Molecular Sciences
, 23
(13)
, Article 7182. 10.3390/ijms23137182.
|
|
Binette, Alexa Pichet;
Palmqvist, Sebastian;
Bali, Divya;
Farrar, Gill;
Buckley, Christopher J;
Wolk, David A;
Zetterberg, Henrik;
... Hansson, Oskar; + view all
(2022)
Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer’s dementia in mild cognitive impairment patients.
Alzheimer's Research and Therapy
, 14
, Article 46. 10.1186/s13195-022-00990-0.
|
|
|
Bjurström, Martin F;
Blennow, Kaj;
Zetterberg, Henrik;
Bodelsson, Mikael;
Waldén, Markus;
Dietz, Nicholas;
Hall, Sara;
... Mattsson-Carlgren, Niklas; + view all
(2022)
Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain: associations with pain severity and central sensitization.
Pain Reports
, 7
(1)
, Article e988. 10.1097/PR9.0000000000000988.
|
|
|
Black, Stefanie AG;
Stepanchuk, Anastasiia A;
Templeton, George W;
Hernandez, Yda;
Ota, Tomoko;
Roychoudhury, Shyamosree;
Smith, Eric E;
... Tsutsui, Shigeki; + view all
(2022)
Diagnosing Alzheimer's Disease from Circulating Blood Leukocytes Using a Fluorescent Amyloid Probe.
Journal of Alzheimer's Disease
, 85
(4)
pp. 1721-1734.
10.3233/JAD-215402.
|
|
Blennow, Kaj;
Stomrud, Erik;
Zetterberg, Henrik;
Borlinghaus, Niels;
Corradini, Veronika;
Manuilova, Ekaterina;
Muller-Hubner, Laura;
... Hansson, Oskar; + view all
(2022)
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer's disease.
Clinical Chemistry and Laboratory Medicine
, 61
(2)
pp. 234-244.
10.1515/cclm-2022-0516.
|
|
Blennow Nordström, Erik;
Lilja, Gisela;
Ullén, Susann;
Blennow, Kaj;
Friberg, Hans;
Hassager, Christian;
Kjærgaard, Jesper;
... Cronberg, Tobias; + view all
(2022)
Serum neurofilament light levels are correlated to long-term neurocognitive outcome measures after cardiac arrest.
Brain Injury
, 36
(6)
pp. 800-809.
10.1080/02699052.2022.2048693.
|
|
Bowman, Emily ML;
Cardwell, Christopher;
McAuley, Daniel F;
McGuinness, Bernadette;
Passmore, Anthony P;
Beverland, David;
Zetterberg, Henrik;
... Cunningham, Emma L; + view all
(2022)
Factors influencing resilience to postoperative delirium in adults undergoing elective orthopaedic surgery.
British Journal of Surgery
, Article znac197. 10.1093/bjs/znac197.
|
|
Brand, Abby L;
Lawler, Paige E;
Bollinger, James G;
Li, Yan;
Schindler, Suzanne E;
Li, Melody;
Lopez, Samir;
... Bateman, Randall J; + view all
(2022)
The performance of plasma amyloid beta measurements in identifying amyloid plaques in Alzheimer's disease: a literature review.
Alzheimer's Research & Therapy
, 14
(1)
, Article 195. 10.1186/s13195-022-01117-1.
|
|
Braun, Gabriel A;
Dear, Alexander J;
Sanagavarapu, Kalyani;
Zetterberg, Henrik;
Linse, Sara;
(2022)
Amyloid-β peptide 37, 38 and 40 individually and cooperatively inhibit amyloid-β 42 aggregation.
Chemical Science
, 13
(8)
pp. 2423-2439.
10.1039/d1sc02990h.
|
|
|
Braun, Madelene;
Bjurnemark, Caroline;
Seo, Woosung;
Freyhult, Eva;
Nyholm, Dag;
Niemelä, Valter;
Blennow, Kaj;
... Virhammar, Johan; + view all
(2022)
Higher levels of neurofilament light chain and total tau in CSF are associated with negative outcome after shunt surgery in patients with normal pressure hydrocephalus.
Fluids Barriers of the CNS
, 19
(1)
, Article 15. 10.1186/s12987-022-00306-2.
|
|
|
Brinkley, Tina E;
Leng, Iris;
Register, Thomas C;
Neth, Bryan J;
Zetterberg, Henrik;
Blennow, Kaj;
Craft, Suzanne;
(2022)
Changes in Adiposity and Cerebrospinal Fluid Biomarkers Following a Modified Mediterranean Ketogenic Diet in Older Adults at Risk for Alzheimer's Disease.
Frontiers in Neuroscience
, 16
, Article 906539. 10.3389/fnins.2022.906539.
|
|
Brum, Wagner S;
de Bastiani, Marco Antônio;
Bieger, Andrei;
Therriault, Joseph;
Ferrari-Souza, João P;
Benedet, Andréa L;
Saha-Chaudhuri, Paramita;
... Alzheimer's Disease Neuroimaging Initiative (ADNI); + view all
(2022)
A three-range approach enhances the prognostic utility of CSF biomarkers in Alzheimer's disease.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 8
(1)
, Article e12270. 10.1002/trc2.12270.
|
|
Brune, Synne;
Høgestøl, Einar A;
de Rodez Benavent, Sigrid A;
Berg-Hansen, Pål;
Beyer, Mona K;
Leikfoss, Ingvild Sørum;
Bos, Steffan D;
... Harbo, Hanne F; + view all
(2022)
Serum neurofilament light chain concentration predicts disease worsening in multiple sclerosis.
Multiple Sclerosis Journal
10.1177/13524585221097296.
(In press).
|
|
Bruno, Davide;
Jauregi Zinkunegi, Ainara;
Pomara, Nunzio;
Zetterberg, Henrik;
Blennow, Kaj;
Koscik, Rebecca Langhough;
Carlsson, Cynthia;
... Mueller, Kimberly D; + view all
(2022)
Cross-sectional associations of CSF tau levels with Rey's AVLT: A recency ratio study.
Neuropsychology
10.1037/neu0000821.
(In press).
|
|
Cacciaglia, Raffaele;
Operto, Gregory;
Falcon, Carles;
De Echavarri-Gomez, Jose Maria Gonzalez;
Sanchez-Benavides, Gonzalo;
Brugulat-Serrat, Anna;
Mila-Aloma, Marta;
... Gispert, Juan Domingo; + view all
(2022)
Genotypic effects of APOE-epsilon 4 on resting-state connectivity in cognitively intact individuals support functional brain compensation.
Cerebral Cortex
, Article bhac239. 10.1093/cercor/bhac239.
(In press).
|
|
Cacciaglia, Raffaele;
Salvadó, Gemma;
Molinuevo, José Luis;
Shekari, Mahnaz;
Falcon, Carles;
Operto, Gregory;
Suárez-Calvet, Marc;
... ALFA study; + view all
(2022)
Age, sex and APOE-ε4 modify the balance between soluble and fibrillar β-amyloid in non-demented individuals: topographical patterns across two independent cohorts.
Molecular Psychiatry
10.1038/s41380-022-01436-7.
(In press).
|
|
|
Camporesi, E;
Nilsson, J;
Vrillon, A;
Cognat, E;
Hourregue, C;
Zetterberg, H;
Blennow, K;
... Brinkmalm, G; + view all
(2022)
Quantification of the trans-synaptic partners neurexin-neuroligin in CSF of neurodegenerative diseases by parallel reaction monitoring mass spectrometry.
EBioMedicine
, 75
, Article 103793. 10.1016/j.ebiom.2021.103793.
|
|
|
Cattaneo, Gabriele;
Solana-Sánchez, Javier;
Abellaneda-Pérez, Kilian;
Portellano-Ortiz, Cristina;
Delgado-Gallén, Selma;
Alviarez Schulze, Vanessa;
Pachón-García, Catherine;
... Bartrés-Faz, David; + view all
(2022)
Sense of Coherence Mediates the Relationship Between Cognitive Reserve and Cognition in Middle-Aged Adults.
Frontiers in Psychology
, 13
, Article 835415. 10.3389/fpsyg.2022.835415.
|
|
Cedres, Nira;
Ferreira, Daniel;
Nemy, Milan;
Machado, Alejandra;
Pereira, Joana B;
Shams, Sara;
Wahlund, Lars-Olof;
... Westman, Eric; + view all
(2022)
Association of Cerebrovascular and Alzheimer Disease Biomarkers With Cholinergic White Matter Degeneration in Cognitively Unimpaired Individuals.
Neurology
, 99
(15)
e1619-e1629.
10.1212/WNL.0000000000200930.
|
|
Chatterjee, P;
Pedrini, S;
Ashton, NJ;
Tegg, M;
Goozee, K;
Singh, AK;
Karikari, TK;
... Martins, RN; + view all
(2022)
Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
Alzheimer's & Dementia
, 18
(6)
pp. 1141-1154.
10.1002/alz.12447.
|
|
Chen, Zhengwei;
Wang, Danqing;
Yu, Qing;
Johnson, Jillian;
Shipman, Richard;
Zhong, Xiaofang;
Huang, Junfeng;
... Li, Lingjun; + view all
(2022)
In-Depth Site-Specific O-Glycosylation Analysis of Glycoproteins and Endogenous Peptides in Cerebrospinal Fluid (CSF) from Healthy Individuals, Mild Cognitive Impairment (MCI), and Alzheimer's Disease (AD) Patients.
ACS Chemical Biology
, 17
(11)
pp. 2059-3068.
10.1021/acschembio.1c00932.
|
|
Cheng, D;
Luo, Z;
Fu, X;
Stephenson, S;
Di Germanio, C;
Norris, PJ;
Fuchs, D;
... Jiang, W; + view all
(2022)
Elevated Cerebrospinal Fluid Anti-CD4 Autoantibody Levels in HIV Associate with Neuroinflammation.
Microbiology Spectrum
, 10
(1)
, Article e0197521. 10.1128/spectrum.01975-21.
|
|
|
Chouliaras, Leonidas;
Thomas, Alan;
Malpetti, Maura;
Donaghy, Paul;
Kane, Joseph;
Mak, Elijah;
Savulich, George;
... O'Brien, John Tiernan; + view all
(2022)
Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy.
Journal of Neurology, Neurosurgery & Psychiatry
, 93
(6)
pp. 651-658.
10.1136/jnnp-2021-327788.
|
|
Clarin, Marcus;
Petersson, Annika;
Zetterberg, Henrik;
Ekblom, Kim;
(2022)
Detection of subarachnoid haemorrhage with spectrophotometry of cerebrospinal fluid – a comparison of two methods.
Clinical Chemistry and Laboratory Medicine
, 60
(7)
10.1515/cclm-2021-1320.
|
|
Correia, Manuel;
Silva, Isabel;
Gabriel, Denis;
Simrén, Joel;
Carneiro, Angelo;
Ribeiro, Sara;
Dória, Hugo Mota;
... Maia, Luis F; + view all
(2022)
Early plasma biomarker dynamic profiles are associated with acute ischemic stroke outcomes.
European Journal of Neurology
, 29
(6)
pp. 1630-1642.
10.1111/ene.15273.
|
|
Cullen, NC;
Janelidze, S;
Mattsson-Carlgren, N;
Palmqvist, S;
Bittner, T;
Suridjan, I;
Jethwa, A;
... Hansson, O; + view all
(2022)
Test-retest variability of plasma biomarkers in Alzheimer's disease and its effects on clinical prediction models.
Alzheimer's & Dementia
10.1002/alz.12706.
(In press).
|
|
Dauar, MT;
Labonté, A;
Picard, C;
Miron, J;
Rosa-Neto, P;
Zetterberg, H;
Blennow, K;
... Poirier, J; + view all
(2022)
Characterization of the contactin 5 protein and its risk-associated polymorphic variant throughout the Alzheimer's disease spectrum.
Alzheimer's and Dementia
10.1002/alz.12868.
(In press).
|
|
David-Bercholz, J;
Acker, L;
Caceres, AI;
Wu, PY;
Goenka, S;
Franklin, NO;
Rodriguiz, RM;
... Terrando, N; + view all
(2022)
Conserved YKL-40 changes in mice and humans after postoperative delirium.
Brain, Behavior, & Immunity - Health
, 26
, Article 100555. 10.1016/j.bbih.2022.100555.
|
|
Dehlin, Mats;
Fatima, Tahzeeb;
Jacobsson, Lennart TH;
Kern, Silke;
Zettergren, Anna;
Blennow, Kaj;
Zetterberg, Henrik;
... Skoog, Ingmar; + view all
(2022)
Reply to "Pathway for ascertaining the role of uric acid in neurodegenerative diseases," Roman Youssef.
Alzheimers Dementia
, 14
(1)
, Article e12328. 10.1002/dad2.12328.
|
|
del Campo, M;
Zetterberg, H;
Gandy, S;
Onyike, CU;
Oliveira, F;
Udeh-Momoh, C;
Lleó, A;
... Pijnenburg, Y; + view all
(2022)
New developments of biofluid-based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia.
Alzheimer's and Dementia
10.1002/alz.12643.
(In press).
|
|
|
Delaby, Constance;
Alcolea, Daniel;
Hirtz, Christophe;
Vialaret, Jérôme;
Kindermans, Jana;
Morichon, Lisa;
Fortea, Juan;
... Lehmann, Sylvain; + view all
(2022)
Blood amyloid and tau biomarkers as predictors of cerebrospinal fluid profiles.
Journal of Neural Transmission
10.1007/s00702-022-02474-9.
(In press).
|
|
|
Delvenne, A;
Gobom, J;
Tijms, B;
Bos, I;
Reus, LM;
Dobricic, V;
Kate, MT;
... Vos, SJB; + view all
(2022)
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
Alzheimer's and Dementia
10.1002/alz.12713.
(In press).
|
|
Dhiman, K;
Villemagne, VL;
Fowler, C;
Bourgeat, P;
Li, QX;
Collins, S;
Bush, AI;
... Gupta, V; + view all
(2022)
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study.
Biomedicines
, 10
(5)
, Article 1045. 10.3390/biomedicines10051045.
|
|
Dhiman, Kunal;
Villemagne, Victor L;
Fowler, Christopher;
Bourgeat, Pierrick;
Li, Qiao-Xin;
Collins, Steven;
Rowe, Christopher C;
... Gupta, Veer; + view all
(2022)
Cerebrospinal fluid levels of fatty acid-binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 14
(1)
, Article e12377. 10.1002/dad2.12377.
|
|
Donaghy, Paul C;
Firbank, Michael;
Petrides, George;
Lloyd, Jim;
Barnett, Nicola;
Olsen, Kirsty;
Heslegrave, Amanda;
... O'Brien, John T; + view all
(2022)
The relationship between plasma biomarkers and amyloid PET in dementia with Lewy bodies.
Parkinsonism & Related Disorders
, 101
pp. 111-116.
10.1016/j.parkreldis.2022.07.008.
|
|
|
Dong, Ruocheng;
Denier-Fields, Diandra N;
Lu, Qiongshi;
Suridjan, Ivonne;
Kollmorgen, Gwendlyn;
Wild, Norbert;
Betthauser, Tobey James;
... Engelman, Corinne D; + view all
(2022)
Principal components from untargeted cerebrospinal fluid metabolomics associated with Alzheimer's disease biomarkers.
Neurobiology of Aging
, 117
pp. 12-23.
10.1016/j.neurobiolaging.2022.04.009.
|
|
Dreos, A;
Ge, J;
Najera, F;
Tebikachew, BE;
Perez-Inestrosa, E;
Moth-Poulsen, K;
Blennow, K;
... Hanrieder, J; + view all
(2022)
Investigating New Applications of a Photoswitchable Fluorescent Norbornadiene as a Multifunctional Probe for Delineation of Amyloid Plaque Polymorphism.
ACS Sensors
10.1021/acssensors.2c02496.
(In press).
|
|
Driscoll, Ira;
Ma, Yue;
Lose, Sarah R;
Gallagher, Catherine L;
Johnson, Sterling C;
Asthana, Sanjay;
Hermann, Bruce P;
... Okonkwo, Ozioma C; + view all
(2022)
AD-associated CSF biomolecular changes are attenuated in KL-VS heterozygotes.
Alzheimers Dementia
, 14
(1)
, Article e12383. 10.1002/dad2.12383.
|
|
Dumurgier, Julien;
Sabia, Séverine;
Zetterberg, Henrik;
Teunissen, Charlotte;
Hanseeuw, Bernard;
Orellana, Adelina;
Schraen, Susanna;
... for the Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2022)
A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging.
Neurology
, 99
(7)
e669-e678.
10.1212/WNL.0000000000200735.
|
|
Edén, Arvid;
Grahn, Anna;
Bremell, Daniel;
Aghvanyan, Anahit;
Bathala, Pradeepthi;
Fuchs, Dietmar;
Gostner, Johanna;
... Gisslén, Magnus; + view all
(2022)
Viral Antigen and Inflammatory Biomarkers in Cerebrospinal Fluid in Patients With COVID-19 Infection and Neurologic Symptoms Compared With Control Participants Without Infection or Neurologic Symptoms.
JAMA Network Open
, 5
(5)
, Article e2213253. 10.1001/jamanetworkopen.2022.13253.
|
|
Eratne, Dhamidhu;
Loi, Samantha M;
Li, Qiao-Xin;
Stehmann, Christiane;
Malpas, Charles B;
Santillo, Alexander;
Janelidze, Shorena;
... MiND Study Group; + view all
(2022)
Cerebrospinal fluid neurofilament light chain differentiates primary psychiatric disorders from rapidly progressive, Alzheimer's disease and frontotemporal disorders in clinical settings.
Alzheimer's and Dementia
, 18
(11)
pp. 2218-2233.
10.1002/alz.12549.
|
|
Fauria, K;
Minguillon, C;
Knezevic, I;
Tort-Colet, N;
Stankeviciute, L;
Hernández, L;
Rădoi, A;
... Grau-Rivera, O; + view all
(2022)
Exploring cognitive and biological correlates of sleep quality and their potential links with Alzheimer's disease (ALFASleep project): protocol for an observational study.
BMJ Open
, 12
(12)
, Article e067159. 10.1136/bmjopen-2022-067159.
|
|
Ferrari-Souza, João Pedro;
Ferreira, Pâmela CL;
Bellaver, Bruna;
Tissot, Cécile;
Wang, Yi-Ting;
Leffa, Douglas T;
Brum, Wagner S;
... Pascoal, Tharick A; + view all
(2022)
Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer’s disease.
Molecular Psychiatry
10.1038/s41380-022-01716-2.
|
|
|
Frank, B;
Ally, M;
Brekke, B;
Zetterberg, H;
Blennow, K;
Sugarman, MA;
Ashton, NJ;
... Alosco, ML; + view all
(2022)
Plasma p-tau₁₈₁ shows stronger network association to Alzheimer's disease dementia than neurofilament light and total tau.
Alzheimer's & Dementia
, 18
(8)
pp. 1523-1536.
10.1002/alz.12508.
|
|
Friis, T;
Wikström, AK;
Acurio, J;
León, J;
Zetterberg, H;
Blennow, K;
Nelander, M;
... Bergman, L; + view all
(2022)
Cerebral Biomarkers and Blood-Brain Barrier Integrity in Preeclampsia.
Cells
, 11
(5)
, Article 789. 10.3390/cells11050789.
|
|
|
Gafson, Arie R;
Jiang, Xiaotong;
Shen, Changyu;
Kapoor, Raj;
Zetterberg, Henrik;
Fox, Robert J;
Belachew, Shibeshih;
(2022)
Serum Neurofilament Light and Multiple Sclerosis Progression Independent of Acute Inflammation.
JAMA Network Open
, 5
(2)
, Article e2147588. 10.1001/jamanetworkopen.2021.47588.
|
|
|
Garcia-Moreno, Hector;
Prudencio, Mercedes;
Thomas-Black, Gilbert;
Solanky, Nita;
Jansen-West, Karen R;
Hanna Al-Shaikh, Rana;
Heslegrave, Amanda;
... Giunti, Paola; + view all
(2022)
Tau and neurofilament light-chain as fluid biomarkers in spinocerebellar ataxia type 3.
European Journal of Neurology
, 29
(8)
pp. 2439-2452.
10.1111/ene.15373.
|
|
Gerards, Michelle;
Schild, Ann-Katrin;
Meiberth, Dix;
Rostamzadeh, Ayda;
Vehreschild, Jörg Janne;
Wingen-Heimann, Sebastian;
Johannis, Wibke;
... Jessen, Frank; + view all
(2022)
Alzheimer's Disease Plasma Biomarkers Distinguish Clinical Diagnostic Groups in Memory Clinic Patients.
Dementia and Geriatric Cognitive Disorders
10.1159/000524390.
(In press).
|
|
Gibson, Lucy L;
Pollak, Thomas A;
Heslegrave, Amanda;
Hye, Abdul;
Batzu, Lucia;
Rota, Silvia;
Trivedi, Dhaval;
... Aarsland, Dag; + view all
(2022)
Plasma Neurofilament Light and p-tau181 and Risk of Psychosis in Parkinson's Disease.
Journal of Parkinson's Disease
pp. 1-12.
10.3233/JPD-223182.
(In press).
|
|
Gobom, Johan;
Benedet, Andréa L;
Mattsson-Carlgren, Niklas;
Montoliu-Gaya, Laia;
Schultz, Nina;
Ashton, Nicholas J;
Janelidze, Shorena;
... Blennow, Kaj; + view all
(2022)
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer's disease continuum.
Molecular Neurodegeneration
, 17
, Article 81. 10.1186/s13024-022-00586-0.
|
|
Gonzalez-Ortiz, Fernando;
Turton, Michael;
Kac, Przemysław R;
Smirnov, Denis;
Premi, Enrico;
Ghidoni, Roberta;
Benussi, Luisa;
... Karikari, Thomas K; + view all
(2022)
Brain-derived tau: a novel blood-based biomarker for Alzheimer's disease-type neurodegeneration.
Brain
, Article awac407. 10.1093/brain/awac407.
(In press).
|
|
Gracias, Jessica;
Orhan, Funda;
Hörbeck, Elin;
Holmén-Larsson, Jessica;
Khanlarkani, Neda;
Malwade, Susmita;
Goparaju, Sravan K;
... Sellgren, Carl M; + view all
(2022)
Cerebrospinal fluid concentration of complement component 4A is increased in first episode schizophrenia.
Nature Communications
, 13
, Article 6427. 10.1038/s41467-022-33797-6.
|
|
Grindegård, Linnéa;
Cronberg, Tobias;
Backman, Sofia;
Blennow, Kaj;
Dankiewicz, Josef;
Friberg, Hans;
Hassager, Christian;
... Moseby-Knappe, Marion; + view all
(2022)
Association Between EEG Patterns and Serum Neurofilament Light After Cardiac Arrest: A Post Hoc Analysis of the TTM Trial.
Neurology
10.1212/WNL.0000000000200335.
(In press).
|
|
Hagberg, Lars;
Edén, Arvid;
Zetterberg, Henrik;
Price, Richard W;
Gisslén, Magnus;
(2022)
Blood biomarkers for HIV infection with focus on neurologic complications-A review.
Acta Neurologica Scandinavica
10.1111/ane.13629.
(In press).
|
|
Hanbouch, L;
Schaack, B;
Kasri, A;
Fontaine, G;
Gkanatsiou, E;
Brinkmalm, G;
Camporesi, E;
... Potier, MC; + view all
(2022)
Specific Mutations in the Cholesterol-Binding Site of APP Alter Its Processing and Favor the Production of Shorter, Less Toxic Aβ Peptides.
Molecular Neurobiology
10.1007/s12035-022-03025-9.
(In press).
|
|
Hansson, Caroline;
Zetterberg, Henrik;
Snellman, Anniina;
Blennow, Kaj;
Jonsdottir, Ingibjörg H;
(2022)
Biomarkers of brain injury in patients with stress-related exhaustion: A longitudinal study.
Psychoneuroendocrinology
, 146
, Article 105929. 10.1016/j.psyneuen.2022.105929.
|
|
Hansson, O;
Kumar, A;
Janelidze, S;
Stomrud, E;
Insel, PS;
Blennow, K;
Zetterberg, H;
... Mattsson-Carlgren, N; + view all
(2022)
The genetic regulation of protein expression in cerebrospinal fluid.
EMBO Molecular Medicine
, Article e16359. 10.15252/emmm.202216359.
(In press).
|
|
Hansson, Oskar;
Edelmayer, Rebecca M;
Boxer, Adam L;
Carrillo, Maria C;
Mielke, Michelle M;
Rabinovici, Gil D;
Salloway, Stephen;
... Teunissen, Charlotte E; + view all
(2022)
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease.
Alzheimer's & Dementia
, 18
(12)
pp. 2669-2686.
10.1002/alz.12756.
|
|
Harding, Daniel;
Rosadas, Carolina;
Tsoti, Sandra Maria;
Heslegrave, Amanda;
Stewart, Molly;
Kelleher, Peter;
Zetterberg, Henrik;
... Dhasmana, Divya; + view all
(2022)
Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers.
Journal of NeuroVirology
10.1007/s13365-022-01088-x.
|
|
|
Hatton, Christopher;
Ghanem, Simona S;
Koss, David J;
Abdi, Ilham Y;
Gibbons, Elizabeth;
Guerreiro, Rita;
Bras, Jose;
... Erskine, Daniel; + view all
(2022)
Prion-like α-synuclein pathology in the brain of infants with Krabbe disease.
Brain
, 145
(4)
pp. 1257-1263.
10.1093/brain/awac002.
|
|
Havdal, Lise Beier;
Berven, Lise Lund;
Selvakumar, Joel;
Stiansen-Sonerud, Tonje;
Leegaard, Truls Michael;
Tjade, Trygve;
Zetterberg, Henrik;
... Wyller, Vegard Bruun Bratholm; + view all
(2022)
Neurological Involvement in COVID-19 Among Non-Hospitalized Adolescents and Young Adults.
Frontiers in Neurology
, 13
, Article 915712. 10.3389/fneur.2022.915712.
|
|
|
Head, Elizabeth;
Zetterberg, Henrik;
(2022)
Commentary on Oeckl et al., “Serum Beta-Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181”.
Annals of Neurology
, 92
(1)
pp. 3-5.
10.1002/ana.26414.
|
|
Hegen, H;
Arrambide, G;
Gnanapavan, S;
Kaplan, B;
Khalil, M;
Saadeh, R;
Teunissen, C;
... Deisenhammer, F; + view all
(2022)
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A consensus statement.
Multiple Sclerosis Journal
10.1177/13524585221134217.
(In press).
|
|
Hegen, H;
Walde, J;
Berek, K;
Arrambide, G;
Gnanapavan, S;
Kaplan, B;
Khalil, M;
... Deisenhammer, F; + view all
(2022)
Cerebrospinal fluid kappa free light chains for the diagnosis of multiple sclerosis: A systematic review and meta-analysis.
Multiple Sclerosis Journal
10.1177/13524585221134213.
(In press).
|
|
Henjum, Kristi;
Watne, Leiv Otto;
Godang, Kristin;
Halaas, Nathalie Bodd;
Eldholm, Rannveig Saksholm;
Blennow, Kaj;
Zetterberg, Henrik;
... Knapskog, Anne Brita; + view all
(2022)
Cerebrospinal fluid catecholamines in Alzheimer's disease patients with and without biological disease.
Transl Psychiatry
, 12
, Article 151. 10.1038/s41398-022-01901-5.
|
|
|
Hildenborg, M;
Kåhlin, J;
Granath, F;
Schening, A;
Granström, A;
Ebberyd, A;
Klevenvall, L;
... Eriksson, LI; + view all
(2022)
The Neuroimmune Response to Surgery – An Exploratory Study of Trauma-Induced Changes in Innate Immunity and Heart Rate Variability.
Frontiers in Immunology
, 13
, Article 911744. 10.3389/fimmu.2022.911744.
|
|
|
Hill, Emily;
Moffat, Kevin G;
Wall, Mark J;
Zetterberg, Henrik;
Blennow, Kaj;
Karikari, Thomas K;
(2022)
Functional Applications of Stable Tau Oligomers in Cell Biology and Electrophysiology Studies.
Protein Aggregation : Methods in Molecular Biology
, 2551
pp. 147-161.
10.1007/978-1-0716-2597-2_11.
|
|
Hill, Emily;
Moffat, Kevin G;
Wall, Mark J;
Zetterberg, Henrik;
Blennow, Kaj;
Karikari, Thomas K;
(2022)
A Validated Method to Prepare Stable Tau Oligomers.
Protein Aggregation: Methods in Molecular Biology
, 2551
pp. 203-224.
10.1007/978-1-0716-2597-2_14.
|
|
Hossain, Iftakher;
Blennow, Kaj;
Posti, Jussi P;
Zetterberg, Henrik;
(2022)
Tau as a fluid biomarker of concussion and neurodegeneration.
Concussion
, 7
(2)
, Article CNC98. 10.2217/cnc-2022-0004.
|
|
Humaloja, J;
Lähde, M;
Ashton, NJ;
Matti, R;
Hästbacka, J;
Jakkula, P;
Friberg, H;
... COMACARE Study Groups; + view all
(2022)
GFAp and tau protein as predictors of neurological outcome after out-of-hospital cardiac arrest: A post hoc analysis of the COMACARE trial.
Resuscitation
, 170
pp. 141-149.
10.1016/j.resuscitation.2021.11.033.
|
|
|
Imarisio, Alberto;
Pilotto, Andrea;
Garrafa, Emirena;
Conforti, Francesca;
Masciocchi, Stefano;
Turrone, Rosanna;
Gipponi, Stefano;
... Padovani, Alessandro; + view all
(2022)
Plasma Cystatin C correlates with plasma NfL levels and predicts disease progression in Parkinson's disease.
Neurodegenerative Diseases
10.1159/000523982.
(In press).
|
|
Iram, Tal;
Kern, Fabian;
Kaur, Achint;
Myneni, Saket;
Morningstar, Allison R;
Shin, Heather;
Garcia, Miguel A;
... Wyss-Coray, Tony; + view all
(2022)
Young CSF restores oligodendrogenesis and memory in aged mice via Fgf17.
Nature
, 605
(7910)
pp. 509-515.
10.1038/s41586-022-04722-0.
|
|
Isgren, Anniella;
Goteson, Andreas;
Holmen-Larsson, Jessica;
Pelanis, Aurimantas;
Sellgren, Carl;
Joas, Erik;
Sparding, Timea;
... Landen, Mikael; + view all
(2022)
Cerebrospinal fluid proteomic study of two bipolar disorder cohorts.
Molecular Psychiatry
10.1038/s41380-022-01724-2.
|
|
Iverson, GL;
Minkkinen, M;
Karr, JE;
Berghem, K;
Zetterberg, H;
Blennow, K;
Posti, JP;
(2022)
Examining four blood biomarkers for the detection of acute intracranial abnormalities following mild traumatic brain injury in older adults.
Frontiers in Neurology
, 13
, Article 960741. 10.3389/fneur.2022.960741.
|
|
Jaervilehto, Julius;
Harjuhaahto, Sandra;
Palu, Edouard;
Auranen, Mari;
Kvist, Jouni;
Zetterberg, Henrik;
Koskivuori, Johanna;
... Tyynismaa, Henna; + view all
(2022)
Serum Creatine, Not Neurofilament Light, Is Elevated in CHCHD10-Linked Spinal Muscular Atrophy.
Frontiers in Neurology
, 13
, Article 793937. 10.3389/fneur.2022.793937.
|
|
|
Janelidze, Shorena;
Bali, Divya;
Ashton, Nicholas J;
Barthélemy, Nicolas R;
Vanbrabant, Jeroen;
Stoops, Erik;
Vanmechelen, Eugeen;
... Hansson, Oskar; + view all
(2022)
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
Brain
, Article awac333. 10.1093/brain/awac333.
(In press).
|
|
Janelidze, S;
Palmqvist, S;
Leuzy, A;
Stomrud, E;
Verberk, IMW;
Zetterberg, H;
Ashton, NJ;
... Hansson, O; + view all
(2022)
Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p-tau.
Alzheimer's & Dementia
, 18
(2)
pp. 283-293.
10.1002/alz.12395.
|
|
|
Jansen, Iris E;
van der Lee, Sven J;
Gomez-Fonseca, Duber;
de Rojas, Itziar;
Dalmasso, Maria Carolina;
Grenier-Boley, Benjamin;
Zettergren, Anna;
... van der Flier, Wiesje; + view all
(2022)
Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers.
Acta Neuropathologica
10.1007/s00401-022-02454-z.
(In press).
|
|
Jansen, Willemijn J;
Janssen, Olin;
Tijms, Betty M;
Vos, Stephanie JB;
Ossenkoppele, Rik;
Visser, Pieter Jelle;
Amyloid Biomarker Study Group;
... Zetterberg, Henrik; + view all
(2022)
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
JAMA Neurology
10.1001/jamaneurol.2021.5216.
(In press).
|
|
Jeppsson, A;
Bjerke, M;
Hellström, P;
Blennow, K;
Zetterberg, H;
Kettunen, P;
Wikkelsø, C;
... Tullberg, M; + view all
(2022)
Shared CSF Biomarker Profile in Idiopathic Normal Pressure Hydrocephalus and Subcortical Small Vessel Disease.
Frontiers in Neurology
, 13
, Article 839307. 10.3389/fneur.2022.839307.
|
|
|
Jiang, Richeng;
Smailovic, Una;
Haytural, Hazal;
Tijms, Betty M;
Li, Hao;
Haret, Robert Mihai;
Shevchenko, Ganna;
... Nilsson, Per; + view all
(2022)
Increased CSF-decorin predicts brain pathological changes driven by Alzheimer's Aβ amyloidosis.
Acta Neuropathologica Communications volume
, 10
(1)
, Article 96. 10.1186/s40478-022-01398-5.
|
|
Jiang, Y;
Zhou, X;
Ip, FC;
Chan, P;
Chen, Y;
Lai, NCH;
Cheung, K;
... Ip, NY; + view all
(2022)
Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.
Alzheimer's & Dementia
, 18
(1)
pp. 88-102.
10.1002/alz.12369.
|
|
Johansson, Kalle;
Wasling, Pontus;
Novakova, Lenka;
Sjödin, Simon;
Brinkmalm, Ann;
Brinkmalm, Gunnar;
Blennow, Kaj;
... Axelsson, Markus; + view all
(2022)
Cerebrospinal fluid amyloid precursor protein as a potential biomarker of fatigue in multiple sclerosis: A pilot study.
Multiple Sclerosis and Related Disorders
, 63
, Article 103846. 10.1016/j.msard.2022.103846.
(In press).
|
|
Johnsson, Magnus;
Farman, Helen H;
Blennow, Kaj;
Zetterberg, Henrik;
Malmeström, Clas;
Axelsson, Markus;
Lycke, Jan;
(2022)
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab.
Multiple Sclerosis Journal
10.1177/13524585221108080.
(In press).
|
|
|
Jonaitis, Erin M;
Zetterberg, Henrik;
Koscik, Rebecca Langhough;
Betthauser, Tobey J;
Van Hulle, Carol A;
Hogan, Kirk;
Hegge, Laura;
... Blennow, Kaj; + view all
(2022)
Crosswalk study on blood collection-tube types for Alzheimer's disease biomarkers.
Alzheimer's & Dementia
, 14
(1)
, Article e12266. 10.1002/dad2.12266.
|
|
|
Jons, Daniel;
Zetterberg, Henrik;
Bistrom, Martin;
Alonso-Magdalena, Lucia;
Gunnarsson, Martin;
Vrethem, Magnus;
Blennow, Kaj;
... Andersen, Oluf; + view all
(2022)
Axonal injury in asymptomatic individuals preceding onset of multiple sclerosis.
Annals of Clinical and Translational Neurology
10.1002/acn3.51568.
(In press).
|
|
Jónsson, GG;
Marklund, N;
Blennow, K;
Zetterberg, H;
Wanhainen, A;
Lindström, D;
Eriksson, J;
(2022)
Dynamics of Selected Biomarkers in Cerebrospinal Fluid During Complex Endovascular Aortic Repair – A Pilot Study.
Annals of Vascular Surgery
, 78
pp. 141-151.
10.1016/j.avsg.2021.04.034.
|
|
Jung, M;
Pan, X;
Cunningham, EL;
Passmore, AP;
McGuinness, B;
McAuley, DF;
Beverland, D;
... Green, BD; + view all
(2022)
The Influence of Orthopedic Surgery on Circulating Metabolite Levels, and their Associations with the Incidence of Postoperative Delirium.
Metabolites
, 12
(7)
, Article 616. 10.3390/metabo12070616.
|
|
|
Jutten, Roos J;
Thompson, Louisa;
Sikkes, Sietske AM;
Maruff, Paul;
Molinuevo, José Luis;
Zetterberg, Henrik;
Alber, Jessica;
... Snyder, Peter J; + view all
(2022)
A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach.
Journal of Alzheimer's Disease
pp. 1-14.
10.3233/JAD-215098.
(In press).
|
|
Kac, Przemysław R;
Gonzalez-Ortiz, Fernando;
Simrén, Joel;
Dewit, Nele;
Vanmechelen, Eugeen;
Zetterberg, Henrik;
Blennow, Kaj;
... Karikari, Thomas K; + view all
(2022)
Diagnostic value of serum versus plasma phospho-tau for Alzheimer's disease.
Alzheimer's Research & Therapy
, 14
(1)
, Article 65. 10.1186/s13195-022-01011-w.
|
|
Kapoor, M;
Carr, AS;
Foiani, MS;
Heslegrave, AJ;
Zetterberg, H;
Malaspina, A;
Compton, L;
... Lunn, MP; + view all
(2022)
Association of plasma neurofilament light chain with disease activity in chronic inflammatory demyelinating polyradiculoneuropathy.
European Journal of Neurology
10.1111/ene.15496.
(In press).
|
|
|
Karikari, Thomas K;
Ashton, Nicholas J;
Brinkmalm, Gunnar;
Brum, Wagner S;
Benedet, Andréa L;
Montoliu-Gaya, Laia;
Lantero-Rodriguez, Juan;
... Zetterberg, Henrik; + view all
(2022)
Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility.
Nature Reviews Neurology
, 18
pp. 400-418.
10.1038/s41582-022-00665-2.
|
|
Karikari, TK;
Ashton, NJ;
Zetterberg, H;
Blennow, K;
(2022)
Editorial: Blood Biomarkers of Neurodegenerative Diseases.
Frontiers in Molecular Neuroscience
, 15
, Article 966139. 10.3389/fnmol.2022.966139.
|
|
|
Kerwin, Diana;
Abdelnour, Carla;
Caramelli, Paulo;
Ogunniyi, Adesola;
Shi, Jiong;
Zetterberg, Henrik;
Traber, Martin;
(2022)
Alzheimer's disease diagnosis and management: Perspectives from around the world.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 14
(1)
, Article e12334. 10.1002/dad2.12334.
|
|
|
Keshavan, Ashvini;
O'Shea, Frankie;
Chapman, Miles D;
Hart, Melanie S;
Lunn, Michael Pt;
Paterson, Ross W;
Rohrer, Jonathan D;
... Schott, Jonathan M; + view all
(2022)
CSF biomarkers for dementia.
Practical Neurology
10.1136/practneurol-2021-003310.
(In press).
|
|
Kettunen, Petronella;
Bjerke, Maria;
Eckerström, Carl;
Jonsson, Michael;
Zetterberg, Henrik;
Blennow, Kaj;
Svensson, Johan;
(2022)
Blood-brain barrier dysfunction and reduced cerebrospinal fluid levels of soluble amyloid precursor protein-β in patients with subcortical small-vessel disease.
Alzheimers Dement
, 14
(1)
, Article e12296. 10.1002/dad2.12296.
|
|
Kläppe, U;
Chamoun, S;
Shen, Q;
Finn, A;
Evertsson, B;
Zetterberg, H;
Blennow, K;
... Ingre, C; + view all
(2022)
Cardiac troponin T is elevated and increases longitudinally in ALS patients.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
, 23
(1-2)
pp. 58-65.
10.1080/21678421.2021.1939384.
|
|
|
Kmezic, I;
Samuelsson, K;
Finn, A;
Upate, Z;
Blennow, K;
Zetterberg, H;
Press, R;
(2022)
Neurofilament light chain and total tau in the differential diagnosis and prognostic evaluation of acute and chronic inflammatory polyneuropathies.
European Journal of Neurology
, 29
(9)
pp. 2810-2822.
10.1111/ene.15428.
|
|
Knorr, U;
Simonsen, AH;
Jensen, CS;
Zetterberg, H;
Blennow, K;
Akhøj, M;
Forman, J;
... Kessing, LV; + view all
(2022)
Alzheimer's disease related biomarkers in bipolar disorder - A longitudinal one-year case-control study.
Journal of Affective Disorders
, 297
pp. 623-633.
10.1016/j.jad.2021.10.074.
|
|
Kumar, Ashish;
Sharma, Mitu;
Su, Yixin;
Singh, Sangeeta;
Hsu, Fang-Chi;
Neth, Bryan J;
Register, Thomas C;
... Deep, Gagan; + view all
(2022)
Small extracellular vesicles in plasma reveal molecular effects of modified Mediterranean-ketogenic diet in participants with mild cognitive impairment.
Brain Communications
10.1093/braincomms/fcac262.
(In press).
|
|
Lagebrant, Alice;
Lang, Margareta;
Nielsen, Niklas;
Blennow, Kaj;
Dankiewicz, Josef;
Friberg, Hans;
Hassager, Christian;
... Moseby Knappe, Marion; + view all
(2022)
Brain injury markers in blood predict signs of hypoxic ischaemic encephalopathy on head computed tomography after cardiac arrest.
Resuscitation
10.1016/j.resuscitation.2022.12.006.
(In press).
|
|
Lauvsnes, MB;
Zetterberg, H;
Blennow, K;
Kvaloy, JT;
Tjensvoll, AB;
Maroni, S;
Beyer, MK;
... Omdal, R; + view all
(2022)
Neurofilament light in plasma is a potential biomarker of central nervous system involvement in systemic lupus erythematosus.
Journal of Neurology
, 269
pp. 3064-3074.
10.1007/s00415-021-10893-z.
|
|
Le, Leah T;
Price, Richard W;
Gisslen, Magnus;
Zetterberg, Henrik;
Emu, Brinda;
Fabre, Roxane;
Christian, Pradier;
... Vassallo, Matteo; + view all
(2022)
Correlation between CD4/CD8 ratio and neurocognitive performance during early HIV infection.
HIV Medicine
10.1111/hiv.13411.
(In press).
|
|
Leckey, Claire A;
Zetterberg, Henrik;
(2022)
Neurofilament light chain - defining the analyte.
Brain Communications
10.1093/braincomms/fcac070.
(In press).
|
|
|
Lennol, Matthew Paul;
Sánchez-Domínguez, Irene;
Cuchillo-Ibañez, Inmaculada;
Camporesi, Elena;
Brinkmalm, Gunnar;
Alcolea, Daniel;
Fortea, Juan;
... Sáez-Valero, Javier; + view all
(2022)
Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer's disease patients.
Alzheimer's Research & Therapy
, 14
, Article 161. 10.1186/s13195-022-01108-2.
|
|
Liu, Yuan;
Zhang, Hua;
Zhong, Xiaofang;
Li, Zihui;
Zetterberg, Henrik;
Li, Lingjun;
(2022)
Isotopic N,N-dimethyl leucine tags for absolute quantification of clusterin and apolipoprotein E in Alzheimer's disease.
Journal of Proteomics
, 257
, Article 104507. 10.1016/j.jprot.2022.104507.
|
|
Lopez-Font, Inmaculada;
Lennol, Matthew P;
Iborra-Lazaro, Guillermo;
Zetterberg, Henrik;
Blennow, Kaj;
Saez-Valero, Javier;
(2022)
Altered Balance of Reelin Proteolytic Fragments in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
International Journal of Molecular Sciences
, 23
(14)
, Article 7522. 10.3390/ijms23147522.
|
|
|
Lukkarinen, Heikki;
Jeppsson, Anna;
Wikkelso, Carsten;
Blennow, Kaj;
Zetterberg, Henrik;
Constantinescu, Radu;
Remes, Anne M;
... Tullberg, Mats; + view all
(2022)
Cerebrospinal fluid biomarkers that reflect clinical symptoms in idiopathic normal pressure hydrocephalus patients.
Fluids and Barriers of the CNS
, 19
(1)
, Article 11. 10.1186/s12987-022-00309-z.
|
|
|
Lukkarinen, Heikki;
Vanninen, Aleksi;
Tesseur, Ina;
Pemberton, Darrel;
Van Der Ark, Peter;
Kokkola, Tarja;
Herukka, Sanna-Kaisa;
... Leinonen, Ville; + view all
(2022)
Concordance of Alzheimer's Disease-Related Biomarkers Between Intraventricular and Lumbar Cerebrospinal Fluid in Idiopathic Normal Pressure Hydrocephalus.
Journal of Alzheimer's Disease
10.3233/JAD-220652.
(In press).
|
|
Mander, Bryce A;
Dave, Abhishek;
Lui, Kitty K;
Sprecher, Katherine E;
Berisha, Destiny;
Chappel-Farley, Miranda G;
Chen, Ivy Y;
... Benca, Ruth M; + view all
(2022)
Inflammation, tau pathology, and synaptic integrity associated with sleep spindles and memory prior to β-amyloid positivity.
Sleep
, 45
(9)
, Article zsac135. 10.1093/sleep/zsac135.
|
|
McGuigan, S;
Evered, L;
Scott, D;
Silbert, B;
Zetterberg, H;
Blennow, K;
(2022)
Comparing the effect of xenon and sevoflurane anesthesia on postoperative neural injury biomarkers: a randomized controlled trial.
Medical Gas Research
, 12
(1)
pp. 10-17.
10.4103/2045-9912.324591.
|
|
|
Mcmahon, JH;
Evans, VA;
Lau, JSY;
Symons, J;
Zerbato, JM;
Chang, J;
Solomon, A;
... Lewin, SR; + view all
(2022)
Neurotoxicity with high dose disulfiram and vorinostat used for HIV latency reversal.
AIDS
, 36
(1)
pp. 75-82.
10.1097/QAD.0000000000003091.
|
|
Mens, Helene;
Fjordside, Lasse;
Gynthersen, Rosa MM;
Ørbæk, Mathilde T;
Andersen, Åse Bengaard;
Andreasson, Ulf;
Blennow, Kaj;
... Lebech, Anne-Mette; + view all
(2022)
Neurofilament Light in Cerebrospinal Fluid is Associated With Disease Staging in European Lyme Neuroborreliosis.
Journal of Central Nervous System Disease
, 14
10.1177/11795735221098126.
|
|
|
Meyer, Pierre-François;
Ashton, Nicholas J;
Karikari, Thomas K;
Strikwerda-Brown, Cherie;
Köbe, Theresa;
Gonneaud, Julie;
Pichet Binette, Alexa;
... Presymptomatic Evaluation of Experimental or Novel Treatments fo; + view all
(2022)
Plasma p-tau231, p-tau181, PET Biomarkers, and Cognitive Change in Older Adults.
Annals of Neurology
, 91
(4)
pp. 548-560.
10.1002/ana.26308.
|
|
Michalowska, Malgorzata M;
Herholz, Karl;
Hinz, Rainer;
Amadi, Chinenye;
McInnes, Lynn;
Anton-Rodriguez, Jose M;
Karikari, Thomas K;
... Carter, Stephen F; + view all
(2022)
Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78–94.
Molecular Psychiatry
10.1038/s41380-022-01685-6.
(In press).
|
|
|
Michno, Wojciech;
Koutarapu, Srinivas;
Camacho, Rafael;
Toomey, Christina;
Stringer, Katie;
Minta, Karolina;
Ge, Junyue;
... Hanrieder, Jörg; + view all
(2022)
Chemical traits of cerebral amyloid angiopathy in familial British-, Danish-, and non-Alzheimerʼs dementias.
Journal of Neurochemistry
10.1111/jnc.15694.
(In press).
|
|
Milà-Alomà, Marta;
Ashton, Nicholas J;
Shekari, Mahnaz;
Salvadó, Gemma;
Ortiz-Romero, Paula;
Montoliu-Gaya, Laia;
Benedet, Andrea L;
... Blennow, Kaj; + view all
(2022)
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer’s disease.
Nature Medicine
, 28
pp. 1797-1801.
10.1038/s41591-022-01925-w.
|
|
Moody, Jason F;
Dean, Douglas C;
Kecskemeti, Steve R;
Blennow, Kaj;
Zetterberg, Henrik;
Kollmorgen, Gwendlyn;
Suridjan, Ivonne;
... Bendlin, Barbara B; + view all
(2022)
Associations between diffusion MRI microstructure and cerebrospinal fluid markers of Alzheimer's disease pathology and neurodegeneration along the Alzheimer's disease continuum.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 14
(1)
, Article e12381. 10.1002/dad2.12381.
|
|
Moore, EE;
Khan, OA;
Shashikumar, N;
Pechman, KR;
Liu, D;
Bell, SP;
Nair, S;
... Jefferson, AL; + view all
(2022)
Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage.
Stroke
, 53
(3)
pp. 808-816.
10.1161/STROKEAHA.121.034349.
|
|
Morenas-Rodríguez, E;
Li, Y;
Nuscher, B;
Franzmeier, N;
Xiong, C;
Suárez-Calvet, M;
Fagan, AM;
... Laske, C; + view all
(2022)
Soluble TREM2 in CSF and its association with other biomarkers and cognition in autosomal-dominant Alzheimer's disease: a longitudinal observational study.
The Lancet Neurology
, 21
(4)
pp. 329-341.
10.1016/S1474-4422(22)00027-8.
|
|
|
Morrison, Madeline S;
Aparicio, Hugo J;
Blennow, Kaj;
Zetterberg, Henrik;
Ashton, Nicholas J;
Karikari, Thomas K;
Tripodis, Yorghos;
... Alosco, Michael L; + view all
(2022)
Antemortem plasma phosphorylated tau (181) predicts Alzheimer's disease neuropathology and regional tau at autopsy.
Brain
, 145
(10)
pp. 3546-3557.
10.1093/brain/awac175.
|
|
Morrow, Autumn;
Panyard, Daniel J;
Deming, Yuetiva K;
Jonaitis, Erin;
Dong, Ruocheng;
Vasiljevic, Eva;
Betthauser, Tobey J;
... Engelman, Corinne D; + view all
(2022)
Cerebrospinal Fluid Sphingomyelins in Alzheimer's Disease, Neurodegeneration, and Neuroinflammation.
Journal of Alzheimer's Disease
pp. 1-14.
10.3233/JAD-220349.
(In press).
|
|
Moscoso, A;
Karikari, TK;
Grothe, MJ;
Ashton, NJ;
Lantero-Rodriguez, J;
Snellman, A;
Zetterberg, H;
... Schöll, M; + view all
(2022)
CSF biomarkers and plasma p-tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design.
Alzheimer's and Dementia
10.1002/alz.12570.
(In press).
|
|
|
Moseby-Knappe, Marion;
Levin, Helena;
Blennow, Kaj;
Ullén, Susann;
Zetterberg, Henrik;
Lilja, Gisela;
Dankiewicz, Josef;
... Nielsen, Niklas; + view all
(2022)
Biomarkers of brain injury after cardiac arrest; a statistical analysis plan from the TTM2 trial biobank investigators.
Resuscitation Plus
, 10
, Article 100258. 10.1016/j.resplu.2022.100258.
|
|
Nair, Ajay Kumar;
Van Hulle, Carol A;
Bendlin, Barbara B;
Zetterberg, Henrik;
Blennow, Kaj;
Wild, Norbert;
Kollmorgen, Gwendlyn;
... Rosenkranz, Melissa A; + view all
(2022)
Asthma amplifies dementia risk: Evidence from CSF biomarkers and cognitive decline.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 8
(1)
, Article e12315. 10.1002/trc2.12315.
|
|
|
Needham, Edward J;
Ren, Alexander L;
Digby, Richard J;
Norton, Emma J;
Ebrahimi, Soraya;
Outtrim, Joanne G;
Chatfield, Doris A;
... Cambridge NeuroCOVID Group the CITIID-NIHR COVID-19 BioResource; + view all
(2022)
Brain injury in COVID-19 is associated with dysregulated innate and adaptive immune responses.
Brain
, Article awac321. 10.1093/brain/awac321.
(In press).
|
|
Neerland, Bjørn Erik;
Busund, Rolf;
Haaverstad, Rune;
Helbostad, Jorunn L;
Landsverk, Svein Aslak;
Martinaityte, Ieva;
Norum, Hilde Margrethe;
... Wyller, Torgeir Bruun; + view all
(2022)
Alpha-2-adrenergic receptor agonists for the prevention of delirium and cognitive decline after open heart surgery (ALPHA2PREVENT): protocol for a multicentre randomised controlled trial.
BMJ Open
, 12
(6)
, Article e057460. 10.1136/bmjopen-2021-057460.
|
|
Nelson, DW;
Granberg, T;
Andersen, P;
Jokhadar, E;
Kåhlin, J;
Granström, A;
Hallinder, H;
... Eriksson, LI; + view all
(2022)
The Karolinska NeuroCOVID study protocol: Neurocognitive impairment, biomarkers and advanced imaging in critical care survivors.
Acta Anaesthesiologica Scandinavica
10.1111/aas.14062.
(In press).
|
|
Neumann, Alexander;
Küçükali, Fahri;
Bos, Isabelle;
Vos, Stephanie JB;
Engelborghs, Sebastiaan;
De Pooter, Tim;
Joris, Geert;
... EMIF-AD study group; + view all
(2022)
Rare variants in IFFO1, DTNB, NLRC3 and SLC22A10 associate with Alzheimer's disease CSF profile of neuronal injury and inflammation.
Molecular Psychiatry
10.1038/s41380-022-01437-6.
(In press).
|
|
Newcombe, Virginia FJ;
Ashton, Nicholas J;
Posti, Jussi P;
Glocker, Ben;
Manktelow, Anne;
Chatfield, Doris A;
Winzeck, Stefan;
... Menon, David K; + view all
(2022)
Post-acute blood biomarkers and disease progression in traumatic brain injury.
Brain
10.1093/brain/awac126.
(In press).
|
|
|
Nilsson, J;
Constantinescu, J;
Nellgård, B;
Jakobsson, P;
Brum, WS;
Gobom, J;
Forsgren, L;
... Brinkmalm, A; + view all
(2022)
Cerebrospinal Fluid Biomarkers of Synaptic Dysfunction Are Altered in Parkinson's Disease and Related Disorders.
Movement Disorders
10.1002/mds.29287.
(In press).
|
|
Nilsson, J;
Cousins, KAQ;
Gobom, J;
Portelius, E;
Chen-Plotkin, A;
Shaw, LM;
Grossman, M;
... Brinkmalm, A; + view all
(2022)
Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders.
Alzheimer's and Dementia
10.1002/alz.12809.
|
|
Nilsson, Johanna;
Ashton, Nicholas J;
Benedet, Andrea L;
Montoliu-Gaya, Laia;
Gobom, Johan;
Pascoal, Tharick A;
Chamoun, Mira;
... Blennow, Kaj; + view all
(2022)
Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer's disease.
Alzheimer's Research & Therapy
, 14
(1)
, Article 78. 10.1186/s13195-022-01021-8.
|
|
Noveir, Sasan D;
Kerman, Bilal E;
Xian, Haotian;
Meuret, Cristiana;
Smadi, Sabrina;
Martinez, Ashley E;
Johansson, Johannes;
... Yassine, Hussein N; + view all
(2022)
Effect of the ABCA1 agonist CS-6253 on amyloid-beta and lipoprotein metabolism in cynomolgus monkeys.
Alzheimer's Research & Therapy
, 14
(1)
, Article 87. 10.1186/s13195-022-01028-1.
|
|
Oliveira, DV;
Coupland, KG;
Shao, W;
Jin, S;
Del Gaudio, F;
Wang, S;
Fox, R;
... Karlström, H; + view all
(2022)
Active immunotherapy reduces NOTCH3 deposition in brain capillaries in a CADASIL mouse model.
EMBO Molecular Medicine
, Article e16556. 10.15252/emmm.202216556.
|
|
Padovani, Alessandro;
Canale, Antonio;
Schiavon, Lorenzo;
Masciocchi, Stefano;
Imarisio, Alberto;
Risi, Barbara;
Bonzi, Giulio;
... Pilotto, Andrea; + view all
(2022)
Is amyloid involved in acute neuroinflammation? A CSF analysis in encephalitis.
Alzheimer's & Dementia
10.1002/alz.12554.
(In press).
|
|
|
Page, Valerie J;
Watne, Leiv Otto;
Heslegrave, Amanda;
Clark, Allan;
McAuley, Daniel F;
Sanders, Robert D;
Zetterberg, Henrik;
(2022)
Plasma neurofilament light chain protein as a predictor of days in delirium and deep sedation, mortality and length of stay in critically ill patients.
eBioMedicine
, 80
, Article 104043. 10.1016/j.ebiom.2022.104043.
|
|
Palmqvist, Sebastian;
Stomrud, Erik;
Cullen, Nicholas;
Janelidze, Shorena;
Manuilova, Ekaterina;
Jethwa, Alexander;
Bittner, Tobias;
... Hansson, Oskar; + view all
(2022)
An accurate fully automated panel of plasma biomarkers for Alzheimer's disease.
Alzheimer's & Dementia
10.1002/alz.12751.
(In press).
|
|
Parker, M;
White, M;
Casey, C;
Kunkel, D;
Bo, A;
Blennow, K;
Zetterberg, H;
... Sanders, RD; + view all
(2022)
Cohort Analysis of the Association of Delirium Severity With Cerebrospinal Fluid Amyloid-Tau-Neurodegeneration Pathologies.
The Journals of Gerontology: Series A
, 77
(3)
pp. 494-501.
10.1093/gerona/glab203.
|
|
Parra, Mario A;
Orellana, Paulina;
Leon, Tomas;
Victoria, Cabello G;
Henriquez, Fernando;
Gomez, Rodrigo;
Avalos, Constanza;
... Duran-Aniotz, Claudia; + view all
(2022)
Biomarkers for dementia in Latin American countries: Gaps and opportunities.
Alzheimer's & Dementia
10.1002/alz.12757.
(In press).
|
|
Pekkarinen, Pirkka T;
Carbone, Federico;
Minetti, Silvia;
Ramoni, Davide;
Ristagno, Giuseppe;
Latini, Roberto;
Wihersaari, Lauri;
... Skrifvars, Markus B; + view all
(2022)
Markers of neutrophil mediated inflammation associate with disturbed continuous electroencephalogram after out of hospital cardiac arrest.
Acta Anaesthesiologica Scandinavica
10.1111/aas.14145.
(In press).
|
|
Pengo, Marta;
Alberici, Antonella;
Libri, Ilenia;
Benussi, Alberto;
Gadola, Yasmine;
Ashton, Nicholas J;
Zetterberg, Henrik;
... Borroni, Barbara; + view all
(2022)
Sex influences clinical phenotype in frontotemporal dementia.
Neurological Sciences
10.1007/s10072-022-06185-7.
(In press).
|
|
Pereira, Joana B;
Janelidze, Shorena;
Strandberg, Olof;
Whelan, Christopher D;
Zetterberg, Henrik;
Blennow, Kaj;
Palmqvist, Sebastian;
... Hansson, Oskar; + view all
(2022)
Microglial activation protects against accumulation of tau aggregates in nondemented individuals with underlying Alzheimer’s disease pathology.
Nature Aging
10.1038/s43587-022-00310-z.
(In press).
|
|
Pichet Binette, Alexa;
Janelidze, Shorena;
Cullen, Nicholas;
Dage, Jeffrey L;
Bateman, Randall J;
Zetterberg, Henrik;
Blennow, Kaj;
... Hansson, Oskar; + view all
(2022)
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
Alzheimer's & Dementia
10.1002/alz.12787.
(In press).
|
|
Pilotto, Andrea;
Parigi, Marta;
Bonzi, Giulio;
Battaglio, Beatrice;
Ferrari, Elisabetta;
Mensi, Lorenza;
Benussi, Alberto;
... Padovani, Alessandro; + view all
(2022)
Differences Between Plasma and Cerebrospinal Fluid p-tau181 and p-tau231 in Early Alzheimer's Disease.
Journal of Alzheimer's Disease
pp. 1-7.
10.3233/JAD-215646.
(In press).
|
|
Pomara, Nunzio;
Bruno, Davide;
Plaska, Chelsea Reichert;
Ramos-Cejudo, Jaime;
Osorio, Ricardo S;
Pillai, Anilkumar;
Imbimbo, Bruno P;
... Blennow, Kaj; + view all
(2022)
Plasma Amyloid-β dynamics in late-life major depression: a longitudinal study.
Translational Psychiatry
, 12
, Article 301. 10.1038/s41398-022-02077-8.
|
|
|
Quilico Cousins, Katheryn Alexandra;
Arezoumandan, Sanaz;
Shellikeri, Sanjana;
Ohm, Daniel;
Shaw, Leslie M;
Grossman, Murray;
Wolk, David;
... Irwin, David John; + view all
(2022)
CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology.
Neurology
, 99
(20)
e2303-e2312.
10.1212/WNL.0000000000201202.
|
|
Rabe, Christina;
Bittner, Tobias;
Jethwa, Alexander;
Suridjan, Ivonne;
Manuilova, Ekaterina;
Friesenhahn, Michel;
Stomrud, Erik;
... Alzheimer's Disease Neuroimaging Initiative† and the Swedish Bio; + view all
(2022)
Clinical performance and robustness evaluation of plasma amyloid-β42/40 prescreening.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
10.1002/alz.12801.
(In press).
|
|
Redondo-Camos, Maria;
Cattaneo, Gabriele;
Perellon-Alfonso, Ruben;
Alviarez-Schulze, Vanessa;
Morris, Timothy P;
Solana-Sanchez, Javier;
Espana-Irla, Goretti;
... Bartres-Faz, David; + view all
(2022)
Local Prefrontal Cortex TMS-Induced Reactivity Is Related to Working Memory and Reasoning in Middle-Aged Adults.
Frontiers in Psychology
, 13
, Article 813444. 10.3389/fpsyg.2022.813444.
|
|
|
Revelas, Mary;
Thalamuthu, Anbupalam;
Zettergren, Anna;
Oldmeadow, Christopher;
Najar, Jenna;
Seidu, Nazib M;
Armstrong, Nicola J;
... Mather, Karen A; + view all
(2022)
High polygenic risk score for exceptional longevity is associated with a healthy metabolic profile.
Geroscience
10.1007/s11357-022-00643-y.
(In press).
|
|
Rippon, Brady;
Palta, Priya;
Tahmi, Mouna;
Sherwood, Greysi;
Soto, Luisa;
Cespedes, Sandino;
Mesen, Yanette;
... Luchsinger, José A; + view all
(2022)
Plasma Amyloid and in vivo Brain Amyloid in Late Middle-Aged Hispanics.
Journal of Alzheimer's Disease
pp. 1-10.
10.3233/JAD-210391.
(In press).
|
|
Rise, Henning H;
Brune, Synne;
Chien, Claudia;
Berge, Tone;
Bos, Steffan D;
Andorrà, Magí;
Valdeolivas, Irene Pulido;
... Høgestøl, Einar A; + view all
(2022)
Brain disconnectome mapping derived from white matter lesions and serum neurofilament light levels in multiple sclerosis: A longitudinal multicenter study.
NeuroImage: Clinical
, 35
, Article 103099. 10.1016/j.nicl.2022.103099.
|
|
Robertson, Josefina;
Nellgård, Bengt;
Hultén, Lillemor Mattsson;
Nilsson, Staffan;
Dalla, Keti;
Börjesson, Mats;
Zetterberg, Henrik;
... Gisslén, Magnus; + view all
(2022)
Sex difference in circulating soluble form of ACE2 protein in moderate and severe COVID-19 and healthy controls.
Frontiers in Medicine
, 9
, Article 1058120. 10.3389/fmed.2022.1058120.
|
|
Rodrigues, M;
Bhattacharjee, P;
Brinkmalm, A;
Do, DT;
Pearson, CM;
De, S;
Ponjavic, A;
... Klenerman, D; + view all
(2022)
Structure-specific amyloid precipitation in biofluids.
Nature Chemistry
, 14
pp. 1045-1053.
10.1038/s41557-022-00976-3.
|
|
Rodríguez-Fernández, Blanca;
Vilor-Tejedor, Natalia;
Arenaza-Urquijo, Eider M;
Sánchez-Benavides, Gonzalo;
Suárez-Calvet, Marc;
Operto, Grégory;
Minguillón, Carolina;
... ALFA study; + view all
(2022)
Genetically predicted telomere length and Alzheimer's disease endophenotypes: a Mendelian randomization study.
Alzheimer's Research & Therapy
, 14
, Article 167. 10.1186/s13195-022-01101-9.
|
|
Rosén, Anders;
Gennser, Mikael;
Oscarsson, Nicklas;
Kvarnström, Andreas;
Sandström, Göran;
Seeman-Lodding, Helen;
Simrén, Joel;
(2022)
Protein tau concentration in blood increases after SCUBA diving: an observational study.
European Journal of Applied Physiology
10.1007/s00421-022-04892-9.
|
|
|
Rosenkranz, MA;
Dean, DC;
Bendlin, BB;
Jarjour, NN;
Esnault, S;
Zetterberg, H;
Heslegrave, A;
... Busse, WW; + view all
(2022)
Neuroimaging and biomarker evidence of neurodegeneration in asthma.
Journal of Allergy and Clinical Immunology
, 149
(2)
589-598.e6.
10.1016/j.jaci.2021.09.010.
|
|
Rosenstein, Igal;
Rasch, Sofia;
Axelsson, Markus;
Novakova, Lenka;
Blennow, Kaj;
Zetterberg, Henrik;
Lycke, Jan;
(2022)
Increased intrathecal neurofilament light and immunoglobulin M predict severe disability in relapsing-remitting multiple sclerosis.
Frontiers in Immunology
, 13
, Article 967953. 10.3389/fimmu.2022.967953.
|
|
Sainio, MT;
Rasila, T;
Molchanova, SM;
Järvilehto, J;
Torregrosa-Muñumer, R;
Harjuhaahto, S;
Pennonen, J;
... Tyynismaa, H; + view all
(2022)
Neurofilament Light Regulates Axon Caliber, Synaptic Activity, and Organelle Trafficking in Cultured Human Motor Neurons.
Frontiers in Cell and Developmental Biology
, 9
, Article 820105. 10.3389/fcell.2021.820105.
|
|
|
Saloner, Rowan;
Fonseca, Corrina;
Paolillo, Emily W;
Asken, Breton M;
Djukic, Nina A;
Lee, Shannon;
Nilsson, Johanna;
... Casaletto, Kaitlin B; + view all
(2022)
Combined Effects of Synaptic and Axonal Integrity on Longitudinal Gray Matter Atrophy in Cognitively Unimpaired Adults.
Neurology
, 99
(20)
e2285-e2293.
10.1212/WNL.0000000000201165.
|
|
Salvadó, Gemma;
Milà-Alomà, Marta;
Shekari, Mahnaz;
Ashton, Nicholas J;
Operto, Grégory;
Falcon, Carles;
Cacciaglia, Raffaele;
... ALFA Study; + view all
(2022)
Reactive astrogliosis is associated with higher cerebral glucose consumption in the early Alzheimer's continuum.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-022-05897-4.
(In press).
|
|
|
Salvadó, Gemma;
Shekari, Mahnaz;
Falcon, Carles;
Operto, Grégory;
Milà-Alomà, Marta;
Sánchez-Benavides, Gonzalo;
Cacciaglia, Raffaele;
... ALFA Study, .; + view all
(2022)
Brain alterations in the early Alzheimer's continuum with amyloid-β, tau, glial and neurodegeneration CSF markers.
Brain Communications
, 4
(3)
, Article fcac134. 10.1093/braincomms/fcac134.
|
|
Schindler, Suzanne E;
Karikari, Thomas K;
Ashton, Nicholas J;
Henson, Rachel L;
Yarasheski, Kevin E;
West, Tim;
Meyer, Mathew R;
... Morris, John C; + view all
(2022)
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light.
Neurology
10.1212/WNL.0000000000200358.
(In press).
|
|
Scott, Gregory D;
Arnold, Moriah R;
Beach, Thomas G;
Gibbons, Christopher H;
Kanthasamy, Anumantha G;
Lebovitz, Russell M;
Lemstra, Afina W;
... Irwin, David J; + view all
(2022)
Fluid and Tissue Biomarkers of Lewy Body Dementia: Report of an LBDA Symposium.
Frontiers in Neurology
, 12
, Article 805135. 10.3389/fneur.2021.805135.
|
|
|
Seto, Mabel;
Mahoney, Emily R;
Dumitrescu, Logan;
Ramanan, Vijay K;
Engelman, Corinne D;
Deming, Yuetiva;
Albert, Marilyn;
... Hohman, Timothy J; + view all
(2022)
Exploring common genetic contributors to neuroprotection from amyloid pathology.
Brain Communications
10.1093/braincomms/fcac066.
(In press).
|
|
Shahid, Syed Salman;
Wen, Qiuting;
Risacher, Shannon L;
Farlow, Martin R;
Unverzagt, Frederick W;
Apostolova, Liana G;
Foroud, Tatiana M;
... Wu, Yu-Chien; + view all
(2022)
Hippocampal-subfield microstructures and their relation to plasma biomarkers in Alzheimer's disease.
Brain
, 145
(6)
pp. 2149-2160.
10.1093/brain/awac138.
|
|
Shahim, Pashtun;
Zetterberg, Henrik;
Simren, Joel;
Ashton, Nicholas J;
Norato, Gina;
Schöll, Michael;
Tegner, Yelverton;
... Blennow, Kaj; + view all
(2022)
Association of Plasma Biomarker Levels With Their CSF Concentration and the Number and Severity of Concussions in Professional Athletes.
Neurology
, 99
(4)
e347-e354.
10.1212/WNL.0000000000200615.
|
|
Sihag, S;
Naze, S;
Taghdiri, F;
Gumus, M;
Tator, C;
Green, R;
Colella, B;
... Kozloski, JR; + view all
(2022)
Functional brain activity constrained by structural connectivity reveals cohort-specific features for serum neurofilament light chain.
Communications Medicine
, 2
, Article 8. 10.1038/s43856-021-00065-5.
|
|
|
Simrén, J;
Weninger, H;
Brum, WS;
Khalil, S;
Benedet, AL;
Blennow, K;
Zetterberg, H;
(2022)
Differences between blood and cerebrospinal fluid glial fibrillary Acidic protein levels: The effect of sample stability.
Alzheimer's and Dementia
10.1002/alz.12806.
(In press).
|
|
Simrén, Joel;
Andreasson, Ulf;
Gobom, Johan;
Suarez Calvet, Marc;
Borroni, Barbara;
Gillberg, Christopher;
Nyberg, Lars;
... Blennow, Kaj; + view all
(2022)
Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years.
Brain Communications
, 4
(4)
, Article fcac174. 10.1093/braincomms/fcac174.
(In press).
|
|
|
Simrén, Joel;
Brum, Wagner S;
Ashton, Nicholas J;
Benedet, Andrea L;
Karikari, Thomas K;
Kvartsberg, Hlin;
Sjons, Emma;
... Blennow, Kaj; + view all
(2022)
CSF tau368/total-tau ratio reflects cognitive performance and neocortical tau better compared to p-tau181 and p-tau217 in cognitively impaired individuals.
Alzheimers Res Ther
, 14
, Article 192. 10.1186/s13195-022-01142-0.
|
|
Skillback, Tobias;
Blennow, Kaj;
Zetterberg, Henrik;
Skoog, Johan;
Ryden, Lina;
Wetterberg, Hanna;
Guo, Xinxin;
... Kern, Silke; + view all
(2022)
Slowing gait speed precedes cognitive decline by several years.
Alzheimer's & Dementia
10.1002/alz.12537.
|
|
|
Smailovic, Una;
Ferreira, Daniel;
Ausén, Birgitta;
Ashton, Nicholas James;
Koenig, Thomas;
Zetterberg, Henrik;
Blennow, Kaj;
(2022)
Decreased Electroencephalography Global Field Synchronization in Slow-Frequency Bands Characterizes Synaptic Dysfunction in Amnestic Subtypes of Mild Cognitive Impairment.
Frontiers in Aging Neuroscience
, 14
, Article 755454. 10.3389/fnagi.2022.755454.
|
|
Smirnov, DS;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
Simrén, J;
Lantero-Rodriguez, J;
Karikari, TK;
... Galasko, D; + view all
(2022)
Plasma biomarkers for Alzheimer’s Disease in relation to neuropathology and cognitive change.
Acta Neuropathologica
10.1007/s00401-022-02408-5.
(In press).
|
|
|
Smith, R;
Cullen, NC;
Pichet Binette, A;
Leuzy, A;
Blennow, K;
Zetterberg, H;
Klein, G;
... Hansson, O; + view all
(2022)
Tau-PET is superior to phospho-tau when predicting cognitive decline in symptomatic AD patients.
Alzheimer's and Dementia
10.1002/alz.12875.
(In press).
|
|
Snellman, A;
Ekblad, LL;
Koivumäki, M;
Lindgrén, N;
Tuisku, J;
Perälä, M;
Kallio, L;
... Rinne, JO; + view all
(2022)
ASIC-E4: Interplay of Beta-Amyloid, Synaptic Density and Neuroinflammation in Cognitively Normal Volunteers With Three Levels of Genetic Risk for Late-Onset Alzheimer's Disease – Study Protocol and Baseline Characteristics.
Frontiers in Neurology
, 13
, Article 826423. 10.3389/fneur.2022.826423.
|
|
|
Snellman, Anniina;
Lantero-Rodriguez, Juan;
Emeršič, Andreja;
Vrillon, Agathe;
Karikari, Thomas K;
Ashton, Nicholas J;
Gregorič Kramberger, Milica;
... Blennow, Kaj; + view all
(2022)
N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases.
Brain
10.1093/brain/awab481.
(In press).
|
|
|
Stavrou, Marina;
Kagiava, Alexia;
Choudury, Sarah G;
Jennings, Matthew J;
Wallace, Lindsay M;
Fowler, Allison M;
Heslegrave, Amanda;
... Kleopa, Kleopas A; + view all
(2022)
A translatable RNAi-driven gene therapy silences PMP22/Pmp22 genes and improves neuropathy in CMT1A mice.
Journal of Clinical Investigation
, Article e159814. 10.1172/JCI159814.
(In press).
|
|
Stevenson-Hoare, Joshua;
Heslegrave, Amanda;
Leonenko, Ganna;
Fathalla, Dina;
Bellou, Eftychia;
Luckcuck, Lauren;
Marshall, Rachel;
... Escott-Price, Valentina; + view all
(2022)
Plasma biomarkers and genetics in the diagnosis and prediction of Alzheimer's disease.
Brain
10.1093/brain/awac128.
(In press).
|
|
Sveijer, Malin;
Von Bahr Greenwood, Tatiana;
Jädersten, Martin;
Kvedaraite, Egle;
Zetterberg, Henrik;
Blennow, Kaj;
Lourda, Magda;
... Henter, Jan-Inge; + view all
(2022)
Screening for neurodegeneration in Langerhans cell histiocytosis with neurofilament light in plasma.
British Journal of Haematology
10.1111/bjh.18247.
(In press).
|
|
Swann, OJ;
Turner, M;
Heslegrave, A;
Zetterberg, H;
(2022)
Fluid biomarkers and risk of neurodegenerative disease in retired athletes with multiple concussions: Results from the International Concussion and Head Injury Research Foundation Brain health in Retired athletes Study of Ageing and Impact-Related Neurodegenerative Disease (ICHIRF-BRAIN study).
BMJ Open Sport and Exercise Medicine
, 8
(3)
, Article e001327. 10.1136/bmjsem-2022-001327.
|
|
Taylor, Jennifer;
Parker, Margaret;
Casey, Cameron P;
Tanabe, Sean;
Kunkel, David;
Rivera, Cameron;
Zetterberg, Henrik;
... Sanders, Robert D; + view all
(2022)
Postoperative delirium and changes in the blood-brain barrier, neuroinflammation, and cerebrospinal fluid lactate: a prospective cohort study.
British Journal of Anaesthesia
, 129
(2)
pp. 219-230.
10.1016/j.bja.2022.01.005.
|
|
Teunissen, CE;
Verberk, IMW;
Thijssen, EH;
Vermunt, L;
Hansson, O;
Zetterberg, H;
van der Flier, WM;
... Del Campo, M; + view all
(2022)
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation.
The Lancet Neurology
, 21
(1)
pp. 66-77.
10.1016/S1474-4422(21)00361-6.
|
|
Therriault, J;
Pascoal, TA;
Lussier, FZ;
Tissot, C;
Chamoun, M;
Bezgin, G;
Servaes, S;
... Rosa-Neto, P; + view all
(2022)
Biomarker modeling of Alzheimer’s disease using PET-based Braak staging.
Nature Aging
10.1038/s43587-022-00204-0.
|
|
Therriault, Joseph;
Vermeiren, Marie;
Servaes, Stijn;
Tissot, Cécile;
Ashton, Nicholas J;
Benedet, Andréa Lessa;
Karikari, Thomas K;
... Rosa-Neto, Pedro; + view all
(2022)
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography.
JAMA Neurology
10.1001/jamaneurol.2022.4485.
(In press).
|
|
Thomas, Alan J;
Hamilton, Calum A;
Heslegrave, Amanda;
Barker, Sally;
Durcan, Rory;
Lawley, Sarah;
Barnett, Nicola;
... O'Brien, John; + view all
(2022)
A Longitudinal Study of Plasma pTau181 in Mild Cognitive Impairment with Lewy Bodies and Alzheimer's Disease.
Movement Disorders
10.1002/mds.28994.
(In press).
|
|
Tissot, C;
Therriault, J;
Kunach, P;
Benedet, AL;
Pascoal, TA;
Ashton, NJ;
Karikari, TK;
... Rosa-Neto, P; + view all
(2022)
Comparing tau status determined via plasma pTau181, pTau231 and [¹⁸F]MK6240 tau-PET.
eBioMedicine
, 76
, Article 103837. 10.1016/j.ebiom.2022.103837.
|
|
|
Tjernberg, Ivar;
Gyllemark, Paula;
Zetterberg, Henrik;
Blennow, Kaj;
Ernerudh, Jan;
Forsberg, Pia;
Sjowall, Johanna;
(2022)
Cerebrospinal fluid markers of inflammation and brain injury in Lyme neuroborreliosis – a prospective follow-up study.
Clinical Chemistry and Laboratory Medicine
, 60
(7)
pp. 1124-1132.
10.1515/cclm-2022-0097.
|
|
Tyrberg, Erika;
Hagberg, Lars;
Andersson, Lars-Magnus;
Nilsson, Staffan;
Yilmaz, Aylin;
Mellgren, Åsa;
Blennow, Kaj;
... Gisslén, Magnus; + view all
(2022)
The effect of vitamin B supplementation on neuronal injury in people living with HIV – a randomised controlled trial.
Brain Communications
10.1093/braincomms/fcac259.
(In press).
|
|
van Egmond, Lieve T;
Bukhari, Shervin;
Benedet, Andrea Lessa;
Ashton, Nicholas J;
Meth, Elisa MS;
Boukas, Alexander;
Engström, Joachim;
... Benedict, Christian; + view all
(2022)
Acute sleep loss increases CNS health biomarkers and compromises the ability to stay awake in a sex-and weight-specific manner.
Translational Psychiatry
, 12
, Article 379. 10.1038/s41398-022-02146-y.
|
|
Vasilevskaya, Anna;
Taghdiri, Foad;
Multani, Namita;
Ozzoude, Miracle;
Tarazi, Apameh;
Khodadadi, Mozhgan;
Wennberg, Richard;
... Tartaglia, Maria Carmela; + view all
(2022)
Investigating the use of plasma pTau181 in retired contact sports athletes.
Journal of Neurology
, 269
pp. 5582-5595.
10.1007/s00415-022-11223-7.
|
|
Vidal-Piñeiro, D;
Sørensen, Ø;
Blennow, K;
Capogna, E;
Halaas, NB;
Idland, AV;
Mowinckel, AM;
... Fjell, AM; + view all
(2022)
Relationship between cerebrospinal fluid neurodegeneration biomarkers and temporal brain atrophy in cognitively healthy older adults.
Neurobiology of Aging
10.1016/j.neurobiolaging.2022.04.010.
(In press).
|
|
Vijiaratnam, Nirosen;
Lawton, Michael;
Heslegrave, Amanda J;
Guo, Tong;
Tan, Manuela;
Jabbari, Edwin;
Real, Raquel;
... PRoBaND clinical consortium; + view all
(2022)
Combining biomarkers for prognostic modelling of Parkinson's disease.
Journal of Neurology, Neurosurgery and Psychiatry (JNNP)
10.1136/jnnp-2021-328365.
(In press).
|
|
Vijiaratnam, Nirosen;
Lawton, Michael;
Real, Raquel;
Heslegrave, Amanda J;
Guo, Tong;
Athauda, Dilan;
Gandhi, Sonia;
... PRoBaND Clinical Consortium; + view all
(2022)
Diabetes and Neuroaxonal Damage in Parkinson's Disease.
Movement Disorders
, 37
(7)
pp. 1568-1569.
10.1002/mds.29067.
|
|
|
Visser, Pieter Jelle;
Reus, Lianne M;
Gobom, Johan;
Jansen, Iris;
Dicks, Ellen;
Van der Lee, Sven J;
Tsolaki, Magda;
... Tijms, Betty M; + view all
(2022)
Correction: Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer’s disease.
[Corrigendum].
Molecular Neurodegeneration
, 17
, Article 37. 10.1186/s13024-022-00540-0.
|
|
Visser, Pieter Jelle;
Reus, Lianne M;
Gobom, Johan;
Jansen, Iris;
Dicks, Ellen;
van der Lee, Sven J;
Tsolaki, Magda;
... Tijms, Betty M; + view all
(2022)
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease.
Molecular Neurodegeneration
, 17
(1)
, Article 27. 10.1186/s13024-022-00521-3.
|
|
|
Vogt, NM;
Hunt, JF;
Adluru, N;
Ma, Y;
Van Hulle, CA;
Dean, DC;
Kecskemeti, SR;
... Bendlin, BB; + view all
(2022)
Interaction of amyloid and tau on cortical microstructure in cognitively unimpaired adults.
Alzheimer's & Dementia
, 18
(1)
pp. 65-76.
10.1002/alz.12364.
|
|
Vrillon, Agathe;
Mouton-Liger, François;
Martinet, Matthieu;
Cognat, Emmanuel;
Hourregue, Claire;
Dumurgier, Julien;
Bouaziz-Amar, Elodie;
... Paquet, Claire; + view all
(2022)
Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study.
Alzheimer's Research & Therapy
, 14
, Article 71. 10.1186/s13195-022-01014-7.
|
|
Wagen, AZ;
Coath, W;
Keshavan, A;
James, SN;
Parker, TD;
Lane, CA;
Buchanan, SM;
... Schott, JM; + view all
(2022)
Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study.
The Lancet Healthy Longevity
, 3
(9)
e607-e616.
10.1016/S2666-7568(22)00167-2.
|
|
Wang, Danqing;
Ma, Min;
Huang, Junfeng;
Gu, Ting-Jia;
Cui, Yusi;
Li, Miyang;
Wang, Zicong;
... Li, Lingjun; + view all
(2022)
Boost-DiLeu: Enhanced Isobaric N,N-Dimethyl Leucine Tagging Strategy for a Comprehensive Quantitative Glycoproteomic Analysis.
Analytical Chemistry
, 94
(34)
pp. 11773-11782.
10.1021/acs.analchem.2c01773.
|
|
Watne, Leiv Otto;
Pollmann, Christian Thomas;
Neerland, Bjorn Erik;
Quist-Paulsen, Else;
Halaas, Nathalie Bodd;
Idland, Ane-Victoria;
Hassel, Bjørnar;
... Giil, Lasse M; + view all
(2022)
Cerebrospinal fluid quinolinic acid is strongly associated with delirium and mortality in hip fracture patients.
Journal of Clinical Investigation
, Article e163472. 10.1172/JCI163472.
|
|
Waury, Katharina;
Willemse, Eline AJ;
Vanmechelen, Eugeen;
Zetterberg, Henrik;
Teunissen, Charlotte E;
Abeln, Sanne;
(2022)
Bioinformatics tools and data resources for assay development of fluid protein biomarkers.
Biomarker Research
, 10
, Article 83. 10.1186/s40364-022-00425-w.
|
|
Weidung, Bodil;
Hemmingsson, Eva-Stina;
Olsson, Jan;
Sundström, Torbjörn;
Blennow, Kaj;
Zetterberg, Henrik;
Ingelsson, Martin;
... Lövheim, Hugo; + view all
(2022)
VALZ-Pilot: High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 8
(1)
, Article e12264. 10.1002/trc2.12264.
|
|
Weiner, Sophia;
Sauer, Mathias;
Visser, Pieter Jelle;
Tijms, Betty M;
Vorontsov, Egor;
Blennow, Kaj;
Zetterberg, Henrik;
(2022)
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers.
Clinical Proteomics
, 19
, Article 13. 10.1186/s12014-022-09354-0.
|
|
Wesenhagen, Kirsten EJ;
Gobom, Johan;
Bos, Isabelle;
Vos, Stephanie JB;
Martinez-Lage, Pablo;
Popp, Julius;
Tsolaki, Magda;
... Tijms, Betty M; + view all
(2022)
Effects of age, amyloid, sex, and APOE ε4 on the CSF proteome in normal cognition.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 14
(1)
, Article e12286. 10.1002/dad2.12286.
|
|
Wiberg, S;
Holmgaard, F;
Zetterberg, H;
Nilsson, J-C;
Kjaergaard, J;
Wanscher, M;
Langkilde, AR;
... Vedel, AG; + view all
(2022)
Biomarkers of Cerebral Injury for Prediction of Postoperative Cognitive Dysfunction in Patients Undergoing Cardiac Surgery.
Journal of Cardiothoracic and Vascular Anesthesia
, 36
(1)
pp. 125-132.
10.1053/j.jvca.2021.05.016.
|
|
Williams, TE;
Holdsworth, KP;
Nicholas, JM;
Eshaghi, A;
Katsanouli, T;
Wellington, H;
Heslegrave, A;
... Chataway, J; + view all
(2022)
Assessing Neurofilaments as Biomarkers of Neuroprotection in Progressive Multiple Sclerosis: From the MS-STAT Randomized Controlled Trial.
Neurology, Neuroimmunology and Neuroinflammation
, 9
(2)
, Article e1130. 10.1212/NXI.0000000000001130.
|
|
|
Williams, Thomas;
Tur, Carmen;
Eshaghi, Arman;
Doshi, Anisha;
Chan, Dennis;
Binks, Sophie;
Wellington, Henny;
... Chataway, Jeremy; + view all
(2022)
Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial.
Multiple Sclerosis Journal
10.1177/13524585221114441.
(In press).
|
|
|
Winfree, Rebecca L;
Dumitrescu, Logan;
Blennow, Kaj;
Zetterberg, Henrik;
Gifford, Katherine A;
Pechman, Kimberly R;
Jefferson, Angela L;
... Alzheimer's Disease Neuroimaging Initiative; + view all
(2022)
Biological correlates of elevated soluble TREM2 in cerebrospinal fluid.
Neurobiology of Aging
, 118
pp. 88-98.
10.1016/j.neurobiolaging.2022.06.013.
|
|
|
Woollacott, IOC;
Swift, IJ;
Sogorb-Esteve, A;
Heller, C;
Knowles, K;
Bouzigues, A;
Russell, LL;
... Rohrer, JD; + view all
(2022)
CSF glial markers are elevated in a subset of patients with genetic frontotemporal dementia.
Annals of Clinical and Translational Neurology
10.1002/acn3.51672.
|
|
Zetterberg, Henrik;
(2022)
Biofluid-based biomarkers for Alzheimer's disease-related pathologies: An update and synthesis of the literature.
Alzheimer's and Dementia
, 18
(9)
pp. 1687-1693.
10.1002/alz.12618.
|
|
Zetterberg, Henrik;
Brody, David L;
(2022)
Combinatorial Diagnostics of Sports-Related Concussion.
Journal of Neurotrauma
10.1089/neu.2023.29133.editorial.
(In press).
|
|
Zetterberg, Henrik;
Schott, Jonathan M;
(2022)
Objectifying Subjective Cognitive Decline: The Prognostic Role of Alzheimer Biomarkers.
Neurology
, 99
(17)
pp. 735-736.
10.1212/WNL.0000000000201172.
|
|
Zetterberg, Henrik;
Schott, Jonathan M;
(2022)
Blood biomarkers for Alzheimer's disease and related disorders.
Acta Neurologica Scandinavica
, 146
(1)
pp. 51-55.
10.1111/ane.13628.
|
|
Zicha, Stephen;
Bateman, Randall J;
Shaw, Leslie M;
Zetterberg, Henrik;
Bannon, Anthony W;
Horton, Wesley A;
Baratta, Mike;
... Foundation for the National Institutes of Health (FNIH) Biomarke, .; + view all
(2022)
Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity.
Alzheimer's & Dementia
10.1002/alz.12697.
(In press).
|
|
Ziff, Oliver J;
Ashton, Nicholas J;
Mehta, Puja R;
Brown, Rachel;
Athauda, Dilan;
Heaney, Judith;
Heslegrave, Amanda J;
... Paterson, Ross W; + view all
(2022)
Amyloid processing in COVID-19-associated neurological syndromes.
Journal of Neurochemistry
, 161
(2)
pp. 146-157.
10.1111/jnc.15585.
|
2021
|
Aamodt, AH;
Høgestøl, EA;
Popperud, TH;
Holter, JC;
Dyrhol-Riise, AM;
Tonby, K;
Stiksrud, B;
... Harbo, HF; + view all
(2021)
Blood neurofilament light concentration at admittance: a potential prognostic marker in COVID-19.
Journal of Neurology
10.1007/s00415-021-10517-6.
(In press).
|
|
|
Alagaratnam, J;
De Francesco, D;
Zetterberg, H;
Heslegrave, A;
Toombs, J;
Kootstra, NA;
Underwood, J;
... Winston, A; + view all
(2021)
Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
Journal of NeuroVirology
10.1007/s13365-021-01026-3.
(In press).
|
|
|
Alagaratnam, J;
Stöhr, W;
Toombs, J;
Heslegrave, A;
Zetterberg, H;
Gisslén, M;
Pett, S;
... RIVER trial study group, .; + view all
(2021)
No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach.
Journal of Virus Eradication
, 7
(3)
, Article 100056. 10.1016/j.jve.2021.100056.
|
|
Alagaratnam, J;
Von Widekind, S;
De Francesco, D;
Underwood, J;
Edison, P;
Winston, A;
Zetterberg, H;
(2021)
Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis.
BMJ Neurology Open
, 3
(1)
, Article e000143. 10.1136/bmjno-2021-000143.
|
|
|
Alawode, Deborah OT;
Heslegrave, Amanda J;
Fox, Nick C;
Zetterberg, Henrik;
(2021)
Donanemab removes Alzheimer's plaques: what is special about its target?
The Lancet Healthy Longevity
, 2
(7)
e395-e396.
10.1016/S2666-7568(21)00144-6.
|
|
Alawode, DOT;
Heslegrave, AJ;
Ashton, NJ;
Karikari, TK;
Simrén, J;
Montoliu-Gaya, L;
Pannee, J;
... Zetterberg, H; + view all
(2021)
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease.
Journal of Internal Medicine
, 290
(3)
pp. 583-601.
10.1111/joim.13332.
|
|
|
Alcolea, D;
Delaby, C;
Muñoz, L;
Torres, S;
Estellés, T;
Zhu, N;
Barroeta, I;
... Lleó, A; + view all
(2021)
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2021-326603.
(In press).
|
|
|
Alemany, S;
Crous-Bou, M;
Vilor-Tejedor, N;
Milà-Alomà, M;
Suárez-Calvet, M;
Salvadó, G;
Cirach, M;
... Luis Molinuevo, J; + view all
(2021)
Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals.
Environment International
, 157
, Article 106864. 10.1016/j.envint.2021.106864.
|
|
|
Allison, SL;
Jonaitis, EM;
Koscik, RL;
Hermann, BP;
Mueller, KD;
Cary, RP;
Ma, Y;
... Johnson, SC; + view all
(2021)
Neurodegeneration, Alzheimer's disease biomarkers, and longitudinal verbal learning and memory performance in late middle age.
Neurobiology of Aging
, 102
pp. 151-160.
10.1016/j.neurobiolaging.2021.01.030.
|
|
Altmann, P;
Ponleitner, M;
Rommer, PS;
Haslacher, H;
Mucher, P;
Leutmezer, F;
Petzold, A;
... Bsteh, G; + view all
(2021)
Seven day pre-analytical stability of serum and plasma neurofilament light chain.
Scientific Reports
, 11
(1)
, Article 11034. 10.1038/s41598-021-90639-z.
|
|
|
Anderson, AM;
Kundu, S;
Tang, B;
Vaida, F;
Okwuegbuna, O;
McClernon, D;
Cherner, M;
... Letendre, SL; + view all
(2021)
Cerebrospinal fluid CXCL10 is associated with the presence of low level CSF HIV during suppressive antiretroviral therapy.
Journal of Neuroimmunology
, 353
, Article 577493. 10.1016/j.jneuroim.2021.577493.
|
|
Andersson, M;
Oras, J;
Thörn, SE;
Karlsson, O;
Kälebo, P;
Zetterberg, H;
Blennow, K;
(2021)
Signs of neuroaxonal injury in preeclampsia-A case control study.
PLoS One
, 16
(2)
, Article e0246786. 10.1371/journal.pone.0246786.
|
|
|
Andersson, P;
Johnsson, J;
Björnsson, O;
Cronberg, T;
Hassager, C;
Zetterberg, H;
Stammet, P;
... Frigyesi, A; + view all
(2021)
Predicting neurological outcome after out-of-hospital cardiac arrest with cumulative information; development and internal validation of an artificial neural network algorithm.
Critical Care
, 25
, Article 83. 10.1186/s13054-021-03505-9.
|
|
|
Andersson-Hall, U;
Svedin, P;
Mallard, C;
Blennow, K;
Zetterberg, H;
Holmäng, A;
(2021)
Growth differentiation factor 15 increases in both cerebrospinal fluid and serum during pregnancy.
PLoS ONE
, 16
(5)
, Article e0248980. 10.1371/journal.pone.0248980.
|
|
|
Andréasson, M;
Lagali, N;
Badian, RA;
Utheim, TP;
Scarpa, F;
Colonna, A;
Allgeier, S;
... Svenningsson, P; + view all
(2021)
Parkinson's disease with restless legs syndrome-an in vivo corneal confocal microscopy study.
npj Parkinsons Disease
, 7
(1)
, Article 4. 10.1038/s41531-020-00148-5.
|
|
|
Andreou, D;
Jørgensen, KN;
Nerland, S;
Smelror, RE;
Wedervang-Resell, K;
Johannessen, CH;
Myhre, AM;
... Agartz, I; + view all
(2021)
Lower plasma total tau in adolescent psychosis: Involvement of the orbitofrontal cortex.
Journal of Psychiatric Research
, 144
pp. 255-261.
10.1016/j.jpsychires.2021.10.031.
|
|
|
Anesten, B;
Zetterberg, H;
Nilsson, S;
Brew, BJ;
Fuchs, D;
Price, RW;
Gisslén, M;
(2021)
Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection.
BMC Neurology
, 21
, Article 494. 10.1186/s12883-021-02527-8.
|
|
|
Arber, C;
Alatza, A;
Leckey, CA;
Paterson, RW;
Zetterberg, H;
Wray, S;
(2021)
Mass spectrometry analysis of tau and amyloid-beta in iPSC-derived models of Alzheimer's disease and dementia.
Journal of Neurochemistry
10.1111/jnc.15315.
(In press).
|
|
|
Arber, C;
Lovejoy, C;
Harris, L;
Willumsen, N;
Alatza, A;
Casey, JM;
Lines, G;
... Wray, S; + view all
(2021)
Familial Alzheimer's Disease Mutations in PSEN1 Lead to Premature Human Stem Cell Neurogenesis.
Cell Reports
, 34
(2)
, Article 108615. 10.1016/j.celrep.2020.108615.
|
|
|
Archer, DB;
Moore, EE;
Pamidimukkala, U;
Shashikumar, N;
Pechman, KR;
Blennow, K;
Zetterberg, H;
... Gifford, KA; + view all
(2021)
The relationship between white matter microstructure and self-perceived cognitive decline.
NeuroImage: Clinical
, 32
, Article 102794. 10.1016/j.nicl.2021.102794.
|
|
|
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2021)
Spitting image: can saliva biomarkers reflect Alzheimer's disease?
EBioMedicine
, 68
, Article 103437. 10.1016/j.ebiom.2021.103437.
|
|
|
Ashton, NJ;
Janelidze, S;
Al Khleifat, A;
Leuzy, A;
van der Ende, EL;
Karikari, TK;
Benedet, AL;
... Hansson, O; + view all
(2021)
A multicentre validation study of the diagnostic value of plasma neurofilament light.
Nature Communications
, 12
(1)
, Article 3400. 10.1038/s41467-021-23620-z.
|
|
|
Ashton, NJ;
Leuzy, A;
Karikari, TK;
Mattsson-Carlgren, N;
Dodich, A;
Boccardi, M;
Corre, J;
... Hansson, O; + view all
(2021)
The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05253-y.
(In press).
|
|
|
Ashton, NJ;
Pascoal, TA;
Karikari, TK;
Benedet, AL;
Lantero-Rodriguez, J;
Brinkmalm, G;
Snellman, A;
... Blennow, K; + view all
(2021)
Plasma p-tau231: a new biomarker for incipient Alzheimer’s disease pathology.
Acta Neuropathologica
10.1007/s00401-021-02275-6.
(In press).
|
|
|
Ashton, NJ;
Suárez-Calvet, M;
Karikari, TK;
Lantero-Rodriguez, J;
Snellman, A;
Sauer, M;
Simrén, J;
... Zetterberg, H; + view all
(2021)
Effects of pre-analytical procedures on blood biomarkers for Alzheimer's pathophysiology, glial activation, and neurodegeneration.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12168. 10.1002/dad2.12168.
|
|
|
Austin, K;
Lee, BJ;
Flood, TR;
Toombs, J;
Borisova, M;
Lauder, M;
Heslegrave, A;
... Smith, NA; + view all
(2021)
Serum neurofilament light concentration does not increase following exposure to low velocity football heading.
Science and Medicine in Football
, 5
(3)
pp. 188-194.
10.1080/24733938.2020.1853210.
|
|
Backeström, A;
Papadopoulos, K;
Eriksson, S;
Olsson, T;
Andersson, M;
Blennow, K;
Zetterberg, H;
... Rolandsson, O; + view all
(2021)
Acute hyperglycaemia leads to altered frontal lobe brain activity and reduced working memory in type 2 diabetes.
PLOS One
, 16
(3)
, Article e0247753. 10.1371/journal.pone.0247753.
|
|
|
Badji, Atef;
Pereira, Joana B;
Shams, Sara;
Skoog, Johan;
Marseglia, Anna;
Poulakis, Konstantinos;
Rydén, Lina;
... Westman, Eric; + view all
(2021)
Cerebrospinal Fluid Biomarkers, Brain Structural and Cognitive Performances Between Normotensive and Hypertensive Controlled, Uncontrolled and Untreated 70-Year-Old Adults.
Frontiers in Aging Neuroscience
, 13
, Article 777475. 10.3389/fnagi.2021.777475.
|
|
|
Ballweg, T;
White, M;
Parker, M;
Casey, C;
Bo, A;
Farahbakhsh, Z;
Kayser, A;
... Sanders, RD; + view all
(2021)
Association between plasma tau and postoperative delirium incidence and severity: a prospective observational study.
British Journal of Anaesthesia
, 126
(2)
pp. 458-466.
10.1016/j.bja.2020.08.061.
|
|
Banerjee, G;
Forsgard, N;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
... Werring, DJ; + view all
(2021)
Cerebrospinal fluid metallomics in cerebral amyloid angiopathy: an exploratory analysis.
Journal of Neurology
10.1007/s00415-021-10711-6.
(In press).
|
|
|
Barro, C;
Zetterberg, H;
(2021)
The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases.
Journal of Neuroscience Methods
, 361
, Article 109281. 10.1016/j.jneumeth.2021.109281.
|
|
Barro, C;
Zetterberg, H;
(2021)
Neurological symptoms and blood neurofilament light levels.
Acta Neurologica Scandinavica
, 144
(1)
pp. 13-20.
10.1111/ane.13415.
|
|
Bayoumy, S;
Verberk, IMW;
den Dulk, B;
Hussainali, Z;
Zwan, M;
van der Flier, WM;
Ashton, NJ;
... Teunissen, CE; + view all
(2021)
Clinical and analytical comparison of six Simoa assays for plasma P-tau isoforms P-tau181, P-tau217, and P-tau231.
Alzheimer’s Research & Therapy
, 13
(1)
, Article 198. 10.1186/s13195-021-00939-9.
|
|
|
Behzadi, A;
Pujol-Calderón, F;
Tjust, AE;
Wuolikainen, A;
Höglund, K;
Forsberg, K;
Portelius, E;
... Andersen, PM; + view all
(2021)
Neurofilaments can differentiate ALS subgroups and ALS from common diagnostic mimics.
Scientific Reports
, 11
(1)
, Article 22128. 10.1038/s41598-021-01499-6.
|
|
|
Bejanin, A;
Iulita, MF;
Vilaplana, E;
Carmona-Iragui, M;
Benejam, B;
Videla, L;
Barroeta, I;
... Fortea, J; + view all
(2021)
Association of Apolipoprotein E ɛ4 Allele With Clinical and Multimodal Biomarker Changes of Alzheimer Disease in Adults With Down Syndrome.
JAMA Neurology
, 78
(8)
pp. 937-947.
10.1001/jamaneurol.2021.1893.
|
|
|
Benedet, AL;
Milà-Alomà, M;
Vrillon, A;
Ashton, NJ;
Pascoal, TA;
Lussier, F;
Karikari, TK;
... Suárez-Calvet, M; + view all
(2021)
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum.
JAMA Neurology
10.1001/jamaneurol.2021.3671.
(In press).
|
|
|
Benjamin, LA;
Paterson, RW;
Moll, R;
Pericleous, C;
Brown, R;
Mehta, PR;
Athauda, D;
... Efthymiou, M; + view all
(2021)
Antiphospholipid antibodies and neurological manifestations in acute COVID-19: A single-centre cross-sectional study.
EClinicalMedicine
, Article 101070. 10.1016/j.eclinm.2021.101070.
(In press).
|
|
|
Benussi, A;
Ashton, NJ;
Karikari, TK;
Alberici, A;
Saraceno, C;
Ghidoni, R;
Benussi, L;
... Borroni, B; + view all
(2021)
Prodromal frontotemporal dementia: clinical features and predictors of progression.
Alzheimer's Research and Therapy
, 13
(1)
, Article 188. 10.1186/s13195-021-00932-2.
|
|
|
Bergman, L;
Hastie, R;
Zetterberg, H;
Blennow, K;
Schell, S;
Langenegger, E;
Moodley, A;
... Cluver, C; + view all
(2021)
Evidence of neuroinflammation and blood–brain barrier disruption in women with preeclampsia and eclampsia.
Cells
, 10
(11)
, Article 3045. 10.3390/cells10113045.
|
|
|
Bergström, P;
Trybala, E;
Eriksson, CE;
Johansson, M;
Satir, TM;
Widéhn, S;
Fruhwürth, S;
... Bergström, T; + view all
(2021)
Herpes Simplex Virus 1 and 2 Infections during Differentiation of Human Cortical Neurons.
Viruses
, 13
(10)
, Article 2072. 10.3390/v13102072.
|
|
|
Bergström, S;
Remnestål, J;
Yousef, J;
Olofsson, J;
Markaki, I;
Carvalho, S;
Corvol, J-C;
... Nilsson, P; + view all
(2021)
Multi-cohort profiling reveals elevated CSF levels of brain-enriched proteins in Alzheimer's disease.
Annals of Clinical and Translational Neurology
, 8
(7)
pp. 1456-1470.
10.1002/acn3.51402.
|
|
|
Bjursten, S;
Pandita, A;
Zhao, Z;
Fröjd, C;
Ny, L;
Jensen, C;
Ullerstam, T;
... Levin, M; + view all
(2021)
Early rise in brain damage markers and high ICOS expression in CD4+ and CD8+ T cells during checkpoint inhibitor-induced encephalomyelitis.
Journal for ImmunoTherapy of Cancer
, 9
(7)
10.1136/jitc-2021-002732.
|
|
|
Blomqvist, M;
Zetterberg, H;
Blennow, K;
Månsson, J-E;
(2021)
Sulfatide in health and disease. The evaluation of sulfatide in cerebrospinal fluid as a possible biomarker for neurodegeneration.
Molecular and Cellular Neuroscience
, 116
, Article 103670. 10.1016/j.mcn.2021.103670.
|
|
|
Bocchetta, M;
Todd, EG;
Peakman, G;
Cash, DM;
Convery, RS;
Russell, LL;
Thomas, DL;
... Rohrer, JD; + view all
(2021)
Differential early subcortical involvement in genetic FTD within the GENFI cohort.
NeuroImage: Clinical
, Article 102646. 10.1016/j.nicl.2021.102646.
(In press).
|
|
|
Bocci, M;
Oudenaarden, C;
Sàenz‐sardà, X;
Simrén, J;
Edén, A;
Sjölund, J;
Möller, C;
... Pietras, K; + view all
(2021)
Infection of brain pericytes underlying neuropathology of covid‐19 patients.
International Journal of Molecular Sciences
, 22
(21)
, Article 11622. 10.3390/ijms222111622.
|
|
|
Brinkmalm, G;
Zetterberg, H;
(2021)
The phosphorylation cascade hypothesis of Alzheimer’s disease.
Nature Aging
, 1
(6)
pp. 498-499.
10.1038/s43587-021-00077-9.
|
|
Brockmann, K;
Quadalti, C;
Lerche, S;
Rossi, M;
Wurster, I;
Baiardi, S;
Roeben, B;
... Parchi, P; + view all
(2021)
Association between CSF alpha-synuclein seeding activity and genetic status in Parkinson’s disease and dementia with Lewy bodies.
Acta Neuropathologica Communications
, 9
, Article 175. 10.1186/s40478-021-01276-6.
|
|
|
Brugulat-Serrat, A;
Cañas, A;
Canals, L;
Marne, P;
Gramunt, N;
Milà-Alomà, M;
Suárez-Calvet, M;
... ALFA study; + view all
(2021)
Enhancing the Sensitivity of Memory Tests: Reference Data for the Free and Cued Selective Reminding Test and the Logical Memory Task from Cognitively Healthy Subjects with Normal Alzheimer's Disease Cerebrospinal Fluid Biomarker Levels.
Journal of Alzheimer's Disease
10.3233/JAD-210640.
(In press).
|
|
|
Bruno, D;
Plaska, CR;
Clark, DPA;
Zetterberg, H;
Blennow, K;
Verbeek, MM;
Pomara, N;
(2021)
CSF α-synuclein correlates with CSF neurogranin in late-life depression.
International Journal of Neuroscience
, 131
(4)
pp. 357-361.
10.1080/00207454.2020.1744596.
|
|
Camporesi, E;
Lashley, T;
Gobom, J;
Lantero-Rodriguez, J;
Hansson, O;
Zetterberg, H;
Blennow, K;
(2021)
Neuroligin-1 in brain and CSF of neurodegenerative disorders: investigation for synaptic biomarkers.
Acta Neuropathologica Communications
, 9
, Article 19. 10.1186/s40478-021-01119-4.
|
|
|
Casaletto, KB;
Zetterberg, H;
Blennow, K;
Brinkmalm, A;
Honer, W;
Schneider, JA;
Bennett, DA;
... Kramer, J; + view all
(2021)
Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study.
Neurology
, 97
(3)
e284-e297.
10.1212/WNL.0000000000012145.
|
|
Chan, CK;
Sieber, FE;
Blennow, K;
Inouye, SK;
Kahn, G;
Leoutsakos, J-MS;
Marcantonio, ER;
... Oh, ES; + view all
(2021)
Association of Depressive Symptoms With Postoperative Delirium and CSF Biomarkers for Alzheimer's Disease Among Hip Fracture Patients.
American Journal of Geriatric Psychiatry
, 29
(12)
pp. 1212-1221.
10.1016/j.jagp.2021.02.001.
|
|
Chatterjee, P;
Pedrini, S;
Stoops, E;
Goozee, K;
Villemagne, VL;
Asih, PR;
Verberk, IMW;
... Martins, RN; + view all
(2021)
Plasma glial fibrillary acidic protein is elevated in cognitively normal older adults at risk of Alzheimer's disease.
Translational Psychiatry
, 11
(1)
, Article 27. 10.1038/s41398-020-01137-1.
|
|
|
Chebli, J;
Rahmati, M;
Lashley, T;
Edeman, B;
Oldfors, A;
Zetterberg, H;
Abramsson, A;
(2021)
The localization of amyloid precursor protein to ependymal cilia in vertebrates and its role in ciliogenesis and brain development in zebrafish.
Scientific Reports
, 11
, Article 19115. 10.1038/s41598-021-98487-7.
|
|
|
Chiu, M-J;
Yang, S-Y;
Chen, T-F;
Lin, C-H;
Yang, F-C;
Chen, W-P;
Zetterberg, H;
(2021)
Synergistic Association between Plasma Aβ1-42 and p-tau in Alzheimer's Disease but Not in Parkinson's Disease or Frontotemporal Dementia.
ACS Chemical Neuroscience
10.1021/acschemneuro.1c00010.
(In press).
|
|
|
Chong, JR;
Ashton, NJ;
Karikari, TK;
Tanaka, T;
Saridin, FN;
Reilhac, A;
Robins, EG;
... Chen, CP; + view all
(2021)
Plasma P‐tau181 to Aβ42 ratio is associated with brain amyloid burden and hippocampal atrophy in an Asian cohort of Alzheimer's disease patients with concomitant cerebrovascular disease.
Alzheimer's & Dementia
, 17
(10)
pp. 1649-1662.
10.1002/alz.12332.
|
|
Chong, JR;
Ashton, NJ;
Karikari, TK;
Tanaka, T;
Scholl, M;
Zetterberg, H;
Blennow, K;
... Lai, MKP; + view all
(2021)
Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
Journal of Neurology, Neurosurgery and Psychiatry
, 92
(11)
pp. 1231-1241.
10.1136/jnnp-2021-327370.
|
|
|
Cicognola, C;
Hansson, O;
Scheltens, P;
Kvartsberg, H;
Zetterberg, H;
Teunissen, CE;
Blennow, K;
(2021)
Cerebrospinal fluid N-224 tau helps discriminate Alzheimer's disease from subjective cognitive decline and other dementias.
Alzheimer's Research & Therapy
, 13
(1)
, Article 38. 10.1186/s13195-020-00756-6.
|
|
|
Cicognola, C;
Janelidze, S;
Hertze, J;
Zetterberg, H;
Blennow, K;
Mattsson-Carlgren, N;
Hansson, O;
(2021)
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment.
Alzheimer's Research & Therapy
, 13
, Article 68. 10.1186/s13195-021-00804-9.
|
|
|
Clark, C;
Lewczuk, P;
Kornhuber, J;
Richiardi, J;
Maréchal, B;
Karikari, TK;
Blennow, K;
... Popp, J; + view all
(2021)
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
Alzheimer's Research & Therapy
, 13
, Article 65. 10.1186/s13195-021-00805-8.
|
|
|
Clarke, GJB;
Skandsen, T;
Zetterberg, H;
Einarsen, CE;
Feyling, C;
Follestad, T;
Vik, A;
... Håberg, AK; + view all
(2021)
One-Year Prospective Study of Plasma Biomarkers From CNS in Patients With Mild Traumatic Brain Injury.
Frontiers in Neurology
, 12
, Article 643743. 10.3389/fneur.2021.643743.
|
|
|
Climaco Pinto, R;
Karaman, I;
Lewis, MR;
Hällqvist, J;
Kaluarachchi, M;
Graça, G;
Chekmeneva, E;
... Ebbels, T; + view all
(2021)
Finding Correspondence between Metabolomic Features in Untargeted Liquid Chromatography-Mass Spectrometry Metabolomics Datasets.
Analytical Chemistry
, 94
(14)
pp. 5493-5503.
10.1021/acs.analchem.1c03592.
|
|
Cousins, KAQ;
Phillips, JS;
Irwin, DJ;
Lee, EB;
Wolk, DA;
Shaw, LM;
Zetterberg, H;
... Grossman, M; + view all
(2021)
ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration.
Alzheimer's & Dementia
, 17
(5)
pp. 822-830.
10.1002/alz.12233.
|
|
Cullen, NC;
Leuzy, A;
Palmqvist, S;
Janelidze, S;
Stomrud, E;
Pesini, P;
Sarasa, L;
... Hansson, O; + view all
(2021)
Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations.
Nature Aging
, 1
pp. 114-123.
10.1038/s43587-020-00003-5.
|
|
Cummings, J;
Schwartz, GG;
Nicholls, SJ;
Khan, A;
Halliday, C;
Toth, PP;
Sweeney, M;
... Ray, KK; + view all
(2021)
Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial.
Journal of Alzheimer's Disease
10.3233/JAD-210570.
(In press).
|
|
|
Cunningham, JL;
Virhammar, J;
Rönnberg, B;
Castro Dopico, X;
Kolstad, L;
Albinsson, B;
Kumlien, E;
... Rostami, E; + view all
(2021)
Anti-SARS-CoV2 antibody responses in serum and cerebrospinal fluid of COVID-19 patients with neurological symptoms.
The Journal of Infectious Diseases
10.1093/infdis/jiab153.
(In press).
|
|
|
Dams-O'Connor, K;
Bellgowan, PSF;
Corriveau, R;
Pugh, MJ;
Smith, DH;
Schneider, JA;
Whittaker, K;
(2021)
Alzheimer's Disease-Related Dementias Summit 2019: National research priorities for the investigation of traumatic brain injury as a risk factor for Alzheimer's Disease and Related Dementias.
Journal of Neurotrauma
, 38
(23)
pp. 3186-3194.
10.1089/neu.2021.0216.
|
|
Dansson, HV;
Stempfle, L;
Egilsdóttir, H;
Schliep, A;
Portelius, E;
Blennow, K;
Zetterberg, H;
(2021)
Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer’s disease.
Alzheimer's Research and Therapy
, 13
, Article 151. 10.1186/s13195-021-00886-5.
|
|
|
de Rojas, I;
Moreno-Grau, S;
Tesi, N;
Grenier-Boley, B;
Andrade, V;
Jansen, IE;
Pedersen, NL;
... Ruiz, A; + view all
(2021)
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
Nature Communications
, 12
(1)
, Article 3417. 10.1038/s41467-021-22491-8.
|
|
|
Delaby, C;
Teunissen, CE;
Blennow, K;
Alcolea, D;
Arisi, I;
Amar, EB;
Beaume, A;
... Lehmann, S; + view all
(2021)
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview.
Alzheimer's & Dementia
10.1002/alz.12545.
(In press).
|
|
|
Diaz-Lucena, D;
Kruse, N;
Thüne, K;
Schmitz, M;
Villar-Piqué, A;
da Cunha, JEG;
Hermann, P;
... Llorens, F; + view all
(2021)
TREM2 expression in the brain and biological fluids in prion diseases.
Acta Neuropathologica
10.1007/s00401-021-02296-1.
(In press).
|
|
|
Dong, R;
Darst, BF;
Deming, Y;
Ma, Y;
Lu, Q;
Zetterberg, H;
Blennow, K;
... Engelman, CD; + view all
(2021)
CSF metabolites associate with CSF tau and improve prediction of Alzheimer's disease status.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
, Article e12167. 10.1002/dad2.12167.
|
|
|
Driscoll, I;
Ma, Y;
Gallagher, CL;
Johnson, SC;
Asthana, S;
Hermann, BP;
Sager, MA;
... Okonkwo, OC; + view all
(2021)
Age-Related Tau Burden and Cognitive Deficits Are Attenuated in KLOTHO KL-VS Heterozygotes.
Journal of Alzheimer's Disease
, 79
(3)
pp. 1297-1305.
10.3233/JAD-200944.
|
|
|
Edén, A;
Kanberg, N;
Gostner, J;
Fuchs, D;
Hagberg, L;
Andersson, L-M;
Lindh, M;
... Gisslén, M; + view all
(2021)
CSF Biomarkers in Patients With COVID-19 and Neurologic Symptoms: A Case Series.
Neurology
, 96
(2)
e294-e300.
10.1212/WNL.0000000000010977.
|
|
Edén, A;
Simrén, J;
Price, RW;
Zetterberg, H;
Gisslén, M;
(2021)
Neurochemical biomarkers to study CNS effects of COVID-19: a narrative review and synthesis.
Journal of Neurochemistry
, 159
(1)
pp. 61-77.
10.1111/jnc.15459.
|
|
Ennis, GE;
Koscik, RL;
Ma, Y;
Jonaitis, EM;
Van Hulle, CA;
Betthauser, TJ;
Randall, AM;
... Bendlin, BB; + view all
(2021)
Insulin resistance is related to cognitive decline but not change in CSF biomarkers of Alzheimer's disease in non-demented adults.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12220. 10.1002/dad2.12220.
|
|
|
Eratne, D;
Janelidze, S;
Malpas, CB;
Loi, S;
Walterfane, M;
Merritt, A;
Diouf, I;
... Santillo, A; + view all
(2021)
Plasma neurofilament light chain protein is not increased in treatment-resistant schizophrenia and first-degree relatives.
Australian and New Zealand Journal of Psychiatry
10.1177/00048674211058684.
(In press).
|
|
|
Eriksson, H;
Banote, RK;
Larsson, D;
Blennow, K;
Zetterberg, H;
Zelano, J;
(2021)
Brain injury markers in new-onset seizures in adults: A pilot study.
Seizure
, 92
pp. 62-67.
10.1016/j.seizure.2021.08.012.
|
|
|
Fällmar, D;
Rostami, E;
Kumlien, E;
Ashton, NJ;
Jackmann, S;
Pavel, R;
Blennow, K;
... Virhammar, J; + view all
(2021)
The extent of neuroradiological findings in COVID-19 shows correlation with blood biomarkers, Glasgow coma scale score and days in intensive care.
Journal of Neuroradiology
10.1016/j.neurad.2021.11.003.
(In press).
|
|
|
Fatima, T;
Jacobsson, LTH;
Kern, S;
Zettergren, A;
Blennow, K;
Zetterberg, H;
Johansson, L;
... Skoog, I; + view all
(2021)
Association between serum urate and CSF markers of Alzheimer's disease pathology in a population-based sample of 70-year-olds.
Alzheimers Dementia
, 13
(1)
, Article e12241. 10.1002/dad2.12241.
|
|
|
Forsberg, M;
Olsson, M;
Seth, H;
Wasling, P;
Zetterberg, H;
Hedner, J;
Hanse, E;
(2021)
Ion concentrations in cerebrospinal fluid in wakefulness, sleep and sleep deprivation in healthy humans.
Journal of Sleep Research
10.1111/jsr.13522.
(In press).
|
|
|
Franklin, HD;
Russell, LL;
Peakman, G;
Greaves, CV;
Bocchetta, M;
Nicholas, J;
Poos, J;
... Genetic FTD Initiative, GENFI, .; + view all
(2021)
The Revised Self-Monitoring Scale detects early impairment of social cognition in genetic frontotemporal dementia within the GENFI cohort.
Alzheimer's Research & Therapy
, 13
(1)
, Article 127. 10.1186/s13195-021-00865-w.
|
|
|
Frithiof, R;
Rostami, E;
Kumlien, E;
Virhammar, J;
Fällmar, D;
Hultström, M;
Lipcsey, M;
... Punga, AR; + view all
(2021)
Critical illness polyneuropathy, myopathy and neuronal biomarkers in COVID-19 patients: A prospective study.
Clinical Neurophysiology
10.1016/j.clinph.2021.03.016.
(In press).
|
|
|
Gaetani, L;
Bellomo, G;
Parnetti, L;
Blennow, K;
Zetterberg, H;
Di Filippo, M;
(2021)
Neuroinflammation and Alzheimer's Disease: A Machine Learning Approach to CSF Proteomics.
Cells
, 10
(8)
, Article 1930. 10.3390/cells10081930.
|
|
|
Gallo, V;
McElvenny, DM;
Seghezzo, G;
Kemp, S;
Williamson, E;
Lu, K;
Mian, S;
... Pearce, N; + view all
(2021)
Concussion and long-term cognitive function among rugby players-The BRAIN Study.
Alzheimer's & Dementia
10.1002/alz.12455.
(In press).
|
|
|
García-Ayllón, M-S;
Moreno-Pérez, O;
García-Arriaza, J;
Ramos-Rincón, J-M;
Cortés-Gómez, M-Á;
Brinkmalm, G;
Andrés, M;
... Sáez-Valero, J; + view all
(2021)
Plasma ACE2 species are differentially altered in COVID-19 patients.
FASEB Journal
, 35
(8)
, Article e21745. 10.1096/fj.202100051R.
|
|
|
Garland, P;
Morton, M;
Zolnourian, A;
Durnford, A;
Gaastra, B;
Toombs, J;
Heslegrave, AJ;
... Galea, I; + view all
(2021)
Neurofilament light predicts neurological outcome after subarachnoid haemorrhage.
Brain
10.1093/brain/awaa451.
(In press).
|
|
|
Giovannelli, I;
Bayatti, N;
Brown, A;
Wang, D;
Mickunas, M;
Camu, W;
Veyrune, J-L;
... Kirby, J; + view all
(2021)
Amyotrophic lateral sclerosis transcriptomics reveals immunological effects of low-dose interleukin-2.
Brain Communications
, 3
(3)
, Article fcab141. 10.1093/braincomms/fcab141.
(In press).
|
|
|
Gisslen, M;
Keating, SM;
Spudich, S;
Arechiga, V;
Stephenson, S;
Zetterberg, H;
Di Germanio, C;
... Price, RW; + view all
(2021)
Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression.
PLoS One
, 16
(5)
, Article e0250987. 10.1371/journal.pone.0250987.
|
|
|
Gkanatsiou, E;
Nilsson, J;
Toomey, CE;
Vrillon, A;
Kvartsberg, H;
Portelius, E;
Zetterberg, H;
... Brinkmalm, G; + view all
(2021)
Amyloid pathology and synaptic loss in pathological aging.
Journal of Neurochemistry
10.1111/jnc.15487.
(In press).
|
|
|
Gkanatsiou, E;
Sahlin, C;
Portelius, E;
Johannesson, M;
Söderberg, L;
Fälting, J;
Basun, H;
... Brinkmalm, G; + view all
(2021)
Characterization of monomeric and soluble aggregated Aβ in Down's syndrome and Alzheimer's disease brains.
Neuroscience Letters
, 754
, Article 135894. 10.1016/j.neulet.2021.135894.
|
|
|
Gleason, CE;
Zuelsdorff, M;
Gooding, DC;
Kind, AJH;
Johnson, AL;
James, TT;
Lambrou, NH;
... Zetterberg, H; + view all
(2021)
Alzheimer's disease biomarkers in Black and non-Hispanic White cohorts: A contextualized review of the evidence.
Alzheimer's & Dementia
10.1002/alz.12511.
(In press).
|
|
|
Gleerup, HS;
Sanna, F;
Hogh, P;
Simren, J;
Blennow, K;
Zetterberg, H;
Hasselbalch, SG;
... Simonsen, AH; + view all
(2021)
Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population.
Frontiers in Aging Neuroscience
, 13
, Article 659898. 10.3389/fnagi.2021.659898.
|
|
|
Gobom, J;
Parnetti, L;
Rosa-Neto, P;
Vyhnalek, M;
Gauthier, S;
Cataldi, S;
Lerch, O;
... Blennow, K; + view all
(2021)
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid.
Clinical Chemistry and Laboratory Medicine
10.1515/cclm-2021-0651.
(In press).
|
|
|
Gonzalez, Maria C;
Ashton, Nicholas J;
Gomes, Bárbara Fernandes;
Tovar-Rios, Diego Alejandro;
Blanc, Frédéric;
Karikari, Thomas K;
Mollenhauer, Brit;
... European–Dementia With Lewy Bodies (E-DLB) Consortium, .; + view all
(2021)
Association of Plasma p-tau181 and p-tau231 Concentrations With Cognitive Decline in Patients With Probable Dementia With Lewy Bodies.
JAMA Neurology
, 79
(1)
pp. 32-37.
10.1001/jamaneurol.2021.4222.
|
|
Goteson, A;
Isgren, A;
Jonsson, L;
Sparding, T;
Smedler, E;
Pelanis, A;
Zetterberg, H;
... Landen, M; + view all
(2021)
Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder.
Molecular Psychiatry
, 26
pp. 7446-7453.
10.1038/s41380-021-01236-5.
|
|
Graham, NSN;
Zimmerman, KA;
Moro, F;
Heslegrave, A;
Maillard, SA;
Bernini, A;
Miroz, J-P;
... Sharp, DJ; + view all
(2021)
Axonal marker neurofilament light predicts long-term outcomes and progressive neurodegeneration after traumatic brain injury.
Science Translational Medicine
, 13
(613)
, Article eabg9922. 10.1126/scitranslmed.abg9922.
|
|
Grau-Rivera, O;
Navalpotro-Gomez, I;
Sánchez-Benavides, G;
Suárez-Calvet, M;
Milà-Alomà, M;
Arenaza-Urquijo, EM;
Salvadó, G;
... ALFA Study; + view all
(2021)
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
Alzheimer's Research & Therapy
, 13
, Article 46. 10.1186/s13195-021-00781-z.
|
|
|
Grothe, MJ;
Moscoso, A;
Ashton, NJ;
Karikari, TK;
Lantero-Rodriguez, J;
Snellman, A;
Zetterberg, H;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy.
Neurology
10.1212/WNL.0000000000012513.
(In press).
|
|
|
Guzmán-Vélez, E;
Zetterberg, H;
Fox-Fuller, JT;
Vila-Castelar, C;
Sanchez, JS;
Baena, A;
Garcia-Ospina, G;
... Quiroz, YT; + view all
(2021)
Associations between plasma neurofilament light, in vivo brain pathology, and cognition in non-demented individuals with autosomal-dominant Alzheimer's disease.
Alzheimer's & Dementia
, 17
(5)
pp. 813-821.
10.1002/alz.12248.
|
|
Halaas, NB;
Zetterberg, H;
Idland, A-V;
Knapskog, A-B;
Watne, LO;
Blennow, K;
(2021)
Cerebrospinal Fluid Concentration of Neurogranin in Hip Fracture Patients with Delirium.
Journal of Alzheimer's Disease
10.3233/JAD-201341.
(In press).
|
|
|
Hallén, T;
Olsson, DS;
Hammarstrand, C;
Farahmand, D;
Olofsson, AC;
Jakobsson Ung, E;
Jakobsson, S;
... Skoglund, T; + view all
(2021)
Circulating brain injury biomarkers increase after endoscopic surgery for pituitary tumors.
Journal of Clinical Neuroscience
, 89
pp. 113-121.
10.1016/j.jocn.2021.04.030.
|
|
|
Hansson, O;
Batrla, R;
Brix, B;
Carrillo, MC;
Corradini, V;
Edelmayer, RM;
Esquivel, RN;
... Blennow, K; + view all
(2021)
The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau.
Alzheimer's & Dementia
, 17
(9)
pp. 1575-1582.
10.1002/alz.12316.
|
|
Hay, M;
Ryan, L;
Huentelman, M;
Konhilas, J;
Hoyer-Kimura, C;
Beach, TG;
Serrano, GE;
... Parthasarathy, S; + view all
(2021)
Serum Neurofilament Light is elevated in COVID-19 Positive Adults in the ICU and is associated with Co-Morbid Cardiovascular Disease, Neurological Complications, and Acuity of Illness.
Cardiology and Cardiovascular Medicine
, 5
(5)
pp. 551-565.
10.26502/fccm.92920221.
|
|
|
Henter, J-I;
Kvedaraite, E;
Martin Munoz, D;
Cheng Munthe-Kaas, M;
Zeller, B;
Nystad, TA;
Bjorklund, C;
... von Bahr Greenwood, T; + view all
(2021)
Response to mitogen-activated protein kinase inhibition of neurodegeneration in Langerhans cell histiocytosis monitored by cerebrospinal fluid neurofilament light as a biomarker: a pilot study.
British Journal of Haematology
10.1111/bjh.17781.
(In press).
|
|
|
Hill, E;
Karikari, TK;
Lantero-Rodriguez, J;
Zetterberg, H;
Blennow, K;
Richardson, MJ;
Wall, MJ;
(2021)
Truncating tau reveals different pathophysiological actions of oligomers in single neurons.
Communications Biology
, 4
, Article 1265. 10.1038/s42003-021-02791-x.
|
|
|
Holmegaard, L;
Stanne, TM;
Andreasson, U;
Zetterberg, H;
Blennow, K;
Blomstrand, C;
Jood, K;
(2021)
Proinflammatory Protein Signatures in Cryptogenic and Large Artery Atherosclerosis Stroke.
Acta Neurologica Scandinavica
, 143
(3)
pp. 303-312.
10.1111/ane.13366.
|
|
|
Hong, S;
Dobricic, V;
Ohlei, O;
Bos, I;
Vos, SJB;
Prokopenko, D;
Tijms, BM;
... Bertram, L; + view all
(2021)
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levels.
Alzheimer's & Dementia
, 17
(10)
pp. 1628-1640.
10.1002/alz.12330.
|
|
Illán-Gala, I;
Lleo, A;
Karydas, A;
Staffaroni, AM;
Zetterberg, H;
Sivasankaran, R;
Grinberg, LT;
... Rojas, JC; + view all
(2021)
Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease.
Neurology
, 96
(5)
e671-e683.
10.1212/WNL.0000000000011226.
|
|
Izzo, NJ;
Yuede, CM;
LaBarbera, KM;
Limegrover, CS;
Rehak, C;
Yurko, R;
Waybright, L;
... Catalano, SM; + view all
(2021)
Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification.
Alzheimer's & Dementia
10.1002/alz.12302.
|
|
|
James, S-N;
Nicholas, JM;
Lane, CA;
Parker, TD;
Lu, K;
Keshavan, A;
Buchanan, SM;
... Fox, NC; + view all
(2021)
A population‐based study of head injury, cognitive function and pathological markers.
Annals of Clinical and Translational Neurology
10.1002/acn3.51331.
(In press).
|
|
|
Janelidze, S;
Teunissen, CE;
Zetterberg, H;
Allué, JA;
Sarasa, L;
Eichenlaub, U;
Bittner, T;
... Hansson, O; + view all
(2021)
Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease.
JAMA Neurology
10.1001/jamaneurol.2021.3180.
(In press).
|
|
|
Jiang, W;
Luo, Z;
Stephenson, S;
Li, H;
Di Germanio, C;
Norris, PJ;
Fuchs, D;
... Price, RW; + view all
(2021)
Cerebrospinal fluid and plasma lipopolysaccharide (LPS) levels in HIV-1 infection and associations with inflammation, blood-brain barrier permeability and neuronal injury.
Journal of Infectious Diseases
, 223
(9)
pp. 1612-1620.
10.1093/infdis/jiaa765.
|
|
Johnson, M;
Fernell, E;
Gillberg, C;
Fasth, A;
Dinkler, L;
Blennow, K;
Zetterberg, H;
(2021)
No neurochemical evidence of neuronal injury or glial activation in children with Pediatric Acute-onset Neuropsychiatric Syndrome: An explorative pilot study.
The World Journal of Biological Psychiatry
10.1080/15622975.2021.1907716.
(In press).
|
|
|
Kagiava, A;
Karaiskos, C;
Richter, J;
Tryfonos, C;
Jennings, MJ;
Heslegrave, AJ;
Sargiannidou, I;
... Kleopa, KA; + view all
(2021)
AAV9-mediated Schwann cell-targeted gene therapy rescues a model of demyelinating neuropathy.
Gene Therapy
10.1038/s41434-021-00250-0.
(In press).
|
 |
|
Kamer, AR;
Pushalkar, S;
Gulivindala, D;
Butler, T;
Li, Y;
Annam, KRC;
Glodzik, L;
... De Leon, MJ; + view all
(2021)
Periodontal dysbiosis associates with reduced CSF Aβ42 in cognitively normal elderly.
Alzheimer's & Dementia
, 13
(1)
, Article e12172. 10.1002/dad2.12172.
|
|
|
Kanberg, N;
Simrén, J;
Edén, A;
Andersson, LM;
Nilsson, S;
Ashton, NJ;
Sundvall, PD;
... Gisslén, M; + view all
(2021)
Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up.
EBioMedicine
, 70
, Article 103512. 10.1016/j.ebiom.2021.103512.
|
|
|
Kang, MS;
Shin, M;
Ottoy, J;
Aliaga, AA;
Mathotaarachchi, S;
Quispialaya, K;
Pascoal, TA;
... Rosa-Neto, P; + view all
(2021)
Preclinical in vivo longitudinal assessment of KG207-M as a disease-modifying Alzheimer's disease therapeutic.
Journal of Cerebral Blood Flow & Metabolism
10.1177/0271678X211035625.
(In press).
|
|
|
Karikari, TK;
Benedet, AL;
Ashton, NJ;
Lantero Rodriguez, J;
Snellman, A;
Suárez-Calvet, M;
Saha-Chaudhuri, P;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Diagnostic performance and prediction of clinical progression of plasma phospho-tau181 in the Alzheimer's Disease Neuroimaging Initiative.
Molecular Psychiatry
, 26
pp. 429-442.
10.1038/s41380-020-00923-z.
|
|
Karikari, TK;
Emeršič, A;
Vrillon, A;
Lantero-Rodriguez, J;
Ashton, NJ;
Kramberger, MG;
Dumurgier, J;
... Blennow, K; + view all
(2021)
Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis.
Alzheimer's & Dementia
, 17
(5)
pp. 755-767.
10.1002/alz.12236.
|
|
|
Keshavan, A;
Pannee, J;
Karikari, T;
Lantero Rodriguez, J;
Ashton, NJ;
Nicholas, JM;
Cash, D;
... Schott, J; + view all
(2021)
Population-based blood screening for pre-clinical Alzheimer's disease in a British birth cohort at age 70.
Brain
, 144
(2)
pp. 434-449.
10.1093/brain/awaa403.
|
|
Keshavan, A;
Wellington, H;
Chen, Z;
Khatun, A;
Chapman, M;
Hart, M;
Cash, DM;
... Schott, JM; + view all
(2021)
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.
Alzheimer's & Dementia
, 13
(1)
, Article e12131. 10.1002/dad2.12131.
|
|
|
Kivimäki, M;
Walker, KA;
Pentti, J;
Nyberg, S;
Mars, N;
Vahtera, J;
Suominen, SB;
... Lindbohm, J; + view all
(2021)
Cognitive stimulation in the workplace, plasma proteins, and risk of dementia: three analyses of population cohort studies.
The British Medical Journal
, 374
, Article n1804. 10.1136/bmj.n1804.
|
|
|
Koivikko, P;
Posti, JP;
Mohammadian, M;
Lagerstedt, L;
Azurmendi, L;
Hossain, I;
Katila, AJ;
... Takala, RSK; + view all
(2021)
Potential of heart fatty-acid binding protein, neurofilament light, interleukin-10 and S100 calcium-binding protein B in the acute diagnostics and severity assessment of traumatic brain injury.
Emergency Medicine Journal
10.1136/emermed-2020-209471.
(In press).
|
|
|
Lantero-Rodriguez, J;
Snellman, A;
Benedet, AL;
Mila-Aloma, M;
Camporesi, E;
Montoliu-Gaya, L;
Ashton, NJ;
... Blennow, K; + view all
(2021)
P-tau235: a novel biomarker for staging preclinical Alzheimer's disease.
EMBO Molecular Medicine
, Article e15098. 10.15252/emmm.202115098.
(In press).
|
|
|
Larsen, JR;
Kobborg, T;
Shahim, P;
Blennow, K;
Rasmussen, LS;
Zetterberg, H;
(2021)
Serum-neuroproteins, near-infrared spectroscopy, and cognitive outcome after beach-chair shoulder surgery: observational cohort study analyses.
Acta Anaesthesiologica Scandinavica
, 65
(1)
pp. 26-33.
10.1111/aas.13691.
|
|
Laurikkala, J;
Aneman, A;
Peng, A;
Reinikainen, M;
Pham, P;
Jakkula, P;
Hästbacka, J;
... Skrifvars, MB; + view all
(2021)
Association of deranged cerebrovascular reactivity with brain injury following cardiac arrest: a post-hoc analysis of the COMACARE trial.
Critical Care
, 25
, Article 350. 10.1186/s13054-021-03764-6.
|
|
|
Lemarquis, A;
Campbell, T;
Aranda-Guillén, M;
Hennings, V;
Brodin, P;
Kämpe, O;
Blennow, K;
... Ekwall, O; + view all
(2021)
Severe COVID-19 in an APS1 patient with interferon autoantibodies treated with plasmapheresis.
Journal of Allergy and Clinical Immunology
10.1016/j.jaci.2021.03.034.
(In press).
|
|
|
Lemercier, P;
Vergallo, A;
Lista, S;
Zetterberg, H;
Blennow, K;
Potier, M-C;
Habert, M-O;
... Hampel, H; + view all
(2021)
Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP in individuals at risk of Alzheimer's disease.
Neurobiology of Aging
, 107
pp. 57-69.
10.1016/j.neurobiolaging.2021.07.005.
|
|
Lerche, S;
Sjoedin, S;
Brinkmalm, A;
Blennow, K;
Wurster, I;
Roeben, B;
Zimmermann, M;
... Brockmann, K; + view all
(2021)
CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB.
Movement Disorders
10.1002/mds.28704.
(In press).
|
|
|
Leuzy, A;
Ashton, NJ;
Mattsson-Carlgren, N;
Dodich, A;
Boccardi, M;
Corre, J;
Drzezga, A;
... Hansson, O; + view all
(2021)
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-021-05258-7.
(In press).
|
|
|
Lindberg, O;
Kern, S;
Skoog, J;
Machado, A;
Pereira, JB;
Sacuiu, SF;
Wahlund, LO;
... Skoog, I; + view all
(2021)
Effects of amyloid pathology and the APOE ε4 allele on the association between cerebrospinal fluid Aβ38 and Aβ40 and brain morphology in cognitively normal 70-years-olds.
Neurobiology of Aging
, 101
pp. 1-12.
10.1016/j.neurobiolaging.2020.10.033.
|
|
|
Lindbohm, JV;
Mars, N;
Walker, KA;
Singh-Manoux, A;
Livingston, G;
Brunner, EJ;
Sipilä, PN;
... Kivimäki, M; + view all
(2021)
Plasma proteins, cognitive decline, and 20-year risk of dementia in the Whitehall II and Atherosclerosis Risk in Communities studies.
Alzheimer's and Dementia
10.1002/alz.12419.
(In press).
|
|
|
Lleó, A;
Zetterberg, H;
Pegueroles, J;
Karikari, TK;
Carmona-Iragui, M;
Ashton, NJ;
Montal, V;
... Fortea, J; + view all
(2021)
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome.
Nature Communications
, 12
, Article 4304. 10.1038/s41467-021-24319-x.
|
|
|
Lord, J;
Zettergren, A;
Ashton, NJ;
Karikari, TK;
Benedet, AL;
Simrén, J;
Hye, A;
... Proitsi, P; + view all
(2021)
A genome-wide association study of plasma phosphorylated tau181.
Neurobiology of Aging
10.1016/j.neurobiolaging.2021.04.018.
(In press).
|
|
|
Lukkarinen, H;
Tesseur, I;
Pemberton, D;
Van Der Ark, P;
Timmers, M;
Slemmon, R;
Janssens, L;
... Leinonen, V; + view all
(2021)
Time Trends of Cerebrospinal Fluid Biomarkers of Neurodegeneration in Idiopathic Normal Pressure Hydrocephalus.
Journal of Alzheimer's Disease
10.3233/JAD-201361.
(In press).
|
|
|
Lussier, FZ;
Benedet, AL;
Therriault, J;
Pascoal, TA;
Tissot, C;
Chamoun, M;
Mathotaarachchi, S;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Plasma levels of phosphorylated tau 181 are associated with cerebral metabolic dysfunction in cognitively impaired and amyloid-positive individuals.
Brain Communications
, 3
(2)
, Article fcab073. 10.1093/braincomms/fcab073.
|
|
|
Ly, H;
Verma, N;
Sharma, S;
Kotiya, D;
Despa, S;
Abner, EL;
Nelson, PT;
... Despa, F; + view all
(2021)
The association of circulating amylin with β‐amyloid in familial Alzheimer's disease.
Alzheimer's & Dementia
, 7
(1)
, Article e12130. 10.1002/trc2.12130.
|
|
|
Lybeck, A;
Friberg, H;
Nielsen, N;
Rundgren, M;
Ullén, S;
Zetterberg, H;
Blennow, K;
... Westhall, E; + view all
(2021)
Postanoxic electrographic status epilepticus and serum biomarkers of brain injury.
Resuscitation
, 158
pp. 253-257.
10.1016/j.resuscitation.2020.10.027.
|
|
Ma, Y;
Norton, DL;
Van Hulle, CA;
Chappell, RJ;
Lazar, KK;
Jonaitis, EM;
Koscik, RL;
... Carlsson, CM; + view all
(2021)
Measurement batch differences and between-batch conversion of Alzheimer's disease cerebrospinal fluid biomarker values.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12194. 10.1002/dad2.12194.
|
|
|
Mallach, A;
Gobom, J;
Arber, C;
Piers, TM;
Hardy, J;
Wray, S;
Zetterberg, H;
(2021)
Differential stimulation of pluripotent stem cell-derived human microglia leads to exosomal proteomic changes affecting neurons.
Cells
, 10
(11)
, Article 2866. 10.3390/cells10112866.
|
|
|
Mallach, A;
Gobom, J;
Zetterberg, H;
Hardy, J;
Piers, TM;
Wray, S;
Pocock, JM;
(2021)
The influence of the R47H triggering receptor expressed on myeloid cells 2 variant on microglial exosome profiles.
Brain Communications
, 3
(2)
, Article fcab009. 10.1093/braincomms/fcab009.
|
|
|
Manera, AL;
Dadar, M;
Van Swieten, JC;
Borroni, B;
Sanchez-Valle, R;
Moreno, F;
Laforce, R;
... GENFI Consortium, .; + view all
(2021)
MRI data-driven algorithm for the diagnosis of behavioural variant frontotemporal dementia.
Journal of Neurology, Neurosurgery & Psychiatry
, 92
(6)
pp. 608-616.
10.1136/jnnp-2020-324106.
|
|
|
Marklund, N;
Vedung, F;
Lubberink, M;
Tegner, Y;
Johansson, J;
Blennow, K;
Zetterberg, H;
... Antoni, G; + view all
(2021)
Tau aggregation and increased neuroinflammation in athletes after sports-related concussions and in traumatic brain injury patients – A PET/MR study.
NeuroImage: Clinical
, 30
, Article 102665. 10.1016/j.nicl.2021.102665.
|
|
|
Mattila, OS;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
Harve-Rytsälä, H;
Pihlasviita, S;
Ritvonen, J;
... Lindsberg, PJ; + view all
(2021)
Ultra-Early Differential Diagnosis of Acute Cerebral Ischemia and Hemorrhagic Stroke by Measuring the Prehospital Release Rate of GFAP.
Clinical Chemistry
, Article hvab128. 10.1093/clinchem/hvab128.
(In press).
|
|
|
Mengel, D;
Mok, TH;
Nihat, A;
Liu, W;
Rissman, RA;
Galasko, D;
Zetterberg, H;
... Walsh, DM; + view all
(2021)
NT1-Tau Is Increased in CSF and Plasma of CJD Patients, and Correlates with Disease Progression.
Cells
, 10
(12)
, Article 3514. 10.3390/cells10123514.
|
|
|
Michno, W;
Blennow, K;
Zetterberg, H;
Brinkmalm, G;
(2021)
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer’s disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma.
Journal of Neurochemistry
, 159
(2)
pp. 234-257.
10.1111/jnc.15466.
|
|
Michno, W;
Wehrli, PM;
Koutarapu, S;
Marsching, C;
Minta, K;
Ge, J;
Meyer, SW;
... Hanrieder, J; + view all
(2021)
Structural Amyloid Plaque Polymorphism is Associated with Distinct Lipid Accumulations Revealed by Trapped Ion Mobility Mass Spectrometry Imaging (TIMS MSI).
Journal of Neurochemistry
10.1111/jnc.15557.
(In press).
|
|
|
Michno, W;
Stringer, KM;
Enzlein, T;
Passarelli, MK;
Escrig, S;
Vitanova, K;
Wood, J;
... Hanrieder, J; + view all
(2021)
Following spatial Aβ aggregation dynamics in evolving Alzheimer's disease pathology by imaging stable isotope labeling kinetics.
Science Advances
, 7
(25)
10.1126/sciadv.abg4855.
|
|
|
Mielke, MM;
Frank, RD;
Dage, JL;
Jeromin, A;
Ashton, NJ;
Blennow, K;
Karikari, TK;
... Petersen, RC; + view all
(2021)
Comparison of Plasma Phosphorylated Tau Species With Amyloid and Tau Positron Emission Tomography, Neurodegeneration, Vascular Pathology, and Cognitive Outcomes.
JAMA Neurology
, 78
(9)
pp. 1108-1117.
10.1001/jamaneurol.2021.2293.
|
|
Mielke, MM;
Przybelski, SA;
Lesnick, TG;
Kern, S;
Zetterberg, H;
Blennow, K;
Knopman, DS;
... Vemuri, P; + view all
(2021)
Comparison of CSF neurofilament light chain, neurogranin, and tau to MRI markers.
Alzheimer's & Dementia
, 17
(5)
pp. 801-812.
10.1002/alz.12239.
|
|
Milà-Alomà, M;
Brinkmalm, A;
Ashton, NJ;
Kvartsberg, H;
Shekari, M;
Operto, G;
Salvadó, G;
... ALFA Study; + view all
(2021)
CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study.
Neurology
10.1212/WNL.0000000000012853.
(In press).
|
|
|
Mila-Aloma, M;
Shekari, M;
Salvado, G;
Gispert, JD;
Arenaza-Urquijo, EM;
Operto, G;
Falcon, C;
... Molinuevo, JL; + view all
(2021)
Cognitively unimpaired individuals with a low burden of A beta pathology have a distinct CSF biomarker profile.
Alzheimer's Research and Therapy
, 13
, Article 134. 10.1186/s13195-021-00863-y.
|
|
|
Millere, E;
Rots, D;
Simrén, J;
Ashton, NJ;
Kupats, E;
Micule, I;
Priedite, V;
... Kenina, V; + view all
(2021)
Plasma neurofilament light chain as a potential biomarker in Charcot‐Marie‐Tooth disease.
European Journal of Neurology
, 28
(3)
pp. 974-981.
10.1111/ene.14689.
|
|
Millere, E;
Rots, D;
Glazere, I;
Taurina, G;
Kurjane, N;
Priedite, V;
Gailite, L;
... Kenina, V; + view all
(2021)
Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy.
Frontiers in Neurology |
, 11
, Article 586610. 10.3389/fneur.2020.586610.
|
|
|
Minta, K;
Brinkmalm, G;
Thelin, EP;
Al Nimer, F;
Piehl, F;
Tullberg, M;
Jeppsson, A;
... Andreasson, U; + view all
(2021)
Cerebrospinal fluid brevican and neurocan fragment patterns in human traumatic brain injury.
Clinica Chimica Acta
, 512
pp. 74-83.
10.1016/j.cca.2020.11.017.
|
|
Minta, K;
Brinkmalm, G;
Portelius, E;
Johansson, P;
Svensson, J;
Kettunen, P;
Wallin, A;
... Andreasson, U; + view all
(2021)
Brevican and Neurocan Peptides as Potential Cerebrospinal Fluid Biomarkers for Differentiation Between Vascular Dementia and Alzheimer's Disease.
Journal of Alzheimer's Disease
, 79
(2)
pp. 729-741.
10.3233/JAD-201039.
|
|
Minta, K;
Jeppsson, A;
Brinkmalm, G;
Portelius, E;
Zetterberg, H;
Blennow, K;
Tullberg, M;
(2021)
Lumbar and ventricular CSF concentrations of extracellular matrix proteins before and after shunt surgery in idiopathic normal pressure hydrocephalus.
Fluids and Barriers of the CNS
, 18
(1)
10.1186/s12987-021-00256-1.
|
|
|
Montoliu-Gaya, L;
Strydom, A;
Blennow, K;
Zetterberg, H;
Ashton, NJ;
(2021)
Blood Biomarkers for Alzheimer's Disease in Down Syndrome.
Journal of Clinical Medicine
, 10
(16)
, Article 3639. 10.3390/jcm10163639.
|
|
|
Moore, EE;
Liu, D;
Li, J;
Schimmel, SJ;
Cambronero, FE;
Terry, JG;
Nair, S;
... Jefferson, AL; + view all
(2021)
Association of Aortic Stiffness With Biomarkers of Neuroinflammation, Synaptic Dysfunction, and Neurodegeneration.
Neurology
, 97
(4)
e329-e340.
10.1212/WNL.0000000000012257.
|
|
Moscoso, A;
Grothe, MJ;
Ashton, NJ;
Karikari, TK;
Rodriguez, JL;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative, ,; + view all
(2021)
Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum.
Brain
, 144
(1)
pp. 325-339.
10.1093/brain/awaa399.
|
|
|
Moscoso, A;
Grothe, MJ;
Ashton, NJ;
Karikari, TK;
Lantero Rodríguez, J;
Snellman, A;
Suárez-Calvet, M;
... Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2021)
Longitudinal Associations of Blood Phosphorylated Tau181 and Neurofilament Light Chain With Neurodegeneration in Alzheimer Disease.
JAMA Neurology
, 78
(4)
pp. 396-406.
10.1001/jamaneurol.2020.4986.
|
|
|
Moseby-Knappe, M;
Mattsson-Carlgren, N;
Stammet, P;
Backman, S;
Blennow, K;
Dankiewicz, J;
Friberg, H;
... Cronberg, T; + view all
(2021)
Serum markers of brain injury can predict good neurological outcome after out-of-hospital cardiac arrest.
Intensive Care Medicine
10.1007/s00134-021-06481-4.
(In press).
|
|
|
Najar, J;
Van der Lee, SJ;
Joas, E;
Wetterberg, H;
Hardy, J;
Guerreiro, R;
Bras, J;
... Zettergren, A; + view all
(2021)
Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE ɛ4 negatives.
Alzheimer's & Dementia
, 13
(1)
, Article e12142. 10.1002/dad2.12142.
|
|
Najar, J;
Hällström, T;
Zettergren, A;
Johansson, L;
Joas, E;
Fässberg, MM;
Zetterberg, H;
... Skoog, I; + view all
(2021)
Reproductive period and preclinical cerebrospinal fluid markers for Alzheimer disease: a 25-year study.
Menopause
10.1097/GME.0000000000001816.
(In press).
|
|
|
Natarajan, K;
Ullgren, A;
Khoshnood, B;
Johansson, C;
Laffita-Mesa, JM;
Pannee, J;
Zetterberg, H;
... Graff, C; + view all
(2021)
Plasma metabolomics of presymptomatic PSEN1-H163Y mutation carriers: a pilot study.
Annals of Clinical and Translational Neurology
10.1002/acn3.51296.
(In press).
|
|
|
Nazir, FH;
Camporesi, E;
Brinkmalm, G;
Lashley, T;
Toomey, CE;
Kvartsberg, H;
Zetterberg, H;
... Becker, B; + view all
(2021)
Molecular forms of neurogranin in cerebrospinal fluid.
Journal of Neurochemistry
10.1111/jnc.15252.
(In press).
|
|
|
Needham, EJ;
Stoevesandt, O;
Thelin, EP;
Zetterberg, H;
Zanier, ER;
Al Nimer, F;
Ashton, NJ;
... Coles, AJ; + view all
(2021)
Complex Autoantibody Responses Occur following Moderate to Severe Traumatic Brain Injury.
The Journal of Immunology
, 207
(1)
pp. 90-100.
10.4049/jimmunol.2001309.
|
|
Nilsson, J;
Gobom, J;
Sjödin, S;
Brinkmalm, G;
Ashton, NJ;
Svensson, J;
Johansson, P;
... Brinkmalm, A; + view all
(2021)
Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease.
Alzheimers Dementia
, 13
(1)
, Article e12179. 10.1002/dad2.12179.
|
|
|
O'Connor, A;
Pannee, J;
Poole, T;
Arber, C;
Portelius, E;
Swift, IJ;
Heslegrave, AJ;
... Fox, NC; + view all
(2021)
Plasma amyloid-β ratios in autosomal dominant Alzheimer's disease: the influence of genotype.
Brain
10.1093/brain/awab166.
(In press).
|
|
|
Ossenkoppele, R;
Reimand, J;
Smith, R;
Leuzy, A;
Strandberg, O;
Palmqvist, S;
Stomrud, E;
... Hansson, O; + view all
(2021)
Tau PET correlates with different Alzheimer's disease-related features compared to CSF and plasma p-tau biomarkers.
EMBO Molecular Medicine
, Article e14398. 10.15252/emmm.202114398.
|
|
|
Palmqvist, S;
Tideman, P;
Cullen, N;
Zetterberg, H;
Blennow, K;
Dage, JL;
Stomrud, E;
... Hansson, O; + view all
(2021)
Prediction of future Alzheimer's disease dementia using plasma phospho-tau combined with other accessible measures.
Nature Medicine
, 27
pp. 1034-1042.
10.1038/s41591-021-01348-z.
|
|
Pannee, J;
Shaw, LM;
Korecka, M;
Waligorska, T;
Teunissen, CE;
Stoops, E;
Vanderstichele, HMJ;
... Zetterberg, H; + view all
(2021)
The global Alzheimer's Association round robin study on plasma amyloid β methods.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12242. 10.1002/dad2.12242.
|
|
|
Pascoal, TA;
Benedet, AL;
Ashton, NJ;
Kang, MS;
Therriault, J;
Chamoun, M;
Savard, M;
... Rosa-Neto, P; + view all
(2021)
Microglial activation and tau propagate jointly across Braak stages.
Nature Medicine
, 27
pp. 1592-1599.
10.1038/s41591-021-01456-w.
|
|
Patel, H;
Ashton, NJ;
Dobson, RJB;
Andersson, L-M;
Yilmaz, A;
Blennow, K;
Gisslen, M;
(2021)
Proteomic blood profiling in mild, severe and critical COVID-19 patients.
Scientific Reports
, 11
, Article 6357. 10.1038/s41598-021-85877-0.
|
|
|
Paterson, RW;
Benjamin, LA;
Mehta, PR;
Brown, RL;
Athauda, D;
Ashton, NJ;
Leckey, CA;
... Schott, JM; + view all
(2021)
Serum and cerebrospinal fluid biomarker profiles in acute SARS-CoV-2-associated neurological syndromes.
Brain Communications
, 3
(3)
, Article fcab099. 10.1093/braincomms/fcab099.
|
|
|
Peakman, G;
Russell, LL;
Convery, RS;
Nicholas, JM;
van Swieten, JC;
Jiskoot, LC;
Moreno, F;
... Mitchell, S; + view all
(2021)
Comparison of clinical rating scales in genetic frontotemporal dementia within the GENFI cohort.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2021-326868.
(In press).
|
|
|
Pereira, JB;
Janelidze, S;
Smith, R;
Mattsson-Carlgren, N;
Palmqvist, S;
Teunissen, CE;
Zetterberg, H;
... Hansson, O; + view all
(2021)
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.
Brain
, Article awab223. 10.1093/brain/awab223.
(In press).
|
|
|
Perino, J;
Patterson, M;
Momen, M;
Borisova, M;
Heslegrave, A;
Zetterberg, H;
Gruel, J;
... Sample, SJ; + view all
(2021)
Neurofilament light plasma concentration positively associates with age and negatively associates with weight and height in the dog.
Neuroscience Letters
, 744
, Article 135593. 10.1016/j.neulet.2020.135593.
|
|
|
Picard, C;
Nilsson, N;
Labonté, A;
Auld, D;
Rosa-Neto, P;
Alzheimer's Disease Neuroimaging Initiative;
Ashton, NJ;
... PREVENT-AD research group; + view all
(2021)
Apolipoprotein B is a novel marker for early tau pathology in Alzheimer's disease.
Alzheimer's & Dementia: The Journal of the Alzheimer's Association
10.1002/alz.12442.
(In press).
|
|
|
Pilotto, A;
Imarisio, A;
Conforti, F;
Scalvini, A;
Masciocchi, S;
Nocivelli, S;
Turrone, R;
... Padovani, A; + view all
(2021)
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease.
Parkinsonism & Related Disorders
, 87
pp. 41-47.
10.1016/j.parkreldis.2021.04.016.
|
|
Pilotto, A;
Masciocchi, S;
Volonghi, I;
De Giuli, V;
Caprioli, F;
Mariotto, S;
Ferrari, S;
... Padovani, A; + view all
(2021)
SARS-CoV-2 encephalitis is a cytokine release syndrome: evidences from cerebrospinal fluid analyses.
Clinical Infectious Diseases
, 73
(9)
e3019-e3026.
10.1093/cid/ciaa1933.
|
|
Pilotto, A;
Imarisio, A;
Carrarini, C;
Russo, M;
Masciocchi, S;
Gipponi, S;
Cottini, E;
... Padovani, A; + view all
(2021)
Plasma Neurofilament Light Chain Predicts Cognitive Progression in Prodromal and Clinical Dementia with Lewy Bodies.
Journal of Alzheimer's Disease
10.3233/JAD-210342.
(In press).
|
|
|
Pomara, N;
Bruno, D;
Plaska, CR;
Pillai, A;
Ramos-Cejudo, J;
Osorio, R;
Imbimbo, BP;
... Blennow, K; + view all
(2021)
Evidence of upregulation of the cholinergic anti-inflammatory pathway in late-life depression.
Journal of Affective Disorders
, 286
pp. 275-281.
10.1016/j.jad.2021.03.012.
|
|
Poos, JM;
Russell, LL;
Peakman, G;
Bocchetta, M;
Greaves, CV;
Jiskoot, LC;
van der Ende, EL;
... Genetic FTD Initiative, GENF; + view all
(2021)
Impairment of episodic memory in genetic frontotemporal dementia: A GENFI study.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12185. 10.1002/dad2.12185.
|
|
|
Pujol-Calderón, F;
Zetterberg, H;
Portelius, E;
Löwhagen Hendén, P;
Rentzos, A;
Karlsson, J-E;
Höglund, K;
... Rosengren, LE; + view all
(2021)
Prediction of Outcome After Endovascular Embolectomy in Anterior Circulation Stroke Using Biomarkers.
Translational Stroke Research
10.1007/s12975-021-00905-5.
(In press).
|
|
|
Rådestig, MA;
Skoog, J;
Zetterberg, H;
Kern, J;
Zettergren, A;
Sacuiu, S;
Waern, M;
... Kern, S; + view all
(2021)
Cognitive Performance and Cerebrospinal Fluid Markers in Preclinical Alzheimer's Disease: Results from the Gothenburg H70 Birth Cohort Studies.
Journal of Alzheimer's Disease
, 79
(1)
pp. 225-235.
10.3233/JAD-200751.
|
|
|
Raftopoulos, R;
Kuhle, J;
Grant, D;
Hickman, SJ;
Altmann, DR;
Leppert, D;
Blennow, K;
... Gnanapavan, S; + view all
(2021)
Neurofilament results for the phase II neuroprotection study of phenytoin in optic neuritis.
European Journal of Neurology
, 28
(2)
pp. 587-594.
10.1111/ene.14591.
|
|
Remnestål, J;
Bergström, S;
Olofsson, J;
Sjöstedt, E;
Uhlén, M;
Blennow, K;
Zetterberg, H;
... Månberg, A; + view all
(2021)
Association of CSF proteins with tau and amyloid β levels in asymptomatic 70-year-olds.
Alzheimer's Research & Therapy
, 13
, Article 54. 10.1186/s13195-021-00789-5.
|
|
|
Robertson, J;
Edèn, A;
Nyström, K;
Hagberg, L;
Yilmaz, A;
Gostner, JM;
Fuchs, D;
... Gisslèn, M; + view all
(2021)
Increased immune activation and signs of neuronal injury in HIV-negative people on preexposure prophylaxis.
AIDS
, 35
(13)
pp. 2129-2136.
10.1097/QAD.0000000000002980.
|
|
Rosadas, C;
Zetterberg, H;
Heslegrave, A;
Haddow, J;
Borisova, M;
Taylor, GP;
(2021)
Neurofilament Light in CSF and Plasma Is a Marker of Neuronal Damage in HTLV-1-Associated Myelopathy and Correlates With Neuroinflammation.
Neurology Neuroimmunology & Neuroinflammation
, 8
(6)
, Article e1090. 10.1212/NXI.0000000000001090.
|
|
|
Rosenstein, I;
Axelsson, M;
Novakova, L;
Blennow, K;
Zetterberg, H;
Lycke, J;
(2021)
Exploring CSF neurofilament light as a biomarker for MS in clinical practice; a retrospective registry-based study.
Multiple Sclerosis Journal
10.1177/13524585211039104.
(In press).
|
|
|
Rosenstein, I;
Rasch, S;
Axelsson, M;
Novakova, L;
Blennow, K;
Zetterberg, H;
Lycke, J;
(2021)
Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: a real-world investigation.
Journal of Neurochemistry
10.1111/jnc.15500.
(In press).
|
|
|
Rossor, AM;
Kapoor, M;
Wellington, H;
Spaulding, EL;
Sleigh, JN;
Burgess, RW;
Laura, M;
... Mm, R; + view all
(2021)
A longitudinal and cross-sectional study of plasma neurofilament light chain concentration in Charcot-Marie-Tooth disease.
Journal of the Peripheral Nervous System
10.1111/jns.12477.
(In press).
|
|
Salami, A;
Adolfsson, R;
Andersson, M;
Blennow, K;
Lundquist, A;
Adolfsson, AN;
Schöll, M;
... Nyberg, L; + view all
(2021)
Association of APOE ɛ4 and Plasma p-tau181 with Preclinical Alzheimer's Disease and Longitudinal Change in Hippocampus Function.
Journal of Alzheimer's Disease
10.3233/JAD-210673.
(In press).
|
|
|
Salvadó, G;
Milà-Alomà, M;
Shekari, M;
Minguillon, C;
Fauria, K;
Niñerola-Baizán, A;
Perissinotti, A;
... Gispert, JD; + view all
(2021)
Cerebral amyloid‐β load is associated with neurodegeneration and gliosis: Mediation by p‐tau and interactions with risk factors early in the Alzheimer's continuum.
Alzheimer's & Dementia
, 17
(5)
pp. 788-800.
10.1002/alz.12245.
|
|
|
Samuelsson, J;
Najar, J;
Wallengren, O;
Kern, S;
Wetterberg, H;
Mellqvist Fässberg, M;
Zetterberg, H;
... Zettergren, A; + view all
(2021)
Interactions between dietary patterns and genetic factors in relation to incident dementia among 70-year-olds.
European Journal of Nutrition
10.1007/s00394-021-02688-9.
(In press).
|
|
|
Samuelsson, J;
Kern, S;
Zetterberg, H;
Blennow, K;
Rothenberg, E;
Wallengren, O;
Skoog, I;
(2021)
A Western-style dietary pattern is associated with cerebrospinal fluid biomarker levels for preclinical Alzheimer's disease-A population-based cross-sectional study among 70-year-olds.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 7
(1)
, Article e12183. 10.1002/trc2.12183.
|
|
|
Sánchez-Benavides, G;
Suárez-Calvet, M;
Milà-Alomà, M;
Arenaza-Urquijo, EM;
Grau-Rivera, O;
Operto, G;
Gispert, JD;
... ALFA Study; + view all
(2021)
Amyloid-β positive individuals with subjective cognitive decline present increased CSF neurofilament light levels that relate to lower hippocampal volume.
Neurobiology of Aging
, 104
pp. 24-31.
10.1016/j.neurobiolaging.2021.02.026.
|
|
|
Sanders, RD;
Craigova, L;
Schessler, B;
Casey, C;
White, M;
Parker, M;
Kunkel, D;
... Lennertz, R; + view all
(2021)
Postoperative troponin increases after noncardiac surgery are associated with raised neurofilament light: a prospective observational cohort study.
British Journal of Anaesthesia
, 126
(4)
pp. 791-798.
10.1016/j.bja.2020.10.012.
|
|
Shahim, P;
Zetterberg, H;
(2021)
Neurochemical markers of traumatic brain injury – relevance to acute diagnostics, disease monitoring, and neuropsychiatric outcome prediction.
Biological Psychiatry
10.1016/j.biopsych.2021.10.010.
(In press).
|
|
|
Shepley, BR;
Ainslie, PN;
Hoiland, RL;
Donnelly, J;
Sekhon, MS;
Zetterberg, H;
Blennow, K;
(2021)
Negligible influence of moderate to severe hyperthermia on blood-brain barrier permeability and neuronal-parenchymal integrity in healthy men.
Journal of Applied Physiology
, 130
(3)
pp. 792-800.
10.1152/japplphysiol.00645.2020.
|
|
Shi, L;
Winchester, LM;
Westwood, S;
Baird, AL;
Anand, SN;
Buckley, NJ;
Hye, A;
... Nevado-Holgado, AJ; + view all
(2021)
Replication study of plasma proteins relating to Alzheimer's pathology.
Alzheimer's and Dementia
, 17
(9)
pp. 1452-1464.
10.1002/alz.12322.
|
|
Shi, L;
Buckley, NJJ;
Bos, I;
Engelborghs, S;
Sleegers, K;
Frisoni, GB;
Wallin, A;
... Nevado-Holgado, AJ; + view all
(2021)
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.
Frontiers in Aging Neuroscience
, 13
, Article 712545. 10.3389/fnagi.2021.712545.
|
|
|
Simrén, J;
Leuzy, A;
Karikari, TK;
Hye, A;
Benedet, AL;
Lantero-Rodriguez, J;
Mattsson-Carlgren, N;
... Ashton, NJ; + view all
(2021)
The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer's disease.
Alzheimer's & Dementia
, 17
(7)
pp. 1145-1156.
10.1002/alz.12283.
|
|
Simrén, J;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2021)
Blood neurofilament light in remote settings: Alternative protocols to support sample collection in challenging pre-analytical conditions.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 13
(1)
, Article e12145. 10.1002/dad2.12145.
|
|
|
Sjöbom, U;
Hellström, W;
Löfqvist, C;
Nilsson, AK;
Holmström, G;
Pupp, IH;
Ley, D;
... Hellström, A; + view all
(2021)
Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants.
Jama Network Open
, 4
(4)
, Article e214138. 10.1001/jamanetworkopen.2021.4138.
|
|
|
Skillbäck, T;
Blennow, K;
Zetterberg, H;
Shams, S;
Machado, A;
Pereira, J;
Lindberg, O;
... Kern, S; + view all
(2021)
Sex differences in CSF biomarkers for neurodegeneration and blood-brain barrier integrity.
Alzheimers Dement (Amst)
, 13
(1)
, Article e12141. 10.1002/dad2.12141.
|
|
|
Skoog, I;
Kern, S;
Najar, J;
Guerreiro, R;
Bras, J;
Waern, M;
Zetterberg, H;
... Zettergren, A; + view all
(2021)
A non-APOE polygenic risk score for Alzheimer's disease is associated with CSF neurofilament light in a representative sample of cognitively unimpaired 70-year-olds.
The Journals of Gerontology: Series A
10.1093/gerona/glab030.
(In press).
|
|
|
Sogorb-Esteve, A;
Swift, IJ;
Woollacott, IOC;
Warren, JD;
Zetterberg, H;
Rohrer, JD;
(2021)
Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation.
Journal of Neuroinflammation
, 18
(1)
, Article 224. 10.1186/s12974-021-02247-3.
|
|
|
Stockfelt, M;
Larsson, G;
Engström, H;
Puttonen, H;
Zetterberg, H;
Blennow, K;
Sjöwall, C;
... Lundell, A-C; + view all
(2021)
Activated low-density granulocytes in peripheral and intervillous blood and neutrophil inflammation in placentas from SLE pregnancies.
Lupus Science & Medicine
, 8
(1)
, Article e000463. 10.1136/lupus-2020-000463.
|
|
|
Stockfelt, M;
Lundell, A-C;
Hetland, ML;
Østergaard, M;
Uhlig, T;
Heiberg, MS;
Haavardsholm, EA;
... Rudin, A; + view all
(2021)
Plasma interferon-alpha is associated with double-positivity for autoantibodies but is not a predictor of remission in early rheumatoid arthritis-a spin-off study of the NORD-STAR randomized clinical trial.
Arthritis Research & Therapy
, 23
, Article 189. 10.1186/s13075-021-02556-1.
|
|
|
Stokowska, A;
Bunketorp Käll, L;
Blomstrand, C;
Simrén, J;
Nilsson, M;
Zetterberg, H;
Blennow, K;
... Pekna, M; + view all
(2021)
Plasma neurofilament light chain levels predict improvement in late phase after stroke.
European Journal of Neurology
, 28
(7)
pp. 2218-2228.
10.1111/ene.14854.
|
|
|
Sun, X;
Wang, Q;
Blennow, K;
Zetterberg, H;
McCarthy, M;
Loewenstein, DA;
Vontell, R;
... Zhang, B; + view all
(2021)
Association of neurogranin gene expression with Alzheimer's disease pathology in the perirhinal cortex.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 7
(1)
, Article e12162. 10.1002/trc2.12162.
|
|
|
Tanaka, T;
Ruifen, JC;
Ying-Hwey, N;
Tan, CH;
Lim, CZJ;
Zhang, Y;
Stephenson, MC;
... Chen, C; + view all
(2021)
Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort.
European Journal of Neurology
, 28
(5)
pp. 1479-1489.
10.1111/ene.14704.
|
|
Targa, ADS;
Benitez, ID;
Dakterzada, F;
Fontenele-Araujo, J;
Minguez, O;
Zetterberg, H;
Blennow, K;
... Pinol-Ripoll, G; + view all
(2021)
The circadian rest-activity pattern predicts cognitive decline among mild-moderate Alzheimer's disease patients.
Alzheimer's Research and Therapy
, 13
, Article 161. 10.1186/s13195-021-00903-7.
|
|
|
Targa, A;
Dakterzada, F;
Benítez, I;
López, R;
Pujol, M;
Dalmases, M;
Arias, A;
... Piñol-Ripoll, G; + view all
(2021)
Decrease in sleep depth is associated with higher cerebrospinal fluid neurofilament light levels in patients with Alzheimer's disease.
Sleep
, 44
(2)
, Article zsaa147. 10.1093/sleep/zsaa147.
|
|
Teipel, S;
Bruno, D;
Plaska, CR;
Heslegrave, A;
Ramos-Cejudo, J;
Osorio, RS;
Zetterberg, H;
... Pomara, N; + view all
(2021)
Association of CSF sTREM2, a marker of microglia activation, with cholinergic basal forebrain volume in major depressive disorder.
Journal of Affective Disorders
, 293
pp. 429-434.
10.1016/j.jad.2021.06.030.
|
|
Therriault, J;
Benedet, AL;
Pascoal, TA;
Lussier, FZ;
Tissot, C;
Karikari, TK;
Ashton, NJ;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Association of plasma P-tau181 with memory decline in non-demented adults.
Brain Communications
, 3
(3)
, Article fcab136. 10.1093/braincomms/fcab136.
|
|
|
Thijssen, EH;
La Joie, R;
Strom, A;
Fonseca, C;
Iaccarino, L;
Wolf, A;
Spina, S;
... Boxer, AL; + view all
(2021)
Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance study.
The Lancet Neurology
, 20
(9)
pp. 739-752.
10.1016/S1474-4422(21)00214-3.
|
|
Thompson, AGB;
Anastasiadis, P;
Druyeh, R;
Whitworth, I;
Nayak, A;
Nihat, A;
Mok, TH;
... Mead, S; + view all
(2021)
Evaluation of plasma tau and neurofilament light chain biomarkers in a 12-year clinical cohort of human prion diseases.
Molecular Psychiatry
10.1038/s41380-021-01045-w.
(In press).
|
|
|
Tijms, BM;
Gobom, J;
Teunissen, C;
Dobricic, V;
Tsolaki, M;
Verhey, F;
Popp, J;
... Visser, PJ; + view all
(2021)
Csf proteomic alzheimer’s disease-predictive subtypes in cognitively intact amyloid negative individuals.
Proteomes
, 9
(3)
, Article 36. 10.3390/proteomes9030036.
|
|
|
Tiraboschi, JM;
Rojas, J;
Zetterberg, H;
Blennow, K;
Niubo, J;
Gostner, J;
Navarro-Alcaraz, A;
... Podzamczer, D; + view all
(2021)
No Changes in Human Immunodeficiency Virus (HIV) Suppression and Inflammatory Markers in Cerebrospinal Fluid in Patients Randomly Switched to Dolutegravir Plus Lamivudine (Spanish HIV/AIDS Research Network, PreEC/RIS 62).
The Journal of Infectious Diseases
, 223
(11)
pp. 1928-1933.
10.1093/infdis/jiaa645.
|
|
Tissot, C;
L Benedet, A;
Therriault, J;
Pascoal, TA;
Lussier, FZ;
Saha-Chaudhuri, P;
Chamoun, M;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2021)
Plasma pTau181 predicts cortical brain atrophy in aging and Alzheimer's disease.
Alzheimer's Research & Therapy
, 13
, Article 69. 10.1186/s13195-021-00802-x.
|
|
|
Tobieson, L;
Zetterberg, H;
Blennow, K;
Marklund, N;
(2021)
Extracellular fluid, cerebrospinal fluid and plasma biomarkers of axonal and neuronal injury following intracerebral hemorrhage.
Scientific Reports
, 11
, Article 16950. 10.1038/s41598-021-96364-x.
|
|
|
Tofiq, A;
Zetterberg, H;
Blennow, K;
Basun, H;
Cederholm, T;
Eriksdotter, M;
Faxén-Irving, G;
... Freund-Levi, Y; + view all
(2021)
Effects of Peroral Omega-3 Fatty Acid Supplementation on Cerebrospinal Fluid Biomarkers in Patients with Alzheimer’s Disease: A Randomized Controlled Trial—The OmegAD Study.
Journal of Alzheimer's Disease
, 83
(3)
pp. 1291-1301.
10.3233/JAD-210007.
|
|
|
Toombs, J;
Zetterberg, H;
(2021)
Untangling the tau microtubule-binding region.
Brain
, 144
(2)
pp. 359-362.
10.1093/brain/awaa468.
|
|
Toppala, S;
Ekblad, LL;
Tuisku, J;
Helin, S;
Johansson, JJ;
Laine, H;
Löyttyniemi, E;
... Rinne, JO; + view all
(2021)
Association of Early Beta-amyloid Accumulation and Neuroinflammation Measured with [11C]PBR28 in Elderly Individuals Without Dementia.
Neurology
, 96
(12)
e1608-e1619.
10.1212/WNL.0000000000011612.
|
|
|
Tosun, D;
Veitch, D;
Aisen, P;
Jack, CR;
Jagust, WJ;
Petersen, RC;
Saykin, AJ;
... Weiner, MW; + view all
(2021)
Detection of β-amyloid positivity in Alzheimer's Disease Neuroimaging Initiative participants with demographics, cognition, MRI and plasma biomarkers.
Brain Communications
, 3
(2)
, Article fcab008. 10.1093/braincomms/fcab008.
|
|
|
Tsitsopoulos, PP;
Holmström, U;
Blennow, K;
Zetterberg, H;
Marklund, N;
(2021)
Cerebrospinal fluid biomarkers of glial and axonal injury in cervical spondylotic myelopathy.
Journal of Neurosurgery: Spine
pp. 1-10.
10.3171/2020.8.SPINE20965.
(In press).
|
|
Umek, T;
Olsson, T;
Gissberg, O;
Saher, O;
Zaghloul, EM;
Lundin, KE;
Wengel, J;
... Zain, R; + view all
(2021)
Oligonucleotides Targeting DNA Repeats Downregulate Huntingtin Gene Expression in Huntington's Patient-Derived Neural Model System.
Nucleic Acid Therapeutics
10.1089/nat.2021.0021.
(In press).
|
|
|
van der Ende, EL;
Bron, EE;
Poos, JM;
Jiskoot, LC;
Panman, JL;
Papma, JM;
Meeter, LH;
... GENFI consortium; + view all
(2021)
A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia.
Brain
10.1093/brain/awab382.
(In press).
|
|
|
Van Hulle, C;
Jonaitis, EM;
Betthauser, TJ;
Batrla, R;
Wild, N;
Kollmorgen, G;
Andreasson, U;
... Blennow, K; + view all
(2021)
An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum.
Alzheimer's & Dementia
, 17
(3)
pp. 431-445.
10.1002/alz.12204.
|
|
Vera, Jaime H;
Eftychiou, Nicholas;
Schuerer, Matti;
Rullmann, Michael;
Barthel, Henryk;
Sabri, Osama;
Gisslen, Magnus;
... Dizdarevic, Sabina; + view all
(2021)
Clinical Utility of β-Amyloid PET Imaging in People Living With HIV With Cognitive Symptoms.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 87
(2)
pp. 826-833.
10.1097/QAI.0000000000002648.
|
|
|
Verberk, IMW;
Misdorp, EO;
Koelewijn, J;
Ball, AJ;
Blennow, K;
Dage, JL;
Fandos, N;
... Teunissen, CE; + view all
(2021)
Characterization of pre-analytical sample handling effects on a panel of Alzheimer's disease–related blood-based biomarkers: Results from the Standardization of Alzheimer's Blood Biomarkers (SABB) working group.
Alzheimer's and Dementia
10.1002/alz.12510.
|
|
|
Vergallo, A;
Lemercier, P;
Cavedo, E;
Lista, S;
Vanmechelen, E;
De Vos, A;
Zetterberg, H;
... INSIGHT-preAD study group, and the Alzheimer Precision Medicine; + view all
(2021)
Plasma β-secretase1 concentrations correlate with basal forebrain atrophy and neurodegeneration in cognitively healthy individuals at risk for AD.
Alzheimer's & Dementia
, 17
(4)
pp. 629-640.
10.1002/alz.12228.
|
|
Vilor-Tejedor, N;
Ciampa, I;
Operto, G;
Falcón, C;
Suárez-Calvet, M;
Crous-Bou, M;
Shekari, M;
... Vilanova, M; + view all
(2021)
Perivascular spaces are associated with tau pathophysiology and synaptic dysfunction in early Alzheimer’s continuum.
Alzheimer's Research and Therapy
, 13
, Article 135. 10.1186/s13195-021-00878-5.
|
|
|
Walgrave, H;
Balusu, S;
Snoeck, S;
Vanden Eynden, E;
Craessaerts, K;
Thrupp, N;
Wolfs, L;
... Salta, E; + view all
(2021)
Restoring miR-132 expression rescues adult hippocampal neurogenesis and memory deficits in Alzheimer's disease.
Cell Stem Cell
10.1016/j.stem.2021.05.001.
(In press).
|
|
|
Wall, A;
Anger, O;
Jood, K;
Blomstrand, C;
Andreasson, U;
Blennow, K;
Zetterberg, H;
... Svensson, J; + view all
(2021)
Circulating granulocyte colony-stimulating factor and functional outcome after ischemic stroke: an observational study.
Neurological Research
10.1080/01616412.2021.1948766.
(In press).
|
|
|
Wang, H;
Robinson, JL;
Kocabas, P;
Gustafsson, J;
Anton, M;
Cholley, P-E;
Huang, S;
... Nielsen, J; + view all
(2021)
Genome-scale metabolic network reconstruction of model animals as a platform for translational research.
Proceedings of the National Academy of Sciences
, 118
(30)
, Article e2102344118. 10.1073/pnas.2102344118.
|
|
|
Weber, TA;
Lundkvist, J;
Wanngren, J;
Kvartsberg, H;
Jin, S;
Larssen, P;
Wu, D;
... Karlström, H; + view all
(2021)
γ-Secretase modulators show selectivity for γ-secretase–mediated amyloid precursor protein intramembrane processing.
Journal of Cellular and Molecular Medicine
10.1111/jcmm.17146.
(In press).
|
|
|
Weinhofer, I;
Rommer, P;
Zierfuss, B;
Altmann, P;
Foiani, M;
Heslegrave, A;
Zetterberg, H;
... Berger, J; + view all
(2021)
Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy.
Nature Communications
, 12
, Article 1816. 10.1038/s41467-021-22114-2.
|
|
|
Wiberg, S;
Holmgaard, F;
Blennow, K;
Nilsson, JC;
Kjaergaard, J;
Wanscher, M;
Langkilde, AR;
... Vedel, AG; + view all
(2021)
Associations between mean arterial pressure during cardiopulmonary bypass and biomarkers of cerebral injury in patients undergoing cardiac surgery: secondary results from a randomized controlled trial.
Interactive CardioVascular and Thoracic Surgery
, 32
(2)
pp. 229-235.
10.1093/icvts/ivaa264.
|
|
Wightman, DP;
Jansen, IE;
Savage, JE;
Shadrin, AA;
Bahrami, S;
Holland, D;
Rongve, A;
... Posthuma, D; + view all
(2021)
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
Nature Genetics
, 53
(9)
pp. 1276-1282.
10.1038/s41588-021-00921-z.
|
|
Wilke, C;
Reich, S;
van Swieten, JC;
Borroni, B;
Sanchez-Valle, R;
Moreno, F;
Laforce, R;
... Synofzik, M; + view all
(2021)
Stratifying the Presymptomatic Phase of Genetic Frontotemporal Dementia by Serum NfL and pNfH: A Longitudinal Multicentre Study.
Annals of Neurology
10.1002/ana.26265.
(In press).
|
|
Williams, T;
Zetterberg, H;
Chataway, J;
(2021)
Serum Neurofilament Light concentrations are not associated with renal function in secondary progressive multiple sclerosis.
Biomarkers in Neuropsychiatry
, 5
, Article 100044. 10.1016/j.bionps.2021.100044.
|
|
|
Xu, J;
Green, R;
Kim, M;
Lord, J;
Ebshiana, A;
Westwood, S;
Baird, AL;
... On Behalf Of The European Medical Information Framework Consorti; + view all
(2021)
Sex-Specific Metabolic Pathways Were Associated with Alzheimer's Disease (AD) Endophenotypes in the European Medical Information Framework for AD Multimodal Biomarker Discovery Cohort.
Biomedicines
, 9
(11)
, Article 1610. 10.3390/biomedicines9111610.
|
|
|
Xu, L;
Ramadan, S;
Akingbade, OE;
Zhang, Y;
Alodan, S;
Graham, N;
Zimmerman, KA;
... Li, B; + view all
(2021)
Detection of Glial Fibrillary Acidic Protein in Patient Plasma Using On-Chip Graphene Field-Effect Biosensors, in Comparison with ELISA and Single-Molecule Array.
ACS Sensors
10.1021/acssensors.1c02232.
(In press).
|
|
|
Zerr, I;
Villar-Piqué, A;
Hermann, P;
Schmitz, M;
Varges, D;
Ferrer, I;
Riggert, J;
... Llorens, F; + view all
(2021)
Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
Alzheimer's Research & Therapy
, 13
(1)
, Article 86. 10.1186/s13195-021-00815-6.
|
|
|
Zetterberg, H;
(2021)
Glial fibrillary acidic protein: a blood biomarker to differentiate neurodegenerative from psychiatric diseases.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2021-326994.
(In press).
|
|
Zetterberg, H;
Stomrud, E;
(2021)
Alzheimer's disease in primary care: new tools for improved and simplified diagnostics.
Journal of Internal Medicine
, 290
(2)
pp. 477-479.
10.1111/joim.13249.
|
|
Zetterberg, H;
Bendlin, BB;
(2021)
Neurodegenerative dementias: screening for major threats to healthy longevity with blood biomarkers.
The Lancet Healthy Longevity
, 2
(2)
e58-e59.
10.1016/S2666-7568(21)00009-X.
|
|
|
Zetterberg, H;
Blennow, K;
(2021)
Moving fluid biomarkers for Alzheimer's disease from research tools to routine clinical diagnostics.
Molecular Neurodegeneration
, 16
, Article 10. 10.1186/s13024-021-00430-x.
|
|
|
Zettergren, A;
Lord, J;
Ashton, NJ;
Benedet, AL;
Karikari, TK;
Lantero Rodriguez, J;
Snellman, A;
... Blennow, K; + view all
(2021)
Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative.
Alzheimer's Research and Therapy
, 13
, Article 17. 10.1186/s13195-020-00754-8.
|
|
|
Zhang, JV;
Irwin, DJ;
Blennow, K;
Zetterberg, H;
Lee, EB;
Shaw, LM;
Rascovsky, K;
... Grossman, M; + view all
(2021)
Neurofilament Light Chain Related to Longitudinal Decline in Frontotemporal Lobar Degeneration.
Neurology Clinical Practice
, 11
(2)
pp. 105-116.
10.1212/CPJ.0000000000000959.
|
|
Zhen-Yi, AO;
Byrne, L;
Brogueira Rodrigues, F;
Tortelli, R;
Johnson, E;
Foiani, M;
Arridge, M;
... Wild, E; + view all
(2021)
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington’s disease.
Scientific Reports
, 11
, Article 3481. 10.1038/s41598-021-83000-x.
|
|
|
zu Eulenburg, P;
Buchheim, J-I;
Ashton, NJ;
Vassilieva, G;
Blennow, K;
Zetterberg, H;
Chouker, A;
(2021)
Changes in Blood Biomarkers of Brain Injury and Degeneration Following Long-Duration Spaceflight.
JAMA Neurology
10.1001/jamaneurol.2021.3589.
(In press).
|
2020
|
Åberg, ND;
Wall, A;
Anger, O;
Jood, K;
Andreasson, U;
Blennow, K;
Zetterberg, H;
... Svensson, J; + view all
(2020)
Circulating levels of vascular endothelial growth factor and post-stroke long-term functional outcome.
Acta Neurologica Scandinavica
10.1111/ane.13219.
(In press).
|
|
|
Alić, I;
Goh, PA;
Murray, A;
Portelius, E;
Gkanatsiou, E;
Gough, G;
Mok, KY;
... Nižetić, D; + view all
(2020)
Patient-specific Alzheimer-like pathology in trisomy 21 cerebral organoids reveals BACE2 as a gene dose-sensitive AD suppressor in human brain.
Molecular Psychiatry
10.1038/s41380-020-0806-5.
|
|
|
Alifier, M;
Olsson, B;
Andreasson, U;
Cullen, NC;
Czyżewska, J;
Jakubów, P;
Sieśkiewicz, A;
... Blennow, K; + view all
(2020)
Cardiac Surgery is Associated with Biomarker Evidence of Neuronal Damage.
Journal of Alzheimer's Disease
10.3233/JAD-191165.
(In press).
|
|
|
Altmann, P;
De Simoni, D;
Kaider, A;
Ludwig, B;
Rath, J;
Leutmezer, F;
Zimprich, F;
... Rommer, PS; + view all
(2020)
Increased serum neurofilament light chain concentration indicates poor outcome in Guillain-Barré syndrome.
Journal of Neuroinflammation
, 17
, Article 86. 10.1186/s12974-020-01737-0.
|
|
|
Altmann, P;
Leutmezer, F;
Zach, H;
Wurm, R;
Stattmann, M;
Ponleitner, M;
Petzold, A;
... Bsteh, G; + view all
(2020)
Serum neurofilament light chain withstands delayed freezing and repeated thawing.
Scientific Reports
, 10
, Article 19982. 10.1038/s41598-020-77098-8.
|
|
|
Anderson, AM;
Jang, JH;
Easley, KA;
Fuchs, D;
Gisslen, M;
Zetterberg, H;
Blennow, K;
... Letendre, SL; + view all
(2020)
Cognitive and Neuronal Link With Inflammation: A Longitudinal Study in People With and Without HIV Infection.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 85
(5)
pp. 617-625.
10.1097/QAI.0000000000002484.
|
|
Andersson, E;
Janelidze, S;
Lampinen, B;
Nilsson, M;
Leuzy, A;
Stomrud, E;
Blennow, K;
... Hansson, O; + view all
(2020)
Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.
Neurobiology of Aging
, 95
pp. 143-153.
10.1016/j.neurobiolaging.2020.07.018.
(In press).
|
|
|
Antonell, A;
Tort-Merino, A;
Ríos, J;
Balasa, M;
Borrego-Écija, S;
Auge, JM;
Muñoz-García, C;
... Sánchez-Valle, R; + view all
(2020)
Synaptic, axonal damage and inflammatory cerebrospinal fluid biomarkers in neurodegenerative dementias.
Alzheimer's & Dementia
, 16
(2)
pp. 262-272.
10.1016/j.jalz.2019.09.001.
|
|
Arber, C;
Toombs, J;
Lovejoy, C;
Ryan, NS;
Paterson, RW;
Willumsen, N;
Gkanatsiou, E;
... Wray, S; + view all
(2020)
Familial Alzheimer’s disease patient-derived neurons reveal distinct mutation-specific effects on amyloid beta.
Molecular Psychiatry
, 25
pp. 2919-2931.
10.1038/s41380-019-0410-8.
|
|
Arenaza-Urquijo Em, EM;
Salvadó, G;
Operto, G;
Minguillón, C;
Sánchez-Benavides, G;
Crous-Bou, M;
Grau-Rivera, O;
... ALFA study, .; + view all
(2020)
Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer's biomarkers.
Neurology
, 95
(15)
e2065-e2074.
10.1212/WNL.0000000000010527.
|
|
Ashton, NJ;
Hye, A;
Rajkumar, AP;
Leuzy, A;
Snowden, S;
Suarez-Calvet, M;
Karikari, TK;
... Aarsland, D; + view all
(2020)
An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders.
Nature Reviews Neurology
, 16
(5)
pp. 265-284.
10.1038/s41582-020-0348-0.
|
|
Bäckström, D;
Linder, J;
Mo, SJ;
Riklund, K;
Zetterberg, H;
Blennow, K;
Forsgren, L;
(2020)
NfL as a biomarker for neurodegeneration and survival in Parkinson disease.
Neurology
10.1212/WNL.0000000000010084.
(In press).
|
|
|
Bader, JM;
Geyer, PE;
Müller, JB;
Strauss, MT;
Koch, M;
Leypoldt, F;
Koertvelyessy, P;
... Mann, M; + view all
(2020)
Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease.
Molecular Systems Biology
, 16
(6)
, Article e9356. 10.15252/msb.20199356.
|
|
|
Baldacci, F;
Lista, S;
Manca, ML;
Chiesa, PA;
Cavedo, E;
Lemercier, P;
Zetterberg, H;
... Alzheimer Precision Medicine Initiative (APMI), .; + view all
(2020)
Age and sex impact plasma NFL and t-Tau trajectories in individuals with subjective memory complaints: a 3-year follow-up study.
Alzheimer's Research & Therapy
, 12
(1)
, Article 147. 10.1186/s13195-020-00704-4.
|
|
|
Banerjee, G;
Ambler, G;
Keshavan, A;
Paterson, RW;
Foiani, MS;
Toombs, J;
Heslegrave, A;
... Werring, DJ; + view all
(2020)
Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy.
Journal of Alzheimer's Disease
, 74
(4)
pp. 1189-1201.
10.3233/JAD-191254.
(In press).
|
|
Banote, RK;
Chebli, J;
Şatır, TM;
Varshney, GK;
Camacho, R;
Ledin, J;
Burgess, SM;
... Zetterberg, H; + view all
(2020)
Amyloid precursor protein-b facilitates cell adhesion during early development in zebrafish.
Scientific Reports
, 10
, Article 10127. 10.1038/s41598-020-66584-8.
|
|
|
Barbu, M;
Kolsrud, O;
Ricksten, S-E;
Dellgren, G;
Zetterberg, H;
Blennow, K;
Björk, K;
... Jeppsson, A; + view all
(2020)
Dextran- Versus Crystalloid-Based Prime in Cardiac Surgery: A Prospective Randomized Pilot Study.
The Annals of Thoracic Surgery
, 110
(5)
pp. 1541-1547.
10.1016/j.athoracsur.2020.03.031.
|
|
Benedet, AL;
Leuzy, A;
Pascoal, TA;
Ashton, NJ;
Mathotaarachchi, S;
Savard, M;
Therriault, J;
... Alzheimer’s Disease Neuroimaging Initiative, .; + view all
(2020)
Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
Brain
, 143
(12)
pp. 3793-3804.
10.1093/brain/awaa342.
|
|
Benedict, C;
Blennow, K;
Zetterberg, H;
Cedernaes, J;
(2020)
Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men.
Neurology
10.1212/WNL.0000000000008866.
(In press).
|
|
|
Benussi, A;
Ashton, NJ;
Karikari, TK;
Gazzina, S;
Premi, E;
Benussi, L;
Ghidoni, R;
... Borroni, B; + view all
(2020)
Serum Glial Fibrillary Acidic Protein (GFAP) Is a Marker of Disease Severity in Frontotemporal Lobar Degeneration.
Journal of Alzheimer's Disease
10.3233/JAD-200608.
(In press).
|
|
|
Benussi, A;
Karikari, TK;
Ashton, N;
Gazzina, S;
Premi, E;
Benussi, L;
Ghidoni, R;
... Borroni, B; + view all
(2020)
Diagnostic and prognostic value of serum NfL and p-Tau181 in frontotemporal lobar degeneration.
Journal of Neurology, Neurosurgery, and Psychiatry
, 91
(9)
pp. 960-967.
10.1136/jnnp-2020-323487.
|
|
|
Bjorefeldt, A;
Roshan, F;
Forsberg, M;
Zetterberg, H;
Hanse, E;
Fisahn, A;
(2020)
Human cerebrospinal fluid promotes spontaneous gamma oscillations in the hippocampus in vitro.
Hippocampus
, 30
(2)
pp. 101-113.
10.1002/hipo.23135.
|
|
Blennow, K;
Chen, C;
Cicognola, C;
Wildsmith, KR;
Manser, PT;
Bohorquez, SMS;
Zhang, Z;
... Höglund, K; + view all
(2020)
Cerebrospinal fluid tau fragment correlates with tau PET: a candidate biomarker for tangle pathology.
Brain
, 143
(2)
, Article 79. 10.1093/brain/awz346.
|
|
Bloniecki, V;
Zetterberg, H;
Aarsland, D;
Vannini, P;
Kvartsberg, H;
Winblad, B;
Blennow, K;
(2020)
Are neuropsychiatric symptoms in dementia linked to CSF biomarkers of synaptic and axonal degeneration?
Alzheimer's Research and Therapy
, 12
(1)
, Article 153. 10.1186/s13195-020-00718-y.
|
|
|
Bodda, C;
Reinert, LS;
Fruhwürth, S;
Richardo, T;
Sun, C;
Zhang, B-C;
Kalamvoki, M;
... Paludan, SR; + view all
(2020)
HSV1 VP1-2 deubiquitinates STING to block type I interferon expression and promote brain infection.
Journal of Experimental Medicine
, 217
(7)
, Article e20191422. 10.1084/jem.20191422.
|
|
|
Boulo, S;
Kuhlmann, J;
Andreasson, U;
Brix, B;
Venkataraman, I;
Herbst, V;
Rutz, S;
... Blennow, K; + view all
(2020)
First amyloid β1-42 certified reference material for re-calibrating commercial immunoassays.
Alzheimer's & Dementia
, 16
(11)
pp. 1493-1503.
10.1002/alz.12145.
|
|
|
Breakell, T;
Tacke, S;
Schropp, V;
Zetterberg, H;
Blennow, K;
Urich, E;
Kuerten, S;
(2020)
Obinutuzumab-Induced B Cell Depletion Reduces Spinal Cord Pathology in a CD20 Double Transgenic Mouse Model of Multiple Sclerosis.
International Journal of Molecular Sciences
, 21
(18)
, Article 6864. 10.3390/ijms21186864.
|
|
|
Brogueira Rodrigues, F;
Byrne, L;
Tortelli, R;
Johnson, E;
Wijeratne, P;
De Vita, E;
Ghazaleh, N;
... Wild, E; + view all
(2020)
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease.
Science Translational Medicine
, 12
(574)
10.1126/scitranslmed.abc2888.
|
|
|
Cacciaglia, R;
Molinuevo, JL;
Falcón, C;
Arenaza-Urquijo, EM;
Sánchez-Benavides, G;
Brugulat-Serrat, A;
Blennow, K;
... ALFA study; + view all
(2020)
APOE-ε4 Shapes the Cerebral Organization in Cognitively Intact Individuals as Reflected by Structural Gray Matter Networks.
Cerebral Cortex
10.1093/cercor/bhaa034.
(In press).
|
|
|
Camporesi, E;
Nilsson, J;
Brinkmalm, A;
Becker, B;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2020)
Fluid Biomarkers for Synaptic Dysfunction and Loss.
Biomarker Insights
, 15
10.1177/1177271920950319.
|
|
|
Camu, W;
Mickunas, M;
Veyrune, J-L;
Payan, C;
Garlanda, C;
Locati, M;
Juntas-Morales, R;
... Bensimon, G; + view all
(2020)
Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial.
EBioMedicine
, Article 102844. 10.1016/j.ebiom.2020.102844.
(In press).
|
|
|
Casey, CP;
Lindroth, H;
Mohanty, R;
Farahbakhsh, Z;
Ballweg, T;
Twadell, S;
Miller, S;
... Sanders, RD; + view all
(2020)
Postoperative delirium is associated with increased plasma neurofilament light.
Brain
, 143
(1)
pp. 47-54.
10.1093/brain/awz354.
|
|
Cavedo, E;
Lista, S;
Houot, M;
Vergallo, A;
Grothe, MJ;
Teipel, S;
Zetterberg, H;
... INSIGHT-preAD Study Group and the Alzheimer Precision Medicine I; + view all
(2020)
Plasma tau correlates with basal forebrain atrophy rates in people at risk for Alzheimer disease.
Neurology
, 94
(1)
e30-e41.
10.1212/WNL.0000000000008696.
|
|
Chatterjee, P;
Cheong, Y-J;
Bhatnagar, A;
Goozee, K;
Wu, Y;
McKay, M;
Martins, IJ;
... Martins, RN; + view all
(2020)
Plasma metabolites associated with biomarker evidence of neurodegeneration in cognitively normal older adults.
Journal of Neurochemistry
, 159
(2)
pp. 389-402.
10.1111/jnc.15128.
|
|
Chatterjee, P;
Mohammadi, M;
Goozee, K;
Shah, TM;
Sohrabi, HR;
Dias, CB;
Shen, K;
... Martins, RN; + view all
(2020)
Serum Hepcidin Levels in Cognitively Normal Older Adults with High Neocortical Amyloid-β Load.
Journal of Alzheimer's Disease
, 76
(1)
pp. 291-301.
10.3233/JAD-200162.
|
|
|
Chaudhary, H;
Meister, SW;
Zetterberg, H;
Löfblom, J;
Lendel, C;
(2020)
Dissecting the structural organization of multiprotein amyloid aggregates using a bottom-up approach.
ACS Chemical Neuroscience
10.1021/acschemneuro.0c00110.
(In press).
|
|
|
Chételat, G;
Arbizu, J;
Barthel, H;
Garibotto, V;
Law, I;
Morbelli, S;
van de Giessen, E;
... Drzezga, A; + view all
(2020)
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias.
The Lancet Neurology
, 19
(11)
pp. 951-962.
10.1016/S1474-4422(20)30314-8.
|
|
Chiesa, PA;
Houot, M;
Vergallo, A;
Cavedo, E;
Lista, S;
Potier, MC;
Zetterberg, H;
... Alzheimer Precision Medicine Initiative (APMI); + view all
(2020)
Association of brain network dynamics with plasma biomarkers in subjective memory complainers.
Neurobiology of Aging
, 88
pp. 83-90.
10.1016/j.neurobiolaging.2019.12.017.
|
|
Cicognola, C;
Satir, TM;
Brinkmalm, G;
Matečko-Burmann, I;
Agholme, L;
Bergström, P;
Becker, B;
... Höglund, K; + view all
(2020)
Tauopathy-Associated Tau Fragment Ending at Amino Acid 224 Is Generated by Calpain-2 Cleavage.
Journal of Alzheimer's Disease
10.3233/JAD-191130.
(In press).
|
|
|
Colom-Cadena, M;
Spires-Jones, T;
Zetterberg, H;
Blennow, K;
Caggiano, A;
DeKosky, ST;
Fillit, H;
... Catalano, SM; + view all
(2020)
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease.
ALZHEIMERS RESEARCH & THERAPY
, 12
(1)
10.1186/s13195-020-00588-4.
|
|
Cullen, NC;
Zetterberg, H;
Insel, PS;
Olsson, B;
Andreasson, U;
Blennow, K;
Hansson, O;
(2020)
Comparing progression biomarkers in clinical trials of early Alzheimer’s disease.
Annals of Clinical and Translational Neurology
10.1002/acn3.51158.
|
|
|
Danielson, M;
Wiklund, A;
Granath, F;
Blennow, K;
Mkrtchian, S;
Nellgård, B;
Oras, J;
... Eriksson, LI; + view all
(2020)
Association between cerebrospinal fluid biomarkers of neuronal injury or amyloidosis and cognitive decline after major surgery.
British Journal of Anaesthesia
10.1016/j.bja.2020.09.043.
(In press).
|
|
|
Danielson, M;
Wiklund, A;
Granath, F;
Blennow, K;
Mkrtchian, S;
Nellgård, B;
Oras, J;
... Eriksson, LI; + view all
(2020)
Neuroinflammatory markers associate with cognitive decline after major surgery: findings of an explorative study.
Annals of Neurology
10.1002/ana.25678.
(In press).
|
|
|
De Scheerder, M-A;
Van Hecke, C;
Zetterberg, H;
Fuchs, D;
De Langhe, N;
Rutsaert, S;
Vrancken, B;
... Vandekerckhove, L; + view all
(2020)
Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption.
Journal of Antimicrobial Chemotherapy
, 75
(5)
pp. 1311-1320.
10.1093/jac/dkaa003.
|
|
Deiner, S;
Baxter, MG;
Mincer, JS;
Sano, M;
Hall, J;
Mohammed, I;
O'Bryant, S;
... Eckenhoff, R; + view all
(2020)
Human plasma biomarker responses to inhalational general anaesthesia without surgery.
British Journal of Anaesthesia
, 125
(3)
pp. 282-290.
10.1016/j.bja.2020.04.085.
|
|
Delsing, L;
Herland, A;
Falk, A;
Hicks, R;
Synnergren, J;
Zetterberg, H;
(2020)
Models of the blood-brain barrier using iPSC-derived cells.
Molecular and Cellular Neuroscience
, 107
, Article 103533. 10.1016/j.mcn.2020.103533.
|
|
|
Dhiman, K;
Gupta, VB;
Villemagne, VL;
Eratne, D;
Graham, PL;
Fowler, C;
Bourgeat, P;
... Martins, RN; + view all
(2020)
Cerebrospinal fluid neurofilament light concentration predicts brain atrophy and cognition in Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 12
(1)
10.1002/dad2.12005.
|
|
|
Dickstein, DL;
De Gasperi, R;
Gama Sosa, MA;
Perez-Garcia, G;
Short, JA;
Sosa, H;
Perez, GM;
... Elder, GA; + view all
(2020)
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure.
Molecular Psychiatry
10.1038/s41380-020-0674-z.
(In press).
|
|
Dutkiewicz, R;
Zetterberg, H;
Andreasson, U;
Blennow, K;
Nellgård, B;
(2020)
Dementia and CSF-Biomarkers for Alzheimer's Disease Predict Mortality after Acute Hip Fracture.
Acta Anaesthesiologica Scandinavica
, 64
(1)
pp. 93-103.
10.1111/aas.13472.
|
|
Eckerström, M;
Nilsson, S;
Zetterberg, H;
Blennow, K;
Grahn, A;
(2020)
Cognitive impairment without altered levels of cerebrospinal fluid biomarkers in patients with encephalitis caused by varicella-zoster virus: a pilot study.
Scientific Reports
, 10
, Article 22400. 10.1038/s41598-020-79800-2.
|
|
|
Ehrenberg, AJ;
Khatun, A;
Coomans, E;
Betts, MJ;
Capraro, F;
Thijssen, EH;
Senkevich, K;
... Paterson, RW; + view all
(2020)
Relevance of biomarkers across different neurodegenerative.
Alzheimer's Research & Therapy
, 12
, Article 56. 10.1186/s13195-020-00601-w.
|
|
|
Engström, Å;
Jumisko, E;
Shahim, P;
Lehto, N;
Blennow, K;
Zetterberg, H;
Tegner, Y;
(2020)
Losing the identity of a hockey player: the long-term effects of concussions.
Concussion
, 5
(2)
, Article CNC74. 10.2217/cnc-2019-0014.
|
|
|
Eriksson, H;
Löwhagen Hendén, P;
Rentzos, A;
Pujol-Calderón, F;
Karlsson, JE;
Höglund, K;
Blennow, K;
... Zelano, J; + view all
(2020)
Acute symptomatic seizures and epilepsy after mechanical thrombectomy.
Epilepsy & Behavior
, 104
(B)
, Article 106520. 10.1016/j.yebeh.2019.106520.
|
|
Falgàs, N;
Ruiz-Peris, M;
Pérez-Millan, A;
Sala-Llonch, R;
Antonell, A;
Balasa, M;
Borrego-Écija, S;
... Sánchez-Valle, R; + view all
(2020)
Contribution of CSF biomarkers to early-onset Alzheimer's disease and frontotemporal dementia neuroimaging signatures.
Human Brain Mapping
10.1002/hbm.24925.
(In press).
|
|
|
Gafson, AR;
Barthélemy, NR;
Bomont, P;
Carare, RO;
Durham, HD;
Julien, J-P;
Kuhle, J;
... Matthews, PM; + view all
(2020)
Neurofilaments: neurobiological foundations for biomarker applications.
Brain
, 143
(7)
pp. 1975-1998.
10.1093/brain/awaa098.
|
|
Gard, A;
Lehto, N;
Engström, Å;
Shahim, P;
Zetterberg, H;
Blennow, K;
Marklund, N;
(2020)
Quality of life of ice hockey players after retirement due to concussions.
Concussion
10.2217/cnc-2020-0007.
|
|
|
Garland, P;
Morton, MJ;
Haskins, W;
Zolnourian, A;
Durnford, A;
Gaastra, B;
Toombs, J;
... Galea, I; + view all
(2020)
Haemoglobin causes neuronal damage in vivo which is preventable by haptoglobin.
Brain Communications
, 2
(1)
, Article fcz053. 10.1093/braincomms/fcz053.
|
|
|
Graham, NSN;
Zimmerman, KA;
Bertolini, G;
Magnoni, S;
Oddo, M;
Zetterberg, H;
Moro, F;
... Sharp, DJ; + view all
(2020)
Multicentre longitudinal study of fluid and neuroimaging BIOmarkers of AXonal injury after traumatic brain injury: the BIO-AX-TBI study protocol.
BMJ Open
, 10
(11)
, Article e042093. 10.1136/bmjopen-2020-042093.
|
|
|
Gray, E;
Oeckl, P;
Amador, MDM;
Andreasson, U;
An, J;
Blennow, K;
Bowser, R;
... Otto, M; + view all
(2020)
A multi-center study of neurofilament assay reliability and inter-laboratory variability.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
, 21
(5-6)
pp. 452-458.
10.1080/21678421.2020.1779300.
|
|
Hagberg, L;
Price, RW;
Zetterberg, H;
Fuchs, D;
Gisslén, M;
(2020)
Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance.
PLOS One
, 15
(7)
, Article e0236162. 10.1371/journal.pone.0236162.
|
|
|
Halaas, NB;
Henjum, K;
Blennow, K;
Dakhil, S;
Idland, A-V;
Nilsson, LN;
Sederevicius, D;
... Fjell, AM; + view all
(2020)
CSF sTREM2 and Tau Work Together in Predicting Increased Temporal Lobe Atrophy in Older Adults.
Cerebral Cortex
, 30
(4)
pp. 2295-2306.
10.1093/cercor/bhz240.
|
|
Hampel, H;
Lista, S;
Vanmechelen, E;
Zetterberg, H;
Giorgi, FS;
Galgani, A;
Blennow, K;
... Alzheimer’s Precision Medicine Initiative (APMI); + view all
(2020)
β-Secretase1 biological markers for Alzheimer's disease: state-of-art of validation and qualification.
Alzheimer's Research & Therapy
, 12
, Article 130. 10.1186/s13195-020-00686-3.
|
|
|
Hanes, J;
Kovac, A;
Kvartsberg, H;
Kontsekova, E;
Fialova, L;
Katina, S;
Kovacech, B;
... Zilka, N; + view all
(2020)
Evaluation of a novel immunoassay to detect p-Tau Thr127 in the CSF to distinguish Alzheimer disease from other dementias.
Neurology
10.1212/WNL.0000000000010814.
(In press).
|
|
|
Hansson, O;
Cullen, N;
Zetterberg, H;
Blennow, K;
Mattsson-Carlgren, N;
(2020)
Plasma phosphorylated tau181 and neurodegeneration in Alzheimer's disease.
Annals of Clinical and Translational Neurology
10.1002/acn3.51253.
(In press).
|
|
|
Hansson, O;
Rutz, S;
Zetterberg, H;
Bauer, E;
Hähl, T;
Manuilova, E;
Mert, MC;
... Stomrud, E; + view all
(2020)
Pre-analytical protocol for measuring Alzheimer's disease biomarkers in fresh CSF.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12137. 10.1002/dad2.12137.
|
|
|
Heller, C;
Chan, E;
Foiani, MS;
Todd, E;
Russell, LL;
Greaves, CV;
Heslegrave, AJ;
... Rohrer, JD; + view all
(2020)
Plasma glial fibrillary acidic protein and neurofilament light chain are measures of disease severity in semantic variant primary progressive aphasia.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2020-325085.
(In press).
|
|
Heller, C;
Foiani, MS;
Moore, K;
Convery, R;
Bocchetta, M;
Neason, M;
Cash, DM;
... GENFI; + view all
(2020)
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2019-321954.
(In press).
|
|
|
Hong, S;
Prokopenko, D;
Dobricic, V;
Kilpert, F;
Bos, I;
Vos, SJB;
Tijms, BM;
... Bertram, L; + view all
(2020)
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
Translational Psychiatry
, 10
, Article 403. 10.1038/s41398-020-01074-z.
|
|
|
Hossain, I;
Mohammadian, M;
Takala, RSK;
Tenovuo, O;
Azurmendi Gil, L;
Frantzén, J;
van Gils, M;
... Posti, JP; + view all
(2020)
Admission Levels of Total Tau and β-Amyloid Isoforms 1–40 and 1–42 in Predicting the Outcome of Mild Traumatic Brain Injury.
Frontiers in Neurology
, 11
, Article 325. 10.3389/fneur.2020.00325.
|
|
|
Huebschmann, NA;
Luoto, TM;
Karr, JE;
Berghem, K;
Blennow, K;
Zetterberg, H;
Ashton, NJ;
... Iverson, GL; + view all
(2020)
Comparing Glial Fibrillary Acidic Protein (GFAP) in Serum and Plasma Following Mild Traumatic Brain Injury in Older Adults.
Frontiers in Neurology
, 11
, Article 1054. 10.3389/fneur.2020.01054.
|
|
|
Idland, AV;
Sala-Llonch, R;
Watne, LO;
Brækhus, A;
Hansson, O;
Blennow, K;
Zetterberg, H;
... Fjell, AM; + view all
(2020)
Biomarker profiling beyond amyloid and tau: cerebrospinal fluid markers, hippocampal atrophy, and memory change in cognitively unimpaired older adults.
Neurobiology of Aging
, 93
pp. 1-15.
10.1016/j.neurobiolaging.2020.04.002.
|
|
|
Iriondo, A;
García-Sebastian, M;
Arrospide, A;
Arriba, M;
Aurtenetxe, S;
Barandiaran, M;
Clerigue, M;
... Martínez-Lage, P; + view all
(2020)
Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults.
Journal of Alzheimer's Disease
10.3233/JAD-200105.
(In press).
|
|
Iverson, GL;
Posti, JP;
Öhman, J;
Blennow, K;
Zetterberg, H;
Luoto, TM;
(2020)
Reliability of serum S100B measurement following mild traumatic brain injury: a comparison of assay measurements from two laboratories.
Brain Injury
, 34
(9)
pp. 1237-1244.
10.1080/02699052.2020.1800092.
|
|
Janelidze, S;
Mattsson, N;
Palmqvist, S;
Smith, R;
Beach, TG;
Serrano, GE;
Chai, X;
... Hansson, O; + view all
(2020)
Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia.
Nature Medicine
, 26
pp. 379-386.
10.1038/s41591-020-0755-1.
|
|
Jons, D;
Zetterberg, H;
Malmeström, C;
Bergström, T;
Axelsson, M;
Blennow, K;
Thulin, M;
... Andersen, O; + view all
(2020)
Intrathecal immunoreactivity in people with or without previous infectious mononucleosis.
Acta Neurologica Scandinavica
, 142
(2)
pp. 161-168.
10.1111/ane.13280.
|
|
Kalafateli, AL;
Satir, TM;
Vallöf, D;
Zetterberg, H;
Jerlhag, E;
(2020)
An amylin and calcitonin receptor agonist modulates alcohol behaviors by acting on reward-related areas in the brain.
Progress in Neurobiology
, Article 101969. 10.1016/j.pneurobio.2020.101969.
(In press).
|
|
|
Kanberg, N;
Ashton, NJ;
Andersson, L-M;
Yilmaz, A;
Lindh, M;
Nilsson, S;
Price, RW;
... Gisslén, M; + view all
(2020)
Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19.
Neurology
, 95
(12)
e1754-e1759.
10.1212/WNL.0000000000010111.
|
|
Kang, MS;
Aliaga, AA;
Shin, M;
Mathotaarachchi, S;
Benedet, AL;
Pascoal, TA;
Therriault, J;
... Rosa-Neto, P; + view all
(2020)
Amyloid-beta modulates the association between neurofilament light chain and brain atrophy in Alzheimer’s disease.
Molecular Psychiatry
10.1038/s41380-020-0818-1.
(In press).
|
|
|
Karikari, TK;
Keeling, S;
Hill, E;
Lantero Rodriguez, J;
Nagel, DA;
Becker, B;
Höglund, K;
... Moffat, KG; + view all
(2020)
An extensive plasmid library to prepare tau protein variants and study their functional biochemistry.
ACS Chemical Neuroscience
, 11
(19)
pp. 3117-3129.
10.1021/acschemneuro.0c00469.
|
|
|
Karikari, TK;
Pascoal, TA;
Ashton, NJ;
Janelidze, S;
Benedet, AL;
Rodriguez, JL;
Chamoun, M;
... Blennow, K; + view all
(2020)
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
The Lancet Neurology
, 19
(5)
pp. 422-433.
10.1016/S1474-4422(20)30071-5.
|
|
Keshavan, A;
Wellington, H;
Chen, Z;
Khatun, A;
Chapman, M;
Hart, M;
Cash, D;
... Schott, JM; + view all
(2020)
Concordance of CSF measures of Alzheimer's pathology with amyloid PET status in a preclinical cohort: A comparison of Lumipulse and established immunoassays.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12097. 10.1002/dad2.12097.
|
|
|
Konijnenberg, E;
Tijms, BM;
Gobom, J;
Dobricic, V;
Bos, I;
Vos, S;
Tsolaki, M;
... Visser, PJ; + view all
(2020)
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer’s disease.
Alzheimer's Research & Therapy
, 12
, Article 65. 10.1186/s13195-020-00628-z.
|
|
|
Korecka, M;
Figurski, MJ;
Landau, SM;
Brylska, M;
Alexander, J;
Blennow, K;
Zetterberg, H;
... Alzheimer’s Disease Neuroimaging Initiative; + view all
(2020)
Analytical and Clinical Performance of Amyloid-Beta Peptides Measurements in CSF of ADNIGO/2 Participants by an LC–MS/MS Reference Method.
Clinical Chemistry
, 66
(4)
pp. 587-597.
10.1093/clinchem/hvaa012.
|
|
Kranaster, L;
Hoyer, C;
Mindt, S;
Neumaier, M;
Mueller, N;
Zill, P;
Schwarz, MJ;
... Sartorius, A; + view all
(2020)
The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid.
European Archives of Psychiatry and Clinical Neuroscience
, 270
pp. 911-919.
10.1007/s00406-019-01086-x.
|
|
Kresge, HA;
Liu, D;
Gupta, DK;
Moore, EE;
Osborn, KE;
Acosta, LMY;
Bell, SP;
... Jefferson, AL; + view all
(2020)
Lower Left Ventricular Ejection Fraction Relates to Cerebrospinal Fluid Biomarker Evidence of Neurodegeneration in Older Adults.
Journal of Alzheimer's Disease
10.3233/JAD-190813.
(In press).
|
|
Kumar, VV;
Huang, H;
Zhao, L;
Verble, DD;
Nutaitis, A;
Tharwani, SD;
Brown, AL;
... Wharton, W; + view all
(2020)
Baseline Results: The Association between Cardiovascular Risk and Preclinical Alzheimer’s Disease Pathology (ASCEND) Study.
Journal of Alzheimer's Disease
, 75
(1)
pp. 109-117.
10.3233/JAD-191103.
|
|
Lantero Rodriguez, J;
Karikari, TK;
Suárez-Calvet, M;
Troakes, C;
King, A;
Emersic, A;
Aarsland, D;
... Ashton, NJ; + view all
(2020)
Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline.
Acta Neuropathologic
10.1007/s00401-020-02195-x.
(In press).
|
|
|
Lauwers, E;
Lalli, G;
Brandner, S;
Collinge, J;
Compernolle, V;
Duyckaerts, C;
Edgren, G;
... De Strooper, B; + view all
(2020)
Potential human transmission of amyloid β pathology: surveillance and risks.
The Lancet Neurology
, 19
(10)
pp. 872-878.
10.1016/S1474-4422(20)30238-6.
|
|
Laverse, E;
Guo, T;
Zimmerman, K;
Foiani, MS;
Velani, B;
Morrow, P;
Adejuwon, A;
... Morris, HR; + view all
(2020)
Plasma glial fibrillary acidic protein and neurofilament light chain, but not tau, are biomarkers of sports-related mild traumatic brain injury.
Brain Communications
, 2
(2)
, Article fcaa137. 10.1093/braincomms/fcaa137.
|
|
|
Lindström, J;
Bremell, D;
Grahn, A;
Blennow, K;
Zetterberg, H;
Studahl, M;
(2020)
CXCL13 in patients with facial palsy caused by varicella zoster virus and Borrelia burgdorferi: a comparative study.
Diagnostic Microbiology and Infectious Disease
, 98
(1)
10.1016/j.diagmicrobio.2020.115095.
(In press).
|
|
|
Llorens, F;
Hermann, P;
Villar-Piqué, A;
Diaz-Lucena, D;
Nägga, K;
Hansson, O;
Santana, I;
... Zerr, I; + view all
(2020)
Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia.
Nature Communications
, 11
, Article 619. 10.1038/s41467-020-14373-2.
|
|
|
Lowe, AJ;
Sjödin, S;
Rodrigues, FB;
Byrne, LM;
Blennow, K;
Tortelli, R;
Zetterberg, H;
(2020)
Cerebrospinal fluid endo-lysosomal proteins as potential biomarkers for Huntington's disease.
PLoS One
, 15
(8)
, Article e0233820. 10.1371/journal.pone.0233820.
|
|
|
Manniche, C;
Simonsen, AH;
Hasselbalch, SG;
Andreasson, U;
Zetterberg, H;
Blennow, K;
Høgh, P;
... Hejl, A-M; + view all
(2020)
Cerebrospinal Fluid Biomarkers to Differentiate Idiopathic Normal Pressure Hydrocephalus from Subcortical Ischemic Vascular Disease.
Journal of Alzheimer's Disease
10.3233/JAD-200036.
(In press).
|
|
|
Mattsson-Carlgren, N;
Andersson, E;
Janelidze, S;
Ossenkoppele, R;
Insel, P;
Strandberg, O;
Zetterberg, H;
... Hansson, O; + view all
(2020)
Aβ deposition is associated with increases in soluble and phosphorylated tau that precede a positive Tau PET in Alzheimer’s disease.
Science Advances
, 6
(16)
, Article eaaz2387. 10.1126/sciadv.aaz2387.
|
|
|
Meregalli, C;
Fumagalli, G;
Alberti, P;
Canta, A;
Chiorazzi, A;
Monza, L;
Pozzi, E;
... Marmiroli, P; + view all
(2020)
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity.
Archives of Toxicology
, 94
pp. 2517-2522.
10.1007/s00204-020-02755-w.
|
|
Michno, W;
Wehrli, P;
Meier, S;
Sehlin, D;
Syvänen, S;
Zetterberg, H;
Blennow, K;
(2020)
Chemical Imaging of Evolving Amyloid Plaque Pathology and Associated Aβ Peptide Aggregation in a Transgenic Mouse Model of Alzheimer's Disease.
Journal of Neurochemistry
, 152
(5)
pp. 602-616.
10.1111/jnc.14888.
|
|
Milà-Alomà, M;
Salvadó, G;
Gispert, JD;
Vilor-Tejedor, N;
Grau-Rivera, O;
Sala-Vila, A;
Sánchez-Benavides, G;
... ALFA study; + view all
(2020)
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum.
Alzheimer's & Dementia
10.1002/alz.12131.
(In press).
|
|
|
Mila-Aloma, M;
Salvado, G;
Shekari, M;
Grau-Rivera, O;
Sala-Vila, A;
Sanchez-Benavides, G;
Arenaza-Urquijo, EM;
... Molinuevo, JL; + view all
(2020)
Comparative Analysis of Different Definitions of Amyloid-beta Positivity to Detect Early Downstream Pathophysiological Alterations in Preclinical Alzheimer.
The Journal of Prevention of Alzheimer’s Disease
, 8
(1)
pp. 68-77.
10.14283/jpad.2020.51.
|
|
|
Minta, K;
Brinkmalm, G;
Al Nimer, F;
Thelin, EP;
Piehl, F;
Tullberg, M;
Jeppsson, A;
... Andreasson, U; + view all
(2020)
Dynamics of cerebrospinal fluid levels of matrix metalloproteinases in human traumatic brain injury.
Scientific Reports
, 10
, Article 18075. 10.1038/s41598-020-75233-z.
|
|
|
Minta, K;
Brinkmalm, G;
Janelidze, S;
Sjödin, S;
Portelius, E;
Stomrud, E;
Zetterberg, H;
... Andreasson, U; + view all
(2020)
Quantification of total apolipoprotein E and its isoforms in cerebrospinal fluid from patients with neurodegenerative diseases.
Alzheimer's Research & Therapy
, 12
(1)
, Article 19. 10.1186/s13195-020-00585-7.
|
|
|
Mollenhauer, B;
Dakna, M;
Kruse, N;
Galasko, D;
Foroud, T;
Zetterberg, H;
Schade, S;
... Graham, D; + view all
(2020)
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression.
Movement Disorders
10.1002/mds.28206.
(In press).
|
|
|
Moore, EE;
Gifford, KA;
Khan, OA;
Liu, D;
Pechman, KR;
Acosta, LMY;
Bell, SP;
... Jefferson, AL; + view all
(2020)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic dysfunction, and axonal injury relate to atrophy in structural brain regions specific to Alzheimer's disease.
Alzheimer’s & Dementia
, 16
(6)
pp. 883-895.
10.1002/alz.12087.
|
|
Moore, EE;
Liu, D;
Pechman, KR;
Acosta, LMY;
Bell, SP;
Davis, LT;
Blennow, K;
... Jefferson, AL; + view all
(2020)
Mild Cognitive Impairment Staging Yields Genetic Susceptibility, Biomarker, and Neuroimaging Differences.
Frontiers in Aging Neuroscience
, 12
, Article 139. 10.3389/fnagi.2020.00139.
|
|
|
Mouton-Liger, F;
Dumurgier, J;
Cognat, E;
Hourregue, C;
Zetterberg, H;
Vanderstichele, H;
Vanmechelen, E;
... Paquet, C; + view all
(2020)
CSF levels of the BACE1 substrate NRG1 correlate with cognition in Alzheimer’s disease.
Alzheimer's Research & Therapy
, 12
, Article 88. 10.1186/s13195-020-00655-w.
|
|
|
Mullin, S;
Smith, L;
Lee, K;
D'Souza, G;
Woodgate, P;
Elflein, J;
Hällqvist, J;
... Schapira, AHV; + view all
(2020)
Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations:
A Nonrandomized, Noncontrolled Trial.
JAMA Neurology
10.1001/jamaneurol.2019.4611.
|
|
|
Mushtaq, M;
Kovalevska, L;
Darekar, S;
Abramsson, A;
Zetterberg, H;
Kashuba, V;
Klein, G;
... Kashuba, E; + view all
(2020)
Cell stemness is maintained upon concurrent expression of RB and the mitochondrial ribosomal protein S18-2.
Proceedings of the National Academy of Sciences of the United States of America
10.1073/pnas.1922535117.
(In press).
|
|
|
Neerland, BE;
Halaas, NB;
Idland, AV;
Henjum, K;
Blennow, K;
Zetterberg, H;
Watne, LO;
(2020)
Fatty Acid-Binding Protein 3 in Cerebrospinal Fluid of Hip Fracture Patients with Delirium.
Journal of Alzheimer's Disease
, 77
(1)
pp. 183-190.
10.3233/JAD-200364.
|
|
|
Neth, BJ;
Mintz, A;
Whitlow, C;
Jung, Y;
Solingapuram Sai, K;
Register, TC;
Kellar, D;
... Craft, S; + view all
(2020)
Modified ketogenic diet is associated with improved cerebrospinal fluid biomarker profile, cerebral perfusion, and cerebral ketone body uptake in older adults at risk for Alzheimer's disease: a pilot study.
Neurobiology of Aging
, 86
pp. 54-63.
10.1016/j.neurobiolaging.2019.09.015.
|
|
Novakova, L;
Axelsson, M;
Malmeström, C;
Zetterberg, H;
Blennow, K;
Svenningsson, A;
Lycke, J;
(2020)
NFL and CXCL13 may reveal disease activity in clinically and radiologically stable MS.
Multiple Sclerosis and Related Disorders
, 46
, Article 102463. 10.1016/j.msard.2020.102463.
|
|
Nyberg, L;
Lundquist, A;
Nordin Adolfsson, A;
Andersson, M;
Zetterberg, H;
Blennow, K;
Adolfsson, R;
(2020)
Elevated plasma neurofilament light in aging reflects brain white-matter alterations but does not predict cognitive decline or Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12050. 10.1002/dad2.12050.
|
|
|
O'Connor, A;
Karikari, TK;
Poole, T;
Ashton, NJ;
Rodriguez, JL;
Khatun, A;
Swift, I;
... Fox, NC; + view all
(2020)
Plasma phospho-tau181 in presymptomatic and symptomatic familial Alzheimer's disease: a longitudinal cohort study.
Molecular Psychiatry
10.1038/s41380-020-0838-x.
(In press).
|
|
Obrocki, P;
Khatun, A;
Ness, D;
Senkevich, K;
Hanrieder, J;
Capraro, F;
Mattsson, N;
... Zetterberg, H; + view all
(2020)
Perspectives in fluid biomarkers in neurodegeneration from the 2019 biomarkers in neurodegenerative diseases course-a joint PhD student course at University College London and University of Gothenburg.
Alzheimer's Research & Therapy
, 12
(1)
, Article 20. 10.1186/s13195-020-00586-6.
|
|
|
Ohrfelt, A;
Dumurgier, J;
Zetterberg, H;
Vrillon, A;
Ashton, NJ;
Kvartsberg, H;
Bouaziz-Amar, E;
... Blennow, K; + view all
(2020)
Full-length and C-terminal neurogranin in Alzheimer's disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays.
Alzheimer's Research & Therapy
, 12
, Article 168. 10.1186/s13195-020-00748-6.
|
|
|
Onatsu, J;
Vanninen, R;
Jäkälä, P;
Mustonen, P;
Pulkki, K;
Korhonen, M;
Hedman, M;
... Taina, M; + view all
(2020)
Tau, S100B and NSE as Blood Biomarkers in Acute Cerebrovascular Events.
In Vivo
, 34
(5)
pp. 2577-2586.
10.21873/invivo.12075.
|
|
|
Orme, T;
Hernandez, D;
Ross, OA;
Kun-Rodrigues, C;
Darwent, L;
Shepherd, CE;
Parkkinen, L;
... Bras, J; + view all
(2020)
Analysis of neurodegenerative disease-causing genes in dementia with Lewy bodies.
Acta Neuropathologica Communications
, 8
(1)
, Article 5. 10.1186/s40478-020-0879-z.
|
|
|
Ou, ZYA;
Byrne, LM;
Rodrigues, FB;
Tortelli, R;
Johnson, EB;
Foiani, MS;
Arridge, M;
... Wild, EJ; + view all
(2020)
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease.
MedRxiv: Cold Spring Harbor, NY, USA.
|
|
|
Palmqvist, S;
Janelidze, S;
Quiroz, YT;
Zetterberg, H;
Lopera, F;
Stomrud, E;
Su, Y;
... Hansson, O; + view all
(2020)
Discriminative Accuracy of Plasma Phospho-tau217 for Alzheimer Disease vs Other Neurodegenerative Disorders.
JAMA
10.1001/jama.2020.12134.
(In press).
|
|
Parbo, P;
Madsen, LS;
Ismail, R;
Zetterberg, H;
Blennow, K;
Eskildsen, SF;
Vorup-Jensen, T;
(2020)
Low plasma neurofilament light levels associated with raised cortical microglial activation suggest inflammation acts to protect prodromal Alzheimer's disease.
Alzheimer's Research & Therapy
, 12
, Article 3. 10.1186/s13195-019-0574-0.
|
|
|
Peluso, MJ;
Thanh, C;
Prator, CA;
Hogan, LE;
Arechiga, VM;
Stephenson, S;
Norris, PJ;
... Henrich, TJ; + view all
(2020)
Cerebrospinal fluid soluble CD30 elevation despite suppressive antiretroviral therapy in individuals living with HIV-1.
Journal of Virus Eradication
, 6
(1)
pp. 19-26.
|
|
|
Pereira, JB;
Janelidze, S;
Ossenkoppele, R;
Kvartsberg, H;
Brinkmalm, A;
Mattsson-Carlgren, N;
Stomrud, E;
... Hansson, O; + view all
(2020)
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease.
Brain
10.1093/brain/awaa395.
(In press).
|
|
|
Petzold, A;
Lu, C-H;
Groves, M;
Gobom, J;
Zetterberg, H;
Shaw, G;
O'Connor, S;
(2020)
Protein aggregate formation permits millennium-old brain preservation.
Journal of the Royal Society Interface
, 17
(162)
, Article 20190775. 10.1098/rsif.2019.0775.
|
|
|
Pilotto, A;
Odolini, S;
Stefano Masciocchi, S;
Comelli, A;
Volonghi, I;
Gazzina, S;
Nocivelli, S;
... Padovani, A; + view all
(2020)
Steroid-Responsive Encephalitis in Coronavirus Disease 2019.
Annals of Neurology
, 88
(2)
pp. 423-427.
10.1002/ana.25783.
|
|
Posti, JP;
Takala, RSK;
Raj, R;
Luoto, TM;
Azurmendi, L;
Lagerstedt, L;
Mohammadian, M;
... Sanchez, JC; + view all
(2020)
Admission Levels of Interleukin 10 and Amyloid β 1–40 Improve the Outcome Prediction Performance of the Helsinki Computed Tomography Score in Traumatic Brain Injury.
Frontiers in Neurology
, 11
, Article 549527. 10.3389/fneur.2020.549527.
|
|
|
Quiroz, YT;
Zetterberg, H;
Reiman, EM;
Chen, Y;
Su, Y;
Fox-Fuller, JT;
Garcia, G;
... Lopera, F; + view all
(2020)
Plasma neurofilament light chain in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional and longitudinal cohort study.
The Lancet Neurology
, 19
(6)
pp. 513-521.
10.1016/S1474-4422(20)30137-X.
|
|
Raket, LL;
Kühnel, L;
Schmidt, E;
Blennow, K;
Zetterberg, H;
Mattsson-Carlgren, N;
(2020)
Utility of plasma neurofilament light and total tau for clinical trials in Alzheimer's disease.
lzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12099. 10.1002/dad2.12099.
|
|
|
Reinert, LS;
Rashidi, AS;
Tran, DN;
Katzilieris-Petras, G;
Hvidt, AK;
Gohr, M;
Fruhwürth, S;
... Paluden, SR; + view all
(2020)
Brain immune cells undergo cGAS-STING-dependent apoptosis during herpes simplex virus type 1 infection.
Journal of Clinical Investigation
10.1172/JCI136824.
(In press).
|
|
|
Rosén, A;
Gennser, M;
Oscarsson, N;
Kvarnström, A;
Sandström, G;
Blennow, K;
Seeman-Lodding, H;
(2020)
Biomarkers of neuronal damage in saturation diving-a controlled observational study.
European Journal of Applied Physiology
10.1007/s00421-020-04499-y.
(In press).
|
|
|
Saddiki, H;
Fayosse, A;
Cognat, E;
Sabia, S;
Engelborghs, S;
Wallon, D;
Alexopoulos, P;
... Dumurgier, J; + view all
(2020)
Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker-based case-control study.
PLOS Medicine
, 17
(8)
, Article e1003289. 10.1371/journal.pmed.1003289.
|
|
|
Sajjad, MU;
Blennow, K;
Knapskog, AB;
Idland, A-V;
Chaudhry, FA;
Wyller, TB;
Zetterberg, H;
(2020)
Cerebrospinal Fluid Levels of Interleukin-8 in Delirium, Dementia, and Cognitively Healthy Patients.
Journal of Alzheimer's Disease
10.3233/JAD-190941.
(In press).
|
|
Satir, TM;
Agholme, L;
Karlsson, A;
Karlsson, M;
Karila, P;
Illes, S;
Bergström, P;
(2020)
Partial reduction of amyloid β production by β-secretase inhibitors does not decrease synaptic transmission.
Alzheimer's Research & Therapy
, 12
, Article 63. 10.1186/s13195-020-00635-0.
|
|
|
Satir, TM;
Nazir, FH;
Vizlin-Hodzic, D;
Hardselius, E;
Blennow, K;
Wray, S;
Zetterberg, H;
... Bergström, P; + view all
(2020)
Accelerated neuronal and synaptic maturation by BrainPhys medium increases Aβ secretion and alters Aβ peptide ratios from iPSC-derived cortical neurons.
Scientific Reports
, 10
, Article 601. 10.1038/s41598-020-57516-7.
|
|
|
Scahill, RI;
Zeun, P;
Osborne-Crowley, K;
Johnson, EB;
Gregory, S;
Parker, C;
Lowe, J;
... Tabrizi, SJ; + view all
(2020)
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis.
The Lancet Neurology
, 19
(6)
pp. 502-512.
10.1016/S1474-4422(20)30143-5.
|
|
|
Shahim, P;
Gill, JM;
Blennow, K;
Zetterberg, H;
(2020)
Fluid Biomarkers for Chronic Traumatic Encephalopathy.
Seminars in Neurology
, 40
(4)
pp. 411-419.
10.1055/s-0040-1715095.
|
|
Shahim, P;
Politis, A;
van der Merwe, A;
Moore, B;
Chou, Y-Y;
Pham, DL;
Butman, JA;
... Chan, L; + view all
(2020)
Neurofilament Light as a Biomarker in Traumatic Brain Injury.
Neurology
, 95
(6)
e610-e622.
10.1212/WNL.0000000000009983.
|
|
Shahim, P;
Politis, A;
van der Merwe, A;
Moore, B;
Ekanayake, V;
Lippa, S;
Chou, Y-Y;
... Chan, L; + view all
(2020)
Time course and diagnostic utility of NfL, tau, GFAp, and UCH-L1 in subacute and chronic TBI.
Neurology
, 95
(6)
e623-e636.
10.1212/WNL.0000000000009985.
|
|
Shams, M;
Martola, J;
Charidimou, A;
Granberg, T;
Ferreira, D;
Westman, E;
Wintermark, M;
... Shams, S; + view all
(2020)
Cerebrospinal Fluid Metals and the Association with Cerebral Small Vessel Disease.
Journal of Alzheimer's Disease
10.3233/JAD-200656.
(In press).
|
|
|
Shi, L;
Winchester, LM;
Liu, BY;
Killick, R;
Ribe, EM;
Westwood, S;
Baird, AL;
... Lovestone, S; + view all
(2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
Journal of Alzheimer's Disease
, 77
(3)
pp. 1353-1368.
10.3233/JAD-200208.
|
|
Shribman, S;
Heller, C;
Burrows, M;
Heslegrave, A;
Swift, I;
Foiani, MS;
Gillett, GT;
... Warner, TT; + view all
(2020)
Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease.
Movement Disorders
10.1002/mds.28333.
(In press).
|
|
|
Skouras, S;
Torner, J;
Andersson, P;
Koush, Y;
Falcon, C;
Minguillon, C;
Fauria, K;
... ALFA Study; + view all
(2020)
Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
Brain
10.1093/brain/awaa011.
(In press).
|
|
Spotorno, N;
Lindberg, O;
Nilsson, C;
Landqvist Waldö, M;
Van Westen, D;
Nilsson, K;
Vestberg, S;
... Alexander, S; + view all
(2020)
Plasma neurofilament light protein correlates with diffusion tensor imaging metrics in frontotemporal dementia.
PLOS ONE
, 15
(10)
, Article e0236384. 10.1371/journal.pone.0236384.
|
|
|
Suárez-Calvet, M;
Karikari, TK;
Ashton, NJ;
Lantero Rodríguez, J;
Milà-Alomà, M;
Gispert, JD;
Salvadó, G;
... ALFA Study; + view all
(2020)
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected.
EMBO Molecular Medicine
, Article e12921. 10.15252/emmm.202012921.
(In press).
|
|
|
Subramanian, ML;
Vig, V;
Chung, J;
Fiorello, MG;
Xia, W;
Zetterberg, H;
Blennow, K;
... Stein, TD; + view all
(2020)
Neurofilament light chain in the vitreous humor of the eye.
Alzheimer's Research & Therapy
, 12
, Article 111. 10.1186/s13195-020-00677-4.
|
|
|
Sugarman, MA;
Zetterberg, H;
Blennow, K;
Tripodis, Y;
McKee, AC;
Stein, TD;
Martin, B;
... Alosco, ML; + view all
(2020)
A longitudinal examination of plasma neurofilament light and total tau for the clinical detection and monitoring of Alzheimer's disease.
Neurobiology of Aging
, 94
pp. 60-70.
10.1016/j.neurobiolaging.2020.05.011.
|
|
Swift, IJ;
Sogorb-Esteve, A;
Heller, C;
Synofzik, M;
Otto, M;
Graff, C;
Galimberti, D;
... Rohrer, JD; + view all
(2020)
Fluid biomarkers in frontotemporal dementia: past, present and future.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2020-323520.
(In press).
|
|
|
Taghdiri, F;
Multani, N;
Ozzoude, M;
Tarazi, A;
Khodadadi, M;
Wennberg, R;
Mikulis, D;
... Tartaglia, MC; + view all
(2020)
Neurofilament-Light in Former Athletes: A Potential Biomarker of Neurodegeneration and Progression.
European Journal of Neurology
, 27
(7)
pp. 1170-1177.
10.1111/ene.14251.
|
|
Tanabe, S;
Bo, A;
White, M;
Parker, M;
Farahbakhsh, Z;
Ballweg, T;
Casey, C;
... Sanders, RD; + view all
(2020)
Cohort study of electroencephalography markers of amyloid-tau-neurodegeneration pathology.
Brain Communications
, 2
(2)
, Article fcaa099. 10.1093/braincomms/fcaa099.
|
|
|
Therriault, J;
Benedet, A;
Pascoal, TA;
Savard, M;
Ashton, N;
Chamoun, M;
Tissot, C;
... Rosa-Neto, P; + view all
(2020)
Determining Amyloid-β positivity using [18F]AZD4694 PET imaging.
The Journal of Nuclear Medicine
10.2967/jnumed.120.245209.
(In press).
|
|
|
Thijssen, EH;
La Joie, R;
Wolf, A;
Strom, A;
Wang, P;
Iaccarino, L;
Bourakova, V;
... Advancing Research and Treatment for Frontotemporal Lobar Degene; + view all
(2020)
Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration.
Nature Medicine
, 26
pp. 389-397.
10.1038/s41591-020-0762-2.
|
|
Thordardottir, S;
Almkvist, O;
Johansson, C;
Zetterberg, H;
Blennow, K;
Graff, C;
(2020)
Cerebrospinal Fluid YKL-40 and Neurogranin in Familial Alzheimer's Disease: A Pilot Study.
Journal of Alzheimer's Disease
10.3233/JAD-191261.
(In press).
|
|
|
Tible, M;
Sandelius, Å;
Höglund, K;
Brinkmalm, A;
Cognat, E;
Dumurgier, J;
Zetterberg, H;
... Blennow, K; + view all
(2020)
Dissection of synaptic pathways through the CSF biomarkers for predicting Alzheimer's disease.
Neurology
, 95
(8)
e953-e961.
10.1212/WNL.0000000000010131.
|
|
Tijms, BM;
Gobom, J;
Reus, L;
Jansen, I;
Hong, S;
Dobricic, V;
Kilpert, F;
... Visser, PJ; + view all
(2020)
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
Brain
, 143
(12)
pp. 3776-3792.
10.1093/brain/awaa325.
|
|
|
Tjensvoll, AB;
Lauvsnes, MB;
Zetterberg, H;
Kvaløy, JT;
Kvivik, I;
Maroni, SS;
Greve, OJ;
... Omdal, R; + view all
(2020)
Neurofilament light is a biomarker of brain involvement in lupus and primary Sjögren's syndrome.
Journal of Neurology
10.1007/s00415-020-10290-y.
|
|
|
Toombs, J;
Zetterberg, H;
(2020)
In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer's disease.
Brain Communications
, 2
(1)
, Article fcaa054. 10.1093/braincomms/fcaa054.
|
|
|
Tsvetanov, KA;
Gazzina, S;
Jones, PS;
van Swieten, J;
Borroni, B;
Sanchez-Valle, R;
Moreno, F;
... Genetic FTD Initiative, GENFI; + view all
(2020)
Brain functional network integrity sustains cognitive function despite atrophy in presymptomatic genetic frontotemporal dementia.
Alzheimer's & Dementia
10.1002/alz.12209.
|
|
|
Tyrberg, T;
Nilsson, S;
Blennow, K;
Zetterberg, H;
Grahn, A;
(2020)
Serum and cerebrospinal fluid neurofilament light chain in patients with central nervous system infections caused by varicella-zoster virus.
Journal of NeuroVirology
10.1007/s13365-020-00889-2.
(In press).
|
|
|
Vallabh, SM;
Minikel, EV;
Williams, VJ;
Carlyle, BC;
McManus, AJ;
Wennick, CD;
Bolling, A;
... Arnold, SE; + view all
(2020)
Cerebrospinal fluid and plasma biomarkers in individuals at risk for genetic prion disease.
BMC Medicine
, 18
, Article 140. 10.1186/s12916-020-01608-8.
|
|
|
van der Lee, SJ;
Conway, OJ;
Jansen, I;
Carrasquillo, MM;
Kleineidam, L;
van den Akker, E;
Hernández, I;
... Holstege, H; + view all
(2020)
Correction to: A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
[Corrigendum].
Acta Neuropathologica
10.1007/s00401-019-02107-8.
(In press).
|
|
|
Vergallo, A;
Lista, S;
Lemercier, P;
Chiesa, PA;
Zetterberg, H;
Blennow, K;
Potier, M-C;
... Alzheimer Precision Medicine Initiative (APMI); + view all
(2020)
Association of plasma YKL-40 with brain amyloid-β levels, memory performance, and sex in subjective memory complainers.
Neurobiology of Aging
, 96
pp. 22-32.
10.1016/j.neurobiolaging.2020.07.009.
|
|
Vermunt, L;
Muniz-Terrera, G;
Ter Meulen, L;
Veal, C;
Blennow, K;
Campbell, A;
Carrié, I;
... IMI-EPAD collaborators, .; + view all
(2020)
Prescreening for European Prevention of
Alzheimer Dementia (EPAD) trial-ready
cohort: impact of AD risk factors and
recruitment settings.
Alzheimer's Research & Therapy
, 12
, Article 8. 10.1186/s13195-019-0576-y.
|
|
|
Virhammar, J;
Kumlien, E;
Fällmar, D;
Frithiof, R;
Jackmann, S;
Sköld, MK;
Kadir, M;
... Rostami, E; + view all
(2020)
Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid.
Neurology
10.1212/WNL.0000000000010250.
(In press).
|
|
|
Virhammar, J;
Nääs, A;
Fällmar, D;
Cunningham, JL;
Klang, A;
Ashton, NJ;
Jackmann, S;
... Rostami, E; + view all
(2020)
Biomarkers for CNS injury in CSF are elevated in COVID-19 and associated with neurological symptoms and disease severity.
European Journal of Neurology
10.1111/ene.14703.
(In press).
|
|
|
von Euler Chelpin, M;
Söderberg, L;
Fälting, J;
Möller, C;
Giorgetti, M;
Constantinescu, R;
Blennow, K;
... Höglund, K; + view all
(2020)
Alpha-Synuclein Protofibrils in Cerebrospinal Fluid: A Potential Biomarker for Parkinson's Disease.
Journal of Parkinson's Disease
10.3233/JPD-202141.
(In press).
|
|
|
Wang, P-N;
Lin, K-J;
Liu, H-C;
Andreasson, U;
Blennow, K;
Zetterberg, H;
Yang, S-Y;
(2020)
Plasma pyroglutamate-modified amyloid beta differentiates amyloid pathology.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 12
(1)
, Article e12029. 10.1002/dad2.12029.
|
|
|
Wentz, E;
Dobrescu, SR;
Dinkler, L;
Gillberg, C;
Gillberg, C;
Blennow, K;
Råstam, M;
(2020)
Thirty years after anorexia nervosa onset, serum neurofilament light chain protein concentration indicates neuronal injury.
European Child & Adolescent Psychiatry
10.1007/s00787-020-01657-7.
|
|
|
Westman, G;
Aurelius, E;
Ahlm, C;
Blennow, K;
Eriksson, K;
Lind, L;
Schliamser, S;
... Studahl, M; + view all
(2020)
Cerebrospinal fluid biomarkers of brain injury, inflammation and synaptic autoimmunity predict long-term neurocognitive outcome in herpes simplex encephalitis.
Clinical Microbiology and Infection
10.1016/j.cmi.2020.09.031.
(In press).
|
|
|
Westwood, S;
Baird, AL;
Anand, SN;
Nevado-Holgado, AJ;
Kormilitzin, A;
Shi, L;
Hye, A;
... Lovestone, S; + view all
(2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
Journal of Alzheimer's Disease
10.3233/JAD-190434.
(In press).
|
|
|
Wihersaari, L;
Ashton, NJ;
Reinikainen, M;
Jakkula, P;
Pettilä, V;
Hästbacka, J;
Tiainen, M;
... COMACARE STUDY GROUP; + view all
(2020)
Neurofilament light as an outcome predictor after cardiac arrest: a post hoc analysis of the COMACARE trial.
Intensive Care Medicine
10.1007/s00134-020-06218-9.
|
|
|
Williams, T;
Zetterberg, H;
Chataway, J;
(2020)
Neurofilaments in progressive multiple sclerosis: a systematic review.
Journal of Neurology
10.1007/s00415-020-09917-x.
(In press).
|
|
|
Woollacott, IOC;
Nicholas, JM;
Heller, C;
Foiani, MS;
Moore, KM;
Russell, LL;
Paterson, RW;
... Rohrer, JD; + view all
(2020)
Cerebrospinal Fluid YKL-40 and Chitotriosidase Levels in Frontotemporal Dementia Vary by Clinical, Genetic and Pathological Subtype.
Dementia and Geriatric Cognitive Disorders
, 49
(1)
pp. 56-76.
10.1159/000506282.
|
|
Xu, C;
Sellgren, CM;
Fatouros-Bergman, H;
Piehl, F;
Blennow, K;
Zetterberg, H;
Brinkmalm, A;
... Karolinska Schizophrenia Project (KaSP) Consortium, .; + view all
(2020)
CSF levels of synaptosomal-associated protein 25 and synaptotagmin-1 in first-episode psychosis subjects.
IBRO Reports
, 8
pp. 136-142.
10.1016/j.ibror.2020.04.001.
|
|
|
Zetterberg, H;
Alawode, D;
Keshavan, A;
o'connor, A;
Weston, P;
Paterson, R;
Heslegrave, A;
... Schott, J; + view all
(2020)
Blood Tests for Alzheimer Disease.
Practical Neurology
|
|
|
Zetterberg, H;
(2020)
Is There a Value of Neurofilament Light as a Biomarker for Neurodegeneration in Parkinson's Disease?
Movement Disorders
, 35
(7)
pp. 1111-1112.
10.1002/mds.28101.
|
|
Zetterberg, H;
(2020)
Neurofilament light in blood - What more is needed for clinical implementation in multiple sclerosis?
EBioMedicine
, 57
, Article 102826. 10.1016/j.ebiom.2020.102826.
|
|
Zetterberg, H;
(2020)
Plasma neurofilament light in progressive multiple sclerosis.
[Editorial comment].
Acta Neurologica Scandinavica
, 141
(1)
pp. 14-15.
10.1111/ane.13184.
|
|
Zetterberg, H;
Bendlin, BB;
(2020)
Biomarkers for Alzheimer's disease—preparing for a new era of disease-modifying therapies.
Molecular Psychiatry
10.1038/s41380-020-0721-9.
(In press).
|
|
Zetterberg, H;
Blennow, K;
(2020)
Blood Biomarkers: Democratizing Alzheimer's Diagnostics.
Neuron
, 106
(6)
pp. 881-883.
10.1016/j.neuron.2020.06.004.
|
|
Zhang, R;
Song, J;
Isgren, A;
Jakobsson, J;
Blennow, K;
Sellgren, CM;
Zetterberg, H;
... Landén, M; + view all
(2020)
Genome-wide study of immune biomarkers in cerebrospinal fluid and serum from patients with bipolar disorder and controls.
Translational Psychiatry
, 10
, Article 58. 10.1038/s41398-020-0737-6.
|
|
2019
|
Abdelnour, C;
van Steenoven, I;
Londos, E;
Blanc, F;
Auestad, B;
Kramberger, MG;
Zetterberg, H;
... Aarsland, D; + view all
(2019)
Correction: Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
[Corrigendum].
Movement Disorders
, 34
(4)
p. 593.
10.1002/mds.27672.
|
|
Allison, SL;
Koscik, RL;
Cary, RP;
Jonaitis, EM;
Rowley, HA;
Chin, NA;
Zetterberg, H;
... Johnson, SC; + view all
(2019)
Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum.
NeuroImage: Clinical
, 23
, Article 101895. 10.1016/j.nicl.2019.101895.
|
|
|
Andersson, A;
Remnestål, J;
Nellgård, B;
Vunk, H;
Kotol, D;
Edfors, F;
Uhlén, M;
... Fredolini, C; + view all
(2019)
Development of parallel reaction monitoring assays for cerebrospinal fluid proteins associated with Alzheimer's disease.
Clinica Chimica Acta
, 494
pp. 79-93.
10.1016/j.cca.2019.03.243.
|
|
|
Arber, C;
Villegas-Llerena, C;
Toombs, J;
Pocock, JM;
Ryan, NS;
Fox, NC;
Zetterberg, H;
... Wray, S; + view all
(2019)
Amyloid precursor protein processing in human neurons with an allelic series of the PSEN1 intron 4 deletion mutation and total presenilin-1 knockout.
Brain Communications
10.1093/braincomms/fcz024.
(In press).
|
|
|
Arboleda-Velasquez, JF;
Lopera, F;
O'Hare, M;
Delgado-Tirado, S;
Marino, C;
Chmielewska, N;
Saez-Torres, KL;
... Quiroz, YT; + view all
(2019)
Resistance to autosomal dominant Alzheimer's disease in an APOE3 Christchurch homozygote: a case report.
Nature Medicine
, 25
(11)
pp. 1680-1683.
10.1038/s41591-019-0611-3.
|
|
Ashton, NJ;
Ide, M;
Zetterberg, H;
Blennow, K;
(2019)
Salivary Biomarkers for Alzheimer's Disease and Related Disorders.
Neurology and Therapy
, 8
(S2)
pp. 83-94.
10.1007/s40120-019-00168-1.
|
|
|
Ashton, NJ;
Leuzy, A;
Lim, YM;
Troakes, C;
Hortobagyi, T;
Hoglund, K;
Aarsland, D;
... Hye, A; + view all
(2019)
Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration.
Acta Neuropathologica Communications
, 7
, Article 5. 10.1186/s40478-018-0649-3.
|
|
|
Ashton, NJ;
Nevado-Holgado, AJ;
Barber, IS;
Lynham, S;
Gupta, V;
Chatterjee, P;
Goozee, K;
... Hye, A; + view all
(2019)
A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.
Science Advances
, 5
(2)
, Article eaau7220. 10.1126/sciadv.aau7220.
|
|
|
Ashton, NJ;
Suárez-Calvet, M;
Heslegrave, A;
Hye, A;
Razquin, C;
Pastor, P;
Sanchez-Valle, R;
... Zetterberg, H; + view all
(2019)
Plasma levels of soluble TREM2 and neurofilament light chain in TREM2 rare variant carriers.
Alzheimer's Research & Therapy
, 11
, Article 94. 10.1186/s13195-019-0545-5.
|
|
|
Babulal, GM;
Quiroz, YT;
Albensi, BC;
Arenaza-Urquijo, E;
Astell, AJ;
Babiloni, C;
Bahar-Fuchs, A;
... International Society to Advance Alzheimer's Research and Treatm, .; + view all
(2019)
Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
Alzheimer's and Dementia
, 15
(2)
pp. 292-312.
10.1016/j.jalz.2018.09.009.
|
|
|
Bateman, R;
Blennow, K;
Doody, R;
Hendrix, S;
Lovestone, S;
Salloway, S;
Schindler, R;
... Zetterberg, H; + view all
(2019)
Plasma Biomarkers of AD Emerging as Essential Tools for Drug Development: An EU/US CTAD Task Force Report.
The Journal of Prevention of Alzheimer's Disease
, 6
(3)
pp. 169-173.
10.14283/jpad.2019.21.
|
|
Bendlin, BB;
Zetterberg, H;
(2019)
Screening with a high precision blood-based assay for Alzheimer disease.
[Editorial comment].
Neurology
10.1212/WNL.0000000000008080.
(In press).
|
|
Benedet, AL;
Ashton, NJ;
Pascoal, TA;
Leuzy, A;
Mathotaarachchi, S;
Kang, MS;
Therriault, J;
... Neto, PR; + view all
(2019)
Plasma neurofilament light associates with Alzheimer's disease metabolic decline in amyloid-positive individuals.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 679-689.
10.1016/j.dadm.2019.08.002.
|
|
|
Bernick, C;
Shan, G;
Zetterberg, H;
Banks, S;
Mishra, VR;
Bekris, L;
Leverenz, JB;
(2019)
Longitudinal change in regional brain volumes with exposure to repetitive head impacts.
Neurology
10.1212/WNL.0000000000008817.
(In press).
|
|
|
Bhattacharjee, P;
Öhrfelt, A;
Lashley, T;
Blennow, K;
Brinkmalm, A;
Zetterberg, H;
(2019)
Mass Spectrometric Analysis of Lewy Body-Enriched α-Synuclein in Parkinson's Disease.
Journal of Proteome Research
, 18
(5)
pp. 2109-2120.
10.1021/acs.jproteome.8b00982.
|
|
Blennow, K;
Diaz-Lucena, D;
Zetterberg, H;
Villar-Pique, A;
Karch, A;
Vidal, E;
Hermann, P;
... Llorens, F; + view all
(2019)
CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2018-320155.
(In press).
|
|
|
Bos, I;
Vos, S;
Verhey, F;
Scheltens, P;
Teunissen, C;
Engelborghs, S;
Sleegers, K;
... Visser, PJ; + view all
(2019)
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrum.
Alzheimer's & Dementia
, 15
(5)
pp. 644-654.
10.1016/j.jalz.2019.01.004.
|
|
Bridel, C;
van Wieringen, WN;
Zetterberg, H;
Tijms, BM;
Teunissen, CE;
and the NFL Group;
Alvarez-Cermeño, JC;
... Wild, EJ; + view all
(2019)
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis.
JAMA Neurology
10.1001/jamaneurol.2019.1534.
(In press).
|
|
Brinkmalm, A;
Öhrfelt, A;
Bhattacharjee, P;
Zetterberg, H;
(2019)
Detection of α-Synuclein in Biological Samples Using Mass Spectrometry.
In:
Alpha-Synuclein Methods and Protocols.
(pp. 209-220).
Humana Press: New York, NY, USA.
|
|
Brinkmalm, A;
Portelius, E;
Brinkmalm, G;
Pannee, J;
Dahlén, R;
Gobom, J;
Blennow, K;
(2019)
Fluid-based proteomics targeted on pathophysiological processes and pathologies in neurodegenerative diseases.
Journal of Neurochemistry
, 151
(4)
pp. 417-434.
10.1111/jnc.14594.
|
|
Brinkmalm, G;
Hong, W;
Wang, Z;
Liu, W;
O'Malley, TT;
Sun, X;
Frosch, MP;
... Walsh, DM; + view all
(2019)
Identification of neurotoxic cross-linked amyloid-β dimers in the Alzheimer's brain.
Brain
, 142
(5)
pp. 1441-1457.
10.1093/brain/awz066.
|
|
Bruno, D;
Gleason, CE;
Koscik, RL;
Pomara, N;
Zetterberg, H;
Blennow, K;
Johnson, SC;
(2019)
The recency ratio is related to CSF amyloid beta 1‐42 levels in MCI‐AD.
International Journal of Geriatric Psychiatry
, 34
(3)
pp. 415-419.
10.1002/gps.5029.
|
|
Chatterjee, P;
Elmi, M;
Goozee, K;
Shah, T;
Sohrabi, HR;
Dias, CB;
Pedrini, S;
... Martins, RN; + view all
(2019)
Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
Journal of Alzheimer's Disease
, 71
(3)
pp. 775-783.
10.3233/JAD-190533.
|
|
|
Chatterjee, P;
Zetterberg, H;
Goozee, K;
Lim, CK;
Jacobs, KR;
Ashton, NJ;
Hye, A;
... Martins, RN; + view all
(2019)
Plasma neurofilament light chain and amyloid-β are associated with the kynurenine pathway metabolites in preclinical Alzheimer's disease.
Journal of Neuroinflammation
, 16
, Article 2019. 10.1186/s12974-019-1567-4.
|
|
|
Chelban, V;
Wilson, MP;
Warman Chardon, J;
Vandrovcova, J;
Zanetti, MN;
Zamba-Papanicolaou, E;
Efthymiou, S;
... SYNaPS Study Group, .; + view all
(2019)
PDXK mutations cause polyneuropathy responsive to PLP supplementation.
Annals of Neurology
10.1002/ana.25524.
(In press).
|
|
|
Chen, Z;
Mengel, D;
Keshavan, A;
Rissman, RA;
Billinton, A;
Perkinton, M;
Percival-Alwyn, J;
... Walsh, DM; + view all
(2019)
Learnings about the complexity of extracellular tau aid development of a blood-based screen for Alzheimer's disease.
Alzheimer's & Dementia
, 15
(3)
pp. 487-496.
10.1016/j.jalz.2018.09.010.
|
|
Cicognola, C;
Brinkmalm, G;
Wahlgren, J;
Portelius, E;
Gobom, J;
Cullen, NC;
Hansson, O;
... Höglund, K; + view all
(2019)
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer's disease.
Acta Neuropathologica
10.1007/s00401-018-1948-2.
(In press).
|
|
|
Clarke, MTM;
Brinkmalm, A;
Foiani, MS;
Woollacott, IOC;
Heller, C;
Heslegrave, A;
Keshavan, A;
... Rohrer, JD; + view all
(2019)
CSF synaptic protein concentrations are raised in those with atypical Alzheimer's disease but not frontotemporal dementia.
Alzheimer's Research and Therapy
, 11
, Article 105. 10.1186/s13195-019-0564-2.
|
|
|
Cohen, AD;
Landau, SM;
Snitz, BE;
Klunk, WE;
Blennow, K;
Zetterberg, H;
(2019)
Fluid and PET biomarkers for amyloid pathology in Alzheimer's disease.
Molecular and Cellular Neuroscience
, 97
pp. 3-17.
10.1016/j.mcn.2018.12.004.
|
|
Craven, CL;
Chapman, MD;
D'Antona, L;
Thompson, SD;
Lakdawala, N;
Zetterberg, H;
Watkins, LD;
(2019)
Lumbar drains can affect CSF biomarker levels.
[Letter].
Journal of Clinical Pathology
, 72
(1)
pp. 91-92.
10.1136/jclinpath-2018-205296.
|
|
|
Cunningham, EL;
McGuinness, B;
McAuley, DF;
Toombs, J;
Mawhinney, T;
O'Brien, S;
Beverland, D;
... Passmore, AP; + view all
(2019)
CSF Beta-amyloid 1-42 Concentration Predicts Delirium Following Elective Arthroplasty Surgery in an Observational Cohort Study.
Annals of Surgery
, 269
(6)
pp. 1200-1205.
10.1097/SLA.0000000000002684.
|
|
De, S;
Whiten, DR;
Ruggeri, FS;
Hughes, C;
Rodrigues, M;
Sideris, D;
Taylor, CG;
... Klenerman, D; + view all
(2019)
Soluble aggregates present in cerebrospinal fluid change in size and mechanism of toxicity during Alzheimer's disease progression.
Acta Neuropathologica Communications
, 7
, Article 120. 10.1186/s40478-019-0777-4.
|
|
|
de Flon, P;
Laurell, K;
Sundström, P;
Blennow, K;
Söderström, L;
Zetterberg, H;
Gunnarsson, M;
(2019)
Comparison of plasma and CSF Neurofilament-light in an MS trial.
Acta Neurologica Scandinavica
, 139
(5)
pp. 462-468.
10.1111/ane.13078.
|
|
De Francesco, D;
Choi, J-P;
Choi, JY;
van Zoest, RA;
Underwood, J;
Schouten, J;
Ku, NS;
... van Zoest, RA; + view all
(2019)
Cognitive function and drivers of cognitive impairment in a European and a Korean cohort of people living with HIV.
International Journal of STD & AIDS
10.1177/0956462419881080.
(In press).
|
|
|
De Francesco, D;
Wit, FW;
Bürkle, A;
Oehlke, S;
Kootstra, NA;
Winston, A;
Franceschi, C;
... The Co-morBidity in Relation to AIDS (COBRA) Collaboration, .; + view all
(2019)
Do people living with HIV experience greater age advancement than their HIV-negative counterparts?
AIDS
, 33
(2)
pp. 259-268.
10.1097/QAD.0000000000002063.
|
|
Deisenhammer, F;
Zetterberg, H;
Fitzner, B;
Zettl, UK;
(2019)
The Cerebrospinal Fluid in Multiple Sclerosis.
[Review].
Frontiers in Immunology
, 10
, Article 726. 10.3389/fimmu.2019.00726.
|
|
|
Delsing, L;
Kallur, T;
Zetterberg, H;
Hicks, R;
Synnergren, J;
(2019)
Enhanced xeno-free differentiation of hiPSC-derived astroglia applied in a blood-brain barrier model.
Fluids and Barriers of the CNS
, 16
, Article 27. 10.1186/s12987-019-0147-4.
|
|
|
DeMarshall, C;
Oh, E;
Kheirkhah, R;
Sieber, F;
Zetterberg, H;
Blennow, K;
Nagele, RG;
(2019)
Detection of early-stage Alzheimer's pathology using blood-based autoantibody biomarkers in elderly hip fracture repair patients.
PLoS One
, 14
(11)
, Article e0225178. 10.1371/journal.pone.0225178.
|
|
|
Deming, Y;
Filipello, F;
Cignarella, F;
Cantoni, C;
Hsu, S;
Mikesell, R;
Li, Z;
... Cruchaga, C; + view all
(2019)
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk.
Science Translational Medicine
, 11
(505)
, Article eaau2291. 10.1126/scitranslmed.aau2291.
|
|
Dhiman, K;
Blennow, K;
Zetterberg, H;
Martins, RN;
Gupta, VB;
(2019)
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis.
Cellular and Molecular Life Sciences
, 76
pp. 1833-1863.
10.1007/s00018-019-03040-5.
|
|
Dumitrescu, L;
Barnes, LL;
Thambisetty, M;
Beecham, G;
Kunkle, B;
Bush, WS;
Gifford, KA;
... Hohman, TJ; + view all
(2019)
Sex differences in the genetic predictors of Alzheimer's pathology.
Brain
, 142
(9)
pp. 2581-2589.
10.1093/brain/awz206.
|
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
Correction: The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(2)
, Article e0212830. 10.1371/journal.pone.0212830.
|
|
|
Ehler, J;
Petzold, A;
Wittstock, M;
Kolbaske, S;
Gloger, M;
Henschel, J;
Heslegrave, A;
... Sauer, M; + view all
(2019)
The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy - A prospective, pilot observational study.
PLoS One
, 14
(1)
, Article e0211184. 10.1371/journal.pone.0211184.
|
|
|
Erickson, CM;
Schultz, SA;
Oh, JM;
Darst, BF;
Ma, Y;
Norton, D;
Betthauser, T;
... Okonkwo, OC; + view all
(2019)
KLOTHO heterozygosity attenuates APOE4-related amyloid burden in preclinical AD.
Neurology
10.1212/WNL.0000000000007323.
(In press).
|
|
Foiani, MS;
Cicognola, C;
Ermann, N;
Woollacott, IOC;
Heller, C;
Heslegrave, AJ;
Keshavan, A;
... Rohrer, JD; + view all
(2019)
Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: an elusive quest.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-319266.
(In press).
|
|
|
Forsberg, M;
Seth, H;
Björefeldt, A;
Lyckenvik, T;
Andersson, M;
Wasling, P;
Zetterberg, H;
(2019)
Ionized calcium in human cerebrospinal fluid and its influence on intrinsic and synaptic excitability of hippocampal pyramidal neurons in the rat.
Journal of Neurochemistry
, 149
(4)
pp. 452-470.
10.1111/jnc.14693.
|
|
Fossati, S;
Ramos Cejudo, J;
Debure, L;
Pirraglia, E;
Sone, JY;
Li, Y;
Chen, J;
... de Leon, MJ; + view all
(2019)
Plasma tau complements CSF tau and P-tau in the diagnosis of Alzheimer's disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 483-492.
10.1016/j.dadm.2019.05.001.
(In press).
|
|
|
Frankel, R;
Törnquist, M;
Meisl, G;
Hansson, O;
Andreasson, U;
Zetterberg, H;
Blennow, K;
... Linse, S; + view all
(2019)
Autocatalytic amplification of Alzheimer-associated Aβ42 peptide aggregation in human cerebrospinal fluid.
Communications Biology
, 2
, Article 365. 10.1038/s42003-019-0612-2.
|
|
|
Gaetani, L;
Blennow, K;
Calabresi, P;
Di Filippo, M;
Parnetti, L;
Zetterberg, H;
(2019)
Neurofilament light chain as a biomarker in neurological disorders.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(8)
pp. 870-881.
10.1136/jnnp-2018-320106.
|
|
|
Gaetani, L;
Eusebi, P;
Mancini, A;
Gentili, L;
Borrelli, A;
Parnetti, L;
Calabresi, P;
... Di Filippo, M; + view all
(2019)
Cerebrospinal fluid neurofilament light chain predicts disease activity after the first demyelinating event suggestive of multiple sclerosis.
Multiple Sclerosis and Related Disorders
, 35
pp. 228-232.
10.1016/j.msard.2019.07.025.
|
|
Gaetani, L;
Salvadori, N;
Lisetti, V;
Eusebi, P;
Mancini, A;
Gentili, L;
Borrelli, A;
... Di Filippo, M; + view all
(2019)
Cerebrospinal fluid neurofilament light chain tracks cognitive impairment in multiple sclerosis.
Journal of Neurology
, 266
pp. 2157-2163.
10.1007/s00415-019-09398-7.
|
|
Gafson, AR;
Savva, C;
Thorne, T;
David, M;
Gomez-Romero, M;
Lewis, MR;
Nicholas, R;
... Matthews, PM; + view all
(2019)
Breaking the cycle: Reversal of flux in the tricarboxylic acid cycle by dimethyl fumarate.
Neurology: Neuroimmunology & NeuroInflammation
, 6
(3)
, Article e562. 10.1212/NXI.0000000000000562.
|
|
Gatenholm, B;
Gobom, J;
Skillbäck, T;
Blennow, K;
Zetterberg, H;
Brittberg, M;
(2019)
Peptidomic Analysis of Cartilage and Subchondral bone in OA patients.
European Journal of Clinical Investigation
, 49
(5)
, Article e13082. 10.1111/eci.13082.
|
|
Gisslen, M;
Heslegrave, A;
Veleva, E;
Yilmaz, A;
Andersson, L-M;
Hagberg, L;
Spudich, S;
... Zetterberg, H; + view all
(2019)
CSF concentrations of soluble TREM2 as a marker of microglial activation in HIV-1 infection.
Neurology, Neuroimmunology and Neuroinflammation
, 6
(1)
, Article e512. 10.1212/NXI.0000000000000512.
|
|
|
Gkanatsiou, E;
Portelius, E;
Toomey, CE;
Blennow, K;
Zetterberg, H;
Lashley, T;
Brinkmalm, G;
(2019)
A distinct brain beta amyloid signature in cerebral amyloid angiopathy compared to Alzheimer's disease.
Neuroscience Letters
, 701
pp. 125-131.
10.1016/j.neulet.2019.02.033.
|
|
Gorgoraptis, N;
Li, LM;
Whittington, A;
Zimmerman, KA;
Maclean, LM;
McLeod, C;
Ross, E;
... Sharp, DJ; + view all
(2019)
In vivo detection of cerebral tau pathology in long-term survivors of traumatic brain injury.
Science Translational Medicine
, 11
(508)
, Article eaaw1993. 10.1126/scitranslmed.aaw1993.
|
|
|
Grand, J;
Kjaergaard, J;
Nielsen, N;
Friberg, H;
Cronberg, T;
Bro-Jeppesen, J;
Karsdal, MA;
... Hassager, C; + view all
(2019)
Serum tau fragments as predictors of death or poor neurological outcome after out-of-hospital cardiac arrest.
Biomarkers
, 24
(6)
pp. 584-591.
10.1080/1354750X.2019.1609580.
|
|
Guerreiro, R;
Escott-Price, V;
Hernandez, DG;
Kun-Rodrigues, C;
Ross, OA;
Orme, T;
Neto, JL;
... Bras, J; + view all
(2019)
Heritability and genetic variance of dementia with Lewy bodies.
Neurobiology of Disease
, 127
pp. 492-501.
10.1016/j.nbd.2019.04.004.
|
|
Hall, S;
Janelidze, S;
Zetterberg, H;
Brix, B;
Mattsson, N;
Surova, Y;
Blennow, K;
(2019)
Cerebrospinal fluid levels of neurogranin in Parkinsonian disorders.
Movement Disorders
10.1002/mds.27950.
(In press).
|
|
Hansson, K;
Dahlen, R;
Hansson, O;
Pernevik, E;
Paterson, R;
Schott, JM;
Magdalinou, N;
... Gobom, J; + view all
(2019)
Use of the tau protein-to-peptide ratio in CSF to improve diagnostic classification of Alzheimer's disease.
Clinical Mass Spectrometry
, 14
(Part B)
pp. 74-82.
10.1016/j.clinms.2019.07.002.
|
|
Hansson, O;
Lehmann, S;
Otto, M;
Zetterberg, H;
Lewczuk, P;
(2019)
Advantages and disadvantages of the use of the CSF Amyloid β (Aβ) 42/40 ratio in the diagnosis of Alzheimer's Disease.
Alzheimer's Research & Therapy
, 11
, Article 34. 10.1186/s13195-019-0485-0.
|
|
|
Hasselgren, C;
Ekbrand, H;
Fässberg, MM;
Zettergren, A;
Zetterberg, H;
Blennow, K;
Skoog, I;
(2019)
APOE ε₄ and the long arm of social inequity: estimated effects of socio-economic status and sex on the timing of dementia onset.
Ageing & Society
, 39
(9)
pp. 1951-1975.
10.1017/S0144686X18000351.
|
|
|
Hedberg-Oldfors, C;
Abramsson, A;
Osborn, DPS;
Danielsson, O;
Fazlinezhad, A;
Nilipour, Y;
Hübbert, L;
... Jamshidi, Y; + view all
(2019)
Cardiomyopathy with lethal arrhythmias associated with inactivation of KLHL24.
Human Molecular Genetics
, 28
(11)
pp. 1919-1929.
10.1093/hmg/ddz032.
|
|
Hepner, A;
Porter, J;
Hare, F;
Nasir, SS;
Zetterberg, H;
Blennow, K;
Martin, MG;
(2019)
Serum Neurofilament Light, Glial Fibrillary Acidic Protein and Tau Are Possible Serum Biomarkers for Activity of Brain Metastases and Gliomas.
World Journal of Oncology
, 10
(4-5)
pp. 169-175.
10.14740/wjon1228.
|
|
|
Hermansson, L;
Yilmaz, A;
Axelsson, M;
Blennow, K;
Fuchs, D;
Hagberg, L;
Lycke, J;
... Gisslén, M; + view all
(2019)
Cerebrospinal fluid levels of glial marker YKL-40 strongly associated with axonal injury in HIV infection.
Journal of Neuroinflammation
, 16
, Article 16. 10.1186/s12974-019-1404-9.
|
|
|
Hermansson, L;
Yilmaz, A;
Price, RW;
Nilsson, S;
McCallister, S;
Makadzange, T;
Das, M;
... Gisslen, M; + view all
(2019)
Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.
PLOS ONE
, 14
(12)
, Article e0226276. 10.1371/journal.pone.0226276.
|
|
|
Heurling, K;
Ashton, NJ;
Leuzy, A;
Zimmer, ER;
Blennow, K;
Zetterberg, H;
Eriksson, J;
... Schöll, M; + view all
(2019)
Synaptic vesicle protein 2A as a potential biomarker in synaptopathies.
Molecular and Cellular Neuroscience
10.1016/j.mcn.2019.02.001.
(In press).
|
|
|
Höglund, K;
Schussler, N;
Kvartsberg, H;
Smailovic, U;
Brinkmalm, G;
Liman, V;
Becker, B;
... Blennow, K; + view all
(2019)
Cerebrospinal fluid neurogranin in an inducible mouse model of neurodegeneration: A translatable marker of synaptic degeneration.
Neurobiology of Disease
, 134
, Article 104645. 10.1016/j.nbd.2019.104645.
|
|
|
Holmøy, T;
Røsjø, E;
Zetterberg, H;
Blennow, K;
Lindstrøm, JC;
Steffensen, LH;
Kampman, MT;
(2019)
Vitamin D supplementation and neurofilament light chain in multiple sclerosis.
Acta Neurologica Scandinavica
, 139
(2)
pp. 172-176.
10.1111/ane.13037.
|
|
Hossain, I;
Mohammadian, M;
Takala, RS;
Tenovuo, O;
Lagerstedt, L;
Ala-Seppälä, HM;
Frantzén, J;
... Posti, JP; + view all
(2019)
Early Levels of Glial Fibrillary Acidic Protein and Neurofilament Light Protein in Predicting the Outcome of Mild Traumatic Brain Injury.
Journal of Neurotrauma
, 36
(10)
pp. 1551-1560.
10.1089/neu.2018.5952.
|
|
Iverson, GL;
Reddi, PJ;
Posti, JP;
Kotilainen, A-K;
Tenovuo, O;
Öhman, J;
Zetterberg, H;
... Luoto, TM; + view all
(2019)
Serum Neurofilament Light is Elevated Differentially in Older Adults with Uncomplicated Mild Traumatic Brain Injuries.
Journal of Neurotrauma
, 36
(16)
pp. 2400-2406.
10.1089/neu.2018.6341.
|
|
Jabbari, E;
Holland, N;
Chelban, V;
Jones, PS;
Lamb, R;
Rawlinson, C;
Guo, T;
... Morris, HR; + view all
(2019)
Diagnosis Across the Spectrum of Progressive Supranuclear Palsy and Corticobasal Syndrome.
JAMA Neurology
, 77
(3)
pp. 377-387.
10.1001/jamaneurol.2019.4347.
|
|
|
Jabbari, E;
Woodside, J;
Guo, T;
Magdalinou, NK;
Chelban, V;
Athauda, D;
Lees, AJ;
... Morris, HR; + view all
(2019)
Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes.
Journal of Neurology, Neurosurgery and Psychiatry
10.1136/jnnp-2018-320151.
|
|
|
Jacobs, KR;
Lim, CK;
Blennow, K;
Zetterberg, H;
Chatterjee, P;
Martins, RN;
Brew, BJ;
... Lovejoy, DB; + view all
(2019)
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tau.
Neurobiology of Aging
, 80
pp. 11-20.
10.1016/j.neurobiolaging.2019.03.015.
|
|
Jensen, CS;
Bahl, JM;
Østergaard, LB;
Høgh, P;
Wermuth, L;
Heslegrave, A;
Zetterberg, H;
... Simonsen, AH; + view all
(2019)
Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasma.
Experimental Gerontology
, 121
pp. 91-98.
10.1016/j.exger.2019.04.003.
|
|
|
Jeppsson, A;
Wikkelsö, C;
Blennow, K;
Zetterberg, H;
Constantinescu, R;
Remes, AM;
Herukka, S-K;
... Tullberg, M; + view all
(2019)
CSF biomarkers distinguish idiopathic normal pressure hydrocephalus from its mimics.
Journal of Neurology, Neurosurgery & Psychiatry
, 90
(10)
pp. 1117-1123.
10.1136/jnnp-2019-320826.
|
|
Johansson, L;
Sacuiu, S;
Kern, S;
Guo, X;
Zetterberg, H;
Blennow, K;
Zettergren, A;
(2019)
Longstanding psychological stress in relation to biomarkers of neuronal dysfunction in cerebrospinal fluid: a 25-year follow-up study in women.
Neurobiology of Aging
, 80
pp. 111-115.
10.1016/j.neurobiolaging.2019.02.013.
|
|
Jonaitis, EM;
Koscik, RL;
Clark, LR;
Ma, Y;
Betthauser, TJ;
Berman, SE;
Allison, SL;
... Johnson, SC; + view all
(2019)
Measuring longitudinal cognition: Individual tests versus composites.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 11
pp. 74-84.
10.1016/j.dadm.2018.11.006.
|
|
Kagiava, A;
Richter, J;
Tryfonos, C;
Karaiskos, C;
Heslegrave, AJ;
Sargiannidou, I;
Rossor, AM;
... Kleopa, KA; + view all
(2019)
Gene replacement therapy after neuropathy onset provides therapeutic benefit in a model of CMT1X.
Human Molecular Genetics
, 28
(21)
pp. 3528-3542.
10.1093/hmg/ddz199.
|
|
Kam, K;
Parekh, A;
Sharma, RA;
Andrade, A;
Lewin, M;
Castillo, B;
Bubu, OM;
... Osorio, RS; + view all
(2019)
Sleep oscillation-specific associations with Alzheimer's disease CSF biomarkers: novel roles for sleep spindles and tau.
Molecular Neurodegeneration
, 14
, Article 10. 10.1186/s13024-019-0309-5.
|
|
|
Kapoor, M;
Foiani, M;
Heslegrave, A;
Zetterberg, H;
Lunn, MP;
Malaspina, A;
Gillmore, JD;
... Reilly, MM; + view all
(2019)
Plasma neurofilament light chain concentration is increased and correlates with the severity of neuropathy in hereditary transthyretin amyloidosis.
Journal of the Peripheral Nervous System
, 24
(4)
pp. 314-319.
10.1111/jns.12350.
|
|
Kehoe, PG;
Al Mulhim, N;
Zetterberg, H;
Blennow, K;
Miners, JS;
(2019)
Cerebrospinal Fluid Changes in the Renin-Angiotensin System in Alzheimer's Disease.
Journal of Alzheimer’s Disease
, 72
(2)
pp. 525-535.
10.3233/JAD-190721.
|
|
|
Khoonsari, PE;
Shevchenko, G;
Herman, S;
Remnestål, J;
Giedraitis, V;
Brundin, R;
Gunnarsson, MD;
... Kultima, K; + view all
(2019)
Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers.
Journal of Alzheimer's Disease
, 67
(2)
pp. 639-651.
10.3233/JAD-180855.
|
|
|
Kim, M;
Snowden, S;
Suvitaival, T;
Ali, A;
Merkler, DJ;
Ahmad, T;
Westwood, S;
... Legido-Quigley, C; + view all
(2019)
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
Alzheimer's & Dementia
, 15
(6)
pp. 817-827.
10.1016/j.jalz.2019.03.004.
|
|
Kranaster, L;
Blennow, K;
Zetterberg, H;
Sartorius, A;
(2019)
Reduced vascular endothelial growth factor levels in the cerebrospinal fluid in patients with treatment resistant major depression and the effects of electroconvulsive therapy—A pilot study.
Journal of Affective Disorders
, 253
pp. 449-453.
10.1016/j.jad.2019.04.080.
|
|
Kun-Rodrigues, C;
Orme, T;
Carmona, S;
Hernandez, DG;
Ross, OA;
Eicher, JD;
Shepherd, C;
... Bras, J; + view all
(2019)
A comprehensive screening of copy number variability in dementia with Lewy bodies.
Neurobiology of Aging
, 75
, Article 223.e1-223.e10. 10.1016/j.neurobiolaging.2018.10.019.
|
|
Law, LL;
Sprecher, KE;
Dougherty, RJ;
Edwards, DF;
Koscik, RL;
Gallagher, CL;
Carlsson, CM;
... Okonkwo, OC; + view all
(2019)
Cardiorespiratory Fitness Modifies Influence of Sleep Problems on Cerebrospinal Fluid Biomarkers in an At-Risk Cohort.
Journal of Alzheimer's Disease
, 69
(1)
pp. 111-121.
10.3233/JAD-180291.
|
|
|
Leavey, N;
Hammond, SP;
Shepstone, L;
Cross, J;
Zetterberg, H;
Cunningham, C;
MacLullich, A;
... Fox, C; + view all
(2019)
Study protocol: ASCRIBED: the impact of Acute SystematiC inflammation upon cerebRospinal fluId and blood BiomarkErs of brain inflammation and injury in dementia: a study in acute hip fracture patients.
BMC Neurology
, 19
(1)
, Article 223. 10.1186/s12883-019-1447-7.
|
|
|
Lerche, S;
Wurster, I;
Röben, B;
Machetanz, G;
Zimmermann, M;
Bernhard, F;
Stransky, E;
... Brockmann, K; + view all
(2019)
Parkinson’s disease: evolution of cognitive impairment and CSF Aβ₁−₄₂ profiles in a prospective longitudinal study.
Journal of Neurology, Neurosurgery and Psychiatry
, 90
(2)
pp. 165-170.
10.1136/jnnp-2018-318956.
|
|
|
Leuzy, A;
Cicognola, C;
Chiotis, K;
Saint-Aubert, L;
Lemoine, L;
Andreasen, N;
Zetterberg, H;
... Nordberg, A; + view all
(2019)
Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer's disease.
European Journal of Nuclear Medicine and Molecular Imaging
10.1007/s00259-018-4242-6.
(In press).
|
|
|
Lleó, A;
Alcolea, D;
Martínez-Lage, P;
Scheltens, P;
Parnetti, L;
Poirier, J;
Simonsen, AH;
... Blennow, K; + view all
(2019)
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD study.
Alzheimer's & Dementia
, 15
(6)
pp. 742-753.
10.1016/j.jalz.2019.01.015.
|
|
Lombardi, V;
Bombaci, A;
Zampedri, L;
Lu, C-H;
Malik, B;
Zetterberg, H;
Heslegrave, AJ;
... Fratta, P; + view all
(2019)
Plasma pNfH levels differentiate SBMA from ALS.
Journal of Neurology, Neurosurgery & Psychiatry
10.1136/jnnp-2019-320624.
(In press).
|
|
|
Lombardi, V;
Querin, G;
Ziff, OJ;
Zampedri, L;
Martinelli, I;
Heller, C;
Foiani, M;
... Fratta, P; + view all
(2019)
Muscle and not neuronal biomarkers correlate with severity in spinal and bulbar muscular atrophy.
Neurology
, 92
(11)
10.1212/WNL.0000000000007097.
(In press).
|
|
|
Lopez-Font, I;
Boix, CP;
Zetterberg, H;
Blennow, K;
Sáez-Valero, J;
(2019)
Characterization of Cerebrospinal Fluid BACE1 Species.
Molecular Neurobiology
, 56
pp. 8603-8616.
10.1007/s12035-019-01677-8.
|
|
Lopez-Font, I;
Sogorb-Esteve, A;
Javier-Torrent, M;
Brinkmalm, G;
Herrando-Grabulosa, M;
García-Lareu, B;
Turon-Sans, J;
... Sáez-Valero, J; + view all
(2019)
Decreased circulating ErbB4 ectodomain fragments as a read-out of impaired signaling function in amyotrophic lateral sclerosis.
Neurobiology of Disease
, 124
pp. 428-438.
10.1016/j.nbd.2018.12.021.
|
|
Merluzzi, AP;
Vogt, NM;
Norton, D;
Jonaitis, E;
Clark, LR;
Carlsson, CM;
Johnson, SC;
... Bendlin, BB; + view all
(2019)
Differential effects of neurodegeneration biomarkers on subclinical cognitive decline.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 5
pp. 129-138.
10.1016/j.trci.2019.02.004.
|
|
|
Michno, W;
Nyström, S;
Wehrli, P;
Lashley, T;
Brinkmalm, G;
Guerard, L;
Syvänen, S;
... Hanrieder, J; + view all
(2019)
Pyroglutamation of amyloid-βx-42 (Aβx-42) followed by Aβ1-40 deposition underlies plaque polymorphism in progressing Alzheimer's disease pathology.
Journal of Biological Chemistry
, 294
pp. 6719-6732.
10.1074/jbc.RA118.006604.
|
|
Michno, W;
Wehrli, PM;
Blennow, K;
Zetterberg, H;
Hanrieder, J;
(2019)
Molecular imaging mass spectrometry for probing protein dynamics in neurodegenerative disease pathology.
Journal of Neurochemistry
, 151
(4)
pp. 488-506.
10.1111/jnc.14559.
|
|
Michno, W;
Wehrli, PM;
Zetterberg, H;
Blennow, K;
Hanrieder, J;
(2019)
GM1 locates to mature amyloid structures implicating a prominent role for glycolipid-protein interactions in Alzheimer pathology.
Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
, 1867
(5)
pp. 458-467.
10.1016/j.bbapap.2018.09.010.
|
|
Mielke, MM;
Syrjanen, JA;
Blennow, K;
Zetterberg, H;
Skoog, I;
Vemuri, P;
Machulda, MM;
... Kern, S; + view all
(2019)
Comparison of variables associated with cerebrospinal fluid neurofilament, total-tau, and neurogranin.
Alzheimer's & Dementia
, 15
(11)
pp. 1437-1447.
10.1016/j.jalz.2019.07.009.
|
|
Mielke, MM;
Syrjanen, JA;
Blennow, K;
Zetterberg, H;
Vemuri, P;
Skoog, I;
Machulda, MM;
... Kern, S; + view all
(2019)
Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures.
Neurology
, 93
(3)
e252-e260.
10.1212/WNL.0000000000007767.
|
|
Miners, JS;
Kehoe, PG;
Love, S;
Zetterberg, H;
Blennow, K;
(2019)
CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology.
Alzheimer's Research & Therapy
, 11
(1)
, Article 81. 10.1186/s13195-019-0534-8.
|
|
|
Minta, K;
Cullen, NC;
Nimer, FA;
Thelin, EP;
Piehl, F;
Clarin, M;
Tullberg, M;
... Andreasson, U; + view all
(2019)
Dynamics of extracellular matrix proteins in cerebrospinal fluid and serum and their relation to clinical outcome in human traumatic brain injury.
Clinical Chemistry and Laboratory Medicine
, 57
(10)
pp. 1565-1573.
10.1515/cclm-2019-0034.
|
|
Minta, K;
Portelius, E;
Janelidze, S;
Hansson, O;
Zetterberg, H;
Blennow, K;
Andreasson, U;
(2019)
Cerebrospinal Fluid Concentrations of Extracellular Matrix Proteins in Alzheimer's Disease.
Journal Of Alzheimers Disease
, 69
(4)
pp. 1213-1220.
10.3233/JAD-190187.
|
|
Mollenhauer, B;
DuBois, BF;
Drake, D;
Duong, J;
Blennow, K;
El-Agnaf, O;
Shaw, LM;
... Zetterberg, H; + view all
(2019)
Antibody‐based methods for the measurement of α‐synuclein concentration in human cerebrospinal fluid – method comparison and round robin study.
Journal of Neurochemistry
, 149
(1)
pp. 126-138.
10.1111/jnc.14569.
|
|
|
Morgan, AR;
Touchard, S;
Leckey, C;
O'Hagan, C;
Nevado-Holgado, AJ;
Barkhof, F;
Bertram, L;
... Sheridan, H; + view all
(2019)
Inflammatory biomarkers in Alzheimer's disease plasma.
Alzheimer's and Dementia
10.1016/j.jalz.2019.03.007.
(In press).
|
|
|
Mullin, S;
Beavan, M;
Bestwick, J;
McNeill, A;
Proukakis, C;
Cox, T;
Hughes, D;
... Schapira, AHV; + view all
(2019)
Evolution and clustering of prodromal parkinsonian features in GBA1 carriers.
Movement Disorders
, 34
(9)
pp. 1365-1373.
10.1002/mds.27775.
|
|
|
Nilsson, IAK;
Millischer, V;
Karrenbauer, VD;
Juréus, A;
Salehi, AM;
Norring, C;
von Hausswolff-Juhlin, Y;
... Landén, M; + view all
(2019)
Plasma neurofilament light chain concentration is increased in anorexia nervosa.
Translational Psychiatry
, 9
(1)
, Article 180. 10.1038/s41398-019-0518-2.
|
|
|
Öhrfelt, A;
Brinkmalm, A;
Dumurgier, J;
Zetterberg, H;
Bouaziz-Amar, E;
Hugon, J;
Paquet, C;
(2019)
A novel ELISA for the measurement of cerebrospinal fluid SNAP-25 in patients with Alzheimer's disease.
Neuroscience
, 420
pp. 136-144.
10.1016/j.neuroscience.2018.11.038.
|
|
Olsson, B;
Alberg, L;
Cullen, NC;
Michael, E;
Wahlgren, L;
Kroksmark, A-K;
Rostasy, K;
... Tulinius, M; + view all
(2019)
NFL is a marker of treatment response in children with SMA treated with nusinersen.
Journal of Neurology
, 226
(9)
pp. 2129-2136.
10.1007/s00415-019-09389-8.
|
|
Olsson, B;
Portelius, E;
Cullen, NC;
Sandelius, Å;
Zetterberg, H;
Andreasson, U;
Höglund, K;
... Blennow, K; + view all
(2019)
Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders.
JAMA Neurology
, 76
(3)
pp. 318-325.
10.1001/jamaneurol.2018.3746.
|
|
Olsson, M;
Ärlig, J;
Hedner, J;
Blennow, K;
Zetterberg, H;
(2019)
Repeated lumbar punctures within 3 days may affect CSF biomarker levels.
Fluids Barriers CNS
, 16
, Article 37. 10.1186/s12987-019-0157-2.
|
|
|
Olsson, M;
Ärlig, J;
Hedner, J;
Blennow, K;
Zetterberg, H;
(2019)
Sleep deprivation and plasma biomarkers for Alzheimer's disease.
[Letter].
Sleep Medicine
, 57
pp. 92-93.
10.1016/j.sleep.2018.12.029.
|
|
Onatsu, J;
Vanninen, R;
Jäkälä, P;
Mustonen, P;
Pulkki, K;
Korhonen, M;
Hedman, M;
... Taina, M; + view all
(2019)
Serum Neurofilament Light Chain Concentration Correlates with Infarct Volume but Not Prognosis in Acute Ischemic Stroke.
Journal of Stroke and Cerebrovascular Diseases
, 28
(8)
pp. 2242-2249.
10.1016/j.jstrokecerebrovasdis.2019.05.008.
|
|
Osborn, KE;
Alverio, JM;
Dumitrescu, L;
Pechman, KR;
Alzheimer’s Disease Neuroimaging Initiative, .;
Gifford, KA;
Hohman, TJ;
... Jefferson, AL; + view all
(2019)
Adverse Vascular Risk Relates to Cerebrospinal Fluid Biomarker Evidence of Axonal Injury in the Presence of Alzheimer's Disease Pathology.
Journal of Alzheimer's Disease
10.3233/JAD-190077.
(In press).
|
|
|
Osborn, KE;
Khan, OA;
Kresge, HA;
Bown, CW;
Liu, D;
Moore, EE;
Gifford, KA;
... Jefferson, AL; + view all
(2019)
Cerebrospinal fluid and plasma neurofilament light relate to abnormal cognition.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 700-709.
10.1016/j.dadm.2019.08.008.
|
|
|
Palmqvist, S;
Insel, PS;
Stomrud, E;
Janelidze, S;
Zetterberg, H;
Brix, B;
Eichenlaub, U;
... Hansson, O; + view all
(2019)
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
EMBO Molecular Medicine
, Article e11170. 10.15252/emmm.201911170.
(In press).
|
|
|
Palmqvist, S;
Insel, PS;
Zetterberg, H;
Blennow, K;
Brix, B;
Stomrud, E;
The Alzheimer's Disease Neuroimaging Initiative, ADNI;
... Hansson, O; + view all
(2019)
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
Alzheimer's & Dementia
, 15
(2)
pp. 194-204.
10.1016/j.jalz.2018.08.014.
|
|
|
Palmqvist, S;
Janelidze, S;
Stomrud, E;
Zetterberg, H;
Karl, J;
Zink, K;
Bittner, T;
... Hansson, O; + view all
(2019)
Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related β-Amyloid Status.
JAMA Neurology
, 76
(9)
pp. 1060-1069.
10.1001/jamaneurol.2019.1632.
|
|
|
Pan, X;
Cunningham, EL;
Passmore, AP;
McGuinness, B;
McAuley, DF;
Beverland, D;
O'Brien, S;
... Green, BD; + view all
(2019)
Cerebrospinal Fluid Spermidine, Glutamine and Putrescine Predict Postoperative Delirium Following Elective Orthopaedic Surgery.
Scientific Reports
, 9
(1)
, Article 4191. 10.1038/s41598-019-40544-3.
|
|
|
Paterson, RW;
Gabelle, A;
Lucey, BP;
Barthélemy, NR;
Leckey, CA;
Hirtz, C;
Lehmann, S;
... Bateman, RJ; + view all
(2019)
SILK studies - capturing the turnover of proteins linked to neurodegenerative diseases.
Nature Reviews Neurology
, 15
pp. 419-427.
10.1038/s41582-019-0222-0.
|
|
Pedersen, A;
Stanne, TM;
Nilsson, S;
Klasson, S;
Rosengren, L;
Holmegaard, L;
Jood, K;
... Jern, C; + view all
(2019)
Circulating neurofilament light in ischemic stroke: temporal profile and outcome prediction.
Journal of Neurology
10.1007/s00415-019-09477-9.
(In press).
|
|
|
Pillai, A;
Bruno, D;
Nierenberg, J;
Pandya, C;
Feng, T;
Reichert, C;
Ramos-Cejudo, J;
... Pomara, N; + view all
(2019)
Complement component 3 levels in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder.
Biomarkers in Neuropsychiatry
, 1
, Article 100007. 10.1016/j.bionps.2019.100007.
|
|
|
Posti, JP;
Takala, RS;
Lagerstedt, L;
Dickens, AM;
Hossain, I;
Mohammadian, M;
Ala-Seppälä, HM;
... Blennow, K; + view all
(2019)
Correlation of Blood Biomarkers and Biomarker Panels with Traumatic Findings on Computed Tomography after Traumatic Brain Injury.
Journal of Neurotrauma
, 36
(14)
pp. 2178-2189.
10.1089/neu.2018.6254.
|
|
Pujol-Calderón, F;
Portelius, E;
Zetterberg, H;
Blennow, K;
Rosengren, LE;
Höglund, K;
(2019)
Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
Neuroscience Letters
, 698
pp. 58-63.
10.1016/j.neulet.2018.12.042.
|
|
Racine, AM;
Merluzzi, AP;
Adluru, N;
Norton, D;
Koscik, RL;
Clark, LR;
Berman, SE;
... Johnson, SC; + view all
(2019)
Association of longitudinal white matter degeneration and cerebrospinal fluid biomarkers of neurodegeneration, inflammation and Alzheimer's disease in late-middle-aged adults.
Brain Imaging and Behavior
, 13
(1)
pp. 41-52.
10.1007/s11682-017-9732-9.
|
|
|
Ribbe, M;
Kern, S;
Börjesson Hansson, A;
Östling, S;
Zetterberg, H;
Blennow, K;
Skoog, I;
(2019)
Amyloid β42 and Total Tau Levels in Cerebrospinal Fluid Associate with Survival in an 85-Year-Old Population-Based Cohort Followed until Death.
Dementia and Geriatric Cognitive Disorders
, 47
(1-2)
pp. 114-123.
10.1159/000499066.
|
|
Rittman, T;
Borchert, R;
Jones, S;
van Swieten, J;
Borroni, B;
Galimberti, D;
Masellis, M;
... Genetic Frontotemporal Dementia Initiative (GENFI); + view all
(2019)
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia.
Neurobiology of Aging
, 77
pp. 169-177.
10.1016/j.neurobiolaging.2018.12.009.
|
|
|
Rosén, A;
Oscarsson, N;
Kvarnström, A;
Gennser, M;
Sandström, G;
Blennow, K;
Seeman-Lodding, H;
(2019)
Serum tau concentration after diving - an observational pilot study.
Diving and Hyperbaric Medicine
, 49
(2)
pp. 88-95.
10.28920/dhm49.2.88-95.
|
|
Rubin, LH;
Tierney, R;
Kawata, K;
Wesley, L;
Lee, JH;
Blennow, K;
Zetterberg, H;
(2019)
NFL blood levels are moderated by subconcussive impacts in a cohort of college football players.
Brain Injury
, 33
(4)
pp. 456-462.
10.1080/02699052.2019.1565895.
|
|
Rydén, L;
Zettergren, A;
Seidu, NM;
Guo, X;
Kern, S;
Blennow, K;
Zetterberg, H;
... Skoog, I; + view all
(2019)
Atrial fibrillation increases the risk of dementia among older adults even in the absence of stroke.
Journal of Internal Medicine
, 286
(1)
pp. 101-110.
10.1111/joim.12902.
|
|
Saller, T;
Petzold, A;
Zetterberg, H;
Kuhle, J;
Chappell, D;
von Dossow, V;
Klawitter, F;
... Ehler, J; + view all
(2019)
A case series on the value of tau and neurofilament protein levels to predict and detect delirium in cardiac surgery patients.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czech Rep.
, 163
(3)
pp. 241-246.
10.5507/bp.2019.043.
|
|
|
Salvadó, G;
Molinuevo, JL;
Brugulat-Serrat, A;
Falcon, C;
Grau-Rivera, O;
Suárez-Calvet, M;
Pavia, J;
... Alzheimer’s Disease Neuroimaging Initiative, for the ALFA Study, .; + view all
(2019)
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers.
Alzheimer's Research and Therapy
, 11
, Article 27. 10.1186/s13195-019-0478-z.
|
|
|
Sandelius, A;
Portelius, E;
Kallen, A;
Zetterberg, H;
Rot, U;
Olsson, B;
Toledo, JB;
... Blennow, K; + view all
(2019)
Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology.
Alzheimer's & Dementia
, 15
(1)
pp. 55-64.
10.1016/j.jalz.2018.08.006.
|
|
|
Sandelius, Å;
Sandgren, S;
Axelsson, M;
Malmeström, C;
Novakova, L;
Kostanjevecki, V;
Vandijck, M;
... Lycke, J; + view all
(2019)
Cerebrospinal fluid growth-associated protein 43 in multiple sclerosis.
Scientific Reports
, 9
, Article 17309. 10.1038/s41598-019-54032-1.
|
|
|
Sanfilippo, C;
Castrogiovanni, P;
Imbesi, R;
Kazakowa, M;
Musumeci, G;
Blennow, K;
Zetterberg, H;
(2019)
Sex Difference in CHI3L1 Expression Levels in Human Brain Aging and in Alzheimer's Disease.
Brain Research
, 1720
, Article 146305. 10.1016/j.brainres.2019.146305.
|
|
Santillo, AF;
Lundgren, S;
Xu, C;
Orhan, F;
Fatouros-Bergman, H;
Blennow, K;
Zetterberg, H;
... Engberg, G; + view all
(2019)
Neurogranin as a potential synaptic marker in the cerebrospinal fluid of patients with a first episode psychosis.
Schizophrenia Research
, 208
pp. 490-492.
10.1016/j.schres.2019.01.010.
|
|
Schiza, N;
Georgiou, E;
Kagiava, A;
Médard, J-J;
Richter, J;
Tryfonos, C;
Sargiannidou, I;
... Kleopa, KA; + view all
(2019)
Gene replacement therapy in a model of Charcot-Marie-Tooth 4C neuropathy.
Brain
, Article awz064. 10.1093/brain/awz064.
(In press).
|
|
|
Shi, L;
Westwood, S;
Baird, AL;
Winchester, L;
Dobricic, V;
Kilpert, F;
Hong, S;
... Nevado-Holgado, AJ; + view all
(2019)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
Alzheimer's and Dementia
10.1016/j.jalz.2019.06.4951.
(In press).
|
|
|
Simrén, J;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
(2019)
An update on fluid biomarkers for neurodegenerative diseases: recent success and challenges ahead.
Current Opinion in Neurobiology
, 61
pp. 29-39.
10.1016/j.conb.2019.11.019.
|
|
Sjödin, S;
Brinkmalm, G;
Öhrfelt, A;
Parnetti, L;
Paciotti, S;
Hansson, O;
Hardy, J;
... Brinkmalm, A; + view all
(2019)
Endo-lysosomal proteins and ubiquitin CSF concentrations in Alzheimer's and Parkinson's disease.
Alzheimer's Research & Therapy
, 11
, Article 82. 10.1186/s13195-019-0533-9.
|
|
Sjögren, M;
Soylu-Kucharz, R;
Dandunna, U;
Stan, TL;
Cavalera, M;
Sandelius, Å;
Zetterberg, H;
(2019)
Leptin deficiency reverses high metabolic state and weight loss without affecting central pathology in the R6/2 mouse model of Huntington's disease.
Neurobiology of Disease
, 132
, Article 104560. 10.1016/j.nbd.2019.104560.
|
|
Sjörsa Dhlman, A;
Blennow, K;
Zetterberg, H;
Glise, K;
Jonsdottir, IH;
(2019)
Growth factors and neurotrophins in patients with stress-related exhaustion disorder.
Psychoneuroendocrinology
, 109
, Article 104415. 10.1016/j.psyneuen.2019.104415.
|
|
Skillback, T;
Kornhuber, J;
Blennow, K;
Zetterberg, H;
Lewczuk, P;
(2019)
Erlangen Score Predicts Cognitive and Neuroimaging Progression in Mild Cognitive Impairment Stage of Alzheimer's Disease.
Journal of Alzheimer's Disease
, 69
(2)
pp. 551-559.
10.3233/JAD-190067.
|
|
|
Staffaroni, AM;
Kramer, AO;
Casey, M;
Kang, H;
Rojas, JC;
Orrú, CD;
Caughey, B;
... Geschwind, MD; + view all
(2019)
Association of Blood and Cerebrospinal Fluid Tau Level and Other Biomarkers With Survival Time in Sporadic Creutzfeldt-Jakob Disease.
JAMA Neurology
10.1001/jamaneurol.2019.1071.
(In press).
|
|
Stamate, D;
Kim, M;
Proitsi, P;
Westwood, S;
Baird, A;
Nevado-Holgado, A;
Hye, A;
... Legido-Quigley, C; + view all
(2019)
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
Alzheimer's & Dementia: Translational Research & Clinical Interventions
, 5
pp. 933-938.
10.1016/j.trci.2019.11.001.
|
|
|
Startin, CM;
Ashton, NJ;
Hamburg, S;
Hithersay, R;
Wiseman, FK;
Mok, KY;
Hardy, J;
... Strydom, A; + view all
(2019)
Plasma biomarkers for amyloid, tau, and cytokines in Down syndrome and sporadic Alzheimer's disease.
Alzheimer's Research & Therapy
, 11
, Article 26. 10.1186/s13195-019-0477-0.
|
|
|
Sudre, CH;
Bocchetta, M;
Heller, C;
Convery, R;
Neason, M;
Moore, KM;
Cash, DM;
... Rohrer, JD; + view all
(2019)
White matter hyperintensities in progranulin-associated frontotemporal dementia – a longitudinal GENFI study.
NeuroImage: Clinical
, Article 102077. 10.1016/j.nicl.2019.102077.
(In press).
|
|
|
Thelin, EP;
Al Nimer, F;
Frostell, A;
Zetterberg, H;
Blennow, K;
Nyström, H;
Svensson, M;
... Nelson, DW; + view all
(2019)
A serum protein biomarker panel improves outcome prediction in human traumatic brain injury.
Journal of Neurotrauma
, 23
(20)
2850-2862..
10.1089/neu.2019.6375.
|
|
Timmers, M;
Tesseur, I;
Bogert, J;
Zetterberg, H;
Blennow, K;
Börjesson-Hanson, A;
Baquero, M;
... Streffer, JR; + view all
(2019)
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease.
Neurobiology of Aging
, 79
pp. 131-141.
10.1016/j.neurobiolaging.2019.03.016.
|
|
Toschi, N;
Lista, S;
Baldacci, F;
Cavedo, E;
Zetterberg, H;
Blennow, K;
Kilimann, I;
... Younsi, N; + view all
(2019)
Biomarker-guided clustering of Alzheimer's disease clinical syndromes.
Neurobiology of Aging
, 83
pp. 42-53.
10.1016/j.neurobiolaging.2019.08.032.
|
|
|
Underwood, J;
De Francesco, D;
Cole, JH;
Caan, MWA;
van Zoest, RA;
Schmand, BA;
Sharp, DJ;
... COmorBidity in Relation to AIDS (COBRA) Collaboration and the Ph, .; + view all
(2019)
Validation of a Novel Multivariate Method of Defining HIV-Associated Cognitive Impairment.
Open Forum Infectious Diseases
, 6
(6)
10.1093/ofid/ofz198.
|
|
|
Vallabh, SM;
Nobuhara, CK;
Llorens, F;
Zerr, I;
Parchi, P;
Capellari, S;
Kuhn, E;
... Schreiber, SL; + view all
(2019)
Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development.
Proceedings of the National Academy of Sciences
, 116
(16)
pp. 7793-7798.
10.1073/pnas.1901947116.
|
|
|
van der Lee, SJ;
Conway, OJ;
Jansen, I;
Carrasquillo, MM;
Kleineidam, L;
van den Akker, E;
Hernández, I;
... Holstege, H; + view all
(2019)
A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
Acta Neuropathologica
, 138
(2)
pp. 237-250.
10.1007/s00401-019-02026-8.
|
|
Vergallo, A;
Megret, L;
Lista, S;
Cavedo, E;
Zetterberg, H;
Blennow, K;
Vanmechelen, E;
... Younesi, E; + view all
(2019)
Plasma amyloid β 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease.
Alzheimer's & Dementia
, 15
(6)
pp. 764-775.
10.1016/j.jalz.2019.03.009.
|
|
Vermunt, L;
Sikkes, SAM;
van den Hout, A;
Handels, R;
Bos, I;
van der Flier, WM;
Kern, S;
... ICTUS/DSA study groups, .; + view all
(2019)
Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype.
Alzheimer's and Dementia
, 15
(7)
pp. 888-898.
10.1016/j.jalz.2019.04.001.
|
|
Voevodskaya, O;
Poulakis, K;
Sundgren, P;
van Westen, D;
Palmqvist, S;
Wahlund, L-O;
Stomrud, E;
... Zetterberg, H; + view all
(2019)
Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.
Neurology
, 92
(5)
E395-E405.
10.1212/WNL.0000000000006852.
|
|
|
Vogels, T;
Leuzy, A;
Cicognola, C;
Ashton, NJ;
Smolek, T;
Novak, M;
Blennow, K;
... Schöll, M; + view all
(2019)
Propagation of Tau Pathology: Integrating Insights From Postmortem and In Vivo Studies.
Biological Psychiatry
10.1016/j.biopsych.2019.09.019.
(In press).
|
|
|
Wehrli, PM;
Michno, W;
Blennow, K;
Zetterberg, H;
Hanrieder, J;
(2019)
Chemometric Strategies for Sensitive Annotation and Validation of Anatomical Regions of Interest in Complex Imaging Mass Spectrometry Data.
Journal of The American Society for Mass Spectrometry
, 30
pp. 2278-2288.
10.1007/s13361-019-02327-y.
|
|
|
Weiffert, T;
Meisl, G;
Flagmeier, P;
De, S;
Dunning, CJR;
Frohm, B;
Zetterberg, H;
... Linse, S; + view all
(2019)
Increased Secondary Nucleation Underlies Accelerated Aggregation of the Four-Residue N-Terminally Truncated Aβ42 Species Aβ5-42.
ACS Chemical Neuroscience
, 10
(5)
pp. 2374-2384.
10.1021/acschemneuro.8b00676.
|
|
Weston, PSJ;
Poole, T;
O'Connor, A;
Heslegrave, A;
Ryan, NS;
Liang, Y;
Druyeh, R;
... Fox, NC; + view all
(2019)
Longitudinal measurement of serum neurofilament light in presymptomatic familial Alzheimer's disease.
Alzheimer's Research & Therapy
, 11
, Article 19. 10.1186/s13195-019-0472-5.
|
|
|
Wharton, W;
Kollhoff, AL;
Gangishetti, U;
Verble, DD;
Upadhya, S;
Zetterberg, H;
Kumar, V;
... Hu, WT; + view all
(2019)
Interleukin 9 alterations linked to alzheimer disease in african americans.
Annals of Neurology
, 86
(3)
pp. 407-418.
10.1002/ana.25543.
|
|
Wilke, C;
Pujol-Calderón, F;
Barro, C;
Stransky, E;
Blennow, K;
Michalak, Z;
Deuschle, C;
... Synofzik, M; + view all
(2019)
Correlations between serum and CSF pNfH levels in ALS, FTD and controls: a comparison of three analytical approaches.
Clinical Chemistry and Laboratory Medicine
, 57
(10)
pp. 1556-1564.
10.1515/cclm-2019-0015.
|
|
Winblad, B;
Ankarcrona, M;
Johansson, G;
Novak, P;
Peter Thelin, E;
Zetterberg, H;
Blennow, K;
(2019)
Head trauma in sports and risk for dementia.
Journal of Internal Medicine
, 285
(6)
pp. 591-593.
10.1111/joim.12918.
|
|
Wu, J;
Hasselgren, C;
Zettergren, A;
Zetterberg, H;
Blennow, K;
Skoog, I;
Halleröd, B;
(2019)
The impact of social networks and APOE ε4 on dementia among older adults: tests of possible interactions.
Aging and Mental Health
10.1080/13607863.2018.1531368.
|
|
Yilmaz, A;
Fuchs, D;
Price, RW;
Spudich, S;
Blennow, K;
Zetterberg, H;
Gisslén, M;
(2019)
Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.
Current HIV/AIDS Reports
10.1007/s11904-019-00420-1.
(In press).
|
|
|
Yilmaz, A;
Mellgren, Å;
Fuchs, D;
Nilsson, S;
Blennow, K;
Zetterberg, H;
Gisslén, M;
(2019)
Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1 infection.
Infectious Diseases
, 51
(11-12)
pp. 838-846.
10.1080/23744235.2019.1670352.
|
|
Zetterberg, H;
(2019)
Blood-based biomarkers for Alzheimer's disease—An update.
Journal of Neuroscience Methods
, 319
pp. 2-6.
10.1016/j.jneumeth.2018.10.025.
|
|
Zetterberg, H;
Apostolova, LG;
Snyder, PJ;
(2019)
Blood-based biomarkers for Alzheimer's disease and related dementias: Keys to success and things to consider.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 11
pp. 784-786.
10.1016/j.dadm.2019.10.001.
(In press).
|
|
|
Zetterberg, H;
Bähr, M;
(2019)
Disease signatures: Biomarkers/indicators of neurodegeneration.
Molecular and Cellular Neuroscience
, 97
pp. 1-2.
10.1016/j.mcn.2019.05.004.
|
|
Zetterberg, H;
Bozzetta, E;
Favole, A;
Corona, C;
Cavarretta, MC;
Ingravalle, F;
Blennow, K;
... Meloni, D; + view all
(2019)
Neurofilaments in blood is a new promising preclinical biomarker for the screening of natural scrapie in sheep.
PLOS ONE
, 14
(12)
, Article e0226697. 10.1371/journal.pone.0226697.
|
|
|
Zetterberg, H;
Burnham, SC;
(2019)
Blood-based molecular biomarkers for Alzheimer's disease.
Molecular Brain
, 12
, Article 26. 10.1186/s13041-019-0448-1.
|
|
|
Zetterberg, H;
Compta, Y;
(2019)
A tear fluid proteome of Parkinson's disease.
Parkinsonism & Related Disorders
, 63
pp. 1-2.
10.1016/j.parkreldis.2019.07.028.
|
|
Zetterberg, H;
Schott, JM;
(2019)
Biomarkers for Alzheimer's disease beyond amyloid and tau.
Nature Medicine
, 25
(2)
pp. 201-203.
10.1038/s41591-019-0348-z.
|
|
Zetterberg, H;
Svenningsson, A;
(2019)
Serum neurofilament light and prediction of multiple sclerosis in clinically isolated syndrome.
Neurology
, 92
(7)
pp. 313-314.
10.1212/WNL.0000000000006906.
|
|
Zetterberg, H;
Van Swieten, JC;
Boxer, AL;
Rohrer, JD;
(2019)
Fluid biomarkers for frontotemporal dementias.
Neuropathology and Applied Neurobiology
, 45
(1)
pp. 81-87.
10.1111/nan.12530.
|
|
Zetterberg, H;
Winblad, B;
Bernick, C;
Yaffe, K;
Majdan, M;
Johansson, G;
Newcombe, V;
... Blennow, K; + view all
(2019)
Head trauma in sports – clinical characteristics, epidemiology and biomarkers.
Journal of Internal Medicine
, 285
(6)
pp. 624-634.
10.1111/joim.12863.
|
|
Zettergren, A;
Hoglund, K;
Kern, S;
Thorvaldsson, V;
Skoog, J;
Hansson, O;
Andreasen, N;
... Zetterberg, H; + view all
(2019)
Association of IL1RAP-related genetic variation with cerebrospinal fluid concentration of Alzheimer-associated tau protein.
Scientific Reports
, 9
(2460)
10.1038/s41598-018-36650-3.
|
|
|
Zhong, X;
Wang, J;
Carlsson, C;
Okonkwo, O;
Zetterberg, H;
Li, L;
(2019)
A Strategy for Discovery and Verification of Candidate Biomarkers in Cerebrospinal Fluid of Preclinical Alzheimer's Disease.
Frontiers in Molecular Neuroscience
, 11
, Article 483. 10.3389/fnmol.2018.00483.
|
|
|
Zhong, X;
Yu, Q;
Ma, F;
Frost, DC;
Lu, L;
Chen, Z;
Zetterberg, H;
... Li, L; + view all
(2019)
HOTMAQ: A Multiplexed Absolute Quantification Method for Targeted Proteomics.
Analytical Chemistry
, 91
(3)
pp. 2112-2119.
10.1021/acs.analchem.8b04580.
|
2018
|
Alosco, ML;
Tripodis, Y;
Fritts, NG;
Heslegrave, A;
Baugh, CM;
Conneely, S;
Mariani, M;
... Stern, RA; + view all
(2018)
Cerebrospinal fluid tau, A beta, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration.
Alzheimer's & Dementia
, 14
(9)
pp. 1159-1170.
10.1016/j.jalz.2018.05.004.
|
|
Anderson, AM;
Easley, KA;
Kasher, N;
Franklin, D;
Heaton, RK;
Zetterberg, H;
Blennow, K;
... Letendre, SL; + view all
(2018)
Neurofilament light chain in blood is negatively associated with neuropsychological performance in HIV-infected adults and declines with initiation of antiretroviral therapy.
Journal of NeuroVirology
, 24
(6)
pp. 695-701.
10.1007/s13365-018-0664-y.
|
|
Andersson-Hall, U;
Svedin, P;
Andreasson, U;
Gren, M;
Ingemansson, A;
Zetterberg, H;
Blennow, K;
... Holmang, A; + view all
(2018)
Central and peripheral leptin and agouti-related protein during and after pregnancy in relation to weight change.
Clinical Endocrinology
, 88
(2)
pp. 263-271.
10.1111/cen.13520.
|
|
Andreasson, U;
Kuhlmann, J;
Pannee, J;
Umek, RM;
Stoops, E;
Vanderstichele, H;
Matzen, A;
... Blennow, K; + view all
(2018)
Commutability of the certified reference materials for the standardization of β-amyloid 1-42 assay in human cerebrospinal fluid: lessons for tau and β-amyloid 1-40 measurements.
Clinical Chemistry and Laboratory Medicine (CCLM)
10.1515/cclm-2018-0147.
(In press).
|
|
Arnoldussen, IAC;
Sundh, V;
Backman, K;
Kern, S;
Ostling, S;
Blennow, K;
Zetterberg, H;
... Gustafson, DR; + view all
(2018)
A 10-Year Follow-Up of Adiposity and Dementia in Swedish Adults Aged 70 Years and Older.
Journal of Alzheimer's Disease
, 63
(4)
pp. 1325-1335.
10.3233/JAD-180099.
|
|
|
Ashton, NJ;
Ide, M;
Scholl, M;
Blennow, K;
Lovestone, S;
Hye, A;
Zetterberg, H;
(2018)
No association of salivary total tau concentration with Alzheimer's disease.
Neurobiology of Aging
, 70
pp. 125-127.
10.1016/j.neurobiolaging.2018.06.014.
|
|
Ashton, NJ;
Schoell, M;
Heurling, K;
Gkanatsiou, E;
Portelius, E;
Hoeglund, K;
Brinkmalm, G;
... Zetterberg, H; + view all
(2018)
Update on biomarkers for amyloid pathology in Alzheimer's disease.
Biomarkers in Medicine
, 12
(7)
pp. 799-812.
10.2217/bmm-2017-0433.
|
|
Axelsson, M;
Sjogren, M;
Andersen, O;
Blennow, K;
Zetterberg, H;
Lycke, J;
(2018)
Neurofilament light protein levels in cerebrospinal fluid predict long-term disability of Guillain-Barre syndrome: A pilot study.
Acta Neurologica Scandinavica
, 138
(2)
pp. 143-150.
10.1111/ane.12927.
|
|
Backstrom, D;
Domellof, ME;
Granasen, G;
Linder, J;
Mayans, S;
Elgh, E;
Zetterberg, H;
... Forsgren, L; + view all
(2018)
Polymorphisms in dopamine-associated genes and cognitive decline in Parkinson's disease.
Acta Neurologica Scandinavica
, 137
(1)
pp. 91-98.
10.1111/ane.12812.
|
|
|
Bäckström, D;
Granåsen, G;
Domellöf, ME;
Linder, J;
Jakobson Mo, S;
Riklund, K;
Zetterberg, H;
... Forsgren, L; + view all
(2018)
Early predictors of mortality in parkinsonism and Parkinson disease: A population-based study.
Neurology
, 91
(22)
e2045-e2056.
10.1212/WNL.0000000000006576.
|
|
|
Becker, B;
Nazir, FH;
Brinkmalm, G;
Camporesi, E;
Kvartsberg, H;
Portelius, E;
Bostrom, M;
... Blennow, K; + view all
(2018)
Alzheimer-associated cerebrospinal fluid fragments of neurogranin are generated by Calpain-1 and prolyl endopeptidase.
Molecular Neurodegeneration
, 13
, Article 47. 10.1186/s13024-018-0279-z.
|
|
|
Bergman, J;
Burman, J;
Gilthorpe, JD;
Zetterberg, H;
Jiltsova, E;
Bergenheim, T;
Svenningsson, A;
(2018)
Intrathecal treatment trial of rituximab in progressive MS: An open-label phase 1b study.
Neurology
10.1212/WNL.0000000000006500.
(In press).
|
|
Bergman, L;
Zetterberg, H;
Kaihola, H;
Hagberg, H;
Blennow, K;
Akerud, H;
(2018)
Blood-based cerebral biomarkers in preeclampsia: Plasma concentrations of NfL, tau, S100B and NSE during pregnancy in women who later develop preeclampsia - A nested case control study.
PLoS ONE
, 13
(5)
, Article e0196025. 10.1371/journal.pone.0196025.
|
|
|
Bernick, C;
Zetterberg, H;
Shan, G;
Banks, S;
Blennow, K;
(2018)
Longitudinal performance of plasma neurofilament light and tau in professional fighters: The Professional Fighters Brain Health Study.
Journal of Neurotrauma
, 35
(20)
pp. 2351-2356.
10.1089/neu.2017.5553.
|
|
Bettcher, BM;
Johnson, SC;
Fitch, R;
Casaletto, KB;
Heffernan, KS;
Asthana, S;
Zetterberg, H;
... Kramer, JH; + view all
(2018)
Cerebrospinal Fluid and Plasma Levels of Inflammation Differentially Relate to CNS Markers of Alzheimer's Disease Pathology and Neuronal Damage.
Journal of Alzheimer's Disease
, 62
(1)
pp. 385-397.
10.3233/JAD-170602.
|
|
|
Bjorefeldt, A;
Illes, S;
Zetterberg, H;
Hanse, E;
(2018)
Neuromodulation via the Cerebrospinal Fluid: Insights from Recent in Vitro Studies.
Frontiers in Neural Circuits
, 12
, Article 5. 10.3389/fncir.2018.00005.
|
|
|
Blennow, K;
Zetterberg, H;
(2018)
Biomarkers for Alzheimer's disease: current status and prospects for the future.
Journal of Internal Medicine
10.1111/joim.12816.
(In press).
|
|
Blennow, K;
Zetterberg, H;
(2018)
The Past and the Future of Alzheimer's Disease Fluid Biomarkers.
Journal of Alzheimer's Disease
, 62
(3)
pp. 1125-1140.
10.3233/JAD-170773.
|
|
|
Bos, I;
Vos, S;
Vandenberghe, R;
Scheltens, P;
Engelborghs, S;
Frisoni, G;
Luis Molinuevo, J;
... Visser, PJ; + view all
(2018)
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
Alzheimer's Research & Therapy
, 10
, Article 64. 10.1186/s13195-018-0396-5.
|
 |
|
Brinkmalm, G;
Sjodin, S;
Simonsen, AH;
Hasselbalch, SG;
Zetterberg, H;
Brinkmalm, A;
Blennow, K;
(2018)
A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.
Proteomics Clinical Applications
, 12
(1)
, Article 1700131. 10.1002/prca.201700131.
|
|
|
Byrne, LM;
Brogueira Rodrigues, F;
Johnson, E;
Wijeratne, P;
De Vita, E;
Alexander, D;
Palermo, G;
... Wild, E; + view all
(2018)
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease.
Science Translational Medicine
, 10
(458)
, Article eaat7108. 10.1126/scitranslmed.aat7108.
|
|
Byrne, LM;
Rodrigues, FB;
Johnson, EB;
Da Vita, E;
Blennow, K;
Scahill, RI;
Zetterberg, H;
... Wild, E; + view all
(2018)
Cerebrospinal fluid neurogranin and TREM2 in Huntington’s disease.
Scientific Reports
, Article 4260. 10.1038/s41598-018-21788-x.
|
|
|
Cam, M;
Durieu, E;
Bodin, M;
Manousopoulou, A;
Koslowski, S;
Vasylieva, N;
Barnych, B;
... Meijer, L; + view all
(2018)
Induction of Amyloid-beta(42) Production by Fipronil and Other Pyrazole Insecticides.
Journal of Alzheimer's Disease
, 62
(4)
pp. 1663-1681.
10.3233/JAD-170875.
|
|
|
Casaletto, KB;
Elahi, FM;
Fitch, R;
Walters, S;
Fox, E;
Staffaroni, AM;
Bettcher, B;
... Kramer, JH; + view all
(2018)
A comparison of biofluid cytokine markers across platform technologies: Correspondence or divergence?
Cytokine
, 111
pp. 481-489.
10.1016/j.cyto.2018.05.032.
|
|
Chatterjee, P;
Goozee, K;
Sohrabi, HR;
Shen, K;
Shah, T;
Asih, PR;
Dave, P;
... Martins, RN; + view all
(2018)
Association of Plasma Neurofilament Light Chain with Neocortical Amyloid-beta Load and Cognitive Performance in Cognitively Normal Elderly Participants.
Journal of Alzheimer's Disease
, 63
(2)
pp. 479-487.
10.3233/JAD-180025.
|
|
Chen-Plotkin, AS;
Zetterberg, H;
(2018)
Updating Our Definitions of Parkinson's Disease for a Molecular Age.
Journal of Parkinson's Disease
, 8
(s1)
S53-S57.
10.3233/JPD-181487.
|
|
|
Clark, LR;
Berman, SE;
Norton, D;
Koscik, RL;
Jonaitis, E;
Blennow, K;
Bendlin, BB;
... Carlsson, CM; + view all
(2018)
Age-accelerated cognitive decline in asymptomatic adults with CSF beta-amyloid.
Neurology
, 90
(15)
E1306-E1315.
10.1212/WNL.0000000000005291.
|
|
Danielson, M;
Reinsfelt, B;
Westerlind, A;
Zetterberg, H;
Blennow, K;
Ricksten, S-E;
(2018)
Effects of methylprednisolone on blood-brain barrier and cerebral inflammation in cardiac surgery—a randomized trial.
Journal of Neuroinflammation
, 15
(1)
, Article 283. 10.1186/s12974-018-1318-y.
|
|
de Leon, MJ;
Pirraglia, E;
Osorio, RS;
Glodzik, L;
Saint-Louis, L;
Kim, H-J;
Fortea, J;
... Blennow, K; + view all
(2018)
The nonlinear relationship between cerebrospinal fluid A beta(42) and tau in preclinical Alzheimer's disease.
PLoS One
, 13
(2)
, Article e0191240. 10.1371/journal.pone.0191240.
|
|
|
Delsing, L;
Dönnes, P;
Sánchez, J;
Clausen, M;
Voulgaris, D;
Falk, A;
Herland, A;
... Synnergren, J; + view all
(2018)
Barrier properties and transcriptome expression in human iPSC-derived models of the blood-brain barrier.
Stem Cells
10.1002/stem.2908.
|
|
|
Deming, Y;
Dumitrescu, L;
Barnes, LL;
Thambisetty, M;
Kunkle, B;
Gifford, KA;
Bush, WS;
... Hohman, TJ; + view all
(2018)
Sex-specific genetic predictors of Alzheimer's disease biomarkers.
Acta Neuropathologica
10.1007/s00401-018-1881-4.
(In press).
|
|
|
Donker Kaat, L;
Meeter, LH;
Chiu, WZ;
Melhem, S;
Boon, AJW;
Blennow, K;
Zetterberg, H;
(2018)
Serum neurofilament light chain in progressive supranuclear palsy.
Parkinsonism & Related Disorders
, 56
pp. 98-101.
10.1016/j.parkreldis.2018.06.018.
|
|
Duits, FH;
Brinkmalm, G;
Teunissen, CE;
Brinkmalm, A;
Scheltens, P;
Van der Flier, WM;
Zetterberg, H;
(2018)
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer's disease.
Alzheimer's Research & Therapy
, 10
, Article 5. 10.1186/s13195-017-0335-x.
|
|
|
Eriksson, Y;
Boström, M;
Sandelius, A;
Blennow, K;
Zetterberg, H;
Kuhn, G;
Kalm, M;
(2018)
The anti-asthmatic drug, montelukast, modifies the neurogenic potential in the young healthy and irradiated brain.
Cell Death & Disease
, 9
, Article 775. 10.1038/s41419-018-0783-7.
|
|
|
Evered, L;
Silbert, B;
Scott, DA;
Zetterberg, H;
Blennow, K;
(2018)
Association of Changes in Plasma Neurofilament Light and Tau Levels With Anesthesia and Surgery Results From the CAPACITY and ARCADIAN Studies.
JAMA Neurology
, 75
(5)
pp. 542-547.
10.1001/jamaneurol.2017.4913.
|
|
Fernström, E;
Minta, K;
Andreasson, U;
Sandelius, Å;
Wasling, P;
Brinkmalm, A;
Höglund, K;
... Kalm, M; + view all
(2018)
Cerebrospinal fluid markers of extracellular matrix remodelling, synaptic plasticity and neuroinflammation before and after cranial radiotherapy.
Journal of Internal Medicine
10.1111/joim.12763.
(In press).
|
|
|
Fjell, AM;
Idland, A-V;
Sala-Llonch, R;
Watne, LO;
Borza, T;
Braekhus, A;
Lona, T;
... Walhovd, KB; + view all
(2018)
Neuroinflammation and Tau Interact with Amyloid in Predicting Sleep Problems in Aging Independently of Atrophy.
Cerebral Cortex
, 28
(8)
pp. 2775-2785.
10.1093/cercor/bhx157.
|
|
Foiani, MS;
Woollacott, IO;
Heller, C;
Bocchetta, M;
Heslegrave, A;
Dick, KM;
Russell, LL;
... Rohrer, JD; + view all
(2018)
Plasma tau is increased in frontotemporal dementia.
Journal of Neurology, Neurosurgery and Psychiatry
, 89
(8)
pp. 804-807.
10.1136/jnnp-2017-317260.
|
|
|
Forland, MG;
Ohrfelt, A;
Dalen, I;
Tysnes, O-B;
Blennow, K;
Zetterberg, H;
Pedersen, KF;
... Lange, J; + view all
(2018)
Evolution of cerebrospinal fluid total α-synuclein in Parkinson's disease.
Parkinsonism & Related Disorders
, 49
pp. 4-8.
10.1016/j.parkreldis.2018.01.018.
|
|
Gaetani, L;
Hoglund, K;
Parnetti, L;
Pujol-Calderon, F;
Becker, B;
Eusebi, P;
Sarchielli, P;
... Blennow, K; + view all
(2018)
A new enzyme-linked immunosorbent assay for neurofilament light in cerebrospinal fluid: analytical validation and clinical evaluation.
Alzheimer's Research & Therapy
, 10
, Article 8. 10.1186/s13195-018-0339-1.
|
|
|
Garcia-Reitboeck, P;
Phillips, A;
Piers, TM;
Villegas-Llerena, C;
Butler, M;
Mallach, A;
Rodrigues, C;
... Pocock, JM; + view all
(2018)
Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis.
Cell Reports
, 24
(9)
pp. 2300-2311.
10.1016/j.celrep.2018.07.094.
|
|
Gifford, KA;
Liu, D;
Neal, JE;
Acosta, LMY;
Bell, SP;
Wiggins, ME;
Wisniewski, KM;
... Jefferson, AL; + view all
(2018)
Validity and Normative Data for the Biber Figure Learning Test: A Visual Supraspan Memory Measure.
Assessment
10.1177/1073191118773870.
|
|
|
Gifford, KA;
Liu, D;
Neal, JE;
Babicz, MA;
Thompson, JL;
Walljasper, LE;
Wiggins, ME;
... Jefferson, AL; + view all
(2018)
The 12-Word Philadelphia Verbal Learning Test Performances in Older Adults: Brain MRI and Cerebrospinal Fluid Correlates and Regression-Based Normative Data.
Dementia and Geriatric Cognitive Disorders Extra
, 8
pp. 476-491.
10.1159/000494209.
|
|
|
Guerreiro, R;
Orme, T;
Neto, JL;
Bras, J;
International DLB Genetics Consortium, .;
(2018)
LRP10 in alpha-synucleinopathies.
Lancet Neurology
, 17
(12)
pp. 1032-1033.
10.1016/S1474-4422(18)30399-5.
|
|
Guerreiro, R;
Ross, OA;
Kun-Rodrigues, C;
Hernandez, DG;
Orme, T;
Eicher, JD;
Shepherd, CE;
... Bras, J; + view all
(2018)
Investigating the genetic architecture of dementia with Lewy bodies: a two-stage genome-wide association study.
The Lancet Neurology
, 17
(1)
pp. 64-74.
10.1016/S1474-4422(17)30400-3.
|
|
Håkansson, I;
Tisell, A;
Cassel, P;
Blennow, K;
Zetterberg, H;
Lundberg, P;
Dahle, C;
... Ernerudh, J; + view all
(2018)
Neurofilament levels, disease activity and brain volume during follow-up in multiple sclerosis.
Journal of Neuroinflammation
, 15
(1)
, Article 209. 10.1186/s12974-018-1249-7.
|
|
Halaas, NB;
Blennow, K;
Idland, A-V;
Wyller, TB;
Ræder, J;
Frihagen, F;
Staff, AC;
... Watne, LO; + view all
(2018)
Neurofilament Light in Serum and Cerebrospinal Fluid of Hip Fracture Patients with Delirium.
Dementia and Geriatric Cognitive Disorders
, 46
(5-6)
pp. 346-357.
10.1159/000494754.
|
|
Halawa, I;
Vlachogiannis, P;
Amandusson, A;
Elf, K;
Engstrom, E-R;
Zetterberg, H;
Kumlien, E;
(2018)
Seizures, CSF neurofilament light and tau in patients with subarachnoid haemorrhage.
Acta Neurologica Scandinavica
, 137
(2)
pp. 199-203.
10.1111/ane.12873.
|
|
|
Hall, S;
Janelidze, S;
Surova, Y;
Widner, H;
Zetterberg, H;
Hansson, O;
(2018)
Cerebrospinal fluid concentrations of inflammatory markers in Parkinson's disease and atypical parkinsonian disorders.
Scientific Reports
, 8
, Article 13276. 10.1038/s41598-018-31517-z.
|
|
|
Hampel, H;
O'Bryant, SE;
Molinuevo, JL;
Zetterberg, H;
Masters, CL;
Lista, S;
Kiddle, SJ;
... Blennow, K; + view all
(2018)
Blood-based biomarkers for Alzheimer disease: mapping the road to the clinic.
[Review].
Nature Reviews Neurology
, 14
pp. 639-652.
10.1038/s41582-018-0079-7.
|
|
Hampel, H;
Toschi, N;
Baldacci, F;
Zetterberg, H;
Blennow, K;
Kilimann, I;
Teipel, SJ;
... Lista, S; + view all
(2018)
Alzheimer's disease biomarker-guided diagnostic workflow using the added value of six combined cerebrospinal fluid candidates: A beta(1-42), total-tau, phosphorylated-tau, NFL, neurogranin, and YKL-40.
Alzheimer's & Dementia
, 14
(4)
pp. 492-501.
10.1016/j.jalz.2017.11.015.
|
|
Hansson, O;
Mikulskis, A;
Fagan, AM;
Teunissen, C;
Zetterberg, H;
Vanderstichele, H;
Molinuevo, JL;
... Blennow, K; + view all
(2018)
The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer's disease diagnosis: A review.
[Review].
Alzheimer's & Dementia
, 14
(10)
pp. 1313-1333.
10.1016/j.jalz.2018.05.008.
|
|
Hansson, O;
Seibyl, J;
Stomrud, E;
Zetterberg, H;
Trojanowski, JQ;
Bittner, T;
Lifke, V;
... Alzheimer's Disease Neuroimaging Initiative, .; + view all
(2018)
CSF biomarkers of Alzheimer's disease concord with amyloid-β PET and predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts.
Alzheimer's & Dementia
, 14
(11)
pp. 1470-1481.
10.1016/j.jalz.2018.01.010.
|
|
Hao, L;
Wang, J;
Page, D;
Asthana, S;
Zetterberg, H;
Carlsson, C;
Okonkwo, OC;
(2018)
Comparative Evaluation of MS-based Metabolomics Software and Its Application to Preclinical Alzheimer's Disease.
Scientific Reports
, 8
, Article 9291. 10.1038/s41598-018-27031-x.
|
|
|
Hasselgren, C;
Dellve, L;
Ekbrand, H;
Zettergren, A;
Zetterberg, H;
Blennow, K;
Skoog, I;
(2018)
Socioeconomic status, gender and dementia: The influence of work environment exposures and their interactions with APOE ɛ4.
SSM - Population Health
, 5
pp. 171-179.
10.1016/j.ssmph.2018.06.009.
|
|
|
Headley, A;
De Leon-Benedetti, A;
Dong, C;
Levin, B;
Loewenstein, D;
Camargo, C;
Rundek, T;
... Sun, X; + view all
(2018)
Neurogranin as a predictor of memory and executive function decline in MCI patients.
Neurology
, 90
(10)
E887-E895.
10.1212/WNL.0000000000005057.
|
|
Henjum, K;
Quist-Paulsen, E;
Zetterberg, H;
Blennow, K;
Nilsson, LNG;
Watne, LO;
(2018)
CSF sTREM2 in deliriumrelation to Alzheimer's disease CSF biomarkers A42, t-tau and p-tau.
Journal of Neuroinflammation
, 15
(304)
10.1186/s12974-018-1331-1.
|
|
|
Herman, S;
Khoonsari, PE;
Tolf, A;
Steinmetz, J;
Zetterberg, H;
Åkerfeldt, T;
Jakobsson, P-J;
... Kultima, K; + view all
(2018)
Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis.
Theranostics
, 8
(16)
pp. 4477-4490.
10.7150/thno.26249.
|
|
|
Heywood, WE;
Hallqvist, J;
Heslegrave, AJ;
Zetterberg, H;
Fenoglio, C;
Scarpini, E;
Rohrer, JD;
... Mills, K; + view all
(2018)
CSF pro-orexin and amyloid-β38 expression in Alzheimer's disease and frontotemporal dementia.
Neurobiology of Aging
, 72
pp. 171-176.
10.1016/j.neurobiolaging.2018.08.019.
|
|
Höglund, K;
Kern, S;
Zettergren, A;
Börjesson-Hansson, A;
Zetterberg, H;
Skoog, I;
Blennow, K;
(2018)
Publisher Correction: Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.
[Corrigendum].
Translational Psychiatry
, 8
(1)
, Article 250. 10.1038/s41398-018-0301-9.
|
|
|
Hohman, TJ;
Dumitrescu, L;
Barnes, LL;
Thambisetty, M;
Beecham, G;
Kunkle, B;
Gifford, KA;
... Jefferson, AL; + view all
(2018)
Sex-Specific Association of Apolipoprotein E With Cerebrospinal Fluid Levels of Tau.
JAMA Neurology
, 75
(8)
pp. 989-998.
10.1001/jamaneurol.2018.0821.
|
|
Janelidze, S;
Mattsson, N;
Stomrud, E;
Lindberg, O;
Palmqvist, S;
Zetterberg, H;
Blennow, K;
(2018)
CSF biomarkers of neuroinflammation and cerebrovascular dysfunction in early Alzheimer disease.
Neurology
, 91
(9)
e867-e877.
10.1212/WNL.0000000000006082.
|
|
|
Jansen, WJ;
Ossenkoppele, R;
Tijms, BM;
Fagan, AM;
Hansson, O;
Klunk, WE;
van der Flier, WM;
... Amyloid Biomarker Study Group, .; + view all
(2018)
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
JAMA Psychiatry
, 75
(1)
pp. 84-95.
10.1001/jamapsychiatry.2017.3391.
|
|
Johansson, L;
Kern, S;
Zetterberg, H;
Blennow, K;
Borjesson-Hansson, A;
Rosengren, L;
Guo, X;
(2018)
Midlife Stress in Relation to Late-Life Cerebrospinal Fluid Biomarkers of Alzheimer's Disease: A 25-Year Follow-Up Study.
Dementia and Geriatric Cognitive Disorders
, 46
(1-2)
pp. 90-99.
10.1159/000490885.
|
|
Johnson, EB;
Byrne, LM;
Gregory, S;
Rodrigues, FB;
Blennow, K;
Durr, A;
Leavitt, BR;
... Wild, EJ; + view all
(2018)
Neurofilament light protein in blood predicts regional atrophy in Huntington disease.
Neurology
, 90
(8)
e717-e723.
10.1212/WNL.0000000000005005.
|
|
Karikari, TK;
Charway-Felli, A;
Hoglund, K;
Blennow, K;
Zetterberg, H;
(2018)
Commentary: Global, regional, and national burden of neurological disorders during 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015.
[Editorial comment].
Frontiers in Neurology
, 9
, Article 201. 10.3389/fneur.2018.00201.
|
|
|
Kaya, I;
Zetterberg, H;
Blennow, K;
Hanrieder, J;
(2018)
Shedding Light on the Molecular Pathology of Amyloid Plaques in Transgenic Alzheimer's Disease Mice Using Multimodal MALDI Imaging Mass Spectrometry.
ACS Chemical Neuroscience
, 9
(7)
pp. 1802-1817.
10.1021/acschemneuro.8b00121.
|
|
|
Kern, S;
Syrjanen, JA;
Blennow, K;
Zetterberg, H;
Skoog, I;
Waern, M;
Hagen, CE;
... Mielke, MM; + view all
(2018)
Association of Cerebrospinal Fluid Neurofilament Light Protein With Risk of Mild Cognitive Impairment Among Individuals Without Cognitive Impairment.
JAMA Neurology
10.1001/jamaneurol.2018.3459.
(In press).
|
|
Kern, S;
Zetterberg, H;
Kern, J;
Zettergren, A;
Waern, M;
Höglund, K;
Andreasson, U;
... Skoog, I; + view all
(2018)
Prevalence of preclinical Alzheimer disease: Comparison of current classification systems.
Neurology
, 90
(19)
e1682-e1691.
10.1212/WNL.0000000000005476.
|
|
|
Keshavan, A;
Heslegrave, A;
Zetterberg, H;
Schott, JM;
(2018)
Stability of blood-based biomarkers of Alzheimer's disease over multiple freeze-thaw cycles.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 10
pp. 448-451.
10.1016/j.dadm.2018.06.001.
|
|
|
Khachaturian, AS;
Hayden, KM;
Mielke, MM;
Tang, Y;
Lutz, MW;
Gold, M;
Kukull, WA;
... Khachaturian, ZS; + view all
(2018)
New thinking about thinking, part two. Theoretical articles for Alzheimer's & Dementia.
[Editorial comment].
Alzheimer's and Dementia
, 14
(6)
pp. 703-706.
10.1016/j.jalz.2018.05.002.
|
|
Khalil, M;
Teunissen, CE;
Otto, M;
Piehl, F;
Sormani, MP;
Gattringer, T;
Barro, C;
... Kuhle, J; + view all
(2018)
Neurofilaments as biomarkers in neurological disorders.
Nature Reviews Neurology
, 14
pp. 577-589.
10.1038/s41582-018-0058-z.
|
|
Kim, WH;
Racine, AM;
Adluru, N;
Hwang, SJ;
Blennow, K;
Zetterberg, H;
Carlsson, CM;
... Singh, V; + view all
(2018)
Cerebrospinal fluid biomarkers of neurofibrillary tangles and synaptic dysfunction are associated with longitudinal decline in white matter connectivity: A multi-resolution graph analysis.
NeuroImage: Clinical
, 21
, Article 101586. 10.1016/j.nicl.2018.10.024.
|
|
Knorr, U;
Simonsen, AH;
Zetterberg, H;
Blennow, K;
Hasselbalch, SG;
Kessing, LV;
(2018)
Biomarkers in cerebrospinal fluid of patients with bipolar disorder versus healthy individuals: A systematic review.
European Neuropsychopharmacology
, 28
(7)
pp. 783-794.
10.1016/j.euroneuro.2018.04.002.
|
|
Koychev, I;
Galna, B;
Zetterberg, H;
Lawson, J;
Zamboni, G;
Ridha, BH;
Rowe, JB;
... Rochester, L; + view all
(2018)
Aβ₄₂/Aβ₄₀ and Aβ₄₂/Aβ₃₈ Ratios Are Associated with Measures of Gait Variability and Activities of Daily Living in Mild Alzheimer’s Disease: A Pilot Study.
Journal of Alzheimer's Disease
, 65
(4)
pp. 1377-1383.
10.3233/JAD-180622.
|
|
Kranaster, L;
Hoyer, C;
Aksay, SS;
Bumb, JM;
Müller, N;
Zill, P;
Schwarz, MJ;
... Sartorius, A; + view all
(2018)
Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study.
Neuropsychobiology
pp. 1-10.
10.1159/000491401.
|
|
|
Kristjansdottir, HL;
Lewerin, C;
Lerner, UH;
Waern, E;
Johansson, H;
Sundh, D;
Karlsson, M;
... Mellström, D; + view all
(2018)
High Serum Serotonin Predicts Increased Risk for Hip Fracture and Nonvertebral Osteoporotic Fractures: The MrOS Sweden Study.
Journal of Bone and Mineral Research
, 33
(9)
pp. 1560-1567.
10.1002/jbmr.3443.
|
|
Kruse, N;
Heslegrave, A;
Gupta, V;
Foiani, M;
Villar-Piqué, A;
Schmitz, M;
Lehmann, S;
... Llorens, F; + view all
(2018)
Interlaboratory Validation of Cerebrospinal Fluid Α-synuclein Quantification in the Diagnosis of Sporadic Creutzfeldt-jakob Disease.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 10
pp. 461-470.
10.1016/j.dadm.2018.06.005.
|
|
|
Kvartsberg, H;
Lashley, T;
Murray, CE;
Brinkmalm, G;
Cullen, NC;
Höglund, K;
Zetterberg, H;
... Portelius, E; + view all
(2018)
The intact postsynaptic protein neurogranin is reduced in brain tissue from patients with familial and sporadic Alzheimer's disease.
Acta Neuropathologica
10.1007/s00401-018-1910-3.
|
|
|
Lashley, T;
Schott, JM;
Weston, P;
Murray, CE;
Wellington, H;
Keshavan, A;
Foti, SC;
... Zetterberg, H; + view all
(2018)
Molecular biomarkers of Alzheimer's disease: progress and prospects.
Disease Models & Mechanisms
, 11
(5)
, Article dmm031781. 10.1242/dmm.031781.
|
|
|
Law, LL;
Rol, RN;
Schultz, SA;
Dougherty, RJ;
Edwards, DF;
Koscik, RL;
Gallagher, CL;
... Okonkwo, OC; + view all
(2018)
Moderate intensity physical activity associates with CSF biomarkers in a cohort at risk for Alzheimer's disease.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 10
pp. 188-195.
10.1016/j.dadm.2018.01.001.
|
|
Leinonen, V;
Rauramaa, T;
Johansson, J;
Bottelbergs, A;
Tesseur, I;
van der Ark, P;
Pemberton, D;
... Rinne, JO; + view all
(2018)
S-[F-18] THK-5117-PET and [C-11] PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-beta Plaques and Tau in Brain Biopsies.
Journal of Alzheimer's Disease
, 64
(1)
pp. 171-179.
10.3233/JAD-180071.
|
|
|
Lewczuk, P;
Ermann, N;
Andreasson, U;
Schultheis, C;
Podhorna, J;
Spitzer, P;
Maler, JM;
... Zetterberg, H; + view all
(2018)
Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer’s disease.
Alzheimer's Research & Therapy
, 10
(1)
, Article 71. 10.1186/s13195-018-0404-9.
|
|
|
Lewczuk, P;
Riederer, P;
O'Bryant, SE;
Verbeek, MM;
Dubois, B;
Visser, PJ;
Jellinger, KA;
... Kornhuber, J; + view all
(2018)
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.
The World Journal of Biological Psychiatry
, 19
(4)
pp. 244-328.
10.1080/15622975.2017.1375556.
|
|
|
Lundin, A;
Delsing, L;
Clausen, M;
Ricchiuto, P;
Sanchez, J;
Sabirsh, A;
Ding, M;
... Falk, A; + view all
(2018)
Human iPS-Derived Astroglia from a Stable Neural Precursor State Show Improved Functionality Compared with Conventional Astrocytic Models.
Stem Cell Reports
, 10
(3)
pp. 1030-1045.
10.1016/j.stemcr.2018.01.021.
|
|
|
Malpas, CB;
Saling, MM;
Velakoulis, D;
Desmond, P;
Hicks, RJ;
Zetterberg, H;
Blennow, K;
(2018)
Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.
Journal of Alzheimer's Disease
, 62
(1)
pp. 417-427.
10.3233/JAD-170250.
|
|
|
Mattsson, N;
Eriksson, O;
Lindberg, O;
Scholl, M;
Lampinen, B;
Nilsson, M;
Insel, PS;
... Hansson, O; + view all
(2018)
Effects of APOE ε4 on neuroimaging, cerebrospinal fluid biomarkers, and cognition in prodromal Alzheimer's disease.
Neurobiology of Aging
, 71
pp. 81-90.
10.1016/j.neurobiolaging.2018.07.003.
|
|
Mattsson, N;
Groot, C;
Jansen, WJ;
Landau, SM;
Villemagne, VL;
Engelborghs, S;
Mintun, MM;
... Ossenkoppele, R; + view all
(2018)
Prevalence of the apolipoprotein E epsilon 4 allele in amyloid beta positive subjects across the spectrum of Alzheimer's disease.
Alzheimer's and Dementia
, 14
(7)
pp. 913-924.
10.1016/j.jalz.2018.02.009.
|
|
Mattsson, N;
Smith, R;
Strandberg, O;
Palmqvist, S;
Scholl, M;
Insel, PS;
Hagerstrom, D;
... Hansson, O; + view all
(2018)
Comparing F-18-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease.
Neurology
, 90
(5)
e388-e395.
10.1212/WNL.0000000000004887.
|
|
|
Mc Ardle, R;
Morris, R;
Hickey, A;
Del Din, S;
Koychev, I;
Gunn, RN;
Lawson, J;
... Rochester, L; + view all
(2018)
Gait in Mild Alzheimer’s Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study.
Journal of Alzheimer's Disease
, 63
(1)
pp. 331-341.
10.3233/JAD-171116.
|
|
|
Mc Ardle, R;
Morrisa, R;
Hickey, A;
Del Din, S;
Koychev, I;
Gunn, RN;
Lawson, J;
... Rochester, A; + view all
(2018)
Correction: Gait in Mild Alzheimer's Disease: Feasibility of Multi-Center Measurement in the Clinic and Home with Body-Worn Sensors: A Pilot Study (vol 63, pg 331, 2018).
[Corrigendum].
Journal of Alzheimer's Disease
, 63
(4)
p. 1557.
10.3233/JAD-189003.
|
|
|
Mehlig, K;
Lapidus, L;
Thelle, DS;
Waern, M;
Zetterberg, H;
Bjorkelund, C;
Skoog, I;
(2018)
Low fasting serum insulin and dementia in nondiabetic women followed for 34 years.
Neurology
, 91
(5)
E427-E435.
10.1212/WNL.0000000000005911.
|
|
|
Meregalli, C;
Fumagalli, G;
Alberti, P;
Canta, A;
Carozzi, VA;
Chiorazzi, A;
Monza, L;
... Cavaletti, G; + view all
(2018)
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy.
Experimental Neurology
, 307
pp. 129-132.
10.1016/j.expneurol.2018.06.005.
|
|
Merluzzi, AP;
Carlsson, CM;
Johnson, SC;
Schindler, SE;
Asthana, S;
Blennow, K;
Zetterberg, H;
(2018)
Neurodegeneration, synaptic dysfunction, and gliosis are phenotypic of Alzheimer dementia.
Neurology
, 91
(5)
E436-E443.
10.1212/WNL.0000000000005901.
|
|
Michno, W;
Kaya, I;
Nystrom, S;
Guerard, L;
Nilsson, KPR;
Hammarstrom, P;
Blennow, K;
... Hanrieder, J; + view all
(2018)
Multimodal Chemical Imaging of Amyloid Plaque Polymorphism Reveals A beta Aggregation Dependent Anionic Lipid Accumulations and Metabolism.
Analytical Chemistry
, 90
(13)
pp. 8130-8138.
10.1021/acs.analchem.8b01361.
|
|
Moens, TG;
Mizielinska, S;
Niccoli, T;
Mitchell, JS;
Thoeng, A;
Ridler, CE;
Grönke, S;
... Isaacs, AM; + view all
(2018)
Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD.
Acta Neuropathologica
, 135
(3)
pp. 445-457.
10.1007/s00401-017-1798-3.
|
|
|
Molinuevo, JL;
Ayton, S;
Batrla, R;
Bednar, MM;
Bittner, T;
Cummings, J;
Fagan, AM;
... Blennow, K; + view all
(2018)
Current state of Alzheimer's fluid biomarkers.
Acta Neuropathologica
, 136
(6)
pp. 821-853.
10.1007/s00401-018-1932-x.
|
|
|
Moore, EE;
Hohman, TJ;
Badami, FS;
Pechman, KR;
Osborn, KE;
Acosta, LMY;
Bell, SP;
... Jefferson, AL; + view all
(2018)
Neurofilament relates to white matter microstructure in older adults.
Neurobiology of Aging
, 70
pp. 233-241.
10.1016/j.neurobiolaging.2018.06.023.
|
|
Moseby-Knappe, M;
Mattsson, N;
Nielsen, N;
Zetterberg, H;
Blennow, K;
Dankiewicz, J;
Dragancea, I;
... Cronberg, T; + view all
(2018)
Serum Neurofilament Light Chain for Prognosis of Outcome After Cardiac Arrest.
JAMA Neurology
10.1001/jamaneurol.2018.3223.
(In press).
|
|
Murray, CE;
Gami-Patel, P;
Gkanatsiou, E;
Brinkmalm, G;
Portelius, E;
Wirths, O;
Heywood, W;
... Lashley, T; + view all
(2018)
The presubiculum is preserved from neurodegenerative changes in Alzheimer's disease.
Acta Neuropathologica Communications
, 6
, Article 62. 10.1186/s40478-018-0563-8.
|
|
|
Nazir, FH;
Becker, B;
Brinkmalm, A;
Höglund, K;
Sandelius, Å;
Bergström, P;
Satir, TM;
... Zetterberg, H; + view all
(2018)
Expression and secretion of synaptic proteins during stem cell differentiation to cortical neurons.
Neurochemistry International
, 121
pp. 38-49.
10.1016/j.neuint.2018.10.014.
|
|
|
Niemela, V;
Burman, J;
Blennow, K;
Zetterberg, H;
Larsson, A;
Sundblom, J;
(2018)
Cerebrospinal fluid sCD27 levels indicate active T cell-mediated inflammation in premanifest Huntington's disease.
PLoS One
, 13
(2)
10.1371/journal.pone.0193492.
|
|
|
Nilholm, C;
Roth, B;
Höglund, P;
Blennow, K;
Englund, E;
Hansson, O;
Zetterberg, H;
(2018)
Dietary intervention with an Okinawan-based Nordic diet in type 2 diabetes renders decreased interleukin-18 concentrations and increased neurofilament light concentrations in plasma.
Nutrition Research
, 60
pp. 13-25.
10.1016/j.nutres.2018.08.002.
|
|
Novakova, L;
Axelsson, M;
Malmestrom, C;
Imberg, H;
Elias, O;
Zetterberg, H;
Nerman, O;
(2018)
Searching for neurodegeneration in multiple sclerosis at clinical onset: Diagnostic value of biomarkers.
PLoS One
, 13
(4)
, Article e0194828. 10.1371/journal.pone.0194828.
|
 |
|
Novakova, L;
Singh, AK;
Axelsson, M;
Ståhlman, M;
Adiels, M;
Malmeström, C;
Zetterberg, H;
... Blomqvist, M; + view all
(2018)
Sulfatide isoform pattern in cerebrospinal fluid discriminates progressive MS from relapsing‐remitting MS.
Journal of Neurochemistry
, 146
(3)
pp. 322-332.
10.1111/jnc.14452.
|
|
Oh, ES;
Blennow, K;
Bigelow, GE;
Inouye, SK;
Marcantonio, ER;
Neufeld, KJ;
Rosenberg, PB;
... Lyketsos, CG; + view all
(2018)
Abnormal Csf Amyloid-beta 42 and Tau Levels in Hip Fracture Patients Without Dementia.
PLoS One
, 13
(9)
, Article e0204695. 10.1371/journal.pone.0204695.
|
|
|
Oliveira, F;
Leuzy, A;
Castelhano, J;
Chiotis, K;
Hasselbalch, SG;
Rinne, J;
Mendonça, A;
... Castelo-Branco, M; + view all
(2018)
Data driven diagnostic classification in Alzheimer's disease based on different reference regions for normalization of PiB-PET images and correlation with CSF concentrations of Aβ species.
NeuroImage Clinical
, 20
pp. 603-610.
10.1016/j.nicl.2018.08.023.
|
|
|
Olsson, M;
Arlig, J;
Hedner, J;
Blennow, K;
Zetterberg, H;
(2018)
Sleep deprivation and cerebrospinal fluid biomarkers for Alzheimer's disease.
Sleep
, 41
(5)
, Article zsy025. 10.1093/sleep/zsy025.
|
|
Osborn, KE;
Liu, D;
Samuels, LR;
Moore, EE;
Cambronero, FE;
Acosta, LMY;
Bell, SP;
... Jefferson, AL; + view all
(2018)
Cerebrospinal fluid β-amyloid₄₂ and neurofilament light relate to white matter hyperintensities.
Neurobiology of Aging
, 68
pp. 18-25.
10.1016/j.neurobiolaging.2018.03.028.
|
|
Paterson, RW;
Slattery, CF;
Poole, T;
Nicholas, JM;
Magdalinou, NK;
Toombs, J;
Chapman, MD;
... Schott, JM; + view all
(2018)
Cerebrospinal fluid in the differential diagnosis of Alzheimer's disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic.
Alzheimer's Research & Therapy
, 10
, Article 32. 10.1186/s13195-018-0361-3.
|
|
Piehl, F;
Kockum, I;
Khademi, M;
Blennow, K;
Lycke, J;
Zetterberg, H;
Olsson, T;
(2018)
Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod.
Multiple Sclerosis Journal
, 24
(8)
pp. 1046-1054.
10.1177/1352458517715132.
|
|
Portelius, E;
Olsson, B;
Höglund, K;
Cullen, NC;
Kvartsberg, H;
Andreasson, U;
Zetterberg, H;
... Blennow, K; + view all
(2018)
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology.
Acta Neuropathologica
10.1007/s00401-018-1851-x.
(In press).
|
|
|
Rahman, MM;
Westermark, GT;
Zetterberg, H;
Härd, T;
Sandgren, M;
(2018)
Protofibrillar and Fibrillar Amyloid-β Binding Proteins in Cerebrospinal Fluid.
Journal of Alzheimer's Disease
, 66
(3)
pp. 1053-1064.
10.3233/JAD-180596.
|
|
|
Ramos-Cejudo, J;
Wisniewski, T;
Marmar, C;
Zetterberg, H;
Blennow, K;
de Leon, MJ;
Fossati, S;
(2018)
Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.
[Review].
EBioMedicine
, 28
pp. 21-30.
10.1016/j.ebiom.2018.01.021.
|
|
|
Roos, P;
von Essen, MR;
Nielsen, TT;
Johannsen, P;
Stokholm, J;
Bie, AS;
Waldemar, G;
... Nielsen, JE; + view all
(2018)
Inflammatory markers of CHMP2B-mediated frontotemporal dementia.
Journal of Neuroimmunology
, 324
pp. 136-142.
10.1016/j.jneuroim.2018.08.009.
|
|
Rostgaard, N;
Roos, P;
Portelius, E;
Blennow, K;
Zetterberg, H;
Simonsen, AH;
Nielsen, JE;
(2018)
CSF neurofilament light concentration is increased in presymptomatic CHMP2B mutation carriers.
Neurology
, 90
(2)
e157-e163.
10.1212/WNL.0000000000004799.
|
|
|
Rot, U;
Sandelius, Å;
Emeršič, A;
Zetterberg, H;
Blennow, K;
(2018)
Cerebrospinal fluid GAP-43 in early multiple sclerosis.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
, 4
(3)
10.1177/2055217318792931.
|
|
|
Rydberg Sterner, T;
Ahlner, F;
Blennow, K;
Dahlin-Ivanoff, S;
Falk, H;
Havstam Johansson, L;
Hoff, M;
... Skoog, I; + view all
(2018)
The Gothenburg H70 Birth cohort study 2014-16: design, methods and study population.
European Journal of Epidemiology
10.1007/s10654-018-0459-8.
(In press).
|
|
|
Sánchez-Valle, R;
Heslegrave, A;
Foiani, MS;
Bosch, B;
Antonell, A;
Balasa, M;
Lladó, A;
... Fox, NC; + view all
(2018)
Serum neurofilament light levels correlate with severity measures and neurodegeneration markers in autosomal dominant Alzheimer's disease.
Alzheimer's Research & Therapy
, 10
, Article 113. 10.1186/s13195-018-0439-y.
|
|
Sandelius, A;
Cullen, NC;
Kallen, A;
Rosengren, L;
Jensen, C;
Kostanjevecki, V;
Vandijck, M;
... Blennow, K; + view all
(2018)
Transient increase in CSF GAP-43 concentration after ischemic stroke.
BMC Neurology
, 18
, Article 202. 10.1186/s12883-018-1210-5.
|
|
|
Sandelius, Å;
Zetterberg, H;
Blennow, K;
Adiutori, R;
Malaspina, A;
Laura, M;
Reilly, MM;
(2018)
Plasma neurofilament light chain concentration in the inherited peripheral neuropathies.
Neurology
, 90
e1-e7.
10.1212/WNL.0000000000004932.
|
|
|
Sanford, R;
Ances, BM;
Meyerhoff, DJ;
Price, RW;
Fuchs, D;
Zetterberg, H;
Spudich, S;
(2018)
Longitudinal Trajectories of Brain Volume and Cortical Thickness in Treated and Untreated Primary Human Immunodeficiency Virus Infection.
Clinical Infectious Diseases
, 67
(11)
pp. 1697-1704.
10.1093/cid/ciy362.
|
|
Schöll, M;
Maass, A;
Mattsson, N;
Ashton, NJ;
Blennow, K;
Zetterberg, H;
Jagust, W;
(2018)
Biomarkers for tau pathology.
Molecular and Cellular Neuroscience
10.1016/j.mcn.2018.12.001.
(In press).
|
|
|
Scott, G;
Zetterberg, H;
Jolly, A;
Cole, JH;
De Simoni, S;
Jenkins, PO;
Feeney, C;
... Sharp, DJ; + view all
(2018)
Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.
Brain
, 141
pp. 459-471.
10.1093/brain/awx339.
|
|
|
Shahim, P;
Tegner, Y;
Marklund, N;
Blennow, K;
Zetterberg, H;
(2018)
Neurofilament light and tau as blood biomarkers for sports-related concussion.
Neurology
, 90
(20)
e1780-e1788.
10.1212/WNL.0000000000005518.
|
|
|
Sharma, RA;
Varga, AW;
Bubu, OM;
Pirraglia, E;
Kam, K;
Parekh, A;
Wohlleber, M;
... Osorio, RS; + view all
(2018)
Obstructive Sleep Apnea Severity Affects Amyloid Burden in Cognitively Normal Elderly. A Longitudinal Study.
American Journal of Respiratory and Critical Care Medicine
, 197
(7)
pp. 933-943.
10.1164/rccm.201704-0704OC.
|
|
|
Simone, R;
Balendra, R;
Moens, TG;
Preza, E;
Wilson, KM;
Heslegrave, A;
Woodling, NS;
... Isaacs, AM; + view all
(2018)
G-quadruplex-binding small molecules ameliorate C9orf72 FTD/ALS pathology in vitro and in vivo.
EMBO Molecular Medicine
, 10
(1)
pp. 22-31.
10.15252/emmm.201707850.
|
|
|
Skillbäck, T;
Lautner, R;
Mattsson, N;
Schott, JM;
Nägga, K;
Kilander, L;
Wimo, A;
... Zetterberg, H; + view all
(2018)
Apolipoprotein E genotypes and longevity across dementia disorders.
Alzheimer's & Dementia
, 14
(7)
pp. 895-901.
10.1016/j.jalz.2018.02.003.
|
|
Skoog, I;
Kern, S;
Zetterberg, H;
Ostling, S;
Borjesson-Hanson, A;
Guo, X;
Blennow, K;
(2018)
Low Cerebrospinal Fluid A beta(42) and A beta(40) are Related to White Matter Lesions in Cognitively Normal Elderly.
Journal of Alzheimer's Disease
, 62
(4)
pp. 1877-1886.
10.3233/JAD-170950.
|
|
|
Sofou, K;
Shahim, P;
Tulinius, M;
Blennow, K;
Zetterberg, H;
Mattsson, N;
Darin, N;
(2018)
Cerebrospinal fluid neurofilament light is associated with survival in mitochondrial disease patients.
Mitochondrion
10.1016/j.mito.2018.07.002.
(In press).
|
|
Sogorb-Esteve, A;
Garcia-Ayllon, M-S;
Gobom, J;
Alom, J;
Zetterberg, H;
Blennow, K;
Saez-Valero, J;
(2018)
Levels of ADAM10 are reduced in Alzheimer's disease CSF.
Journal of Neuroinflammation
, 15
, Article 213. 10.1186/s12974-018-1255-9.
|
|
|
Stromme, P;
Groeneweg, S;
Lima de Souza, EC;
Zevenbergen, C;
Torgersbråten, A;
Holmgren, A;
Gurcan, E;
... Visser, TJ; + view all
(2018)
Mutated thyroid hormone transporter OATP1C1 associates with severe brain hypometabolism and juvenile neurodegeneration.
Thyroid
, 28
(11)
pp. 1406-1415.
10.1089/thy.2018.0595.
|
|
Strydom, A;
Coppus, A;
Blesa, R;
Danek, A;
Fortea, J;
Hardy, J;
Levin, J;
... Zetterberg, H; + view all
(2018)
Alzheimer's disease in Down syndrome: An overlooked population for prevention trials.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 4
pp. 703-713.
10.1016/j.trci.2018.10.006.
|
|
|
Strydom, A;
Heslegrave, A;
Startin, CM;
Mok, KY;
Hardy, J;
Groet, J;
Nizetic, D;
... LonDownS Consortium; + view all
(2018)
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.
Alzheimer's Research & Therapy
, 10
(1)
, Article 39. 10.1186/s13195-018-0367-x.
|
|
|
Taylor, CG;
Meisl, G;
Horrocks, MH;
Zetterberg, H;
Knowles, TPJ;
Klenerman, D;
(2018)
Extrinsic Amyloid-Binding Dyes for Detection of Individual Protein Aggregates in Solution.
Analytical Chemistry
, 90
(17)
pp. 10385-10393.
10.1021/acs.analchem.8b02226.
|
|
|
Ten Kate, M;
Redolfi, A;
Peira, E;
Bos, I;
Vos, SJ;
Vandenberghe, R;
Gabel, S;
... Barkhof, F; + view all
(2018)
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
Alzheimer's Research & Therapy
, 10
, Article 100. 10.1186/s13195-018-0428-1.
|
|
|
Teunissen, CE;
Chiu, M-J;
Yang, C-C;
Yang, S-Y;
Scheltens, P;
Zetterberg, H;
Blennow, K;
(2018)
Plasma Amyloid-beta (A beta(42)) Correlates with Cerebrospinal Fluid A beta(42) in Alzheimer's Disease.
Journal of Alzheimer's Disease
, 62
(4)
pp. 1857-1863.
10.3233/JAD-170784.
|
|
|
Teunissen, CE;
Otto, M;
Engelborghs, S;
Herukka, S-K;
Lehmann, S;
Lewczuk, P;
Lleó, A;
... Blennow, K; + view all
(2018)
White paper by the Society for CSF Analysis and Clinical Neurochemistry: Overcoming barriers in biomarker development and clinical translation.
Alzheimer's Research & Therapy
, 10
(1)
, Article 30. 10.1186/s13195-018-0359-x.
|
|
|
Thompson, AGB;
Luk, C;
Heslegrave, AJ;
Zetterberg, H;
Mead, SH;
Collinge, J;
Jackson, GS;
(2018)
Neurofilament light chain and tau concentrations are markedly increased in the serum of patients with sporadic Creutzfeldt-Jakob disease, and tau correlates with rate of disease progression.
Journal of Neurology, Neurosurgery & Psychiatry
, 89
(9)
pp. 955-961.
10.1136/jnnp-2017-317793.
|
|
Thordardottir, S;
Rodriguez-Vieitez, E;
Almkvist, O;
Ferreira, D;
Saint-Aubert, L;
Kinhult-Stahlbom, A;
Thonberg, H;
... Graff, C; + view all
(2018)
Reduced penetrance of the PSEN1 H163Y autosomal dominant Alzheimer mutation: a 22-year follow-up study.
Alzheimer's Research & Therapy
, 10
, Article 45. 10.1186/s13195-018-0374-y.
|
|
|
Toombs, J;
Foiani, MS;
Wellington, H;
Paterson, RW;
Arber, C;
Heslegrave, A;
Lunn, MP;
... Zetterberg, H; + view all
(2018)
Amyloid β peptides are differentially vulnerable to preanalytical surface exposure, an effect incompletely mitigated by the use of ratios.
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 10
pp. 311-321.
10.1016/j.dadm.2018.02.005.
|
|
|
Toorell, H;
Zetterberg, H;
Blennow, K;
Savman, K;
Hagberg, H;
(2018)
Increase of neuronal injury markers Tau and neurofilament light proteins in umbilical blood after intrapartum asphyxia.
The Journal of Maternal-Fetal & Neonatal Medicine
, 31
(18)
pp. 2468-2472.
10.1080/14767058.2017.1344964.
|
|
|
Ulfhammer, G;
Eden, A;
Mellgren, A;
Fuchs, D;
Zetterberg, H;
Hagberg, L;
Nilsson, S;
... Gisslen, M; + view all
(2018)
Persistent central nervous system immune activation following more than 10 years of effective HIV antiretroviral treatment.
AIDS
, 32
(15)
pp. 2171-2178.
10.1097/QAD.0000000000001950.
|
|
Van Zoest, RA;
Underwood, J;
De Francesco, D;
Sabin, CA;
Cole, JH;
Wit, FW;
Caan, MWA;
... Co-morBidity in Relation to AIDS (COBRA) Collaboration, .; + view all
(2018)
Structural Brain Abnormalities in Successfully Treated HIV Infection: Associations With Disease and Cerebrospinal Fluid Biomarkers.
The Journal of Infectious Diseases
, 217
(1)
pp. 69-81.
10.1093/infdis/jix553.
|
|
Vergallo, A;
Bun, R-S;
Toschi, N;
Baldacci, F;
Zetterberg, H;
Blennow, K;
Cavedo, E;
... Alzheimer Precision Medicine Initiative (APMI); + view all
(2018)
Association of Cerebrospinal Fluid Α-synuclein With Total and Phospho-tau181 Protein Concentrations and Brain Amyloid Load in Cognitively Normal Subjective Memory Complainers Stratified by Alzheimer's Disease Biomarkers.
Alzheimers Dement
, 14
(12)
pp. 1623-1631.
10.1016/j.jalz.2018.06.3053.
|
|
Vogt, NM;
Romano, KA;
Darst, BF;
Engelman, CD;
Johnson, SC;
Carlsson, CM;
Asthana, S;
... Rey, FE; + view all
(2018)
The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer's disease.
Alzheimer's Research & Therapy
, 10
, Article 124. 10.1186/s13195-018-0451-2.
|
|
|
Wallace, C;
Smirl, JD;
Zetterberg, H;
Blennow, K;
Bryk, K;
Burma, J;
Dierijck, J;
... Van Donkelaar, P; + view all
(2018)
Heading in soccer increases serum neurofilament light protein and SCAT3 symptom metrics.
BMJ Open Sport and Exercise Medicine
, 4
(1)
, Article e000433. 10.1136/bmjsem-2018-000433.
|
|
|
Wallace, C;
Zetterberg, H;
Blennow, K;
van Donkelaar, P;
(2018)
No change in plasma tau and serum neurofilament light concentrations in adolescent athletes following sport-related concussion.
PLoS One
, 13
(10)
, Article e0206466. 10.1371/journal.pone.0206466.
|
|
|
Wellington, H;
Paterson, RW;
Suarez-Gonzalez, A;
Poole, T;
Frost, C;
Sjobom, U;
Slattery, CF;
... Schott, JM; + view all
(2018)
CSF Neurogranin or Tau distinguish typical and atypical Alzheimer Disease.
Annals of Clinical and Translational Neurology
, 5
(2)
pp. 162-171.
10.1002/acn3.518.
|
|
Weston, PSJ;
Poole, T;
Ryan, NS;
Nair, A;
Liang, Y;
Macpherson, K;
Druyeh, R;
... Fox, NC; + view all
(2018)
Accelerated long-term forgetting in presymptomatic Autosomal Dominant Alzheimer's disease: A cross-sectional study.
Lancet Neurology
, 17
(2)
pp. 123-132.
10.1016/S1474-4422(17)30434-9.
|
|
|
Willemse, EAJ;
De Vos, A;
Herries, EM;
Andreasson, U;
Engelborghs, S;
van der Flier, WM;
Scheltens, P;
... Teunissen, CE; + view all
(2018)
Neurogranin as Cerebrospinal Fluid Biomarker for Alzheimer Disease: An Assay Comparison Study.
Clinical Chemistry
, 64
(6)
pp. 927-937.
10.1373/clinchem.2017.283028.
|
|
Wiseman, FK;
Pulford, LJ;
Barkus, C;
Liao, F;
Portelius, E;
Webb, R;
Chávez-Gutiérrez, L;
... Fisher, EMC; + view all
(2018)
Trisomy of human chromosome 21 enhances amyloid-β deposition independently of an extra copy of APP.
Brain
, 141
(8)
pp. 2457-2474.
10.1093/brain/awy159.
|
|
|
Woollacott, IOC;
Nicholas, JM;
Heslegrave, A;
Heller, C;
Foiani, MS;
Dick, KM;
Russell, LL;
... Rohrer, JD; + view all
(2018)
Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup.
Alzheimer's Research & Therapy
, 10
, Article 79. 10.1186/s13195-018-0405-8.
|
|
|
Zeitlberger, AM;
Thomas-Black, G;
Garcia-Moreno, H;
Foiani, M;
Heslegrave, AJ;
Zetterberg, H;
Giunti, P;
(2018)
Plasma Markers of Neurodegeneration Are Raised in Friedreich's Ataxia.
Frontiers in Cellular Neuroscience
, 12
, Article 366. 10.3389/fncel.2018.00366.
|
|
|
Zerr, I;
Schmitz, M;
Karch, A;
Villar-Pique, A;
Kanata, E;
Golanska, E;
Diaz-Lucena, D;
... Llorens, F; + view all
(2018)
Cerebrospinal fluid neurofilament light levels in neurodegenerative dementia: Evaluation of diagnostic accuracy in the differential diagnosis of prion diseases.
Alzheimer's & Dementia
, 14
(6)
pp. 751-763.
10.1016/j.jalz.2017.12.008.
|
|
Zetterberg, H;
(2018)
Tauomics and Kinetics in Human Neurons and Biological Fluids.
Neuron
, 97
(6)
pp. 1202-1205.
10.1016/j.neuron.2018.02.030.
|
|
Zetterberg, H;
(2018)
Chitotriosidase: shucking the role of microglia in amyotrophic lateral sclerosis.
Journal of Neurology, Neurosurgery and Psychiatry
, 89
(3)
pp. 228-229.
10.1136/jnnp-2017-317379.
|
|
Zetterberg, H;
(2018)
Om Columbia-sociologin.
Sociologisk Forskning
, 55
(4)
pp. 489-503.
|
|
|
Zetterberg, H;
Blennow, K;
(2018)
From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer's Disease.
Journal of Alzheimer's Disease
, 64
(s1)
S271-S279.
10.3233/JAD-179926.
|
|
Zettergren, A;
Kern, S;
Ryden, L;
Ostling, S;
Blennow, K;
Zetterberg, H;
Falk, H;
(2018)
Genetic Variation in FOXO3 is Associated with Self-Rated Health in a Population-Based Sample of Older Individuals.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences
, 73
(11)
pp. 1453-1458.
10.1093/gerona/gly021.
|
2017
|
Agelii, ML;
Lehtinen-Jacks, S;
Zetterberg, H;
Sundh, V;
Bjorkelund, C;
Lissner, L;
(2017)
Low vitamin D status in relation to cardiovascular disease and mortality in Swedish women - Effect of extended follow-up.
Nutrition Metabolism and Cardiovascular Diseases
, 27
(12)
pp. 1143-1151.
10.1016/j.numecd.2017.10.013.
|
|
|
Agholme, L;
Clarin, M;
Gkanatsiou, E;
Kettunen, P;
Chebli, J;
Brinkmalm, G;
Blennow, K;
... Zetterberg, H; + view all
(2017)
Low-dose γ-secretase inhibition increases secretion of Aβ peptides and intracellular oligomeric Aβ.
Molecular and Cellular Neuroscience
, 85
pp. 211-219.
10.1016/j.mcn.2017.10.009.
|
|
|
Anderson, AM;
Lennox, JL;
Mulligan, MM;
Loring, DW;
Zetterberg, H;
Blennow, K;
Kessing, C;
... Tyor, WR; + view all
(2017)
Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.
Journal of Neurovirology
, 23
(1)
pp. 106-112.
10.1007/s13365-016-0466-z.
|
|
Baldacci, F;
Toschi, N;
Lista, S;
Zetterberg, H;
Blennow, K;
Kilimann, I;
Teipel, S;
... Hampel, H; + view all
(2017)
Two-level diagnostic classification using cerebrospinal fluid YKL-40 in Alzheimer's disease.
Alzheimer's & Dementia
, 13
(9)
pp. 993-1003.
10.1016/j.jalz.2017.01.021.
|
|
Berman, SE;
Clark, LR;
Rivera-Rivera, LA;
Norton, D;
Racine, AM;
Rowley, HA;
Bendlin, BB;
... Johnson, SC; + view all
(2017)
Intracranial Arterial 4D Flow in Individuals with Mild Cognitive Impairment is Associated with Cognitive Performance and Amyloid Positivity.
Journal of Alzheimer's Disease
, 60
(1)
pp. 243-252.
10.3233/JAD-170402.
|
|
|
Blomqvist, M;
Boren, J;
Zetterberg, H;
Blennow, K;
Mansson, J-E;
Stahlman, M;
(2017)
High-throughput analysis of sulfatides in cerebrospinal fluid using automated extraction and UPLC-MS/MS.
Journal of Lipid Research
, 58
(7)
pp. 1482-1489.
10.1194/jlr.D076588.
|
|
|
Booiman, T;
Wit, FW;
Maurer, I;
De Francesco, D;
Sabin, CA;
Harskamp, AM;
Prins, M;
... Comorbidity in Relation to AIDS (COBRA) Collaboration, .; + view all
(2017)
High Cellular Monocyte Activation in People Living With Human Immunodeficiency Virus on Combination Antiretroviral Therapy and Lifestyle-Matched Controls Is Associated With Greater Inflammation in Cerebrospinal Fluid.
Open Forum Infectious Diseases
, 4
(3)
, Article ofx108. 10.1093/ofid/ofx108.
|
|
|
Brownjohn, PW;
Smith, J;
Portelius, E;
Serneels, L;
Kvartsberg, H;
De Strooper, B;
Blennow, K;
... Livesey, FJ; + view all
(2017)
Phenotypic Screening Identifies Modulators of Amyloid Precursor Protein Processing in Human Stem Cell Models of Alzheimer's Disease.
Stem Cell Reports
, 8
(4)
pp. 870-882.
10.1016/j.stemcr.2017.02.006.
|
|
|
Bruno, D;
Nierenberg, J;
Cooper, TB;
Marmar, CR;
Zetterberg, H;
Blennow, K;
Hashimoto, K;
(2017)
The recency ratio is associated with reduced CSF glutamate in late-life depression.
Neurobiology of Learning and Memory
, 141
pp. 14-18.
10.1016/j.nlm.2017.03.011.
|
|
Byrne, LM;
Rodrigues, FB;
Blennow, K;
Durr, A;
Leavitt, BR;
Roos, RAC;
Scahill, RI;
... Wild, EJ; + view all
(2017)
Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis.
The Lancet Neurology
, 16
(8)
pp. 601-609.
10.1016/S1474-4422(17)30124-2.
|
|
|
Casaletto, KB;
Elahi, FM;
Bettcher, BM;
Neuhaus, J;
Bendlin, BB;
Asthana, S;
Johnson, SC;
... Kramer, JH; + view all
(2017)
Neurogranin, a synaptic protein, is associated with memory independent of Alzheimer biomarkers.
Neurology
, 89
(17)
pp. 1782-1788.
10.1212/WNL.0000000000004569.
|
|
Chapuis, J;
Flaig, A;
Grenier-Boley, B;
Eysert, F;
Pottiez, V;
Deloison, G;
Vandeputte, A;
... Lambert, J-C; + view all
(2017)
Genome-wide, high-content siRNA screening identifies the Alzheimer's genetic risk factor FERMT2 as a major modulator of APP metabolism.
Acta Neuropathologica
, 133
(6)
pp. 955-966.
10.1007/s00401-016-1652-z.
|
|
|
Chen, J;
Yu, J-T;
Wojta, K;
Wang, H-F;
Zetterberg, H;
Blennow, K;
Yokoyama, JS;
... Boxer, AL; + view all
(2017)
Genome-wide association study identifies MAPT locus influencing human plasma tau levels.
Neurology
, 88
(7)
pp. 669-676.
10.1212/WNL.0000000000003615.
|
|
Constantinescu, R;
Krýsl, D;
Andrén, K;
Asztély, F;
Bergquist, F;
Zetterberg, H;
Andreasson, U;
... Blennow, K; + view all
(2017)
Cerebrospinal fluid markers of neuronal and glial cell damage in patients with autoimmune neurologic syndromes with and without underlying malignancies.
Journal of Neuroimmunology
, 306
pp. 25-30.
10.1016/j.jneuroim.2017.02.018.
|
|
Craven, CL;
Baudracco, I;
Zetterberg, H;
Lunn, MPT;
Chapman, MD;
Lakdawala, N;
Watkins, LD;
(2017)
The predictive value of T-tau and AB1-42 levels in idiopathic normal pressure hydrocephalus.
Acta Neurochirurgica
, 159
(12)
pp. 2293-2300.
10.1007/s00701-017-3314-x.
|
|
Darst, BF;
Koscik, RL;
Racine, AM;
Oh, JM;
Krause, RA;
Carlsson, CM;
Zetterberg, H;
... Engelman, CD; + view all
(2017)
Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-beta Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.
Journal of Alzheimer's Disease
, 55
(2)
pp. 473-484.
10.3233/JAD-160195.
|
|
De Vos, A;
Bjerke, M;
Brouns, R;
De Roeck, N;
Jacobs, D;
Van den Abbeele, L;
Guldolf, K;
... Vanmechelen, E; + view all
(2017)
Neurogranin and tau in cerebrospinal fluid and plasma of patients with acute ischemic stroke.
BMC Neurology
, 17
, Article 170. 10.1186/s12883-017-0945-8.
|
|
|
Dean, DC;
Hurley, SA;
Kecskemeti, SR;
O'Grady, JP;
Canda, C;
Davenport-Sis, NJ;
Carlsson, CM;
... Bendlin, BB; + view all
(2017)
Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease.
JAMA Neurology
, 74
(1)
pp. 41-49.
10.1001/jamaneurol.2016.3232.
|
|
Deming, Y;
Li, Z;
Kapoor, M;
Harari, O;
Del-Aguila, JL;
Black, K;
Carrell, D;
... Cruchaga, C; + view all
(2017)
Genome-wide association study identifies four novel loci associated with Alzheimer's endophenotypes and disease modifiers.
Acta Neuropathologica
, 133
(5)
pp. 839-856.
10.1007/s00401-017-1685-y.
|
|
|
Deters, KD;
Risacher, SL;
Kim, S;
Nho, K;
West, JD;
Blennow, K;
Zetterberg, H;
... Alzheimer Disease Neuroimaging Initiative, ADNI; + view all
(2017)
Plasma Tau Association with Brain Atrophy in Mild Cognitive Impairment and Alzheimer’s Disease.
Journal of Alzheimer's Disease
, 58
(4)
pp. 1245-1254.
10.3233/JAD-161114.
|
|
|
Disanto, G;
Barro, C;
Benkert, P;
Naegelin, Y;
Schadelin, S;
Giardiello, A;
Zecca, C;
... Swiss Multiple Sclerosis Cohort Study Group, .; + view all
(2017)
Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis.
Annals of Neurology
, 81
(6)
pp. 857-870.
10.1002/ana.24954.
|
|
Drews, A;
De, S;
Flagmeier, P;
Wirthensohn, DC;
Chen, W-H;
Whiten, DR;
Vincke, C;
... Klenerman, D; + view all
(2017)
Inhibiting the Ca2+ Influx Induced by Human CSF.
Cell Reports
, 21
(11)
pp. 3310-3316.
10.1016/j.celrep.2017.11.057.
|
|
|
Edsbagge, M;
Andreasson, U;
Ambarki, K;
Wikkelso, C;
Eklund, A;
Blennow, K;
Zetterberg, H;
(2017)
Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.
Journal of Alzheimer's Disease
, 58
(3)
pp. 821-828.
10.3233/JAD-161257.
|
|
|
Engelborghs, S;
Niemantsverdriet, E;
Struyfs, H;
Blennow, K;
Brouns, R;
Comabella, M;
Dujmovic, I;
... Teunissen, CE; + view all
(2017)
Consensus guidelines for lumbar puncture in patients with neurological diseases.
Alzheimers Dement (Amst)
, 8
pp. 111-126.
10.1016/j.dadm.2017.04.007.
|
|
|
Forland, MG;
Ohrfelt, A;
Oftedal, LS;
Tysnes, O-B;
Larsen, JP;
Blennow, K;
Zetterberg, H;
... Lange, J; + view all
(2017)
Validation of a new assay for alpha-synuclein detection in cerebrospinal fluid.
Clinical Chemistry and Laboratory Medicine
, 55
(2)
pp. 254-260.
10.1515/cclm-2016-0409.
|
|
Forsberg, A;
Cervenka, S;
Fagerlund, MJ;
Rasmussen, LS;
Zetterberg, H;
Harris, HE;
Stridh, P;
... Eriksson, LI; + view all
(2017)
The Immune Response of the Human Brain to Abdominal Surgery.
Annals of Neurology
, 81
(4)
pp. 572-582.
10.1002/ana.24909.
|
|
Gallo, V;
McElvenny, D;
Hobbs, C;
Davoren, D;
Morris, H;
Crutch, S;
Zetterberg, H;
... Pearce, N; + view all
(2017)
BRain health and healthy AgeINg in retired rugby union players, the BRAIN Study: study protocol for an observational study in the UK.
BMJ Open
, 7
(12)
, Article e017990. 10.1136/bmjopen-2017-017990.
|
|
|
Garcia-Ayllon, M-S;
Lopez-Font, I;
Boix, CP;
Fortea, J;
Sanchez-Valle, R;
Lleo, A;
Molinuevo, J-L;
... Saez-Valero, J; + view all
(2017)
C-terminal fragments of the amyloid precursor protein in cerebrospinal fluid as potential biomarkers for Alzheimer disease.
Scientific Reports
, 7
, Article 2477. 10.1038/s41598-017-02841-7.
|
|
|
Hakansson, I;
Tisell, A;
Cassel, P;
Blennow, K;
Zetterberg, H;
Lundberg, P;
Dahle, C;
... Ernerudh, J; + view all
(2017)
Neurofilament light chain in cerebrospinal fluid and prediction of disease activity in clinically isolated syndrome and relapsing-remitting multiple sclerosis.
European Journal of Neurology
, 24
(5)
pp. 703-712.
10.1111/ene.13274.
|
|
Hall, RJ;
Watne, LO;
Cunningham, E;
Zetterberg, H;
Shenkin, SD;
Wyller, TB;
MacLullich, AMJ;
(2017)
CSF biomarkers in delirium: a systematic review.
International Journal of Geriatric Psychiatry
, 33
(11)
pp. 1479-1500.
10.1002/gps.4720.
|
|
|
Hansson, KT;
Skillback, T;
Pernevik, E;
Holmen-Larsson, J;
Brinkmalm, G;
Blennow, K;
Zetterberg, H;
(2017)
Sample Preparation for Endopeptidomic Analysis in Human Cerebrospinal Fluid.
JOVE-Journal of Visualized Experiments
(130)
, Article e56244. 10.3791/56244.
|
|
Hansson, KT;
Skillbäck, T;
Pernevik, E;
Kern, S;
Portelius, E;
Höglund, K;
Brinkmalm, G;
... Gobom, J; + view all
(2017)
Expanding the cerebrospinal fluid endopeptidome.
Proteomics
, 17
(5)
, Article 1600384. 10.1002/pmic.201600384.
|
|
Hansson, O;
Janelidze, S;
Hall, S;
Magdalinou, N;
Lees, AJ;
Andreasson, U;
Norgren, N;
... Swedish BioFINDER Study, .; + view all
(2017)
Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder.
Neurology
, 88
(10)
pp. 930-937.
10.1212/WNL.0000000000003680.
|
|
|
Hashimoto, K;
Ishima, T;
Sato, Y;
Bruno, D;
Nierenberg, J;
Marmar, CR;
Zetterberg, H;
... Pomara, N; + view all
(2017)
Increased levels of ascorbic acid in the cerebrospinal fluid of cognitively intact elderly patients with major depression: a preliminary study.
Scientific Reports
, 7
, Article 3485. 10.1038/s41598-017-03836-0.
|
|
|
Herukka, SK;
Simonsen, AH;
Andreasen, N;
Baldeiras, I;
Bjerke, M;
Blennow, K;
Engelborghs, S;
... Waldemar, G; + view all
(2017)
Recommendations for CSF AD biomarkers in the diagnostic evaluation of MCI.
Alzheimer's and Dementia
, 13
(3)
pp. 285-295.
10.1016/j.jalz.2016.09.009.
|
|
|
Höglund, K;
Kern, S;
Zettergren, A;
Börjesson-Hansson, A;
Zetterberg, H;
Skoog, I;
Blennow, K;
(2017)
Preclinical amyloid pathology biomarker positivity: effects on tau pathology and neurodegeneration.
Translational Psychiatry
, 7
(1)
, Article e995. 10.1038/tp.2016.252.
|
|
|
Hov, KR;
Bolstad, N;
Idland, A-V;
Zetterberg, H;
Blennow, K;
Chaudhry, FA;
Frihagen, F;
... Watne, LO; + view all
(2017)
Cerebrospinal Fluid S100B and Alzheimer's Disease Biomarkers in Hip Fracture Patients with Delirium.
Dementia and Geriatric Cognitive Disorders Extra
, 7
(3)
pp. 374-385.
10.1159/000481853.
|
|
|
Hoy, AR;
Ly, M;
Carlsson, CM;
Okonkwo, OC;
Zetterberg, H;
Blennow, K;
Sager, MA;
... Bendlin, BB; + view all
(2017)
Microstructural white matter alterations in preclinical Alzheimer's disease detected using free water elimination diffusion tensor imaging.
PLoS ONE
, 12
(3)
, Article e0173982. 10.1371/journal.pone.0173982.
|
|
|
Idland, A-V;
Sala-Llonch, R;
Borza, T;
Watne, LO;
Wyller, TB;
Braekhus, A;
Zetterberg, H;
... Fjell, AM; + view all
(2017)
CSF neurofilament light levels predict hippocampal atrophy in cognitively healthy older adults.
Neurobiology of Aging
, 49
pp. 138-144.
10.1016/j.neurobiolaging.2016.09.012.
|
|
Idland, A-V;
Wyller, TB;
Stoen, R;
Eri, LM;
Frihagen, F;
Raeder, J;
Chaudhry, FA;
... Watne, LO; + view all
(2017)
Preclinical Amyloid-beta and Axonal Degeneration Pathology in Delirium.
Journal of Alzheimer's Disease
, 55
(1)
pp. 371-379.
10.3233/JAD-160461.
|
|
Isgren, A;
Sellgren, C;
Ekman, C-J;
Holmen-Larsson, J;
Blennow, K;
Zetterberg, H;
Jakobsson, J;
(2017)
Markers of neuroinflammation and neuronal injury in bipolar disorder: Relation to prospective clinical outcomes.
Brain Behavior and Immunity
, 65
pp. 195-201.
10.1016/j.bbi.2017.05.002.
|
|
|
Jabbari, E;
Zetterberg, H;
Morris, HR;
(2017)
Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers.
Journal of Neurology, Neurosurgery & Psychiatry
, 88
pp. 883-888.
10.1136/jnnp-2017-315857.
|
  |
|
Janelidze, S;
Hertze, J;
Nägga, K;
Nilsson, K;
Nilsson, C;
Swedish BioFINDER Study Group, .;
Wennström, M;
... Hansson, O; + view all
(2017)
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype.
Neurobiology of Aging
, 51
pp. 104-112.
10.1016/j.neurobiolaging.2016.11.017.
|
|
|
Janelidze, S;
Pannee, J;
Mikulskis, A;
Chiao, P;
Zetterberg, H;
Blennow, K;
Hansson, O;
(2017)
Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment.
JAMA Neurology
, 74
(12)
pp. 1492-1501.
10.1001/jamaneurol.2017.2814.
|
|
Jensen, CS;
Portelius, E;
Høgh, P;
Wermuth, L;
Blennow, K;
Zetterberg, H;
Hasselbalch, SG;
(2017)
Effect of physical exercise on markers of neuronal dysfunction in cerebrospinal fluid in patients with Alzheimer's disease.
Alzheimer's and Dementia: Translational Research and Clinical Interventions
, 3
(2)
pp. 284-290.
10.1016/j.trci.2017.03.007.
|
|
Johansson, P;
Almqvist, EG;
Bjerke, M;
Wallin, A;
Johansson, J-O;
Andreasson, U;
Blennow, K;
... Svensson, J; + view all
(2017)
Reduced Cerebrospinal Fluid Concentration of Apolipoprotein A-I in Patients with Alzheimer's Disease.
Journal of Alzheimer's Disease
, 59
(3)
pp. 1017-1026.
10.3233/JAD-170226.
|
|
Johansson, P;
Almqvist, EG;
Wallin, A;
Johansson, J-O;
Andreasson, U;
Blennow, K;
Zetterberg, H;
(2017)
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment.
PLOS ONE
, 12
(5)
, Article e0176760. 10.1371/journal.pone.0176760.
|
|
|
Johansson, V;
Jakobsson, J;
Fortgang, RG;
Zetterberg, H;
Blennow, K;
Cannon, TD;
Hultman, CM;
... Landén, M; + view all
(2017)
Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.
European Archives of Psychiatry and Clinical Neuroscience
, 267
(5)
pp. 391-402.
10.1007/s00406-016-0759-5.
|
|
Kalm, M;
Bostrom, M;
Sandelius, A;
Eriksson, Y;
Ek, CJ;
Blennow, K;
Bjork-Eriksson, T;
(2017)
Serum concentrations of the axonal injury marker neurofilament light protein are not influenced by blood-brain barrier permeability.
Brain Research
, 1668
pp. 12-19.
10.1016/j.brainres.2017.05.011.
|
|
|
Kaya, I;
Brinet, D;
Michno, W;
Baskurt, M;
Zetterbergt, H;
Blenow, K;
Hanrieder, J;
(2017)
Novel Trimodal MALDI Imaging Mass Spectrometry (IMS3) at 10 mu m Reveals Spatial Lipid and Peptide Correlates Implicated in A beta Plaque Pathology in Alzheimer's Disease.
ACS Chemical Neuroscience
, 8
(12)
pp. 2778-2790.
10.1021/acschemneuro.7b00314.
|
|
|
Kaya, I;
Brinet, D;
Michno, W;
Syvanen, S;
Sehlin, D;
Zetterberg, H;
Blennow, K;
(2017)
Delineating Amyloid Plaque Associated Neuronal Sphingolipids in Transgenic Alzheimer's Disease Mice (tgArcSwe) Using MALDI Imaging Mass Spectrometry.
ACS Chemical Neuroscience
, 8
(2)
pp. 347-355.
10.1021/acschemneuro.6b00391.
|
|
|
Kaya, I;
Michno, W;
Brinet, D;
Iacone, Y;
Zanni, G;
Blennow, K;
Zetterberg, H;
(2017)
Histology-Compatible MALDI Mass Spectrometry Based Imaging of Neuronal Lipids for Subsequent Immunofluorescent Staining.
Analytical Chemistry
, 89
(8)
pp. 4685-4694.
10.1021/acs.analchem.7b00313.
|
|
Keshavan, A;
Heslegrave, A;
Zetterberg, H;
Schott, JM;
(2017)
Blood Biomarkers for Alzheimer's Disease: Much Promise, Cautious Progress.
Molecular Diagnosis & Therapy
, 21
(1)
pp. 13-22.
10.1007/s40291-016-0241-0.
|
|
Kessing, CF;
Spudich, S;
Valcour, V;
Cartwright, P;
Chalermchai, T;
Fletcher, JLK;
Takata, H;
... Trautmann, L; + view all
(2017)
High Number of Activated CD8(+) T Cells Targeting HIV Antigens Are Present in Cerebrospinal Fluid in Acute HIV Infection.
JAIDS: Journal of Acquired Immune Deficiency Syndromes
, 75
(1)
pp. 108-117.
10.1097/QAI.0000000000001301.
|
|
Kovacs, GG;
Andreasson, U;
Liman, V;
Regelsberger, G;
Lutz, MI;
Danics, K;
Keller, E;
... Blennow, K; + view all
(2017)
Plasma and cerebrospinal fluid tau and neurofilament concentrations in rapidly progressive neurological syndromes: a neuropathology-based cohort.
European Journal of Neurology
, 24
(11)
1326-e77.
10.1111/ene.13389.
|
|
|
Koychev, I;
Gunn, RN;
Firouzian, A;
Lawson, J;
Zamboni, G;
Ridha, B;
Sahakian, BJ;
... Lovestone, S; + view all
(2017)
PET Tau and Amyloid-beta Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.
Journal of Alzheimer's Disease
, 60
(1)
pp. 283-293.
10.3233/JAD-170129.
|
|
|
Kranaster, L;
Blennow, K;
Zetterberg, H;
Sartorius, A;
(2017)
Electroconvulsive therapy does not alter the synaptic protein neurogranin in the cerebrospinal fluid of patients with major depression.
Journal of Neural Transmission
, 124
(12)
pp. 1641-1645.
10.1007/s00702-017-1802-z.
|
|
Kuhlmann, J;
Andreasson, U;
Pannee, J;
Bjerke, M;
Portelius, E;
Leinenbach, A;
Bittner, T;
... Blennow, K; + view all
(2017)
CSF A beta(1-42) - an excellent but complicated Alzheimer's biomarker - a route to standardisation.
Clinica Chimica Acta
, 467
pp. 27-33.
10.1016/j.cca.2016.05.014.
|
|
|
Kun-Rodrigues, C;
Ross, OA;
Orme, T;
Shepherd, C;
Parkkinen, L;
Darwent, L;
Hernandez, D;
... Bras, J; + view all
(2017)
Analysis of C9orf72 repeat expansions in a large international cohort of dementia with Lewy bodies.
Neurobiology of Aging
, 49
214.e13-214.e15.
10.1016/j.neurobiolaging.2016.08.023.
|
|
Lane, CA;
Parker, TD;
Cash, DM;
Macpherson, K;
Donnachie, E;
Murray-Smith, H;
Barnes, A;
... Schott, JM; + view all
(2017)
Study protocol: Insight 46 - a neuroscience sub-study of the MRC National Survey of Health and Development.
BMC Neurology
, 17
, Article 75. 10.1186/s12883-017-0846-x.
|
|
|
Lautner, R;
Insel, PS;
Skillback, T;
Olsson, B;
Landen, M;
Frisoni, GB;
Herukka, S-K;
... Zetterberg, H; + view all
(2017)
Preclinical effects of APOE epsilon 4 on cerebrospinal fluid A beta 42 concentrations.
Alzheimer's Research & Therapy
, 9
, Article 87. 10.1186/s13195-017-0313-3.
|
|
|
Lerche, S;
Schulte, C;
Srulijes, K;
Pilotto, A;
Rattay, TW;
Hauser, A-K;
Stransky, E;
... Brockmann, K; + view all
(2017)
Cognitive Impairment in Glucocerebrosidase (GBA)-Associated PD: Not Primarily Associated With Cerebrospinal Fluid Abeta and Tau Profiles.
Movement Disorders
, 32
(12)
pp. 1780-1783.
10.1002/mds.27199.
|
|
Lewczuk, P;
Lelental, N;
Lachmann, I;
Holzer, M;
Flach, K;
Brandner, S;
Engelborghs, S;
... Kornhuber, J; + view all
(2017)
Non-Phosphorylated Tau as a Potential Biomarker of Alzheimer's Disease: Analytical and Diagnostic Characterization.
Journal of Alzheimer's Disease
, 55
(1)
pp. 159-170.
10.3233/JAD-160448.
|
|
|
Leyhe, T;
Reynolds, CF;
Melcher, T;
Linnemann, C;
Kloeppel, S;
Blennow, K;
Zetterberg, H;
... Hampel, H; + view all
(2017)
A common challenge in older adults: Classification, overlap, and therapy of depression and dementia.
Alzheimer's & Dementia
, 13
(1)
pp. 59-71.
10.1016/j.jalz.2016.08.007.
|
|
Lista, S;
Toschi, N;
Baldacci, F;
Zetterberg, H;
Blennow, K;
Kilimann, I;
Teipel, SJ;
... Hampel, H; + view all
(2017)
Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer's disease.
Neurochemistry International
, 108
pp. 355-360.
10.1016/j.neuint.2017.05.010.
|
|
Lista, S;
Toschi, N;
Baldacci, F;
Zetterberg, H;
Blennow, K;
Kilimann, I;
Teipel, SJ;
... Hampel, H; + view all
(2017)
Cerebrospinal Fluid Neurogranin as a Biomarker of Neurodegenerative Diseases: A Cross-Sectional Study.
Journal of Alzheimer's Disease
, 59
(4)
pp. 1327-1334.
10.3233/JAD-170368.
|
|
Lista, S;
Zetterberg, H;
O'Bryant, SE;
Blennow, K;
Hampel, H;
(2017)
Evolving Relevance of Neuroproteomics in Alzheimer's Disease.
Neuroproteomics, Methods in Molecular Biology
, 1598
pp. 101-115.
10.1007/978-1-4939-6952-4_5.
|
|
|
Ljungqvist, J;
Zetterberg, H;
Mitsis, M;
Blennow, K;
Skoglund, T;
(2017)
Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study.
Journal of Neurotrauma
, 34
(5)
pp. 1124-1127.
10.1089/neu.2016.4496.
|
|
Lopez-Font, I;
Boix, CP;
Zetterberg, H;
Blennow, K;
Sáez-Valero, J;
(2017)
Alterations in the Balance of Amyloid-β Protein Precursor Species in the Cerebrospinal Fluid of Alzheimer's Disease Patients.
Journal of Alzheimer's Disease
, 57
(4)
pp. 1281-1291.
10.3233/JAD-161275.
|
|
|
Lövheim, H;
Elgh, F;
Johansson, A;
Zetterberg, H;
Blennow, K;
Hallmans, G;
Eriksson, S;
(2017)
Plasma concentrations of free amyloid β cannot predict the development of Alzheimer's disease.
Alzheimer's & Dementia
, 13
(7)
pp. 778-782.
10.1016/j.jalz.2016.12.004.
|
|
Lycke, J;
Zetterberg, H;
(2017)
The role of blood and CSF biomarkers in the evaluation of new treatments against multiple sclerosis.
[Review].
Expert Review of Clinical Immunology
, 13
(12)
pp. 1143-1153.
10.1080/1744666X.2017.1400380.
|
|
|
Magdalinou, NK;
Noyce, AJ;
Pinto, R;
Lindstrom, E;
Holmen-Larsson, J;
Holtta, M;
Blennow, K;
... Gobom, J; + view all
(2017)
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics.
Parkinsonism & Related Disorders
, 37
pp. 65-71.
10.1016/j.parkreldis.2017.01.016.
|
|
Mattsson, N;
Andreasson, U;
Zetterberg, H;
Blennow, K;
Alzheimer’s Disease Neuroimaging Initiative;
(2017)
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer Disease.
JAMA Neurology
, 74
(5)
pp. 557-566.
10.1001/jamaneurol.2016.6117.
|
|
|
Mattsson, N;
Scholl, M;
Strandberg, O;
Smith, R;
Palmqvist, S;
Insel, PS;
Hgerstrom, D;
... Hansson, O; + view all
(2017)
F-18-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease.
EMBO Molecular Medicine
, 9
(9)
pp. 1212-1223.
10.15252/emmm.201707809.
|
|
Mattsson, N;
Zetterberg, H;
Nielsen, N;
Blennow, K;
Dankiewicz, J;
Friberg, H;
Lilja, G;
... Cronberg, T; + view all
(2017)
Serum tau and neurological outcome in cardiac arrest.
Annals of Neurology
, 82
(5)
pp. 665-675.
10.1002/ana.25067.
|
|
|
Mollenhauer, B;
Batrla, R;
El-Agnaf, O;
Galasko, DR;
Lashuel, HA;
Merchant, KM;
Shaw, LM;
... Taylor, P; + view all
(2017)
A user's guide for α‐synuclein biomarker studies in biological fluids: Perianalytical considerations.
Movement Disorders
, 32
(8)
pp. 1117-1130.
10.1002/mds.27090.
|
|
Murray, CE;
Gami-Patel, P;
Gkanatsiou, E;
Brinkmalm, G;
Portelius, E;
Blennow, K;
Ghiso, J;
... Lashley, T; + view all
(2017)
Is the presubiculum protected from neurodegenerative changes? A pathological and biochemical investigation.
Presented at: Alzheimer's Association International Conference, London, United Kingdom.
|
|
Nagga, K;
Gustavsson, A-M;
Stomrud, E;
Lindqvist, D;
van Westen, D;
Blennow, K;
Zetterberg, H;
... Hansson, O; + view all
(2017)
Increased midlife triglycerides predict brain -amyloid and tau pathology 20 years later.
Neurology
, 90
(1)
e73-e81.
10.1212/WNL.0000000000004749.
|
|
|
Novakova, L;
Axelsson, M;
Khademi, M;
Zetterberg, H;
Blennow, K;
Malmeström, C;
Piehl, F;
... Lycke, J; + view all
(2017)
Cerebrospinal fluid biomarkers as a measure of disease activity and treatment efficacy in relapsing-remitting multiple sclerosis.
Journal of Neurochemistry
, 141
(2)
pp. 296-304.
10.1111/jnc.13881.
|
|
Novakova, L;
Axelsson, M;
Khademi, M;
Zetterberg, H;
Blennow, K;
Malmestrom, C;
Piehl, F;
... Lycke, J; + view all
(2017)
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Multiple Sclerosis Journal
, 23
(1)
pp. 62-71.
10.1177/1352458516639384.
|
|
|
Novakova, L;
Zetterberg, H;
Sundstrom, P;
Axelsson, M;
Khademi, M;
Gunnarsson, M;
Malmestrom, C;
... Lycke, J; + view all
(2017)
Monitoring disease activity in multiple sclerosis using serum neurofilament light protein.
Neurology
, 89
(22)
pp. 2230-2237.
10.1212/WNL.0000000000004683.
|
|
|
O'Bryant, SE;
Mielke, MM;
Rissman, RA;
Lista, S;
Vanderstichele, H;
Zetterberg, H;
Lewczuk, P;
... Hampel, H; + view all
(2017)
Blood-based biomarkers in Alzheimer disease: Current state of the science and a novel collaborative paradigm for advancing from discovery to clinic.
Alzheimer's & Dementia
, 13
(1)
pp. 45-58.
10.1016/j.jalz.2016.09.014.
|
|
Oliver, JM;
Jones, MT;
Anzalone, AJ;
Kirk, KM;
Gable, DA;
Repshas, JT;
Johnson, TA;
... Zetterberg, H; + view all
(2017)
A Season of American Football Is Not Associated with Changes in Plasma Tau.
Journal of Neurotrauma
, 34
(23)
pp. 3295-3300.
10.1089/neu.2017.5064.
|
|
|
Olsson, B;
Schott, JM;
Blennow, K;
Zetterberg, H;
(2017)
The use of cerebrospinal fluid biomarkers to measure change in neurodegeneration in Alzheimer's disease clinical trials.
Expert Review of Neurotherapeutics
, 17
(8)
pp. 767-775.
10.1080/14737175.2017.1341311.
|
|
Palmqvist, S;
Scholl, M;
Strandberg, O;
Mattsson, N;
Stomrud, E;
Zetterberg, H;
Blennow, K;
... Hansson, O; + view all
(2017)
Earliest accumulation of beta-amyloid occurs within the default-mode network and concurrently affects brain connectivity.
Nature Communications
, 8
, Article 1214. 10.1038/s41467-017-01150-x.
|
|
|
Palsson, E;
Sellgren, C;
Ryden, E;
Kizza, R;
Pelanis, A;
Zetterberg, H;
Blennow, K;
(2017)
Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls.
Journal of Neural Transmission
, 124
(9)
pp. 1135-1143.
10.1007/s00702-017-1746-3.
|
|
|
Pannee, J;
Blennow, K;
Zetterberg, H;
Portelius, E;
(2017)
Absolute Quantification of Aβ1-42 in CSF Using a Mass Spectrometric Reference Measurement Procedure.
Journal of Visualized Experiments
, 121
, Article e55386. 10.3791/55386.
|
|
Paterson, RW;
(2017)
Cerebrospinal fluid biomarkers in Alzheimer’s Disease: from bedside to bench and back.
Doctoral thesis , UCL (University College London).
|
|
|
Peluso, MJ;
Valcour, V;
Phanuphak, N;
Ananworanich, J;
Fletcher, JLK;
Chalermchai, T;
Krebs, SJ;
... Spudich, S; + view all
(2017)
Immediate initiation of cART is associated with lower levels of cerebrospinal fluid YKL-40, a marker of microglial activation, in HIV-1 infection.
AIDS
, 31
(2)
pp. 247-252.
10.1097/QAD.0000000000001314.
|
|
Pikwer, A;
Castegren, M;
Namdar, S;
Blennow, K;
Zetterberg, H;
Mattsson, N;
(2017)
Effects of surgery and propofol-remifentanil total intravenous anesthesia on cerebrospinal fluid biomarkers of inflammation, Alzheimer's disease, and neuronal injury in humans: a cohort study.
Journal of Neuroinflammation
, 14
, Article 193. 10.1186/s12974-017-0950-2.
|
|
Portelius, E;
Brinkmalm, G;
Pannee, J;
Zetterberg, H;
Blennow, K;
Dahlen, R;
Brinkmalm, A;
(2017)
Proteomic studies of cerebrospinal fluid biomarkers of Alzheimer's disease: an update.
[Review].
Expert Review of Proteomics
, 14
(11)
pp. 1007-1020.
10.1080/14789450.2017.1384697.
|
|
|
Portelius, E;
Mattsson, N;
Pannee, J;
Zetterberg, H;
Gisslen, M;
Vanderstichele, H;
Gkanatsiou, E;
... Blennow, K; + view all
(2017)
Ex vivo O-18-labeling mass spectrometry identifies a peripheral amyloid beta clearance pathway.
Molecular Neurodegeneration
, 12
, Article 18. 10.1186/s13024-017-0152-5.
|
|
Rahimy, E;
Li, F-Y;
Hagberg, L;
Fuchs, D;
Robertson, K;
Meyerhoff, DJ;
Zetterberg, H;
... Spudich, S; + view all
(2017)
Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy.
Journal of Infectious Diseases
, 215
(7)
pp. 1132-1140.
10.1093/infdis/jix013.
|
|
Reid, SJ;
Mckean, NE;
Henty, K;
Portelius, E;
Blennow, K;
Rudiger, SR;
Bawden, CS;
... Snell, RG; + view all
(2017)
Alzheimer's disease markers in the aged sheep (Ovis aries).
Neurobiology of Aging
, 58
pp. 112-119.
10.1016/j.neurobiolaging.2017.06.020.
|
|
|
Russell, CL;
Heslegrave, A;
Mitra, V;
Zetterberg, H;
Pocock, JM;
Ward, MA;
Pike, I;
(2017)
Combined tissue and fluid proteomics with Tandem Mass Tags to identify low-abundance protein biomarkers of disease in peripheral body fluid: An Alzheimer's Disease case study.
Rapid Communications in Mass Spectrometry
, 31
(2)
pp. 153-159.
10.1002/rcm.7777.
|
|
Russell, CL;
Mitra, V;
Hansson, K;
Blennow, K;
Gobom, J;
Zetterberg, H;
Hiltunen, M;
... Pike, I; + view all
(2017)
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.
Journal of Alzheimer's Disease
, 55
(1)
pp. 303-313.
10.3233/JAD-160633.
|
|
Rymo, I;
Kern, S;
Bjerke, M;
Zetterberg, H;
Marlow, T;
Blennow, K;
Gudmundsson, P;
... Waern, M; + view all
(2017)
CSF YKL-40 and GAP-43 are related to suicidal ideation in older women.
Acta Psychiatrica Scandinavica
, 135
(4)
pp. 351-357.
10.1111/acps.12701.
|
|
Sala-Llonch, R;
Idland, A-V;
Borza, T;
Watne, LO;
Wyller, TB;
Brkhus, A;
Zetterberg, H;
... Fjell, AM; + view all
(2017)
Inflammation, Amyloid, and Atrophy in The Aging Brain: Relationships with Longitudinal Changes in Cognition.
Journal of Alzheimer's Disease
, 58
(3)
pp. 829-840.
10.3233/JAD-161146.
|
|
Sanfilippo, C;
Nunnari, G;
Calcagno, A;
Malaguarnera, L;
Blennow, K;
Zetterberg, H;
Di Rosa, M;
(2017)
The chitinases expression is related to Simian Immunodeficiency Virus Encephalitis (SIVE) and in HIV encephalitis (HIVE).
Virus Research
, 227
pp. 220-230.
10.1016/j.virusres.2016.10.012.
|
|
Schultz, SA;
Boots, EA;
Darst, BF;
Zetterberg, H;
Blennow, K;
Edwards, DF;
Koscik, RL;
... Okonkwo, OC; + view all
(2017)
Cardiorespiratory fitness alters the influence of a polygenic risk score on biomarkers of AD.
Neurology
, 88
(17)
pp. 1650-1658.
10.1212/WNL.0000000000003862.
|
|
Selnes, P;
Stav, AL;
Johansen, KK;
Bjornerud, A;
Coello, C;
Auning, E;
Kalheim, L;
... Fladby, T; + view all
(2017)
Impaired synaptic function is linked to cognition in Parkinson's disease.
Annals of Clinical and Translational Neurology
, 4
(10)
pp. 700-713.
10.1002/acn3.446.
|
|
|
Sengupta, U;
Portelius, E;
Hansson, O;
Farmer, K;
Castillo-Carranza, D;
Woltjer, R;
Zetterberg, H;
... Kayed, R; + view all
(2017)
Tau oligomers in cerebrospinal fluid in Alzheimer's disease.
Annals of Clinical and Translational Neurology
, 4
(4)
pp. 226-235.
10.1002/acn3.382.
|
|
|
Shahim, P;
Blennow, K;
Johansson, P;
Svensson, J;
Lista, S;
Hampel, H;
Andersson, LC;
(2017)
Cerebrospinal Fluid Stanniocalcin-1 as a Biomarker for Alzheimer's Disease and Other Neurodegenerative Disorders.
NeuroMolecular Medicine
, 19
(1)
pp. 154-160.
10.1007/s12017-016-8439-1.
|
|
Shahim, P;
Tegner, Y;
Marklund, N;
Höglund, K;
Portelius, E;
Brody, DL;
Blennow, K;
(2017)
Astroglial activation and altered amyloid metabolism in human repetitive concussion.
Neurology
, 88
(15)
pp. 1400-1407.
10.1212/WNL.0000000000003816.
|
|
Shahim, P;
Zetterberg, H;
Tegner, Y;
Blennow, K;
(2017)
Serum neurofilament light as a biomarker for mild traumatic brain injury in contact sports.
Neurology
, 88
(19)
pp. 1788-1794.
10.1212/WNL.0000000000003912.
|
|
Simonsen, AH;
Herukka, SK;
Andreasen, N;
Baldeiras, I;
Bjerke, M;
Blennow, K;
Engelborghs, S;
... Waldemar, G; + view all
(2017)
Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia.
Alzheimer's and Dementia
, 13
(3)
pp. 274-284.
10.1016/j.jalz.2016.09.008.
|
|
|
Singh, AK;
Novakova, L;
Axelsson, M;
Malmestrom, C;
Zetterberg, H;
Lycke, J;
Cardell, SL;
(2017)
High Interferon-gamma Uniquely in V delta 1 T Cells Correlates with Markers of Inflammation and Axonal Damage in Early Multiple Sclerosis.
Frontiers in Immunology
, 8
, Article 260. 10.3389/fimmu.2017.00260.
|
|
|
Sjodin, S;
Hansson, O;
Ohrfelt, A;
Brinkmalm, G;
Zetterberg, H;
Brinkmalm, A;
Blennow, K;
(2017)
Mass Spectrometric Analysis of Cerebrospinal Fluid Ubiquitin in Alzheimer's Disease and Parkinsonian Disorders.
Proteomics Clinical Applications
, 11
(11-12)
10.1002/prca.201700100.
|
|
Skillback, T;
Delsing, L;
Synnergren, J;
Mattsson, N;
Janelidze, S;
Nagga, K;
Kilander, L;
... Zetterberg, H; + view all
(2017)
CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients.
Neurobiology of Aging
, 59
pp. 1-9.
10.1016/j.neurobiolaging.2017.06.028.
|
|
|
Skillbäck, T;
Mattsson, N;
Blennow, K;
Zetterberg, H;
(2017)
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
, 18
(5-6)
pp. 397-403.
10.1080/21678421.2017.1281962.
|
|
Skillback, T;
Mattsson, N;
Hansson, K;
Mirgorodskaya, E;
Dahlen, R;
van der Flier, W;
Scheltens, P;
... Gobom, J; + view all
(2017)
A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease.
Scientific Reports
, 7
, Article 13333. 10.1038/s41598-017-13831-0.
|
|
|
Soylu-Kucharz, R;
Sandelius, A;
Sjogren, M;
Blennow, K;
Wild, EJ;
Zetterberg, H;
Bjorkqvist, M;
(2017)
Neurofilament light protein in CSF and blood is associated with neurodegeneration and disease severity in Huntington's disease R6/2 mice.
Scientific Reports
, 7
, Article 14114. 10.1038/s41598-017-14179-1.
|
|
Sprecher, KE;
Koscik, RL;
Carlsson, CM;
Zetterberg, H;
Blennow, K;
Okonkwo, OC;
Sager, MA;
... Bendlin, BB; + view all
(2017)
Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults.
Neurology
, 89
(5)
pp. 445-453.
10.1212/WNL.0000000000004171.
|
|
Stening, E;
Persson, J;
Eriksson, E;
Wahlund, L-O;
Zetterberg, H;
Soderlund, H;
(2017)
Specific patterns of whole-brain structural covariance of the anterior and posterior hippocampus in young APOE epsilon 4 carriers.
Behavioural Brain Research
, 326
pp. 256-264.
10.1016/j.bbr.2017.03.013.
|
|
Sveinsson, O;
Granqvist, M;
Forslin, Y;
Blennow, K;
Zetterberg, H;
Piehl, F;
(2017)
Successful combined targeting of B- and plasma cells in treatment refractory anti-NMDAR encephalitis.
Journal of Neuroimmunology
, 312
pp. 15-18.
10.1016/j.jneuroim.2017.08.011.
|
|
|
Thordardottir, S;
Stahlbom, AK;
Almkvist, O;
Thonberg, H;
Eriksdotter, M;
Zetterberg, H;
Blennow, K;
(2017)
The effects of different familial Alzheimer's disease mutations on APP processing in vivo.
Alzheimer's Research & Therapy
, 9
, Article 9. 10.1186/s13195-017-0234-1.
|
|
|
Toombs, J;
Foiani, MS;
Paterson, RW;
Heslegrave, A;
Wray, S;
Schott, JM;
Fox, NC;
... Zetterberg, H; + view all
(2017)
Effect of Spinal Manometers on Cerebrospinal Fluid Amyloid-beta Concentration.
Journal of Alzheimer's Disease
, 56
(3)
pp. 885-891.
10.3233/JAD-161126.
|
|
Velickaite, V;
Giedraitis, V;
Strom, K;
Alafuzoff, I;
Zetterberg, H;
Lannfelt, L;
Kilander, L;
... Ingelsson, M; + view all
(2017)
Cognitive function in very old men does not correlate to biomarkers of Alzheimer's disease.
BMC Geriatrics
, 17
, Article 208. 10.1186/s12877-017-0601-6.
|
|
|
Vogt, NM;
Kerby, RL;
Dill-McFarland, KA;
Harding, SJ;
Merluzzi, AP;
Johnson, SC;
Carlsson, CM;
... Rey, FE; + view all
(2017)
Gut microbiome alterations in Alzheimer's disease.
Scientific Reports
, 7
, Article 13537. 10.1038/s41598-017-13601-y.
|
|
Wellington, Henrietta;
(2017)
Neurogranin - A Synaptic Biomarker of Alzheimer's Disease.
Doctoral thesis (Ph.D), UCL (University College London).
|
|
Weston, PSJ;
Poole, T;
Ryan, NS;
Nair, A;
Liang, Y;
Macpherson, K;
Druyeh, R;
... Fox, NC; + view all
(2017)
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.
Neurology
, 89
(21)
pp. 2167-2175.
10.1212/WNL.0000000000004667.
|
|
Westwood, S;
Liu, B;
Baird, AL;
Anand, S;
Nevado-Holgado, AJ;
Newby, D;
Pikkarainen, M;
... Lovestone, S; + view all
(2017)
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology.
Alzheimer's Research & Therapy
, 9
(1)
, Article 31. 10.1186/s13195-017-0258-6.
|
|
|
Yilmaz, A;
Blennow, K;
Hagberg, L;
Nilsson, S;
Price, RW;
Schouten, J;
Spudich, S;
... Gisslen, M; + view all
(2017)
Neurofilament light chain protein as a marker of neuronal injury: review of its use in HIV-1 infection and reference values for HIV-negative controls.
[Review].
Expert Review of Molecular Diagnostics
, 17
(8)
pp. 761-770.
10.1080/14737159.2017.1341313.
|
|
|
Zetterberg, H;
(2017)
Fluid biomarkers for microglial activation and axonal injury in multiple sclerosis.
Acta Neurologica Scandinavica
, 136
(s201)
pp. 15-17.
10.1111/ane.12845.
|
|
Zetterberg, H;
(2017)
Omic and Systems Biology Approaches in Neurodegenerative Diseases Applying fluid biomarkers to Alzheimer's disease.
American Journal of Physiology - Cell Physiology
, 313
(1)
C3-C10.
10.1152/ajpcell.00007.2017.
|
|
|
Zetterberg, H;
(2017)
Review: Tau in biofluids - relation to pathology, imaging and clinical features.
Neuropathology and Applied Neurobiology
, 43
(3)
pp. 194-199.
10.1111/nan.12378.
|
|
Zetterberg, H;
(2017)
Psychosis and biological markers.
[Editorial comment].
Lancet Psychiatry
, 4
(1)
pp. 3-5.
10.1016/S2215-0366(16)30407-2.
|
|
|
Zetterberg, H;
Rohrer, JD;
Schott, JM;
(2017)
Chapter 6 - Cerebrospinal fluid in the dementias.
Handbook of Clinical Neurology
, 146
pp. 85-97.
10.1016/B978-0-12-804279-3.00006-X.
|
|
Zetterberg, H;
Teunissen, C;
(2017)
Fluid biomarkers for disease activity in multiple sclerosis.
[Editorial comment].
Multiple Sclerosis Journal
, 23
(13)
pp. 1660-1661.
10.1177/1352458517736151.
|
2016
|
Abdelnour, C;
Van Steenoven, I;
Londos, E;
Blanc, F;
Auestad, B;
Kramberger, MG;
Zetterberg, H;
... Aarsland, D; + view all
(2016)
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia.
Movement Disorders
, 31
(8)
pp. 1203-1208.
10.1002/mds.26668.
|
|
Aberg, ND;
Stanne, TM;
Jood, K;
Schioler, L;
Blomstrand, C;
Andreasson, U;
Blennow, K;
... Svensson, J; + view all
(2016)
Serum erythropoietin and outcome after ischaemic stroke: a prospective study.
BMJ Open
, 6
(2)
, Article e009827. 10.1136/bmjopen-2015-009827.
|
|
|
Ahlgren, E;
Hagberg, L;
Fuchs, D;
Andersson, L-M;
Nilsson, S;
Zetterberg, H;
Gisslen, M;
(2016)
Association between Plasma Homocysteine Levels and Neuronal Injury in HIV Infection.
PLOS ONE
, 11
(7)
, Article e0158973. 10.1371/journal.pone.0158973.
|
|
Alba Mane-Martinez, M;
Olsson, B;
Bau, L;
Matas, E;
Cobo-Calvo, A;
Andreasson, U;
Blennow, K;
... Zetterberg, H; + view all
(2016)
Glial and neuronal markers in cerebrospinal fluid in different types of multiple sclerosis.
Journal of Neuroimmunology
, 299
pp. 112-117.
10.1016/j.jneuroim.2016.08.004.
|
|
Andersson, C-H;
Hansson, O;
Minthon, L;
Andreasen, N;
Blennow, K;
Zetterberg, H;
Skoog, I;
... Kettunen, P; + view all
(2016)
A Genetic Variant of the Sortilin 1 Gene is Associated with Reduced Risk of Alzheimer's Disease.
Journal of Alzheimer's Disease
, 53
(4)
pp. 1353-1363.
10.3233/JAD-160319.
|
|
Andreasson, U;
Blennow, K;
Zetterberg, H;
(2016)
Update on ultrasensitive technologies to facilitate research on blood biomarkers for central nervous system disorders.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 3
pp. 98-102.
10.1016/j.dadm.2016.05.005.
|
|
Anesten, B;
Yilmaz, A;
Hagberg, L;
Zetterberg, H;
Nilsson, S;
Brew, BJ;
Fuchs, D;
... Gisslén, M; + view all
(2016)
Blood-brain barrier integrity, intrathecal immunoactivation, and neuronal injury in HIV.
Neurology: Neuroimmunology & Neuroinflammation
, 3
(6)
, Article e300. 10.1212/NXI.0000000000000300.
|
|
|
Banote, RK;
Edling, M;
Eliassen, F;
Kettunen, P;
Zetterberg, H;
Abramsson, A;
(2016)
β-Amyloid precursor protein-b is essential for Mauthner cell development in the zebrafish in a Notch-dependent manner.
Developmental Biology
, 413
(1)
pp. 26-38.
10.1016/j.ydbio.2016.03.012.
|
|
Bergman, J;
Dring, A;
Zetterberg, H;
Blennow, K;
Norgren, N;
Gilthorpe, J;
Bergenheim, T;
(2016)
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.
Neurology: Neuroimmunology & Neuroinflammation
, 3
(5)
, Article e271. 10.1212/NXI.0000000000000271.
|
|
|
Bergstrom, P;
Agholme, L;
Nazir, FH;
Satir, TM;
Toombs, J;
Wellington, H;
Strandberg, J;
... Zetterberg, H; + view all
(2016)
Amyloid precursor protein expression and processing are differentially regulated during cortical neuron differentiation.
Scientific Reports
, 6
, Article 292. 10.1038/srep29200.
|
|
|
Blennow, K;
Brody, DL;
Kochanek, PM;
Levin, H;
McKee, A;
Ribbers, GM;
Yaffe, K;
(2016)
Traumatic brain injuries.
Nature Reviews Disease Primers
, 2
, Article 16084. 10.1038/nrdp.2016.84.
|
|
|
Burman, J;
Raininko, R;
Blennow, K;
Zetterberg, H;
Axelsson, M;
Malmestrom, C;
(2016)
YKL-40 is a CSF biomarker of intrathecal inflammation in secondary progressive multiple sclerosis.
Journal of Neuroimmunology
, 292
pp. 52-57.
10.1016/j.jneuroim.2016.01.013.
|
|
|
Cicognola, C;
Chiasserini, D;
Eusebi, P;
Andreasson, U;
Vanderstichele, H;
Zetterberg, H;
Parnetti, L;
(2016)
No diurnal variation of classical and candidate biomarkers of Alzheimer's disease in CSF.
Molecular Neurodegeneration
, 11
, Article 65. 10.1186/s13024-016-0130-3.
|
|
|
Constantinescu, R;
Krysl, D;
Bergquist, F;
Andren, K;
Malmestroem, C;
Asztely, F;
Axelsson, M;
... Zetterberg, H; + view all
(2016)
Cerebrospinal fluid markers of neuronal and glial cell damage to monitor disease activity and predict long-term outcome in patients with autoimmune encephalitis.
European Journal of Neurology
, 23
(4)
pp. 796-806.
10.1111/ene.12942.
|
|
|
Eden, A;
Marcotte, TD;
Heaton, RK;
Nilsson, S;
Zetterberg, H;
Fuchs, D;
Franklin, D;
... Gisslen, M; + view all
(2016)
Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment.
PLOS ONE
, 11
(6)
, Article e0157160. 10.1371/journal.pone.0157160.
|
|
|
Eden, A;
Nilsson, S;
Hagberg, L;
Fuchs, D;
Zetterberg, H;
Svennerholm, B;
Gisslen, M;
(2016)
Asymptomatic Cerebrospinal Fluid HIV-1 Viral Blips and Viral Escape During Antiretroviral Therapy: A Longitudinal Study.
Journal of Infectious Diseases
, 214
(12)
pp. 1822-1825.
10.1093/infdis/jiw454.
|
|
Ferretti, F;
Bigoloni, A;
Passeri, L;
Galli, L;
Longo, V;
Gerevini, S;
Spagnuolo, V;
... Castagna, A; + view all
(2016)
Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients.
Medicine
, 95
(28)
, Article e4144. 10.1097/MD.0000000000004144.
|
|
|
Gren, M;
Shahim, P;
Lautner, R;
Wilson, DH;
Andreasson, U;
Norgren, N;
Blennow, K;
(2016)
Blood biomarkers indicate mild neuroaxonal injury and increased amyloid production after transient hypoxia during breath-hold diving.
Brain Injury
, 30
(10)
pp. 1226-1230.
10.1080/02699052.2016.1179792.
|
|
Guerreiro, R;
Escott-Price, V;
Darwent, L;
Parkkinen, L;
Ansorge, O;
Hernandez, DG;
Nalls, MA;
... Bras, J; + view all
(2016)
Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.
Neurobiology of Aging
, 38
214.e7-214.e10.
10.1016/j.neurobiolaging.2015.10.028.
|
|
Gustavsson, C;
Hall, UA;
Pelanis, A;
Karlsson, OI;
Andersson, L;
Svedin, P;
Mallard, C;
... Holmaeng, A; + view all
(2016)
Cerebrospinal fluid levels of insulin, leptin, and agouti-related protein in relation to BMI in pregnant women.
Obesity
, 24
(6)
pp. 1299-1304.
10.1002/oby.21502.
|
|
Hall, S;
Surova, Y;
Ohrfelt, A;
Blennow, K;
Zetterberg, H;
Hansson, O;
(2016)
Longitudinal Measurements of Cerebrospinal Fluid Biomarkers in Parkinson's Disease.
Movement Disorders
, 31
(6)
pp. 898-905.
10.1002/mds.26578.
|
|
|
Hashimoto, K;
Bruno, D;
Nierenberg, J;
Marmar, CR;
Zetterberg, H;
Blennow, K;
Pomara, N;
(2016)
Abnormality in glutamine-glutamate cycle in the cerebrospinal fluid of cognitively intact elderly individuals with major depressive disorder: a 3-year follow-up study.
Translational Psychiatry
, 6
, Article e744. 10.1038/tp.2016.8.
|
|
|
Heslegrave, A;
Heywood, W;
Paterson, R;
Magdalinou, N;
Svensson, J;
Johansson, P;
Ohrfelt, A;
... Zetterberg, H; + view all
(2016)
Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease.
Molecular Neurodegeneration
, 11
, Article 3. 10.1186/s13024-016-0071-x.
|
|
|
Heywood, WE;
Baud, A;
Bliss, E;
Sirka, E;
Schott, JM;
Zetterberg, H;
Galimberti, D;
... Mills, K; + view all
(2016)
A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status.
Journal of Visualized Experiments
, 116
, Article e54541. 10.3791/54541.
|
|
Heywood, WE;
Galimberti, D;
Bliss, E;
Sirka, E;
Paterson, RW;
Magdalinou, NK;
Carecchio, M;
... Mills, K; + view all
(2016)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay (vol 10, 64, 2015).
[Corrigendum].
Molecular Neurodegeneration
, 11
, Article 20. 10.1186/s13024-016-0086-3.
|
|
|
Holtta, M;
Dean, RA;
Siemers, E;
Mawuenyega, KG;
Sigurdson, W;
May, PC;
Holtzman, DM;
... Gobom, J; + view all
(2016)
A single dose of the gamma-secretase inhibitor semagacestat alters the cerebrospinal fluid peptidome in humans.
Alzheimer's Research & Therapy
, 8
, Article 11. 10.1186/s13195-016-0178-x.
|
|
|
Horrocks, MH;
Lee, SF;
Gandhi, S;
Magdalinou, NK;
Chen, SW;
Devine, MJ;
Tosatto, L;
... Klenerman, D; + view all
(2016)
Single-Molecule Imaging of Individual Amyloid Protein Aggregates in Human Biofluids.
ACS Chemical Neuroscience
, 7
(3)
pp. 399-406.
10.1021/acschemneuro.5b00324.
|
|
Hoscheidt, SM;
Starks, EJ;
Oh, JM;
Zetterberg, H;
Blennow, K;
Krause, RA;
Gleason, CE;
... Bendlin, BB; + view all
(2016)
Insulin Resistance is Associated with Increased Levels of Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Reduced Memory Function in At-Risk Healthy Middle-Aged Adults.
Journal of Alzheimer's Disease
, 52
(4)
pp. 1373-1383.
10.3233/JAD-160110.
|
|
|
Janelidze, S;
Stomrud, E;
Palmqvist, S;
Zetterberg, H;
van Westen, D;
Jeromin, A;
Song, L;
... Hansson, O; + view all
(2016)
Plasma beta-amyloid in Alzheimer's disease and vascular disease.
Scientific Reports
, 6
(26801)
10.1038/srep26801.
|
|
|
Janelidze, S;
Zetterberg, H;
Mattsson, N;
Palmqvist, S;
Vanderstichele, H;
Lindberg, O;
van Westen, D;
... Hansson, O; + view all
(2016)
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease.
Annals of Clinical and Translational Neurology
, 3
(3)
pp. 154-165.
10.1002/acn3.274.
|
|
|
Jensen, CS;
Portelius, E;
Siersnia, V;
Hogh, P;
Wermuth, L;
Blennow, K;
Zetterberg, H;
... Sinionsen, AH; + view all
(2016)
Cerebrospinal Fluid Amyloid Beta and Tau Concentrations Are Not Modulated by 16 Weeks of Moderate- to High-Intensity Physical Exercise in Patients with Alzheimer Disease.
Dementia and Geriatric Cognitive Disorders
, 42
(3-4)
pp. 146-158.
10.1159/000449408.
|
|
Jeppsson, A;
Höltta, M;
Zetterberg, H;
Blennow, K;
Wikkelsø, C;
Tullberg, M;
(2016)
Amyloid mis-metabolism in idiopathic normal pressure hydrocephalus.
Fluids and Barriers of the CNS
, 13
, Article 13. 10.1186/s12987-016-0037-y.
|
|
Jespersen, S;
Pedersen, KK;
Anesten, B;
Zetterberg, H;
Fuchs, D;
Gisslen, M;
Hagberg, L;
... Nielsen, SD; + view all
(2016)
Soluble CD14 in cerebrospinal fluid is associated with markers of inflammation and axonal damage in untreated HIV-infected patients: a retrospective cross-sectional study.
BMC Infectious Diseases
, 16
, Article 176. 10.1186/s12879-016-1510-6.
|
|
|
Kalm, M;
Andreasson, U;
Bjork-Eriksson, T;
Zetterberg, H;
Pekny, M;
Blennow, K;
Pekna, M;
(2016)
C3 deficiency ameliorates the negative effects of irradiation of the young brain on hippocampal development and learning.
Oncotarget
, 7
(15)
pp. 19382-19394.
10.18632/oncotarget.8400.
|
|
|
Kern, J;
Kern, S;
Blennow, K;
Zetterberg, H;
Waern, M;
Guo, X;
Borjesson-Hanson, A;
... Ostling, S; + view all
(2016)
Calcium supplementation and risk of dementia in women with cerebrovascular disease.
Neurology
, 87
(16)
pp. 1674-1680.
10.1212/WNL.0000000000003111.
|
|
Krut, JJ;
Price, RW;
Zetterberg, H;
Fuchs, D;
Hagberg, L;
Yilmaz, A;
Cinque, P;
... Gisslén, M; + view all
(2016)
No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau).
Virulence
, 8
(5)
pp. 599-604.
10.1080/21505594.2016.1212155.
|
|
Kuhle, J;
Barro, C;
Andreasson, U;
Derfuss, T;
Lindberg, R;
Sandelius, A;
Liman, V;
... Zetterberg, H; + view all
(2016)
Comparison of three analytical platforms for quantification of the neurofilament light chain in blood samples: ELISA, electrochemiluminescence immunoassay and Simoa.
Clinical Chemistry and Laboratory Medicine
, 54
(10)
pp. 1655-1661.
10.1515/cclm-2015-1195.
|
|
Lehmann-Werman, R;
Neiman, D;
Zemmour, H;
Moss, J;
Magenheim, J;
Vaknin-Dembinsky, A;
Rubertsson, S;
... Dor, Y; + view all
(2016)
Identification of tissue-specific cell death using methylation patterns of circulating DNA.
Proceedings of the National Academy of Sciences
, 113
(13)
E1826-E1834.
10.1073/pnas.1519286113.
|
|
|
Lehtinen-Jacks, S;
Agelii, ML;
Hunsberger, M;
Zetterberg, H;
Lissner, L;
(2016)
Serum 25-hydroxy vitamin D levels in middle-aged women in relationship to adiposity and height trajectories over three decades.
European Journal of Clinical Nutrition
, 70
(6)
pp. 709-714.
10.1038/ejcn.2016.11.
|
|
Lelental, N;
Brandner, S;
Kofanova, O;
Blennow, K;
Zetterberg, H;
Andreasson, U;
Engelborghs, S;
... Lewczuk, P; + view all
(2016)
Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.
Journal of Alzheimer's Disease
, 52
(1)
pp. 51-64.
10.3233/JAD-150883.
|
|
|
Leuzy, A;
Chiotis, K;
Hasselbalch, SG;
Rinne, JO;
de Mendonca, A;
Otto, M;
Lleo, A;
... Nordberg, A; + view all
(2016)
Pittsburgh compound B imaging and cerebrospinal fluid amyloid-β in a multicentre European memory clinic study.
Brain
, 139
(9)
pp. 2540-2553.
10.1093/brain/aww160.
|
|
|
Lindstrom, J;
Grahn, A;
Zetterberg, H;
Studahl, M;
(2016)
Cerebrospinal fluid viral load and biomarkers of neuronal and glial cells in Ramsay Hunt syndrome.
European Journal of Neuroscience
, 44
(11)
pp. 2944-2949.
10.1111/ejn.13403.
|
|
Mattsson, N;
Insel, PS;
Palmqvist, S;
Portelius, E;
Zetterberg, H;
Weiner, M;
Blennow, K;
(2016)
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.
EMBO Molecular Medicine
, 8
(10)
pp. 1184-1196.
10.15252/emmm.201606540.
|
|
Mattsson, N;
Insel, PS;
Palmqvist, S;
Stomrud, E;
van Westen, D;
Minthon, L;
Zetterberg, H;
... Hansson, O; + view all
(2016)
Increased amyloidogenic APP processing in APOE ɛ4-negative individuals with cerebral β-amyloidosis.
Nature Communications
, 7
, Article 109. 10.1038/ncomms10918.
|
|
|
Mattsson, N;
Schott, JM;
Hardy, J;
Turner, MR;
Zetterberg, H;
(2016)
Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
Journal of Neurology, Neurosurgery and Psychiatry
, 87
(9)
pp. 1000-1004.
10.1136/jnnp-2015-311321.
|
|
|
Mattsson, N;
Zetterberg, H;
Janelidze, S;
Insel, PS;
Andreasson, U;
Stomrud, E;
Palmqvist, S;
... Investigators, ADNI; + view all
(2016)
Plasma tau in Alzheimer disease.
Neurology
, 87
(17)
pp. 1827-1835.
10.1212/WNL.0000000000003246.
|
|
|
Melah, KE;
Lu, SY-F;
Hoscheidt, SM;
Alexander, AL;
Adluru, N;
Destiche, DJ;
Carlsson, CM;
... Bendlin, BB; + view all
(2016)
Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease.
Journal Of Alzheimers Disease
, 50
(3)
pp. 873-886.
10.3233/JAD-150897.
|
|
|
Merisson, E;
Mattsson, N;
Zetterberg, H;
Blennow, K;
Pikwer, A;
Mehmedagic, I;
Acosta, S;
(2016)
Total-tau and neurofilament light in CSF reflect spinal cord ischaemia after endovascular aortic repair.
Neurochemistry International
, 93
pp. 1-5.
10.1016/j.neuint.2015.12.003.
|
|
|
Miller, A-M;
Rutkowska, A;
Bahl, JM;
Herukka, S-K;
Koel-Simmelink, MJA;
Kruse, N;
Mollenhauer, B;
... Lawlor, BA; + view all
(2016)
Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration.
Bioanalysis
, 8
(21)
pp. 2243-2254.
10.4155/bio-2016-0114.
|
|
Mollenhauer, B;
Zimmermann, J;
Sixel-Doering, F;
Focke, NK;
Wicke, T;
Ebentheuer, J;
Schaumburg, M;
... Trenkwalder, C; + view all
(2016)
Monitoring of 30 marker candidates in early Parkinson disease as progression markers.
Neurology
, 87
(2)
pp. 168-177.
10.1212/WNL.0000000000002651.
|
|
|
Murray, CE;
Gami, P;
Portelius, E;
Blennow, K;
Holton, J;
Zetterberg, H;
Revesz, T;
(2016)
Pathological differences observed in the presubiculum and entorhinal cortex in post-mortem Alzheimer's disease brain tissue.
In:
Proceedings of the 2016 Alzheimer’s Research UK Conference.
Alzheimer's Research UK: London, UK.
|
|
Öhrfelt, A;
Axelsson, M;
Malmeström, C;
Novakova, L;
Heslegrave, A;
Blennow, K;
Lycke, J;
(2016)
Soluble TREM-2 in cerebrospinal fluid from patients with multiple sclerosis treated with natalizumab or mitoxantrone.
Multiple Sclerosis Journal
, 22
(12)
pp. 1587-1595.
10.1177/1352458515624558.
|
|
|
Ohrfelt, A;
Brinkmalm, A;
Dumurgier, J;
Brinkmalm, G;
Hansson, O;
Zetterberg, H;
Bouaziz-Amar, E;
... Blennow, K; + view all
(2016)
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease.
Alzheimer's Research & Therapy
, 8
, Article 41. 10.1186/s13195-016-0208-8.
|
|
Öhrfelt, A;
Johansson, P;
Wallin, A;
Andreasson, U;
Zetterberg, H;
Blennow, K;
Svensson, J;
(2016)
Increased Cerebrospinal Fluid Levels of Ubiquitin Carboxyl-Terminal Hydrolase L1 in Patients with Alzheimer's Disease.
Dementia and Geriatric Cognitive Disorders Extra
, 6
(2)
pp. 283-294.
10.1159/000447239.
|
|
|
Oliver, JM;
Jones, MT;
Kirk, KM;
Gable, DA;
Repshas, JT;
Johnson, TA;
Andreasson, U;
... Zetterberg, H; + view all
(2016)
Serum Neurofilament Light in American Football Athletes over the Course of a Season.
Journal of Neurotrauma
, 33
(19)
pp. 1784-1789.
10.1089/neu.2015.4295.
|
|
|
Oliver, JM;
Jones, MT;
Kirk, KM;
Gable, DA;
Repshas, JT;
Johnson, TA;
Andreasson, U;
... Zetterberg, H; + view all
(2016)
Effect of Docosahexaenoic Acid on a Biomarker of Head Trauma in American Football.
Medicine & Science in Sports & Exercise
, 48
(6)
pp. 974-982.
10.1249/MSS.0000000000000875.
|
|
|
Olsson, B;
Blennow, K;
Zetterberg, H;
(2016)
The clinical value of fluid biomarkers for dementia diagnosis reply.
[Letter].
Lancet Neurology
, 15
(12)
pp. 1204-1205.
10.1016/S1474-4422(16)30247-2.
|
|
|
Olsson, B;
Lautner, R;
Andreasson, U;
Ohrfelt, A;
Portelius, E;
Bjerke, M;
Holtta, M;
... Zetterberg, H; + view all
(2016)
CSF and blood biomarkers for the diagnosis of Alzheimer's disease: a systematic review and meta-analysis.
The Lancet Neurology
, 15
(7)
pp. 673-684.
10.1016/s1474-4422(16)00070-3.
|
|
|
Osorio, RS;
Ducca, EL;
Wohlleber, ME;
Tanzi, EB;
Gumb, T;
Twumasi, A;
Tweardy, S;
... de Leon, MJ; + view all
(2016)
Orexin-A is Associated with Increases in Cerebrospinal Fluid Phosphorylated-Tau in Cognitively Normal Elderly Subjects.
Sleep
, 39
(6)
pp. 1253-1260.
10.5665/sleep.5846.
|
|
Padayachee, ER;
Zetterberg, H;
Portelius, E;
Boren, J;
Molinuevo, JL;
Andreasen, N;
Cukalevski, R;
... Andreasson, U; + view all
(2016)
Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele.
Brain Research
, 1651
pp. 11-16.
10.1016/j.brainres.2016.09.022.
|
|
|
Pannee, J;
Portelius, E;
Minthon, L;
Gobom, J;
Andreasson, U;
Zetterberg, H;
Hansson, O;
(2016)
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET.
Journal of Neurochemistry
, 139
(4)
pp. 651-658.
10.1111/jnc.13838.
|
|
Paterson, RW;
Heywood, WE;
Heslegrave, AJ;
Magdalinou, NK;
Andreasson, U;
Sirka, E;
Bliss, E;
... Schott, JM; + view all
(2016)
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology.
Translational Psychiatry
, 6
, Article e952. 10.1038/tp.2016.194.
|
|
|
Pomara, N;
Bruno, D;
Osorio, RS;
Reichert, C;
Nierenberg, J;
Sarreal, AS;
Hernando, RT;
... Blennow, K; + view all
(2016)
State-dependent alterations in cerebrospinal fluid A42 levels in cognitively intact elderly with late-life major depression.
NeuroReport
, 27
(14)
pp. 1068-1071.
10.1097/WNR.0000000000000658.
|
|
Portelius, E;
Durieu, E;
Bodin, M;
Cam, M;
Pannee, J;
Leuxe, C;
Mabondzo, A;
... Meijer, L; + view all
(2016)
Specific triazine herbicides induce amyloid β42 production.
Journal of Alzheimer's Disease
, 54
(4)
pp. 1593-1605.
10.3233/JAD-160310.
|
|
|
Racine, AM;
Clark, LR;
Berman, SE;
Koscik, RL;
Mueller, KD;
Norton, D;
Nicholas, CR;
... Johnson, SC; + view all
(2016)
Associations between Performance on an Abbreviated CogState Battery, Other Measures of Cognitive Function, and Biomarkers in People at Risk for Alzheimer's Disease.
Journal of Alzheimer's Disease
, 54
(4)
pp. 1395-1408.
10.3233/JAD-160528.
|
|
|
Racine, AM;
Koscik, RL;
Berman, SE;
Nicholas, CR;
Clark, LR;
Okonkwo, OC;
Rowley, HA;
... Johnson, SC; + view all
(2016)
Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.
Brain
, 139
(8)
pp. 2261-2274.
10.1093/brain/aww142.
|
|
Remnestal, J;
Just, D;
Mitsios, N;
Fredolini, C;
Mulder, J;
Schwenk, JM;
Uhlen, M;
... Haggmark-Manberg, A; + view all
(2016)
CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease.
Proteomics Clinical Applications
, 10
(12)
pp. 1242-1253.
10.1002/prca.201500150.
|
|
|
Rodrigues, FB;
Byrne, L;
McColgan, P;
Robertson, N;
Tabrizi, SJ;
Leavitt, BR;
Zetterberg, H;
(2016)
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease.
Journal of Neurochemistry
, 139
(1)
pp. 22-25.
10.1111/jnc.13719.
|
|
Rodrigues, FB;
Byrne, LM;
McColgan, P;
Robertson, N;
Tabrizi, SJ;
Zetterberg, H;
Wild, EJ;
(2016)
Cerebrospinal Fluid Inflammatory Biomarkers Reflect Clinical Severity in Huntington's Disease.
PLOS ONE
, 11
(9)
, Article e0163479. 10.1371/journal.pone.0163479.
|
|
Rohrer, JD;
Woollacott, IOC;
Dick, KM;
Brotherhood, E;
Gordon, E;
Fellows, A;
Toombs, J;
... Zetterberg, H; + view all
(2016)
Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia.
NEUROLOGY
, 87
(13)
pp. 1329-1336.
10.1212/WNL.0000000000003154.
|
|
|
Rojas, JC;
Karydas, A;
Bang, J;
Tsai, RM;
Blennow, K;
Liman, V;
Kramer, JH;
... Boxer, AL; + view all
(2016)
Plasma neurofilament light chain predicts progression in progressive supranuclear palsy.
Annals of Clinical and Translational Neurology
, 3
(3)
pp. 216-225.
10.1002/acn3.290.
|
|
|
Sandin, L;
Bergkvist, L;
Nath, S;
Kielkopf, C;
Janefjord, C;
Helmfors, L;
Zetterberg, H;
... Kagedal, K; + view all
(2016)
Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled in Drosophila melanogaster.
The FEBS Journal
, 283
(19)
pp. 3508-3522.
10.1111/febs.13830.
|
|
|
Sanfilippo, C;
Forlenza, O;
Zetterberg, H;
Blennow, K;
(2016)
Increased neurogranin concentrations in cerebrospinal fluid of Alzheimer's disease and in mild cognitive impairment due to AD.
Journal of Neural Transmission
, 123
(12)
pp. 1443-1447.
10.1007/s00702-016-1597-3.
|
|
Shahim, P;
Gren, M;
Liman, V;
Andreasson, U;
Norgren, N;
Tegner, Y;
Mattsson, N;
... Blennow, K; + view all
(2016)
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury.
Scientific Reports
, 6
, Article 367. 10.1038/srep36791.
|
|
|
Shahim, P;
Linemann, T;
Inekci, D;
Karsdal, MA;
Blennow, K;
Tegner, Y;
Zetterberg, H;
(2016)
Serum Tau Fragments Predict Return to Play in Concussed Professional Ice Hockey Players.
Journal of Neurotrauma
, 33
(22)
pp. 1995-1999.
10.1089/neu.2014.3741.
|
|
|
Shahim, P;
Tegner, Y;
Gustafsson, B;
Gren, M;
Arlig, J;
Olsson, M;
Lehto, N;
... Blennow, K; + view all
(2016)
Neurochemical Aftermath of Repetitive Mild Traumatic Brain Injury.
JAMA Neurology
, 73
(11)
pp. 1308-1315.
10.1001/jamaneurol.2016.2038.
|
|
Sjodin, S;
Ohrfelt, A;
Brinkmalm, G;
Zetterberg, H;
Blennow, K;
Brinkmalm, A;
(2016)
Targeting LAMP2 in human cerebrospinal fluid with a combination of immunopurification and high resolution parallel reaction monitoring mass spectrometry.
Clinical Proteomics
, 13
, Article 4. 10.1186/s12014-016-9104-2.
|
|
|
Skoog, I;
Horder, H;
Frandin, K;
Johansson, L;
Ostling, S;
Blennow, K;
Zetterberg, H;
(2016)
Association between APOE Genotype and Change in Physical Function in a Population-Based Swedish Cohort of Older Individuals Followed Over Four Years.
Frontiers in Aging Neuroscience
, 8
, Article 225. 10.3389/fnagi.2016.00225.
|
|
Stanne, TM;
Aberg, ND;
Nilsson, S;
Jood, K;
Blomstrand, C;
Andreasson, U;
Blennow, K;
... Jern, C; + view all
(2016)
Low Circulating Acute Brain-Derived Neurotrophic Factor Levels Are Associated With Poor Long-Term Functional Outcome After Ischemic Stroke.
Stroke
, 47
(7)
pp. 1943-1945.
10.1161/STROKEAHA.115.012383.
|
|
Steinacker, P;
Blennow, K;
Halbgebauer, S;
Shi, S;
Ruf, V;
Oeckl, P;
Giese, A;
... Otto, M; + view all
(2016)
Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease.
Scientific Reports
, 6
, Article 38737. 10.1038/srep38737.
|
|
|
Suarez-Calvet, M;
Kleinberger, G;
Caballero, MAA;
Brendel, M;
Rominger, A;
Alcolea, D;
Fortea, J;
... Haass, C; + view all
(2016)
sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers.
EMBO Molecular Medicine
, 8
(5)
pp. 466-476.
10.15252/emmm.201506123.
|
|
|
Sun, X;
Dong, C;
Levin, B;
Crocco, E;
Loewenstein, D;
Zetterberg, H;
Blennow, K;
(2016)
APOE epsilon 4 carriers may undergo synaptic damage conferring risk of Alzheimer's disease.
Alzheimer's & Dementia
, 12
(11)
pp. 1159-1166.
10.1016/j.jalz.2016.05.003.
|
|
Varga, AW;
Wohlleber, ME;
Gimenez, S;
Romero, S;
Alonso, JF;
Ducca, EL;
Kam, K;
... Osorio, RS; + view all
(2016)
Reduced Slow-Wave Sleep Is Associated with High Cerebrospinal Fluid A beta 42 Levels in Cognitively Normal Elderly.
Sleep
, 39
(11)
pp. 2041-2048.
10.5665/sleep.6240.
|
|
|
Voevodskaya, O;
Sundgren, PC;
Strandberg, O;
Zetterberg, H;
Minthon, L;
Blennow, K;
Wahlund, L-O;
... Hansson, O; + view all
(2016)
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease.
Neurology
, 86
(19)
pp. 1754-1761.
10.1212/WNL.0000000000002672.
|
|
|
Wang, J;
Cunningham, R;
Zetterberg, H;
Asthana, S;
Carlsson, C;
Okonkwo, O;
Li, L;
(2016)
Label-free quantitative comparison of cerebrospinal fluid glycoproteins and endogenous peptides in subjects with Alzheimer's disease, mild cognitive impairment, and healthy individuals.
PROTEOMICS - Clinical Applications
, 10
(12)
pp. 1225-1241.
10.1002/prca.201600009.
|
|
Weston, PS;
Paterson, RW;
Dickson, J;
Barnes, A;
Bomanji, JB;
Kayani, I;
Lunn, MP;
... Schott, JM; + view all
(2016)
Diagnosing Dementia in the Clinical Setting: Can Amyloid PET Provide Additional Value Over Cerebrospinal Fluid?
Journal of Alzheimer's Disease
, 54
(4)
pp. 1297-1302.
10.3233/JAD-160302.
|
|
Winblad, B;
Amouyel, P;
Andrieu, S;
Ballard, C;
Brayne, C;
Brodaty, H;
Cedazo-Minguez, A;
... Zetterberg, H; + view all
(2016)
Defeating Alzheimer's disease and other dementias: a priority for European science and society.
The Lancet Neurology
, 15
(5)
pp. 455-532.
10.1016/S1474-4422(16)00062-4.
|
|
|
Wright, PW;
Pyakurel, A;
Vaida, FF;
Price, RW;
Lee, E;
Peterson, J;
Fuchs, D;
... Ances, BM; + view all
(2016)
Putamen volume and its clinical and neurological correlates in primary HIV infection.
AIDS
, 30
(11)
pp. 1789-1794.
10.1097/QAD.0000000000001103.
|
|
|
Yang, Y;
Tullberg, M;
Mehlig, K;
Rosengren, A;
Toren, K;
Zetterberg, H;
Wikkelso, C;
(2016)
The APOE Genotype in Idiopathic Normal Pressure Hydrocephalus.
PLOS One
, 11
(7)
, Article e0158985. 10.1371/journal.pone.0158985.
|
|
|
Zetterberg, H;
(2016)
Neurofilament Light: A Dynamic Cross-Disease Fluid Biomarker for Neurodegeneration.
Neuron
, 91
(1)
pp. 1-3.
10.1016/j.neuron.2016.06.030.
|
|
Zetterberg, H;
Blennow, K;
(2016)
Fluid biomarkers for mild traumatic brain injury and related conditions.
Nature Reviews Neurology
, 12
(10)
pp. 563-574.
10.1038/nrneurol.2016.127.
|
|
|
Zetterberg, H;
Brinkmalm, A;
(2016)
alpha-Synuclein in Neurodegeneration-A Good Protein that may go Bad.
Brain Pathology
, 26
(3)
pp. 387-388.
10.1111/bpa.12372.
|
|
Zetterberg, H;
Morris, HR;
Hardy, J;
Blennow, K;
(2016)
Update on fluid biomarkers for concussion.
Concussion
, 1
(3)
, Article CNC12. 10.2217/cnc-2015-0002.
|
|
Zettergren, A;
Kern, S;
Gustafson, D;
Gudmundsson, P;
Sigstrom, R;
Ostling, S;
Eriksson, E;
... Skoog, I; + view all
(2016)
The ACE Gene Is Associated with Late-Life Major Depression and Age at Dementia Onset in a Population-Based Cohort.
American Journal of Geriatric Psychiatry
, 25
(2)
pp. 170-177.
10.1016/j.jagp.2016.06.009.
|
2015
|
Cummings, DM;
Liu, W;
Portelius, E;
Bayram, S;
Yasvoina, M;
Ho, SH;
Smits, H;
... Edwards, FA; + view all
(2015)
First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
Brain
, 138
(7)
1992 - 2004.
10.1093/brain/awv127.
|
|
|
Guerreiro, R;
Bras, J;
Toombs, J;
Heslegrave, A;
Hardy, J;
Zetterberg, H;
(2015)
Genetic Variants and Related Biomarkers in Sporadic Alzheimer's Disease.
Curr Genet Med Rep
, 3
19 - 25.
10.1007/s40142-014-0062-6.
|
|
|
Heywood, WE;
Galimberti, D;
Bliss, E;
Sirka, E;
Paterson, RW;
Magdalinou, NK;
Carecchio, M;
... Mills, K; + view all
(2015)
Identification of novel CSF biomarkers for neurodegeneration and their validation by a high-throughput multiplexed targeted proteomic assay.
Molecular Neurodegeneration
, 10
, Article 64. 10.1186/s13024-015-0059-y.
|
|
|
Kvartsberg, H;
Portelius, E;
Andreasson, U;
Brinkmalm, G;
Hellwig, K;
Lelental, N;
Kornhuber, J;
... Lewczuk, P; + view all
(2015)
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer's disease patients and healthy controls.
Alzheimer's Research & Therapy
, 7
, Article 40. 10.1186/s13195-015-0124-3.
|
|
|
Ling, H;
Hardy, J;
Zetterberg, H;
(2015)
Neurological consequences of traumatic brain injuries in sports.
Molecular and Cellular Neuroscience
, 66
(B)
pp. 114-122.
10.1016/j.mcn.2015.03.012.
|
|
|
Paterson, RW;
Toombs, J;
Chapman, MD;
Nicholas, JM;
Heslegrave, AJ;
Slattery, CF;
Foulkes, AJM;
... Schott, JM; + view all
(2015)
Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring
, 1
(3)
pp. 380-384.
10.1016/j.dadm.2015.06.003.
|
|
|
Weston, PS;
Paterson, RW;
Modat, M;
Burgos, N;
Cardoso, MJ;
Magdalinou, N;
Lehmann, M;
... Schott, JM; + view all
(2015)
Using florbetapir positron emission tomography to explore cerebrospinal fluid cut points and gray zones in small sample sizes.
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
, 1
(4)
pp. 440-446.
10.1016/j.dadm.2015.10.001.
|
|
|
Wild, EJ;
Boggio, R;
Langbehn, D;
Robertson, N;
Haider, S;
Miller, JR;
Zetterberg, H;
... Weiss, A; + view all
(2015)
Quantification of mutant huntingtin protein in cerebrospinal fluid from Huntington's disease patients.
J Clin Invest
10.1172/JCI80743.
|
|
2014
|
Ahmed, RM;
Paterson, RW;
Warren, JD;
Zetterberg, H;
O'Brien, JT;
Fox, NC;
Halliday, GM;
(2014)
Biomarkers in dementia: clinical utility and new directions.
J Neurol Neurosurg Psychiatry
, 85
(12)
1426 - 1434.
10.1136/jnnp-2014-307662.
|
|
|
Bras, J;
Guerreiro, R;
Darwent, L;
Parkkinen, L;
Ansorge, O;
Escott-Price, V;
Hernandez, DG;
... Hardy, J; + view all
(2014)
Genetic analysis implicates APOE, SNCA and suggests lysosomal dysfunction in the etiology of dementia with Lewy bodies.
Hum Mol Genet
, 23
(23)
6139 - 6146.
10.1093/hmg/ddu334.
|
|
|
Magdalinou, N;
Lees, AJ;
Zetterberg, H;
(2014)
Cerebrospinal fluid biomarkers in parkinsonian conditions: an update and future directions.
Journal of Neurology, Neurosurgery & Psychiatry
, 85
(10)
pp. 1065-1075.
10.1136/jnnp-2013-307539.
|
|
|
Paterson, RW;
Bartlett, JW;
Blennow, K;
Fox, NC;
Shaw, LM;
Trojanowski, JQ;
Zetterberg, H;
(2014)
Cerebrospinal fluid markers including trefoil factor 3 are associated with neurodegeneration in amyloid-positive individuals.
Transl Psychiatry
, 4
, Article e419. 10.1038/tp.2014.58.
|
|
|
Toombs, J;
Paterson, RW;
Schott, JM;
Zetterberg, H;
(2014)
Amyloid-beta 42 adsorption following serial tube transfer.
ALZHEIMERS RESEARCH & THERAPY
, 6
(1)
10.1186/alzrt236.
|
|
von Otter, M;
Bergström, P;
Quattrone, A;
De Marco, EV;
Annesi, G;
Söderkvist, P;
Wettinger, SB;
... Zetterberg, H; + view all
(2014)
Genetic associations of Nrf2-encoding NFE2L2 variants with Parkinson's disease - a multicenter study.
BMC Medical Genetics
, 15
, Article 131. 10.1186/s12881-014-0131-4.
|
2013
|
Hölttä, M;
Hansson, O;
Andreasson, U;
Hertze, J;
Minthon, L;
Nägga, K;
Andreasen, N;
... Blennow, K; + view all
(2013)
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease.
PLoS One
, 8
(6)
, Article e66381. 10.1371/journal.pone.0066381.
|
|
|
Meredith, JE;
Sankaranarayanan, S;
Guss, V;
Lanzetti, AJ;
Berisha, F;
Neely, RJ;
Slemmon, JR;
... Albright, CF; + view all
(2013)
Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer's Disease.
PLoS One
, 8
(10)
, Article e76523. 10.1371/journal.pone.0076523.
|
|
2012
|
Bendlin, BB;
Carlsson, CM;
Johnson, SC;
Zetterberg, H;
Blennow, K;
Willette, AA;
Okonkwo, OC;
... Sager, MA; + view all
(2012)
CSF T-Tau/Aβ42 predicts white matter microstructure in healthy adults at risk for Alzheimer's disease.
PLoS One
, 7
(6)
, Article e37720. 10.1371/journal.pone.0037720.
|
|
|
Hölttä, M;
Zetterberg, H;
Mirgorodskaya, E;
Mattsson, N;
Blennow, K;
Gobom, J;
(2012)
Peptidome analysis of cerebrospinal fluid by LC-MALDI MS.
PLoS One
, 7
(8)
, Article e42555. 10.1371/journal.pone.0042555.
|
|
|
Mattsson, N;
Rajendran, L;
Zetterberg, H;
Gustavsson, M;
Andreasson, U;
Olsson, M;
Brinkmalm, G;
... Portelius, E; + view all
(2012)
BACE1 inhibition induces a specific cerebrospinal fluid β-amyloid pattern that identifies drug effects in the central nervous system.
PLoS One
, 7
(2)
, Article e31084. 10.1371/journal.pone.0031084.
|
|
|
Neselius, S;
Brisby, H;
Theodorsson, A;
Blennow, K;
Zetterberg, H;
Marcusson, J;
(2012)
CSF-biomarkers in Olympic boxing: diagnosis and effects of repetitive head trauma.
PLoS One
, 7
(4)
, Article e33606. 10.1371/journal.pone.0033606.
|
|
|
Palmqvist, S;
Hertze, J;
Minthon, L;
Wattmo, C;
Zetterberg, H;
Blennow, K;
Londos, E;
(2012)
Comparison of brief cognitive tests and CSF biomarkers in predicting Alzheimer's disease in mild cognitive impairment: six-year follow-up study.
PLoS One
, 7
(6)
, Article e38639. 10.1371/journal.pone.0038639.
|
|
|
Petkova, VI;
Zetterberg, H;
Ehrsson, HH;
(2012)
Rubber hands feel touch, but not in blind individuals.
PLoS One
, 7
(4)
, Article e35912. 10.1371/journal.pone.0035912.
|
|
|
Pillai, A;
Bruno, D;
Sarreal, AS;
Hernando, RT;
Saint-Louis, LA;
Nierenberg, J;
Ginsberg, SD;
... Buckley, PF; + view all
(2012)
Plasma BDNF levels vary in relation to body weight in females.
PLoS One
, 7
(7)
, Article e39358. 10.1371/journal.pone.0039358.
|
|
2011
|
Zetterberg, H;
Mörtberg, E;
Song, L;
Chang, L;
Provuncher, GK;
Patel, PP;
Ferrell, E;
... Blennow, K; + view all
(2011)
Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans.
PLoS One
, 6
(12)
, Article e28263. 10.1371/journal.pone.0028263.
|
|
2010
|
Gao, CM;
Yam, AY;
Wang, X;
Magdangal, E;
Salisbury, C;
Peretz, D;
Zuckermann, RN;
... Allauzen, S; + view all
(2010)
Aβ40 oligomers identified as a potential biomarker for the diagnosis of Alzheimer's disease.
PLoS One
, 5
(12)
, Article e15725. 10.1371/journal.pone.0015725.
|
|
2009
|
Buchhave, P;
Blennow, K;
Zetterberg, H;
Stomrud, E;
Londos, E;
Andreasen, N;
Minthon, L;
(2009)
Longitudinal study of CSF biomarkers in patients with Alzheimer's disease.
PLoS One
, 4
(7)
, Article e6294. 10.1371/journal.pone.0006294.
|
|
